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ABSTRACT 
Non-completion of tuberculosis (TB) treatment has been a major topic of debate ever 
since combined drug therapy started to be used. It has threatened global TB control 
and posed a challenge to many National TB Programmes (NTPs) especially in 
developing countries where the burden of TB is highest and the poor are worst hit. 
As a means of controlling TB, WHO advocated a strategy branded as DOTS, which 
includes direct observation of treatment (DOT). Many countries have implemented 
DOTS, so DOT has become a central component of NTPs’ TB control strategy. 
DOTS as a comprehensive package was shown to be successful in many countries: 
however, this success over-credited the direct observation component, which led to a 
focus on the concept of TB treatment completion. The Nepal NTP implemented 
DOTS in the late 1990s and has achieved high treatment success rates under DOTS, 
but has not been exempted from the debate. There have been many studies which 
have identified the need to minimise non-completion as vital to controlling TB: 
however, few have considered how non-completion could be tackled through 
establishing locally feasible patient-centred care within existing TB control 
procedures. 
The overall aim of my study was, therefore, to gain a better understanding of 
experiences and issues faced by People Living with TB (PLTB) during the course of 
TB treatment under DOTS and identify appropriate ways of addressing the issues 
identified in the context of the NTP in urban setting in Kathmandu, Nepal.. The 
study used a qualitative research approach to investigate why and how different 
factors hindered or facilitated successful completion of TB treatment in an urban TB 
control setting in Nepal. The study used semi-structured qualitative interviews (49), 
focus group discussions (6) and observation techniques to generate data and a 
content analysis approach to analyse the data. Study respondents were PLTB; family 
members of PLTB; health care providers, NTP officials and community members.  
My study shows that, as defined by the NTP, successful completion of TB treatment 
was not straightforward for PLTBs. PLTBs underwent TB treatment in very difficult 
circumstances, as various obstacles to successful TB treatment completion 
complicated the treatment process and thus made PLTBs and their families further 
vulnerable. Obstacles arising from causes related to the health system had a greater 
impact on PLTBs and their families than obstacles arising from causes related to the 
PLTBs.  
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My study also shows that, in the face of mounting difficulties faced by PLTBs and 
their families during the course of treatment, PLTBs' families’ untiring efforts and 
support greatly facilitated the treatment process, regardless of family circumstances. 
This support occurred not only during the illness but beyond the period of treatment, 
despite the devastating impact of TB on the entire family. This finding highlights the 
need to redefine the role of family members in PLTBs' treatment: this has been 
overlooked in many NTPs.  
Arising from my findings, I identify key prerequisites for successful treatment 
completion: appropriate, affordable access to TB services; affordable care; 
appropriate responses to problems; appropriate socio-cultural responses; supervision 
and patient support; appropriate interpersonal communication; care with respect and 
dignity; individual privacy; and mutually beneficial relationships. Finally, I propose 
an implementation framework to establish patient-centred care. I believe that these 
key prerequisites would greatly reduce the burden on PLTBs’ and families’ 
experiences during TB treatment, and thus facilitate successful TB treatment 
completion in the context of urban TB control in Nepal.  
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CHAPTER ONE 
ORIENTATION OF THE STUDY 
1.1 Introduction 
This chapter introduces my thesis. It describes the background of the research problem 
and the rationale of performing the study. It also describes the key terms used in the 
study and presents the overall structure of the thesis. 
1.2 Background to the research problem 
Tuberculosis (TB) is a disease as old as humankind, and by now it should belong to 
the past, as it is a bacterial disease and is curable with antimicrobial drugs. 
Nonetheless, TB remains a unique pandemic. In 2010, there were 8.8 million (range, 
8.5–9.2 million) incident cases of TB, 1.1 million (range, 0.9–1.2 million) deaths from 
TB among HIV-negative people and an additional 0.35 million (range, 0.32–0.39 
million) deaths from HIV-associated TB globally (WHO, 2011).  The vast majority of 
deaths occur in developing countries: the poor are worst hit by the disease (Dye, 
2006). 
Despite several attempts to control TB, and advances in medical science, TB remains 
a major threat to the global community. In the early 1990s, the World Health 
Organisation (WHO) declared TB to be a global emergency. As a response to this 
emergency, WHO recommended the use of the DOTS (Directly Observed Therapy – 
Short Course) strategy. This strategy consists of five key components including a 
standardised ‘short’ course of treatment lasting six to eight months (WHO, 2002). One 
of the components of DOTS is direct observation of therapy (DOT) which requires 
every dose of TB treatment to be directly observed, either by a health worker or 
someone nominated by a health worker; the person observing treatment is often 
known as a DOT provider or treatment supervisor. DOT is intended to help identify 
People living with TB (PLTB) who miss treatment and encourage them to continue 
treatment (WHO, 2003b), and also to help prevent the development of TB bacteria 
that are resistant to rifampicin, the main anti-TB drug (Enerson et al., 2000).  
However, the benefits and costs of DOT to health services and patients are complex, 
potentially causing both positive and negative effects on treatment outcomes, and thus 
this approach to TB treatment delivery has been the subject of much debate (Volmink 
and Garner, 1997; Walley et al., 2001; Zwarenstein et al., 1998; Newell et al., 2006). 
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DOT has been widely used by NTPs across the developing world, and DOTS has 
shown high treatment success rates (WHO, 2003b). However, the question remains: is 
DOT essential for the success of the DOTS strategy, or would implementation of 
DOTS without DOT also achieve high treatment success rates? The answer is not 
straightforward. However, a Cochrane review of randomised controlled trials 
conducted in low, middle and high income countries concluded that, when all other 
elements of the DOTS strategy were in place, treatment outcomes (cure or treatment 
success) were similar whether DOT or self-administered treatment were used 
(Volmink and Garner, 2007).  
The necessity of using DOT in TB treatment was further argued across the medical 
and social sciences. In many instances the debate was centred on differing beliefs in 
the roles of 'science' and evidence (Harper, 2006). A review by Noyes and Popay 
(2007) pointed that instead of prescribing DOT to all PLTBs, a focus was needed on 
the impact of measures (such as DOT) that cause obstacles to PLTB during TB 
treatment. Similarly, a review of qualitative studies on TB treatment adherence by 
Munro et al. (2007) suggested that the focus needs to shift towards establishing 
patient-centred interventions; and that this will require structural obstacles (which may 
be caused by economic, social, policy, organisational and environmental factors) to be 
addressed. 
WHO's Stop TB Strategy, launched in 2006, builds on the foundation of DOTS. To 
some extent it acknowledges the DOT controversy, by introducing some flexibility on 
TB treatment delivery modalities. It emphasises the need for 'supervised treatment, 
which may have to include DOT', (p.10; my emphasis), a move away from mandatory 
provision of DOT. This is a welcome shift. The phrase 'supervision and patient 
support' indicates a desire for patient-centred care in TB control, but is rather unclear. 
This may have been intentional to give more scope for local NTPs to define 
'supervision and patient support' in the light of the contexts in which they operate. 
Questions remain, however, as to whether NTPs have properly thought about what 
changes they should make to their traditional practice of DOT. 
Nonetheless, despite various interventions aimed at improving treatment completion, 
non-completion of TB treatment has been a major obstacle to effective TB control (Jin 
et al., 1993; Chaulet, 1990). Cuneo and Snider (1989) note that up to half of all TB 
patients do not complete the full course of TB treatment. Failure to complete TB 
treatment can lead to prolonged infectiousness, development of drug resistance, 
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relapse, and death. Poor completion of treatment thus poses a serious risk not only for 
the individual but also for the community. There are various reasons why PLTBs fail 
to complete the prescribed course of TB treatment. Non-completion is a multifaceted 
issue determined by the interplay of multiple factors, which I discuss in chapter three. 
There has been little research to understand non-completion that leads to strategies to 
improve treatment completion, as few researchers have looked at treatment 
completion from the perspective of TB patients, and the explanations for non-
completion do not in general inform the design of strategies that could enable patients 
to stay on treatment (Donovan, 1995; Lassen, 1998). This demonstrates a need for 
greater efforts to broaden our understanding of treatment completion, which will lead 
to development of context-specific measures to address the complex issues affecting 
treatment completion (Munro et al., 2007). The absence of in-depth understanding 
gained through appropriately designed research presents major challenges to NTPs.  
1.3 Problem statement 
In Nepal, DOTS implementation started in the late 1990s, and covered the nation by 
mid-2001, since then DOT has remained a central element of the Nepal TB control 
strategy. The NTP achieves high treatment success rates with DOTS: however, case 
detection in urban areas is far below the national figure of 70% detection of estimated 
new cases (NTP, 2008/09). The NTP interpretation of DOT is quite rigid in both rural 
and urban areas, and this can make it difficult for PLTBs to continue their treatment. 
Poor people, and in particular the urban poor, face a major and multiple challenges. It 
seems that the NTP is satisfied with the current achievement of high treatment 
success, and is shifting its focus towards case detection, rather than managing TB 
cases by establishing a patient-centred approach within the programme. However, 
since the NTP adopted WHO's Stop TB strategy, the International Standards for 
Tuberculosis Care (ISTC) and the Patients’ Charter for Tuberculosis Care, it has 
become increasingly important to develop an enabling environment for PLTB to 
successfully complete TB treatment through fostering patient-centred care. These 
international documents place emphasis on context-specific quality delivery of TB 
services, with a central focus on PLTBs. However, the NTP has not properly 
considered the need to shift from the traditional way of delivering TB services 
including the mandatory requirement for institutional DOT. Experts have proposed 
various reasons for this: it could be that there is not sufficient knowledge on how to 
develop a patient-centred approach in the programme; or that the NTP fears changing 
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its practices in the light of contemporary knowledge and locally generated evidence 
due to lack of resources; it could be because the NTP is not yet prepared for change; 
or it could be the NTP feels no change is required as it already achieves high treatment 
success rates, or financial implications of the change to the programme. Whatever the 
reason, sooner or later the NTP must align its TB service delivery in accordance with 
contemporary knowledge towards a more patient-centred care. 
In the context of the NTP's urban TB control programme, there is not yet a clear 
understanding of issues relating to successful TB treatment completion. Although TB 
treatment completion rates remain high in urban areas, it is unclear whether and to 
what extent PLTBs suffer during the course of TB treatment; at what cost treatment is 
continued; how to reduce the burden on PLTB during TB treatment; and whether there 
should be a context-specific patient-centred approach in the urban TB control 
programme to ensure current success is sustained. It is not straightforward to answer 
these questions. The lack of current knowledge in such areas strongly indicates the 
need for a study from the perspective of PLTBs which is qualitative in nature.  
Thus, taking the study context into account, my problem statement is: Despite high 
treatment success in the study area, many PLTBs face difficulties completing the full 
course of TB treatment. High treatment success rates may have been achieved at high 
cost to the PLTBs and their families. The NTP needs to have an explicit understanding 
of issues that hinder successful TB treatment completion, which would then enable it 
to design context-specific TB service delivery measures to reduce the burden on 
PLTB and their family members. There is also a need for the NTP to develop a 
patient-centred approach, following adoption of the Stop TB strategy, the ISTC and 
the Patient Charter for TB Care. 
1.4 My motivation in the study 
I received my community health worker training in general medicine in the 1990s and 
worked for more than 10 years in health service delivery as a government employee, 
mostly in peripheral health institutions in remote districts of Nepal. As a junior health 
worker, I had many opportunities to work with members of different communities 
across the social spectrum, and understand their health needs. However, my 
theoretical understanding of health issues and health service delivery was initially very 
bio-medical, and I had limited understanding of the public health aspects. 
Progressively, my practical experiences in community health interventions and my 
close working relationship with various public health scientists inspired me to pursue 
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a career in public health. As a result, I started working in communicable disease 
control programmes as an emerging public health professional and gradually 
developed my career as a researcher in public health.  
Prior to enrolling on the PhD programme I worked as a Research Assistant within the 
Nepal NTP, involved in two big research projects: action research on engaging the 
private sector in TB control, and a district randomised controlled trial comparing 
community and family based TB treatment delivery strategies in hard to access areas 
of Nepal. My exposure as a researcher in the NTP and interactions with people with 
TB and their family members, community members, programme managers and health 
service providers enabled me to understand issues relating to TB treatment, 
particularly non-completion, resulting in ongoing upheaval for families living with 
TB. Although the NTP was achieving a high treatment success rate overall, this 
seemed to be at substantial personal cost to patients. Similarly, I also observed that 
those failing to complete treatment were blamed for that failure, despite the ‘causes’ 
appearing to be their difficult living conditions, inappropriate TB service delivery 
provision under the DOTS framework and stigma and discrimination attached to TB 
disease and people with TB.  
I therefore became motivated to do further research using a qualitative approach to 
gain in-depth understanding of the problems and issues that people with TB were 
experiencing during the course of their treatment. Moreover, my motivation in this 
study was to identify locally feasible strategies to address the issues and problems 
using a patient friendly approach. The aim was to ensure successful TB treatment 
completion while reducing the burden on people with TB and their families, health 
systems, health services and communities. I hoped that the strategy would ultimately 
influence the NTP to establish a patient-centred approach in TB care.   
1.5 Study timeframe  
I was enrolled as a part-time provisional PhD candidate in December 2001 and 
transferred to a full PhD candidate in late 2003. My field research work was initiated 
in 2004, but was delayed for a year during a period of serious political instability in 
the country. In 2006 my field work recommenced and was completed by 2008. I 
worked full time as a Health Advisor with the Department for International 
Development (DfID) country office Nepal whilst analysing the data part-time over 
two years. 
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1.6 Concepts and definitions 
Below are some key terms and concepts that I used in the study as relevant.  
People Living with Tuberculosis (PLTB): a person with confirmed TB undergoing 
TB treatment is defined as PLTB for the study purpose. In general, such person is 
known as TB patient in the programme and recorded accordingly. I used this concept 
after my first interview respondent rejected the idea of being labelled as ‘TB patient’ 
which, in general, overlooked the human role on people and saw only as an ill person 
with no power. I have provided an explanation on why I used the concept of PLTB in 
the study in chapter four.  
Cured: a PLTB whose sputum smear (or culture) was positive at the beginning of the 
treatment but who was smear- or culture-negative in the last month of treatment and 
on at least one previous occasion. This definition is used in NTP to evaluate treatment 
outcome result of PLTB. 
Treatment completed: a PLTB who completed treatment but who does not have a 
negative sputum smear or culture result in the last month of treatment and on at least 
one previous occasion. The sputum examination may not have been done or the results 
may not be available. 
Treatment success: the sum of cured and treatment completed, the main outcome 
measure in national TB programmes .The distinction between cured and treatment 
completed is whether the patient had sputum checked at the end of treatment or not. 
Non-completion: PLTB registered for TB treatment in NTP fails to complete full 
course of treatment as recommended by the programme known as non-complier to TB 
treatment thus the condition is non-completion to TB treatment. It is an undesired 
condition which could arise as a result of various or a cause during TB treatment.   
Treatment discontinuation/interruption: a PLTB taking treatment under the 
programme who stops treatment or who takes TB drugs on and off. It can be difficult 
to differentiate between these two. However, NTP records on and off cases as ‘late 
patient’ and PLTB who discontinue treatment continuously for two months as 
‘defaulted’.  
Stakeholders or partners: In the study context, stakeholders are defined as 
individuals or institutions engaged in delivering TB services with a role. The concept 
defined here comes from an operational aspect of the programme: however, PLTB, 
their family members and community people should also be seen as key stakeholders 
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in the process of TB treatment but in the study they hold an independent identity thus 
not considered under the definition of stakeholders.  
National Tuberculosis Programme (NTP): countrywide programme for TB control 
which is led by the government and supported by other stakeholders including PLTB, 
their family and community. It is a priority programme of the Ministry of Health and 
Population in Nepal.   
Frontline Health Care Providers: those individuals working in TB control who 
interact with PLTB on a regular basis as part of their job responsibility in their 
working institutions. These people are the one who can provide day-to-day experience 
with TB and their family during TB treatment.  
1.7 Organisation of the thesis 
Chapter one introduces the thesis, and also gives a brief explanation of the research 
problem.   
Chapter two provides a historic overview of global TB prevention and control, along 
with a global synopsis of TB control measures. It also presents progress in TB control, 
with a focus on DOTS and the key challenges faced by developing countries, along 
with an account of Nepal's NTP and the features of TB services in urban settings of 
Nepal.  
Chapter three provides an understanding of the current body of knowledge with regard 
to TB treatment completion, with a focus on factors affecting continuation of TB 
treatment in developing country contexts. It provides the foundations of my study, 
analysing factors helping and hindering PLTBs during treatment and identifying gaps 
in our understanding of TB treatment completion. Finally, this chapter presents a 
theoretical understanding of the issue and a conceptual framework, which lead to the 
aim and objectives of my research. 
Chapter four describes the research design and methods that I used in the study along 
with detailed descriptions of data generation techniques, data sources, data analysis, 
the trustworthiness of the research process and findings, as well as limitations of the 
study and ethical considerations. 
Chapter five presents the study findings followed by initial discussions. It broadly 
examines the issues that hindered or helped successful completion of TB treatment 
from the perspectives of PLTB. The chapter is divided into two major sections: issues 
in successful treatment completion, and factors enabling treatment completion. 
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Chapter six presents further discussion of the key study findings. It also revisits the 
study aim and objectives, and the conceptual framework in the light of the study 
findings and the programme context, and concludes with further limitations of the 
study. 
Chapter seven, the final chapter, presents the conclusions of my study along with the 
policy implications of my study findings with a particular focus on urban TB control 
in Nepal. It also discusses a possible implementation framework for the revised 
conceptual framework of the study. The chapter gives brief information on the uptake 
of interim findings during the course of the study, and the contribution of this study to 
the wider body of knowledge relating to successful TB treatment completion, and 
concludes with suggestions for areas of research that may further advance successful 
TB treatment completion in the context of the Nepal NTP and elsewhere. 
1.8 Conclusions 
This chapter provided an overview of the problems and issues in TB treatment 
completion as a background to the research problem. It presented my motivation in the 
study topic, the study timeframe and the concepts and definitions used in the study. 
The chapter also provided an overview of each chapters of this thesis. The next 
chapter provides background information on: TB situation globally; historic overview 
of TB control approaches; issues and challenges in TB control, and an overview of 
health service delivery and TB control in Nepal. 
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CHAPTER TWO 
TB AND ITS CONTROL: REVIEW OF GLOBAL EVIDENCE 
AND THE NEPAL NTP 
This chapter starts with a historic overview of global TB prevention and control, 
describes epidemiology and gives a global synopsis of TB control measures. The 
chapter also presents progress in TB control with a focus on DOTS and discusses key 
challenges in TB control in the context of developing countries. It also gives an 
account of Nepal's National Health System and NTP along with features of TB 
services in urban settings with a focus on the study area, the Kathmandu Valley.  
2.1 TB: general introduction 
TB is a communicable disease affecting humans around the world, but primarily in the 
developing world. If untreated, it is generally deadly. TB is caused by various strains 
of mycobacteria, usually Mycobacterium tuberculosis in humans. It is transmitted 
through the air when people who have active pulmonary TB disease cough, sneeze or 
spit. Primary infection occurs when a person is exposed for the first time to 
tuberculosis bacilli, but not all people exposed will develop TB disease. The 
progression from infection to disease depends on the immune status of the infected 
person (Wilkinson et al, 1997).Of those who become infected, 10% to 12% will 
develop TB disease, over a period ranging from weeks to decades. However, if the 
infected person is immuno-compromised, the risk of developing active TB is as high 
as 50% (Grange, 1999; Rieder et al, 1999). Active TB can manifest in three forms: 
pulmonary sputum smear positive; pulmonary sputum smear negative; and 
extrapulmonary. Pulmonary TB is the most frequent form of the disease, occurring in 
over 80% of cases. If untreated, each person with pulmonary smear positive TB can 
infect on average 10 to 15 people a year, of which 6% to 10% people will themselves 
develop active TB (Styblo and Bumgarner, 1991). 
For diagnosis of pulmonary TB, use of direct sputum smear examination is considered 
thus generally recommended for TB control programmes. However, where resources 
are available, culture and drug sensitivity testing is also desirable. In addition, more 
high-tech molecular techniques of TB diagnosis such as polymerase chain reaction, 
DNA and RNA probes, are becoming available and are being tried in some developed 
countries. 
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2.2 TB and its control: historic overview 
TB disease is considered as old as the human race. TB is known to have a major 
impact on the health and development of people in many countries. Since the 
seventeenth century, treatment of TB has been a major concern. On 24th March 1882, 
the first real breakthrough was made in the history of TB control when Dr Robert 
Koch isolated the TB infectious agent, Mycobacterium tuberculosis, also known as the 
tubercle bacillus. Koch's discovery helped understanding of the communicable nature 
of the disease and provided a new insight into detecting TB. However, despite 
knowing its communicability nature and transmission route, prevention measures have 
not been successful and TB continues to be a leading infectious disease globally, but 
primarily in developing countries.  
In the early 20th century, treatment of TB patients usually involved bed rest, mostly in 
sanatoria. However, TB remained one of the most feared diseases of the human race 
as all efforts to control TB were ineffective and it continued to be a major public 
health threat in many countries (WHO, 1999). It was also widely believed that TB was 
associated with the supernatural, so its treatment included many superstitious practices 
(Davis, 2000). It is still the case and influence local ways of treating TB in some areas. 
2.3 Vaccine and chemotherapy: a new hope in TB control 
The development of Bacille Calmette-Guerin (BCG) vaccine in 1921 raised new 
hopes in TB control. The vaccine is the most widely used in humans: however, it was 
found to be ineffective in preventing the transmission of pulmonary TB but has been 
shown to be beneficial to infants, especially to prevent meningeal and disseminated 
forms of TB (Styblo and Meijer, 1976; Rodrigues et al, 1993). 
Despite the poor effectiveness of all identified measures, the hope of controlling TB 
has never died, and the search continued to find effective ways of controlling TB. 
Eventually, the chemotherapy era began with the discovery of Streptomycin in 1944 
which became available for wide use in 1946 (Hinshwa et al, 1946). However, its 
toxic effects, clinical deterioration, problems in completing therapy and increasing 
drug resistance threatened its wide use and efficacy (Medical Research Council, 
1948). However, no tangible progress was made in TB treatment until new antibiotics 
were first used between 1945 and 1960. 
In 1951, introduction of is nicotinic acid hydrazide (isoniazid) therapy was perceived 
as a 'miracle drug' for TB (Robitzek and Selikoff, 1954). A number of additional drug 
11 
 
trials during the 1950s and 1960s and their combined suggested that TB is treatable in 
outpatient hospital settings. Treatment was further simplified by the development of 
so-called short course chemotherapy (SCC) –usually nine months of treatment – in the 
1970s, which became more effective with introduction of rifampicin (1963); and the 
duration of SCC was further shortened to six months. Experts noted that SCC was not 
only effective, but the most cost-effective of all therapeutic interventions (Murray et 
al, 1996). However, further challenges arose as the TB bacillus developed resistance 
to anti-TB drugs. The unexpected resurgence of TB cases, especially in the late 1980s 
and early 1990s, dashed hopes of controlling TB in the near future.  
2.4 TB epidemiology: global scenario 
Despite the presence of diagnostic measures and highly cost-effective chemotherapy, 
the TB epidemic is on the rise, and continues to pose a threat not only to health but 
also overall development. One third of the world’s population is estimated to be 
infected with TB, and one in every ten of those infected carry a risk of developing TB 
disease in their lifetime (Kochi 1991; Raviglione et al, 1995). TB is among the leading 
infectious diseases with over nine million new TB cases worldwide each year (WHO, 
2006). In 2008, WHO estimated there were 139 TB cases per 100,000 population 
globally.  
Deaths due to TB are largely preventable; however, it is sometimes said to be the 
single biggest killer in the world, killing nearly two million people a year, or 5,000 
every day; the great majority of deaths are among poor communities in the developing 
world. It is a greater cause of adult deaths in the world than any other communicable 
disease (Kladaut, 1994; Mc Kinney et al, 1998), presenting an increasing threat to 
country economies. TB accounts for 2.8% of global disability adjusted life years 
(DALYs)
1
The burden of disease is largely born by developing countries where it is estimated 
that 98% of TB deaths and 95% of all TB cases occur (WHO, 2002). The South East 
Asia Region bears about 40% of the TB burden with around 5 million TB cases. 
Though TB deaths have declined over the years, the disease still claims more than 
 lost in all age groups and 7% to8% of all DALYs lost among those aged 
15-49 years. TB represents2.5% of the global burden of disease, ranking 7th among 
causes of global DALYs lost (Murray, 1996; WHO, 2006).  
                                                 
1Disability Adjusted Life Years – the sum of years of potential life lost due to premature mortality 
and the years of productive life lost weighted by disability and specific health conditions. 
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500,000 lives each year in the region. Globally, the problem of TB has become more 
challenging due to the spread of HIV infection, and the emergence of Multi Drug 
Resistant (MDR) TB. Grange (1999) noted that if global TB control efforts fail to 
bring fundamental changes to its epidemiology, the world will see a dramatic increase 
in the overall incidence and prevalence of disease, which can lead TB running out of 
control in many countries. 
2.5 Evolution of TB control approaches 
The devastating impact of TB has been from when it was first notified in humans. 
Since then, a number of prevention and control measures have been undertaken, but 
control efforts have not shown great success. However, with the discovery of TB 
chemotherapy and its use in outpatient settings, global TB control efforts moved 
towards the development of vertical TB programmes– a top-down approach to 
controlling TB (Raviglione and Pio, 2002) .By the late 1950s, it was realised that a 
vertical approach to TB control was not affordable by developing countries. With this 
realisation, global TB control actors demanded new approaches; as a result, several 
research studies were initiated to identify new approaches to fighting (Fox et al, 1999; 
Bayer and Wilkinson, 1995; Fox, 1958, 1962; Banerji, 1965; Raviglione and Pio, 
2002). Studies showed the possibility of a countrywide national programme to deliver 
TB services integrated into general health services. However, there was debate around 
whether integration of TB services into general health services should be limited to 
TB service delivery or should also include other managerial components that were 
vertically managed. To date, this debate has led to integration of a few TB services 
within general health services. However, integration was not sufficiently backed up by 
adequate resources or technical skills. In many developing countries such shortages 
lowered the profile of TB control programmes within general health services, so that 
the benefits of such partial integration to TB control were very limited (Raviglione et 
al, 1995; Raviglione and Pio, 2002).  
Gradually, the lesson was learned that new approaches and inventions in diagnostic 
measures and TB drugs would not make a difference to TB control in developing 
countries unless a good public health infrastructure was in place, and TB services 
were easily available, accessible and affordable to people suffering from TB. 
Furthermore, ensuring successful completion of prescribed chemotherapy by TB 
patients was a major issue in the national programmes in developing countries where 
medical, social and financial consequences of TB made people vulnerable to 
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unsuccessful treatment. The TB control community started to realise that TB is a 
social disease and tackling TB control only through medical advances alone was 
simply not possible (Zumla and Grange, 1998; Farmer, 1997; Benatar 1995). 
Finally, 111 years after the causative organism of TB was identified and half a century 
after the introduction of effective therapy, in 1993 the WHO publicly recognised, for 
the first time, that TB was a ‘global emergency’ (WHO, 1994) and recommended 
accelerating TB control efforts globally. This announcement generated a momentum 
and considerations were given to tackle other external societal factors of TB. 
2.5.1 DOTS: a global strategy to control TB 
In 1994, WHO introduced a new TB control strategy, officially branded as DOTS 
(Directly Observed treatment using Short course drugs) (WHO, 2002), to serve as the 
cornerstone of WHO’s Global TB Control Programme.  
Many observational studies in South Africa, China, Bangladesh, and elsewhere have 
shown successful results with DOTS (Enarson et al, 2000; Chowdhury et al, 1997; 
Wilkinson et al, 1996). Even though DOTS was accepted in principle, progress in 
implementation was relatively slow. In fact, almost a decade into DOTS, the 
percentage of infectious cases found and treated had climbed to only 23%. It became 
apparent by 1998 that the global targets of TB control (see Table 1) would not be 
achieved, so following a review of DOTS, the target year was postponed to 2005 
(WHO, 2000) . 
2005: World Health Assembly: 
To detect at least 70% of infectious TB cases 
To treat successfully at least 85% of detected cases 
Stop TB Partnership  
50% reduction in TB prevalence and death rates by 2015 
Millennium Development Goals (MDG) 2015  
Goal 6: Combat HIV/AIDS, malaria and other diseases 
Target 8: to have halted by 2015 and begun to reverse the incidence of HIV/AIDS, 
malaria and other diseases 
Indicator 23: prevalence and deaths associated with TB 
Indicator 24: proportion of TB cases detected and cured under DOTS 
 
  
Table 1: Global TB control targets 
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The DOTS strategy comprises five key elements: political commitment; quality-
assured sputum microscopy for TB diagnosis; standardised short-course chemotherapy 
with direct observation of treatment; regular drug supplies; and monitoring, recording 
and reporting, and supervision. I briefly describe these elements in the following 
sections. 
2.5.1.1 Political commitment 
Lessons from past TB control efforts make it evident that in the absence of strong 
political will, TB control cannot achieve its desired goal. The DOTS strategy strongly 
advocates for sustained political commitment from the government and individuals, 
and seeks to increase financial and human resources for TB control. Furthermore, it 
emphasises the need to make TB control a nationwide activity integrated within the 
general health system at all levels. Despite this call for political commitment, there 
continues to be only limited translation of political commitment into resource 
allocation to address financial and human resource constraints in TB control. 
2.5.1.2 Quality-assured sputum microscopy for TB diagnosis 
Sputum microscopy remains the first option recommended for TB diagnosis, but 
where available and affordable, culture and drug susceptibility testing (DST) is also 
desired. People with chest symptoms seeking care from general health care facilities 
need to be properly screened for TB and sent for sputum microscopy. This requires 
sputum microscopy services to be widely available and accessible to all patients who 
need the service.  
2.5.1.3 Short-course chemotherapy with direct observation of 
treatment  
All patients should be administered TB chemotherapy using DOT. DOT is defined as 
a process of observing TB patients taking their anti-TB drugs by a health care provider 
or a trained person accountable to the health service (WHO, 1997). WHO considers 
that DOT is the cause of the success of the DOTS strategy. It is recommended as a 
standard of care throughout TB treatment if the treatment regimen contains rifampicin 
(WHO, 1999; Bass 1994; Maher 1997; Chaulk 1998; Enarson 2000). However, DOT 
has been a contentious element of DOTS and there has been debate on its impact on 
achievement of successful completion of TB treatment and on case finding (Volmik 
1997, Volmik and Garner, 2003 and 2007; Walley et al, 2001; Zwarenstein et al, 
1998).  
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2.5.1.4 Regular drug supplies 
Uninterrupted availability of TB drugs at the point of TB service delivery at all levels 
is crucial for TB programmes. Without this, TB control is merely a dream. The DOTS 
strategy includes establishing and maintaining a system to supply all TB drugs to all 
service delivery points, driven by a system to forecast drug requirements based on 
case registration numbers. In many countries supply of TB drugs is being managed 
vertically and the introduction of Fixed Dose Combination (FDC) drugs has made the 
drug supply chain more effective. However, ensuring regular supply drugs across 
Nepal remains a major challenge, especially in remote areas with poor transport links.  
2.5.1.5 Monitoring, recording and reporting, and supervision 
Another important component of DOTS is ensuring effective monitoring, evaluation 
and supervision in NTP, with effective communication from central to periphery 
levels. This component requires the establishment and maintenance of a standardized 
recording and reporting system based on individual TB patient records to allow 
periodic assessment of treatment results. It is also important to have established 
supervision mechanisms at all levels to identify any problems arising during 
implementation. Many NTPs in developing countries have established a semi-vertical 
monitoring mechanism with routine cohort analysis of registered TB patients.   
2.5.2 The Global Plan to Stop TB and Stop TB strategy 
The second global stop TB plan (2006-2015), launched in 2006, primarily focuses on 
the actions and funding required achieving the global targets for TB control. Under the 
DOTS strategy nearly 20 million TB patients have completed TB treatment globally, 
the majority from developing countries. Despite this success story, global TB control 
faces several challenges. It was realised that on its own, DOTS, was insufficient to 
address challenges in TB control and achieve the TB-related MDG targets by 2015. 
WHO identified the need for a new strategy that builds on and goes beyond DOTS. As 
a result, in 2006 a new Stop TB Strategy was introduced (WHO, 2006), see Table 2. 
The new strategy emphasises equitable access to the highest quality of care for all TB 
patients and accelerating the progress and impact of TB control. In addition, it focuses 
on reducing families’ and communities’ suffering caused by TB and vulnerability to 
TB, TB/HIV and MDR-TB, and addressing health system issues that impede TB 
control. The aim of the strategy is to reduce deaths and disease, and meet the MDGs 
related to TB by 2015. 
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The foundation of the new Stop TB strategy remains DOTS. The strategy retains 
DOT, the widely-debated element of the DOTS strategy, stating that it helps to ensure 
treatment completion and prevent development of drug resistant TB. Although the 
new strategy refers to DOT along with ‘supervision and patient support’, it remains 
unclear what this means for TB patients and their families.  
VISION: A world free of TB 
GOAL: To dramatically reduce the global burden of TB by 2015 in line with the MDGs and the 
Stop TB Partnership targets 
OBJECTIVES 
- Achieve universal access to high-quality diagnosis and patient-centred treatment 
- Reduce the human suffering and socioeconomic burden associated with TB 
- Protect poor and vulnerable populations from TB, TB/HIV, and MDR-TB 
- Support development of new tools and enable their timely and effective use 
TARGETS : MDG 6, Target 8 
- Halt and begin to reverse the incidence of TB by 2015 
Targets endorsed by Stop TB Partnership 
- By 2005: detect at least 70% of sputum smear positive TB cases and cure at least 85% of these  
- By 2015: reduce prevalence of and deaths due to TB by 50% relative to 1990 
- By 2050: eliminate TB as a public-health problem (less than 1 case per million population) 
COMPONENTS 
1. Pursue high-quality DOTS expansion and enhancement 
- Political commitment with increased and sustained financing 
- Case detection through quality-assured bacteriology 
- Standardised treatment, with supervision and patient support 
- An effective drug supply and management system 
- Monitoring and assessment system, and impact measurement 
2. Address TB/HIV, MDR-TB, and other challenges 
- Implement TB/HIV collaborative activities 
- Prevent and control MDR-TB 
- Address prisoners, refugees and other high-risk groups, and special situations 
3. Contribute to health system strengthening 
- Actively participate in efforts to improve system-wide policy, human resources, financing, 
management, service delivery, and information systems 
- Share innovations that strengthen systems, including the Practical Approach to Lung Health  
- Adapt innovations from other fields 
4. Engage all care providers 
- Public-Public and Public-Private mix (PPM) approaches 
- International Standards for TB Care (ISTC) 
5. Empower people with TB and communities 
- Advocacy, communication, and social mobilisation 
- Community participation in TB care 
- Patients' Charter for TB Care 
6. Enable and promote research 
- Programme-based operational research 
- Research to develop new diagnostics, drugs, and vaccines 
 
Table 2: The Stop TB strategy at a glance 
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2.6 TB control: issues and challenges 
It is essential to identify and understand the key challenges in TB control and address 
them appropriately. Below I discuss some of the key challenges that impede TB 
control efforts and threaten the success of TB control programmes.  
2.6.1 TB and poverty: an unbreakable association 
TB can affect anyone, but there is a clear association between poverty and widespread 
TB. The poor and disadvantaged suffer more from TB than the more privileged. When 
a poor person falls sick, it is likely s/he will receive inadequate health care because of 
the catastrophically high cost of health care. This is true also for TB (Lui et al, 2007), 
even though TB drugs are provided free of cost by the state in many countries. There 
is no doubt that TB has an overwhelming financial impact on patients and their 
families (WHO, 2006). 
Rates of TB are high among the poor, most marginalized and most vulnerable groups, 
and TB further traps them in a vicious cycle of disease and economic devastation. 
Studies have shown that people affected with TB on average lose 3-4 months of work 
time, and significantly longer for people with MDR-TB as they need to take treatment 
for at least two years. The financial impact of TB not only makes life difficult for the 
person directly affected with the disease but also has a devastating impact on the 
livelihood of that person’s family, with 20-30% of a family's household income lost 
on average (Figure 1). If a TB patient dies the family loses about 15 years of income. 
In many cases, children whose parents become sick with TB face severe consequences 
and end up working to support the household, endangering the child's education and 
further hindering the family’s development. TB affects the most economically 
productive age groups (Murry et al, 1993) and reduces the ability of people with TB to 
work. Generally, people with TB have to follow a long path of diagnosis and 
treatment, and even though many national TB programmes offer free diagnosis and 
treatment, there remain substantial costs to patients, including costs of care, 
transportation, food and loss of income. Such costs of accessing TB care can be more 
than twice the monthly income of the poorest (Kempet al, 2007), which makes people 
more vulnerable to poverty. Moreover, TB may push the non-poor towards poverty 
(WHO, 2005b), and a consequence is that the likelihood increases that the patient may 
not complete the full course of treatment. 
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Source: Adapted from Hanson. TB, poverty and inequity: Cited from WHO, 2005b: 
Addressing Poverty in TB control, Options for NTP 
 
It should be possible to control TB in developing countries but the main obstacles are 
disease-associated poverty and inadequate focus on the relationships between TB and 
socio-economic conditions (Squire, et al, 2006). The Table 3 presents six practical 
considerations addressing poverty in TB control. There is a clear need for all TB 
activity needs to be tailored and delivered using an equitable health system approach 
with universal coverage of services. Furthermore, there is a clear need to use 
standardised indicators in national TB programmes in order to understand the 
dimensions of poverty and equity in TB service delivery, to which end the 
participation of people affected with TB must be ensured. 
  
The poor lack: 
• Food security 
• Income stability 
• Access to water, sanitation and health care  
Income poverty  Disease poverty  
TB may lead to: 
• Loss of 20%-30% annual income among the poor 
• Global economic costs: US$ 12 billion annually 
Figure 1: Income poverty and TB 
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Step 1: Establish profile of poor and vulnerable groups 
- Government or other data; Locally done surveys 
Step 2: Assess poverty-related barriers to accessing of tuberculosis services 
- Economic barriers 
- Geographic barriers 
- Social and cultural barriers 
- Health-system barriers 
Step 3: Take action to overcome barriers to access 
- Economic barriers: integrate services within primary-care provision, encourage 
pro-poor Public-Private Mix DOTS, promote tuberculosis control in workplaces, 
improve coverage of smear microscopy networks, avoid user fees, provide free 
smear microscopy and other diagnostic services 
- Geographical barriers: extend diagnostic and treatment services to remote 
regions, provide free transport to patients from such regions, promote 
community-based care 
- Social and cultural barriers: engage former patients and support groups to 
advocate for services and encourage community mobilisation 
- Health-system barriers: engage in health-service decentralisation to ensure 
capacity strengthening in less well served areas and by establishing tuberculosis 
control as a district-level priority 
Step 4: Work with groups that need special consideration 
- Refugee communities, asylum seekers, economic migrants, displaced populations 
- Pockets of deprivation in wealthier countries; ethnic minorities, homeless people 
- Injecting drug users 
- Prison populations 
Step 5: Harness resources for pro-poor services 
- Global Fund to Fight AIDS, TB and Malaria, poverty reduction strategies 
- Technologies to enhance efficiency and effectiveness of services 
Step 6: Assess pro-poor performance of tuberculosis control 
- Harness human and other resources through alliances with partners (such as 
universities) 
- Include socioeconomic variables in routine data collection 
- Include tuberculosis-related questions in district health surveys 
- Undertake periodic studies of care-seeking, diagnostic delay and use of DOTS 
- Do qualitative assessments among community members and patients about who 
benefits from tuberculosis services (including linked services for HIV) and who 
does not 
Source: Adopted from Squire, et al, 2006 
 
  
Table 3: Addressing poverty in tuberculosis control: six practical steps 
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2.6.2 TB and HIV: a growing concern in TB control 
The human immunodeficiency virus (HIV) epidemic and its interaction with TB has 
resulted in a rise in TB case numbers in many countries (Murray, 1991; Rieder, et al. 
1989): this is considered to be one of the major factors for the resurgence of TB. The 
association between TB and HIV presents not only a massive challenge to public 
health but also a threat to socio-economic conditions in the developing world. TB and 
HIV co-infection has therefore become a global issue (Naraian et al, 1992; Raviglione 
et al, 1995; Raviglione et al, 1997). TB is the most common cause of death in HIV 
positive adults (Grant et al, 1997), accounting for about a third of HIV/AIDS deaths 
worldwide (UNAIDS, 2000). Considering the issues of TB and HIV co-infection and 
its impact in TB control, WHO clearly noted that that HIV is the primary reason for 
failure to meet TB control targets (WHO, 2004; WHO, 2005a).  
Although sub-Saharan Africa bears the majority of the HIV-fuelled TB burden, the 
rapidly increasing HIV epidemic in South East Asia and countries in Eastern Europe 
will also increase the number of people with TB resulting from HIV infection. 
Moreover, the impact of the two epidemics on resource-poor countries will have 
significant social, economical, cultural and medical implications, and already 
overloaded health services will face a tremendous increase of co-infected cases; as a 
result, TB control could become even more difficult. Since HIV drives the TB 
epidemic, prevention of HIV should be a priority for the control of TB, and similarly 
TB care and prevention should be a priority concern of HIV/AIDS programmes. 
The cost of managing TB in co-infected patients is substantially higher than the cost 
of care for TB patients without HIV infection (Murray et al, 1991). The burden of TB 
and HIV co-infection can be reduced through close collaboration between TB and 
HIV/AIDS programmes, but weak links between TB and HIV programmes present a 
major challenge. In response to the growing TB HIV co-infection problem, countries 
have started forging collaboration between these two programmes, but implementation 
has been slow. 
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2.6.3 Drug resistant TB: an issue  
The term multidrug-resistant TB (MDR-TB) refers to organisms that are resistance to 
two or more anti-TB drugs including isoniazid and rifampicin. Development of drug 
resistance occurs in nature, but it is also related to human error, such as non-
completion of treatment, patients not taking medication properly, incorrect or 
inadequate prescription of chemotherapy by health workers, weak processes of drug 
delivery to patients, poor case management, and many others (WHO, 1997). The 
presence of drug resistance in a community usually reflects a poorly managed TB 
control programme (Fuijwara et al, 2000; Shah et al., 2007). If not treated, patients 
with resistant TB may transmit resistant strains to others in the community, so from a 
TB control public health perspective, for MDR-TB, no therapy is better than poor 
therapy.  
Several countries are experiencing increasing numbers of MDR-TB cases, so the 
threat it poses to TB control cannot be underestimated. WHO estimates that there are 
about half a million MDR-TB new and existing TB cases each year, with the highest 
prevalence in Eastern Europe (WHO, 2006). DOTS has been promoted widely to 
ensure successful treatment completion and avoid resistance to TB drugs. However, 
access to affordable TB services including adequate first line TB drugs is difficult for 
many people with TB in developing countries, so the theory that use of DOTS will 
prevent MDR-TB may not translate into practice in many settings (Sinder and Castro, 
1998). In fact, such concerns are not new in developing countries, where TB control 
services are still hard to reach for the majority of populations. Farmer et al, (2000) 
clearly note that if the development of MDR-TB is to be avoided, the successful 
implementation of the TB control programme in the public and private health sectors 
is essential to ensure the maximum numbers of TB cases possible are successfully 
treated (Farmer et al, 2000). 
The urgency of the need to combat MDR-TB led to WHO introducing DOTS-Plus in 
1999 (Farmer et al, 2000). Now some countries are implementing DOTS-Plus: Nepal 
started in 2005. The cost of second-line TB treatment is very high and treatment 
management is complex, and also the cure rate is 56% (Hayward, 1998), compared 
with 95% for non-resistant TB patients. Most importantly, countries facing difficulties 
implementing DOTS may not even think of treating MDR-TB through 
implementation of DOTS Plus. 
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2.7 Nepal: country context 
Modern Nepal is a unification of a number of small independent former kingdoms. 
The democratic movement in 1990 instituted multiparty democracy with a provision 
of a constitutional monarchy. However, a decade-long conflict (a Maoist insurgency) 
led to some 13,000 deaths, many of them civilians. The conflict badly damaged the 
economy and development activities. Consequently, a large number of people 
migrated from their usual place of residence: a massive impact on local development 
and delivery of services, including health services. After a decade of conflict, a 
comprehensive peace agreement was signed. Subsequently, the monarchy was 
overthrown, and parliament reinstated. The country is now moving towards restoration 
of democracy. A constituent assembly was elected in 2007 to deliver a new 
constitution, although ongoing disputes among political parties have hampered the 
constitution-making process.   
2.7.1 Population, social and economic context 
Nepal has an estimated population of 29.5 million with almost equal proportions of 
males and females. The majority of the population (84%) resides in rural areas. The 
annual population growth rate is 2.25% (CBS, 2003). The literacy rate in 2001 was 
54% -42% for females and 65% for males - substantially higher in urban areas (64 %) 
than in rural areas (36 %). The country is diverse in many ways: culturally, ethnically 
and religiously. There are about 103 ethnic/caste groups and about 90 languages and 
dialects. In addition, there are complex social hierarchies within communities. The 
abolition of the traditional caste systems that took place many years ago was further 
reemphasised in the Nepal’s Interim Constitution, 2007, which stated ‘the State shall 
not discriminate among citizens on grounds of religion, race, caste, tribe, sex, origin, 
language or ideological conviction or any of these.’ (Nepal’s Interim Constitution, 
2007, clause 13.3, p.6, English translation version). However, various forms of social 
exclusion and discrimination based on ethnicity/caste, religion and language continue. 
This has not only exacerbated poverty among the lower castes, minorities and tribal 
groups, but also affected utilisation of public services. (The low caste groups, 
commonly known as Dalits, are historically linked with occupations regarded as 
ritually impure such as cleaning streets, latrines, waste, dead bodies of animal; 
assisting pregnant women during and after pregnancy; butchering; involved in leather 
works; metal works and many other jobs considered as low grade in the community). 
Dalits were considered polluted and contagious, and thus untouchable by other people 
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especially those from upper castes. Discrimination based on such grounds still exists 
but is less marked in urban than in rural areas. Recently, issue of social inclusion is 
given a high priority but yet to see effective implementation of strategies benefiting 
the excluded. 
Nepal remains the poorest country in South Asia and ranks as the 12th poorest country 
in the world with a per capita Gross Domestic Product (GDP) of US$270 in 2005. 
Although, the poverty rate (people living below the poverty line) declined by 11% – 
from 41% to 31% – between 1995/1996 and 2003/2004, poverty is still widespread, 
especially in rural areas, with almost a quarter of the total population earning less than 
1 US$ per day (MoF, 2006). The incidence of poverty in urban areas declined from 
22% to 10%, while poverty in rural areas also declined from 43% to 35%, but remains 
high and some groups have poverty rates much higher than the national average. See 
Table 4. 
 Poverty Headcount Rate (%) 
 Fiscal Year 1995/1996 Fiscal Year2003/2004 
Nepal  41.8  30.8  
Urban  21.6  9.6  
Rural  43.3  34.6  
Development Regions 
Eastern  38.9  29.3  
Central  32.5  27.1  
Western  38.6  27.1  
Mid-western  59.9  44.8  
Far-western  63.9  41.0  
Ecological Belts 
Mountains  57.0  32.6  
Hills  40.7  34.5  
Terai  40.3  27.6  
Source: CBS, 2004 
 
  
Table 4: Poverty in Nepal 
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2.8 Nepal’s Health Sector Programme 
The Nepal National Health Policy, 1991, aims to improve the health status of the 
people by extending the primary health care system. Within this approach, increased 
access to essential health care services (EHCS) to rural poor is to be provided through 
decentralized primary health care delivery (see figure 2).Government (also known  as 
public sector) is the largest service provider, followed by NGOs and finally the private 
sector. A comprehensive framework of health policies, plans and strategies are in 
place. In order to achieve the health sector aim, the Health Sector Strategy: an Agenda 
for Reform 2003 was introduced. Subsequently, the Nepal Health Sector Program – 
Implementation Plan (NHSP-IP) 2004-2009was developed by encapsulating various 
policies, plans, strategies and lessons learned in the health sector, to serve as an 
implementation tool for the strategy, and became the basis for Nepal's first health 
SWAp (sector-wide approach) with three programme outputs and eight sector outputs.   
Nepal has achieved good progress in some health outcomes: a considerable decline in 
child and maternal mortality over the last 10 to 15 years (NDHS, 2006), and Nepal is 
on track to meet child and maternal health MDGs. The government estimated that 
NHSP-IP saved about 96,000 deaths and nearly 3.2 million disability-adjusted life 
years (DALYs) at a cost of $144 per DALY saved (MoHP, 2010). 
Year of survey 1996 2001 2006 
Under 5 mortality rate (per 1000 births) 118 91 61 
Under 5 mortality net of neonatal mortality (per 1000 births) 68 52 28 
Maternal mortality rate (per 100,000 births) 539 - 281 
Adult mortality (% dying in age group 15-49) 11.5 - 7.9 
Source: Demographic Health Surveys1996, 2001 and 2006 
It should be noted that these health gains (including TB control achievements)were 
made over the last 10 to 15 years during which the country was plunged into deep 
conflict and delivery of basic services including health were affected, especially in 
rural areas. So far, there has not been any credible evidence for any factors responsible 
for better health outcomes during the conflict. However, two suggestions have been 
made: health service delivery was less affected by the conflict than other sectors, as 
both sides (the state and the Maoists) were aware of the need to keep health service 
delivery intact.  
Table 5: Selected health indicators and their change over time 
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Expenditure in health remains low at 5.3% of GDP in 2006 (MoHP, 2010). The per-
capita health expenditure stood at USD 19.09, a relatively low compared with other 
South Asian countries (i.e. Bhutan USD 44 and 29 in India) (WHO, 2008; cited from 
MoHP, 2010). Sharing of the total health expenditure is - Government 24% (USD 
4.28), external funding from partners 21% (USD 3.75) and more than 55% form 
household out-of-pocket. The high household spending is an inequitable which mean 
the poor cannot (or find it very difficult to) afford services in the private sector, and 
thus rely on public health services which are often not adequate to meet their needs 
and not accessible by many. Government's commitment to expand essential health 
services has not been translated into practice thus significant barriers to access to 
health services remain, especially for the poor and excluded, as more than 60% of the 
rural population live more than one hour’s walk from a public health facility.  
2.8.1 Unequal distribution in health outcomes 
Despite good health outcomes at the national level, health gains are not equitable but 
are unevenly distributed across wealth quintiles, social groups and geographic 
locations, and worsening disparities can be observed. For instance, infant mortality is 
73% higher in rural areas than urban areas and more than 100% higher in mountain 
zones than in hill zones. The richest fifth spend 25 times more on health care than the 
poorest fifth (NDHS, 2006). Under-five mortality rates are more than twice as high for 
the poorest compared to the wealthiest. Similarly, infant and maternal mortality rates 
are significantly higher among the poor than the non-poor. The poor have the largest 
unmet demand for family planning, make the lowest use of maternal care, have the 
lowest vaccination coverage, and are least likely to seek care when ill. While the total 
fertility rate has declined, it remains high for Muslims, Dalits and poor women. A 
higher proportion of Brahmans and Newars (the so-called higher casts) receive 
antenatal care by a Skilled Birth Attendant than Muslims and Terai Janajatis (NDHS, 
2006). The average time to travel to a health facility is more than 4.6 times longer for 
the poorest fifth than for the richest fifth (NLSMS, 2002/03). 
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Source: HMIS/MD, DoHS, Annual Report 2004/5 
MD Management Division NTC National TB Centre 
FHD Family Health Division NCASC National Centre for AIDS and STD 
Control 
CHD Child Health Division NPHL National Public Health Laboratory 
EDCD Epidemiology and Disease Control 
Division 
FCHV Female Community Health 
Volunteer 
LMD Logistics Management Division TBA Traditional Birth Attendant 
LCD Leprosy Control Division PHC/OR
C 
Primary Health Care Outreach 
Clinic 
NHTC National Health Training Centre EPI Expanded Programme on 
Immunisation 
 
  
Figure 2: Organisational structure of health service delivery in Nepal 
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2.8.2 The free health care policy: evolution and issues 
In line with the provision stated in the Interim Constitution of Nepal – every citizen 
shall have the right to basic health services free of cost from the State –in 2006 the 
government introduced a 'free health care policy' with the aim of removing financial 
barriers in seeking basic health care services,  especially for the poor and excluded. 
The policy was subsequently extended, adding more services and population groups, 
and now offers essential health care services up to district hospital level free for all 
citizens (see Table 6), along with the removal of user fees.  
Initial observations of the implementation of the free health care policy suggest that 
utilisation of out-patient and in-patient care has increased considerably at all levels. 
However, management, implementation and sustainability of the policy have 
presented substantial challenges. Communication of the policy has been poor: a study 
at ten district hospitals demonstrated that most users, especially the poor and excluded 
(who the policy aims to benefit), were not aware that care was free and paid 
considerable sums for care, instead of being informed by the service provider about 
free care provision – although it could be the case that the provider was also unaware 
of the policy. However, the same study revealed that the distribution of benefits 
among different population groups showed that the poorer groups received a larger 
share of public subsidies at the district hospital (MoHP, 2009).  
Human resource and health service infrastructure to deliver health free services is 
severely constrained – there is one nurse per 5,000 population, one doctor per 18,000 
population and one hospital bed per 2,300 population (MoHP, 2010). It can be 
concluded that if the free health care policy is to be effective, the programme needs to 
increase access to services especially for the poor and excluded. There is a clear need 
to address inequalities in service utilisation; costs of transport and  other associated 
costs of illness; increased workload in some facilities; poorly managed health logistics 
(causing drug stock outs); clarity on what is free and not free; and sustainable 
financing for the implementation and expansion of free health care.   
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Date Policy/Programme Description  Issues/challenges 
December 
15, 2006 
Emergency and inpatient services 
offered free of charge to the poor, 
destitute, elderly, people living with 
physical and psychological disabilities, 
and Female Community Health 
Volunteers at district hospitals and 
primary health care centres (PHCCs) in 
25 low Human Development Index 
(HDI) districts 
- proper identification of targeted groups 
eligible for free care 
- partial implementation of policy poor 
orientation of health service providers 
on free health care policy 
- limited awareness of policy among 
people 
- inadequate monitoring and reporting  
July 17, 
2007  
Outpatient services offered free of 
charge to same target groups at district 
hospitals and PHCCs in low HDI 
districts, and, together with inpatient and 
emergency services, expanded from 25 
to 35 low HDI districts. 
- proper identification of targeted groups 
eligible for free care 
- lack of clarity among providers on 
policy 
- lack of follow-up of policy 
implementation   
Announced: 
October 7, 
2007 
Enacted: 
January 15, 
2008 
User fees removed and essential health 
care services (EHCS) offered to all free 
of charge at all health and sub-health 
posts, including 25 essential drugs at 
sub-health posts and 35 at health posts. 
- Concern over loss of revenue by health 
institutions 
- Over-consumption of free drugs (fake 
illness presented to collect drugs) 
- lack of clarity among providers on 
policy 
- lack of follow-up of policy 
implementation   
January 14, 
2009 
EHCS offered free of charge at PHCCs 
and to target groups in all districts at 
district hospitals. Institutional Deliveries 
(normal, complicated, and caesarean 
sections) free of charge at all 
government facilities nationwide. 
- lack of clarity among providers on 
policy 
- big hospitals were concerned about 
revenue loss 
- management of logistics and ensuring 
financial flow from centre to periphery 
Announced: 
July 13, 
2009 
Enacted: 
July 16, 
2009  
Essential drugs (40 in total) free of 
charge for all at district hospitals  
- Operation guideline of the policy 
delivered late to service delivery sites 
disrupting implementation 
- Local purchase of drugs and concern 
over quality 
- Sustainability of the policy 
Source: compiled from MoHP, 2010 
  
Table 6: Evolution of free health care in Nepal 
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2.8.3 Health services in urban areas: a neglected scenario 
Nepal is experiencing rapid urbanization with 7% urban population growth annually, 
the highest amongst the South Asian countries (UN Habitat, 2007). Urbanization is 
largely unplanned in Nepal: a large number of slums, squatters, homeless and 
unemployed population in cities, resulting in a large number of urban poor living in 
unhealthy conditions. The urban population has risen substantially: it was 4% in 1971, 
6.4% in 1981, 9.2 % in 1991 and 13.9% in 2001 (CBS, 2001). Currently the municipal 
population is about 16% of the total population, and a projection suggests that by 2015 
it will be more than 21% of the total population. About 25% of the total urban 
population (about a million people) are poor. Among the urban poor, more than 60% 
live in slums (UN Habitat, 2005). About 46.3% of urban households have no piped 
drinking water; 45.6% have no sanitary system and 55% have no appropriate garbage 
disposal system (NLSS, 2004). 
The situation described above demonstrates that urban poverty is increasing and urban 
development will be severely challenged by poverty. In terms of health services, 
provision of basic primary health care services is considerably limited in town and 
cities. Some big central hospitals and specialized care centres exist, but are generally 
inaccessible to the urban poor. Limited urban primary health care centres, ineffective 
outreach and referral systems, inadequate information about health service provision 
and low awareness of health among urban dwellers make poor people more vulnerable 
to ill health. Demographic health survey (2006) show that almost all health indicators 
are better in urban areas than in rural areas. However, absence of disaggregated health 
data for the urban poor severely limits overall understanding of the status of the urban 
poor.  
Government health policy documents generally state that providing basic health 
services to urban population is the responsibility of the state. However, 
implementation of the policy has been weak despite increasing health demands of the 
urban poor. In urban areas there are multiple health care providers with varying 
statutory responsibilities, but service delivery is largely uncoordinated and 
unregulated as there is no well-structured and clearly articulated urban health 
policy/strategy to guide urban health care delivery. This poses management and 
implementation problems, and fragments efforts. Moreover, there is lack of clarity 
within policy on who is responsible for providing basic health care in municipalities – 
the municipalities themselves, or the Ministry of Health and Population – further 
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impeding the development of urban health care. Hence, a consistent and focused 
approach to urban health is imperative. 
2.8.4 Challenges in health service delivery 
Although Nepal has made good progress in some health outcomes, there are many 
challenges and constraints in delivering health services effectively, efficiently and 
inclusively. Major challenges at system, sector and sub-sector levels, together with 
fragile political and economic conditions, make delivery of basic health care difficult. 
Key challenges in the health sector include socio-economic disparities (regional-
urban-rural-ethnic/caste) in service delivery and utilisation; accessibility and coverage 
of services; institutional arrangements, planning and management including intra- and 
inter-sectoral coordination and decision-making processes which are highly 
centralised though policies aim for decentralisation. Similarly, inappropriately located 
health institutions, challenging geography, poorly coordinated health programmes, 
lack of human resources especially in rural health institutions, social inequalities and 
discrimination in service provision grossly impede delivery of essential health care 
services especially to the poor and excluded. Moreover, concerns about the quality of 
services provided by public facilities are widespread, and may limit increased 
utilization of health services and damage achievements in health outcomes. 
Addressing all these problems requires an accelerated and sustained health reform 
process that includes effective use of financial, human and institutional resources, a 
clear policy and an effective and efficient delivery mechanism, equitable and socially 
inclusive service delivery provision, and collaborative efforts of private, public and 
NGO stakeholders.  
2.9 National TB Programme of Nepal 
TB is one of the main public health problems in Nepal. The history of the fight against 
TB began in 1937 with the establishment of a TB sanatorium in the Kathmandu 
Valley. The National TB Programme (NTP), one of the priority programmes of the 
Ministry of Health and Population (MoHP), was initiated about four decades ago. The 
NTP operates nationwide, implemented within the national general health system, 
especially in rural areas. However, some components of the programme such as 
training, drug management, microscopy quality control, monitoring and surveillance 
are managed vertically.  
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The National TB Centre (NTC), established in 1989, is the focal point of the NTP at 
national level. It develops policies and strategies and provides technical support in 
areas of programme implementation, monitoring and supervision. It also manages the 
vertical components of the programme mentioned above. At the regional level, 
coordinating NTP activities is the responsibility of the Regional Health Directorate. A 
designated NTP officer oversees such regional responsibilities. At the district level, 
the district health office/district public health office is responsible for planning, 
implementing and monitoring NTP activities within the district. A District 
TB/Leprosy Officer coordinates overall management of TB control activities in the 
district. Within the district, the basic units of management for diagnosis and treatment 
of patients with TB are district hospitals and primary health care centres (PHCC) with 
microscopy facilities. At the periphery, TB suspect identification and treatment 
services are available at Health Posts (HP), Sub-Health Posts (SHP) and other district 
health institutions (NTP 2006).  
2.9.1 NTP’s aims, objectives and strategies 
The NTP aims to reduce the mortality, morbidity and transmission of TB until it is no 
longer a public health problem. In order to assess progress towards these aims the 
NTP has set two targets: to achieve 80% case detection rate of new smear positive TB 
nationally by 2012; and to maintain the existing treatment success rate of 90% 
throughout the programme (NTP 2004).  
2.9.2 TB epidemiology: infection and disease 
The NTP estimates that 45% of the total population is infected with TB bacilli, of 
which about 60% are adults: more than 80,000 have TB. Every year, 40,000 people 
develop active TB, of whom 20,000 have infectious pulmonary disease and could 
transmit TB to others. In 2007 the reported incidence of TB cases was 173/100,000 
with a total number of 48,766 cases. NTP data shows that TB is predominant among 
poor and marginalised groups, and the burden is highest in the urban and terai areas.  
TB mortality: Deaths due to TB are largely preventable if early detection is made and 
successful treatment completion is ensured. Ten years ago, the NTP estimated that 
about 16,000 people were dying from TB every year in Nepal. Current estimates 
suggest 5,000 to 7,000 TB deaths per year - about 17 people every day (NTP 
2008/09).  
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Drug Resistant TB: The most recent survey (2006/07) of MDR-TB that showed 
2.9% of previously untreated TB cases had MDR-TB, an increase from 1.3% in 
2001/2002, which is a cause for concern. Of even more concern for the NTP is that a 
recent study found a prevalence of 5% of XDR-TB among MDR-TB cases registered 
in the NTP (NTP 2008/09). In 2005, Nepal launched a DOTS plus pilot project to treat 
MDR TB cases using a standardised treatment regimen free-of-charge to patients. The 
first annual cohort enrolled 175 MDR-TB cases, and achieved 70% (123) cure rate 
with 17% (29) defaulter rate. The success of MDR-TB treatment in Nepal 
demonstrated that it is possible to deliver fully ambulatory-based MDR-TB care in 
resource-limited settings with good treatment outcomes (Malla et al, 2009). However, 
a research study conducted with MDR-TB patients in Nepal highlights that continuing 
treatment for two years is a problem for many MDR-TB patients due to the high cost 
of care (even though drugs are free), lack of social support especially when they are 
away from home for their treatment, and the highly toxic effects of the drugs (HERD, 
2009). Recently the NTP has started providing limited financial support to MDR-TB 
patients. This is a good first step towards addressing patients’ needs but unless 
adequate financial support combined with social support is provided to MDR-TB 
patients they will continue to face problems continuing their treatment.  
TB and HIV: Nepal has the highest HIV prevalence in South Asia with 0.49% of the 
population aged 15-49 infected (GoN, 2009): a concentrated HIV epidemic among 
high risk population groups such as injecting drug users, male and female sex workers 
and their clients, men who have sex with men, and migrants to high risk districts in 
India and their partners. Increasing HIV prevalence is a concern of the NTP as 
numbers of HIV-related TB cases can be expected to increase as the prevalence of 
HIV increases. Since 1994, Nepal has conducted six rounds of HIV surveillance in 
people with TB. The results indicate that the prevalence of HIV among TB patients is 
low but increasing. The latest survey showed HIV prevalence among TB patients at 
2.4% (NTP, 2008/09). This result indicates there is an immediate need to enhance TB 
and HIV collaboration activities, which though initiated many years ago has made 
only slow progress (NTP 2007).    
  
33 
 
2.9.3 National TB Programme: review of progress 
Nepal is a country where the implementation of any programme nationwide appears to 
be difficult, because of geographic, cultural and social conditions, and widespread 
poverty. However, Nepal has achieved remarkable success with the DOTS strategy. 
The government adopted the DOTS strategy in late 1990s and observed countrywide 
implementation by 2001(see Figure 3). 
 
DOTS: the central strategy of NTP: DOTS is the central strategy of TB control in 
Nepal. There is no doubt that the NTP has achieved remarkable success using DOTS, 
and it  continues to be the NTP’s major TB control strategy within the NTP's long-
term plan (NTP 2004). Under DOTS, the NTP has gained momentum, secured 
considerable political commitment from the government and local DOTS committees
2
                                                 
2DOTS committees were established by the NTP locally to gain community support in DOTS 
implementation. They also help TB patients complete treatment in their areas.  
 
in its effective rollout. However, political commitment in terms of domestic resource 
allocation for the NTP remains weak as more than 80% of NTP funding comes from 
external source thus the NTP relies heavily on donor funding. Lack of adequate 
allocation of domestic resources for essential NTP activities such as drugs, 
microscopy and training could be detrimental to the NTP's success if a single donor 
stops funding or changes its funding modality (NTP, 2004). In 2006, Nepal officially 
adopted the new WHO Stop TB Strategy. In line with this strategy, Nepal also 
adopted the International Standards for TB Care (ISTC). However, effective 
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implementation of all components of the Stop TB Strategy and the ISTC is a challenge 
to the NTP given weak primary health care networks especially in urban areas. 
DOT: All TB cases notified to the NTP are treated under DOTS and policy continues 
to be that conventional health facility-based DOT is used for all TB patients. The NTP 
promoted DOT by claiming that it ensures better adherence to TB treatment and 
prevents drug-resistant TB. Therefore, all TB patients taking rifampicin need to 
comply with the requirements of DOT regardless of whether it causes patients and 
their families to suffer. The effectiveness of DOT has been widely debated 
internationally and is infeasible for many TB patients in the context of Nepal, given its 
complex geography, and inappropriately located health facilities, especially in rural, 
hill and mountain districts where patients have to travel/walk considerable distances to 
reach the nearest health facility. Availability of health workers in these areas for 
routine DOT is also a concern. Even in urban areas, complying with DOT is difficult 
for many TB patients due to inconvenient opening hours of DOTS clinics, social 
stigma attached with TB, travel costs for DOT and distance to DOTS centres from 
patients’ homes (Baral et al, 2007; Kirwan et al, 2009; Karki et al, 2007).  Moreover, 
although the selection of treatment observer should be properly negotiated with TB 
patients and their families to ensure acceptance and execution of treatment plans, the 
programme instead uses a blanket approach for all TB patients which may not be 
feasible for all (Harper, 2006). Although the NTP has achieved about 90% treatment 
success rate under DOTS (see Figure 4), there has been little acknowledgement of the 
hardships that patients have to face to comply with DOT, or of its impact on their 
lives. Some health workers may address issues locally, but the policy remains silent on 
concerns about DOT raised by patients, their families and health workers (Newell et 
al, 2006, Kirwan et al, 2009) even though they were documented in an NTP in-depth 
review in 2007. Nepal conducted a major district-based cluster randomised trial 
comparing feasibility and effectiveness of DOT using community members and 
family members as treatment observers in hill and mountain districts (Newell et al, 
2006). The trial demonstrated that both approaches attained the global target of TB 
treatment completion, and were thus suitable for settings where conventional DOT is 
infeasible for many TB patients. The study also noted that these approaches were 
feasible to implement in Nepal from a programme management perspective, but costs 
of implementing family based DOTS were found to be slightly higher than those of 
community based DOTS (Mirzoev et al, 2008). The NTP recently (2009/10) revised 
its guidelines and training manuals but did not shift its focus from a conventional 
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approach to DOT. However, the guideline spelled out the use of a community member 
as a treatment observer for those living a long way from any health facility, but gave a 
rather weak explanation in of how to use them as treatment supervisors. The guideline 
also mentions using family members as treatment supervisors, but only as a last resort. 
Thus the policy remains focused on conventional health facility-based DOT and has 
little consideration towards advancing patient supervision and support mechanisms in 
the programme.  
 
Source: data compiled from NTP annual reports 
Case finding: Notification of new smear positive TB cases in the NTP 
increased steadily from 1996 until 2001, after which the rates stabilized and further 
increased from 2008 (Figure 5). Similarly, the trend in age distribution among notified 
new smear positive cases over the period from 1997 to 2006 shows a steady shift to 
older patients. In the absence of other information, these two pieces of evidence 
suggest that the TB burden is has declined over recent years, although the data needs 
to be interpreted with caution, and it is too early to be certain that this trend will be 
sustained (NTP, 2007). 
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Source: data compiled from NTP annual reports 
Monitoring and evaluation of NTP activities: NTP has a well established vertical 
monitoring system. Monitoring of treatment outcome relies on a cohort system, 
analysed on a four-monthly basis. These cohorts are followed up for the duration of 
treatment, their outcomes recorded, and the proportion achieving treatment success 
(those cured and those who completed treatment) calculated. The NTP routinely uses 
these data for programme management, and to identify weaknesses in programme 
performance. Every district prepares and analyses four-monthly case finding, smear 
conversion, treatment outcome and programme management reports by conducting a 
four-monthly district DOTS planning and monitoring workshop. Districts then submit 
these reports to a regional DOTS planning and monitoring workshop. Finally, a 
national level four-monthly planning and monitoring workshop held under the NTC's 
guidance prepares the national TB report. Routine supervision at all levels is a core 
activity of the NTP.  
Partnerships in TB control: The first public-private partnership (PPP) project in 
Nepal was initiated in Lalitpur in 1998. This developed a successful PPP model for 
engaging the private health sector in TB control; however, scale-up of this model was 
rather slow due to resource constraints. Now, under new funding provision from the 
Global Fund, the NTP plans to expand the PPP model in at least 25 districts. All 
medical colleges in Nepal have been providing TB services by establishing a DOTS 
centre in their teaching hospitals. DOTS orientation to private practitioners, industrial 
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workers and pharmacists is one of the key regular activities of the NTP. As a result of 
PPP, referral of TB cases from private providers to the NTP has increased remarkably. 
Nepal provides a classic example of community participation in DOTS through the 
establishment of DOTS committees at DOTS treatment centres and sub centres. They 
are engaged in raising awareness in their local community and helping effective 
implementation of DOTS. Similarly, the NTP has established functional partnership 
with several private and non-governmental organizations to deliver MDR-TB services 
across the country. The national reference lab for MDR-TB, almost half of the MDR-
TB treatment centres and close to 30% of the MDR-TB treatment sub-centres are 
operated by the private and NGO sectors. 
2.10 Conclusion 
The chapter provided an overview of global TB control status along and 
challenges to TB control with especial focus on developing countries. In addition 
the chapter also provided an account of Nepal’s health sector with focus on NTP. 
This chapter set a background of the broader research area – tuberculosis and 
national status of TB. The next chapter critically examines the issue relating to TB 
treatment completion which sets a foundation of issues under investigation.  
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CHAPTER THREE 
UNDERSTANDING TB TREATMENT COMPLETION 
In this chapter I describe the current body of knowledge with regard to TB treatment 
completion with a focus on factors affecting continuation of TB treatment in the 
context of developing countries and resource constrained settings. It provides the 
foundations of my doctoral research project by analysing factors helping and 
hindering TB patients during their course of TB treatment. I also discuss knowledge 
gaps in understanding TB treatment completion, taking into account the contexts of 
developing countries and TB service delivery modalities. I further present an outline 
of different measures applied in TB programmes to address issues of non-completion. 
Finally, I develop a theoretical understanding of the issue and a conceptual framework 
leading to the aim and objectives of my research and to guide the research approach. 
3.1 Defining the term ' successful treatment completion' 
Various studies have examined treatment behaviour of people especially in the use of 
long-term treatment therapies. Different models have been used to understand the 
patients’ behaviour and its impact on the effectiveness of treatment regimens and 
different terms have been used interchangeably to capture patients’ treatment 
behaviour, including adherence, compliance, concordance, cooperation, mutuality, 
completion, and therapeutic alliance. The operational definitions of these terms vary 
considerably: however, most definitions contain elements relating to patients’ 
responsibility for self-care, their role in the treatment process, their collaboration with 
health care providers and their obeying of proscriptions in their treatment management 
by health care providers.  
In recent years, the use of the term compliance with treatment has been debated as it 
has the ‘unfortunate connotation that the patient is docile and subservient to the 
provider’ (Sumartojo, 1993). Some experts have noted that treatment is usually an 
independent choice of patients and can therefore best be described as adherence. 
Recently, practitioners have recommended the term concordance to reflect ‘the active 
exchange of information, negotiation, and spirit of cooperation’ (Mullen 1997). 
However, most widely used is the term adherence, which simply refers to how closely 
patients follow a prescribed treatment regimen. It includes a willingness to start 
treatment and an ability to take medications exactly as recommended. However, it has 
been realised that to be able to understand overall aspects of treatment and 
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effectiveness requires a full understanding of the factors that prevent people taking 
medicine correctly and the factors that help them complete their treatment therapy. 
Many of these definitions overlook these aspects, which are important as patients 
often take their medication under very difficult circumstances and have no control 
over many of the factors that prevent and help them take their treatment.  
For the purpose of my study, I will use the outcome oriented term 'treatment 
completion'. I define 'treatment completion' as when a person with TB completes the 
full course of treatment as per the programme requirements. Further to this, I will use 
the term 'successful treatment completion' to reflect the need for a comprehensive 
understanding of the overall treatment process (from start to completion) and factors 
that help or hinder at different stages of treatment. 'Successful treatment completion' is 
where a patient completes the full course of treatment in a supportive environment 
with no harmful consequences of the disease to him/her and their family during and 
after completing the full course of treatment and, by having so, the person will be 
easily able to restore quality of life and productivity. In my experience as a health 
worker and a researcher, I have found many examples of people with TB who 
complete their full course of treatment despite major problems that continue to pose a 
threat to their well-being even after being labelled 'cured' or 'treatment completed' by 
the TB programme. By using this definition, I intend to foster an awareness and 
understanding of the suffering and consequences that are faced or will be faced by TB 
patients (and in the case of cured patients, former TB sufferers) due to TB, and also 
enabling factors that led the person to complete their full course of treatment. It is 
important to remember that, although TB control programmes may achieve high 
treatment completion rates, this might be at major cost to the patients who complete 
treatment.  
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3.2 Understanding TB treatment completion 
One of the international targets of TB control is to ensure 85% of all identified smear-
positive TB cases successfully complete their treatment. However, many national TB 
programmes are struggling to achieve this target, particularly in developing countries. 
Even though effective anti-TB drugs have been used since the 1940s and TB control 
measures have been put in place, the problem remains (Dye 1999; Netto 1999). Non-
completion of TB treatment continues to be a major barrier to tackling TB control 
effectively, despite various interventions aimed at improving treatment completion 
(Jin et al., 1993; Chaulet 1990). Generally, people with TB require treatment for at 
least six months but many TB patients find it difficult to complete treatment even 
when services are available (Fox 1958; Addington, 1979; Cuneo and Snider 1989). 
Several factors impeding successful completion of TB treatment are discussed in 
section 0 of this chapter. Failure to complete TB treatment can lead to prolonged 
infectiousness, development of drug resistance, relapse of TB, and death (Volmink 
and Garner, 2006). Poor completion of treatment thus poses a serious risk not only for 
the individual but also for the community.  
Treatment of TB requires access to appropriate health services designed and delivered 
with a full understanding of patients' needs. However, over the many years of the 
history of TB treatment, patients have experienced difficulties following treatment 
regimens delivered in a biomedical fashion. DOTS is a highly effective strategy 
promoted globally but the TB treatment delivery modality that uses direct observation 
has been a much debated issue. Nevertheless, difficulties experienced by patients in 
the process of their treatment under a strict treatment delivery protocol has raised 
awareness of the issue in TB control programmes and TB treatment completion is now 
recognised as a complex issue influenced by many factors. Advancing TB control 
programmes by improving treatment completion requires a comprehensive and 
holistic understanding of the barriers to and facilitators of treatment completion, using 
systematic approaches feasible for context (Munro et al., 2007). It is important to gain 
patients’ experiences of problems and coping mechanisms, but there seem to be a 
major knowledge gap in this area which limits developing effective solutions specific 
to local contexts: in response there have been calls for qualitative research that can 
contribute to widen understanding in TB treatment completion and help interpret the 
findings of quantitative studies of the effectiveness of promoting interventions 
(Dixon-Woods, 2004). 
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3.3 Pathway to TB treatment: ideal vs. reality 
TB patients often face a prolonged and difficult process in order to access TB 
treatment under normal programme conditions. In this section, I discuss the proscribed 
steps that all TB patients are expected to follow to receive TB treatment in national 
programmes, with specific reference to Nepal's national TB programme. This section 
gives a description of the pathway patients must follow in accessing TB treatment 
(symptom appearance, diagnosis, entry into DOTS, treatment continuation and 
completion, leading to treatment success or otherwise), as shown in Figure 6below. 
This will help develop understanding of the barriers faced by TB patients at different 
stages of care and their implications for TB treatment completion. 
In an ideal world, all people with cough for two weeks or more, the main symptom of 
pulmonary TB, will seek out a formal health service provider, either private or public, 
to diagnose and treat their illness. Once a person with TB symptom(s) voluntarily 
appears to any health provider, it should be the responsibility of the provider to screen 
the person for TB and perform sputum microscopy to rule out TB disease. If the 
person is found to have TB disease, then the provider should arrange TB treatment 
under programme conditions, continue anti-TB treatment with direct observation for at 
least six months, and ensure cure or successful treatment completion. Most TB 
programmes in developing countries follow this approach in line with WHO 
guidelines.   
 
  
Figure 6: General pathways to TB services under programme conditions 
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However, reality is very often different from the ideal and the steps outlined above 
(figure Figure 6) are rarely followed in a linear sequence, as many people face 
multiple barriers in accessing care. People may not see their symptoms as serious 
enough to seek care, due to lack of knowledge about TB symptoms, until it affects 
their routine work. People often look for a range of remedies from a variety of 
different providers at all stages of their illness. In a study from Malawi, for example, 
TB patients made an average of 5 visits to health care providers before TB was 
diagnosed, with women making more visits than men (Kemp et al., 2007). Similarly, 
in Vietnam, TB patients contacted an average of 1.3 different health-care providers to 
seek TB care, and made an average of 2.5 visits to each provider, before contacting 
the designated TB services (Lonnroth et al., 2001).  
In Nepal, the national TB programme recommends the pathway to TB treatment as 
presented in Figure 6. However, several factors make it difficult to follow the route 
suggested by the policy. For example, as in Malawi and Vietnam, patients often visit 
several health care providers and make multiple visits for diagnosis, leading to delays 
in diagnosis of disease, and high costs to patients. Early identification and 
management of TB suspects is emphasised in the programme, but many patients 
experienced long health system delays in diagnosis. This shows the health system's 
inability to implement the policy of early detection of TB leading to rapid treatment. A 
recent qualitative study found that the route TB patients often travel to seek TB care is 
very complex. It involved several visits to different health care providers, ranging 
from traditional healers to highly qualified medical practitioners, and several factors 
influenced the route to treatment such as severity of complaints, ability to pay for 
services, availability of services and peer support for choosing a provider. Factors 
influencing choice of providers included perceived quality, costs and service level of a 
provider, and lack of provider-initiated referral (Asbroek et al., 2008). The study 
findings and other evidence from the field suggest that TB patients have to overcome 
multiple obstacles to receive TB treatment under programme conditions (Harper, 
2007; Newell et al., 2006; Baral et al., 2007). These barriers are related to economic, 
geographical, socio-cultural, health system and patient factors. There is considerable 
overlap and interdependence between the barriers in each category. I discuss these 
barriers later in this chapter.  
  
43 
 
3.4 Factors affecting treatment completion 
Completion of TB treatment is a multifaceted issue determined by various interplays. 
Treatment behaviour is embedded in a complex web of psycho-social, economic, 
cultural, and health system factors, as well as factors associated with the quality and 
accessibility of TB treatment offered by TB control programmes (Liam et al. 1999). 
For many years, researchers have been accumulating knowledge about the scale of 
poor completion of TB treatment, its determinants and various ways of addressing it. 
However, there has been a widely prevalent tendency to blame patient-related factors 
as the cause of poor treatment completion, to the relative neglect of provider- and 
health system-related determinants (WHO, 2003a).  
Frequent interruption of treatment, drop-out from treatment, irregular treatment, non-
compliance with treatment, late patient, defaulter, non-completer – whatever label we 
put on people who do not complete the prescribed course of TB treatment for 
whatever reason – is a major concern for TB control, as it leads to programme failure 
and contributes to rise of MDR-TB (Borgdorff et al. 2002; Sharma & Mohan 2006), 
or even extremely drug resistant TB which is virtually untreatable. One problem cited 
is that it is difficult to anticipate who will comply with treatment. It has been shown 
that demographic factors such as age, sex, ethnicity, and education status are not 
accurate predictors of treatment completion (Weis et al. 1994; Chaulk et al. 1998). On 
the other hand, psychiatric illness, substance abuse (alcohol and drugs) and 
homelessness are typically associated with non-adherence (Weis et al. 1994; Davidson 
et al. 2000). In general, however, there are several factors that make TB patients 
vulnerable to discontinuing their treatment. In this section, I aim to discuss various 
factors that often present obstacles to patients to continue their treatment. Many of 
these factors are interdependent, so presenting them independently is not 
straightforward. I have tried to present them under separate headings but indicated 
some of the links that occur.         
3.4.1 DOT: a tool to ensure treatment completion 
As I have already described in chapter 2, DOT (Directly Observed Treatment) is one 
of the five elements of DOTS. The aims of DOT are twofold: to ensure patients 
continue TB treatment and thus ensure treatment completion (WHO, 2003b); and to 
ensure patients do not take rifampicin intermittently, to prevent development of 
rifampicin-resistant TB (Enarson et al., 2000). DOT is a mandatory component of 
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DOTS. WHO reports that more than 30 million patients with TB have been treated 
using the DOTS strategy, resulting in cure rates of more than 80% and default rates of 
less than 10%. Many experts believe that WHO's focus on DOT has improved overall 
treatment TB completion rates (Frieden and Sbarbaro, 2007). However, the value of 
DOT itself in achieving high treatment success has been the subject of much debate 
(Volmink and Garner, 1997, 2003 and 2007; Walley et al., 2001; Pope and Chaisson, 
2003; Zwarenstein et al., 1998; Newell et al., 2006).   
 Although one of the aim of DOT is to enhance treatment completion, in many settings 
DOT is not feasible to implement especially in areas with poor access to health 
services (Newell et al., 2006). DOT requires a daily visit to a DOTS centre or 
treatment supervisor. In many settings, TB patients have declared that six months of 
DOT is unfeasibly long, negatively affecting their ability to care for their children, 
interfering with their full-time work or study schedules, and making it difficult to 
provide an income for their families (Gupta et al. 2004; Dick et al. 1996); and some 
patients inferred supervised treatment to mean that the health system did not trust 
them (Hurtig et al. 1999).  High transportation costs, conflicts between work and 
DOT, long waiting times at DOT centres, fear of being seen as a TB patient when 
visiting the DOT centre daily, and inconvenient opening hours of DOT clinics were 
some of the problems identified that patients face while continuing treatment under 
DOT (Johansson et al., 1996; Khan et al., 2000 and 2005; Sanou et al., 2004; Joseph 
et al., 2004; Coleman et al., 1998). All these factors grossly compromised patients' 
ability to continue treatment with DOT (Singh et al., 2002; Greene, 2004). 
Considering the constraints on TB patients caused by DOT, it can be said that DOT as 
projected and implemented by national TB programmes can have a negative impact on 
treatment completion, and could also reduce treatment-seeking practices thus 
impinging on case finding as well as treatment completion (Newell et al., 2006). 
Although other elements of DOTS seem to be uncontentious, the debate on DOT 
continues. In a Cochrane review, Volmink and Garner (2007) concluded that 'directly 
observing people taking their TB drugs did not improve the cure rate as compared 
with people without monitoring of treatment'. The authors mentioned further that DOT 
is expensive to implement and there is no good reason to advocate its routine use in 
programmes. This review provided clear evidence that there is no benefit in using 
DOT to achieve high cure or treatment success rates in TB programmes. The study 
reviewed the results of randomised controlled trials conducted in low, middle and 
high-income countries, and proposed self-administered treatment and treatment 
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observation by a family member as acceptable alternatives. Questions were also raised 
about the resource implications to health systems of running DOT, especially in 
developing countries (Volmink, 1997; Volmink and Garner, 2007). Moreover, the 
debate is increasing as the problem of non-completion of treatment and development 
of multi drug resistance becomes more apparent even though patients are treated using 
DOT within the DOTS strategy (Sumatajo, 1993; Van-Si, 1992).  
However, Farmer and Sbarbaro (2007) have challenged the validity of these assertions 
saying that none of the trials reviewed by the Cochrane authors have effectively 
implemented the direct observation component and have not analysed the post-
treatment relapse rates in trial areas. In their opinion, the absence of this latter 
information makes it dangerous to conclude that DOT is useless. They also mentioned 
that use of family members as DOT provider is only a 'feel-good' idea, as they believe 
rigorous monitoring of treatment will not take place, and information provided by 
family supervisors to the health system may be questionable. However, they also 
acknowledged that family members can potentially be effective treatment supervisors 
in certain circumstances. They also stated that there are challenges in implementing 
DOT, to ensure convenience and respectful interaction with patients is maximised. In 
conclusion, they reemphasized that the only way to achieve high cure rates on a 
programme basis is through DOT given by a person accountable to the health system 
and accessible to the patient (Farmer and Sbarbaro, 2007). 
Many of these concerns about DOT emerged along with wider implementation of the 
DOTS strategy. In fact, the debate stimulated the development of DOTS into the 
broader Stop TB strategy (see chapter 2). Two other important documents were also 
simultaneously released in 2006: the Patients’ Charter for TB Care, and the 
International Standards for TB Care. The new Stop TB strategy has tried to address 
some of the concerns raised about DOT under the heading of 'Standardized treatment, 
with supervision and patient support' in its 24 page strategy document. The new 
phrase introduced in the strategy document is 'supervision and patient support'. It 
demonstrates that the strategy considers patients' needs and their right to treatment and 
cure provided in a conducive environment. The document does not make clear what is 
meant by supervision and patient support and there is no guidance on how it could be 
implemented, and is thus rather incomplete from a programme implementation 
perspective. I was in Nepal when it was launched, and perhaps Nepal is one of the first 
few countries that adopted the strategy shortly after its launch. I was at the launch 
where the NTP made much of the new strategy. In my discussion with policy makers 
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on that day I found that they were not clear how 'supervision and patient support' was 
going to be delivered, and concerned that it would require additional resources to 
implement, while the programme was only just managing to run the routine DOTS 
programme with the resources available.  
The most controversial element of DOTS, DOT, remains unchanged in the new 
strategy. However, the wording gives more flexibility than the original DOTS 
strategy. The strategy (WHO 2006x) reads ‘supervised treatment, which may have to 
include direct observation of therapy (DOT)’ [my emphasis]. When referring to 
treatment providers, the strategy states ‘… supervision must be carried out in a 
context-specific and patient-sensitive manner, and is meant to ensure adherence on the 
part both of providers (in giving proper care and support) and of patients (in taking 
regular treatment). Depending on the local conditions, supervision may be undertaken 
at a health facility, in the workplace, in the community or at home. It should be 
provided by a treatment partner or treatment supporter who is acceptable to the patient 
and is trained and supervised by health services’ [again, the emphasis is mine]. The 
words underlined show flexibility in DOT for the programme: however, words may 
mean little or nothing for patients if programmes continue to insist on DOT as before. 
This confusion suggests a need for NTPs to design programme-based operational 
research in order to tailor supervision and patient support in their programme.   
In summary, DOT has not served the aim of facilitating TB patients towards 
completing full treatment course. There are several contradictions around the 
effectiveness of DOT as it has been projected and implemented in TB control. It may 
or may not have been beneficial in controlling TB, but credible evidence to 
demonstrate the claim is missing. DOT needs to be tailored to context: a blanket 
approach is not appropriate. The modality of DOT needs to be sufficiently patient-
friendly to ensure patients can identify their treatment supervisors; the health system 
should facilitate the process. However, explicit understanding on the qualitative 
impact of DOT in TB treatment is lacking, and this limits designing so-called 
'supervision and patient support' mechanisms in TB control.     
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3.4.2 Socio-cultural factors 
TB is not only a biomedical disease, but also a social disease, because it affects not 
only the person with disease but also the entire family; it affects not only the physical 
status of a person with disease but also their social wellbeing as it erodes social 
support networks and relationships; treatment of TB requires not only biomedical 
interventions but also support from family members and the community; and TB is 
prevalent in overcrowded areas and thrives in communities with low social status 
(Macq et al., 2005; Needham, et al., 2004; Long et al., 2001; Hudelson, 1999; Farmer, 
1999).  
Socio-cultural environment, norms and practices have substantial influence on health 
outcomes in general, not only shaping the nature of illness but also playing critical 
roles in care-seeking behaviour and thus treatment completion. This is particularly 
true for TB, since the disease and the suffering it creates not only relates to patients, 
but because society carries entrenched misconceptions about its causes, communicable 
nature, and treatment practices, and treatment is therefore greatly influenced by socio-
cultural beliefs and practices (Meulemans et al., 2002). Researchers have cited the 
need for TB programmes and health service providers to have greater understanding 
of these aspects, particularly those that influence treatment completion (Johansson et 
al., 2000; Khan et al., 2000; Long et al., 2001 and 2002; Meulemans et al., 2002). 
Farmer et al. (1991) and Sagbakken (2003) concur, adding that structural social 
problems may be the most important contributors to poor TB treatment completion. 
Gaining wider understanding of patients’ social and cultural environments is 
important for TB control programmes as it often influences TB treatment and 
completion (Grange & Festenstein, 1993, Ogden et al., 1999; Sumartojo, 1993). 
Similarly, social scientists and anthropologists have long argued that TB control will 
not succeed in the absence of sufficient attention to fundamental aspects of socio-
cultural dimensions (Farmer, 1997; Harper 2005; Ogden, 1999; Weise, 1974). 
Evidence suggests that it is vital for TB control programmes, whether in developed or 
developing countries, to enhance ways of understanding the socio-cultural aspects of 
TB that contribute to poor completion of TB treatment, and that these will be different 
between and within countries because of varying social groups and social settings. The 
current lack of focus on social indices in the management of TB treatment makes TB 
control programmes less effective than they could and should be (Ogden et al., 1999).    
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There is a strong association between social support others provided to TB patients by 
family and others, and their successful completion of TB treatment (Barnhoorn and 
Aadriaanse, 1992). TB patients who receive positive encouragement from their family 
and friends are more likely to successfully complete their treatment. This finding is 
supported by other studies which add that patients who receive more social help are 
also less likely to be stigmatized (Khan et al., 2000; Meulemans et al., 2002). TB 
morbidity and mortality rates are also related to people’s social status. Improved social 
status contributes to lower TB transmission and greater support to TB patients towards 
successful treatment completion, as was observed in developed countries during the 
1950s; and at one time some TB control experts envisaged that TB would soon be 
eliminated (Farmer, 1997). However, due to increasing HIV infection and emergence 
of drug resistant TB, along with an insufficient focus on the socio-cultural dimensions 
of TB, the dream of making TB a disease of the past has not come true and the world 
continues to struggle to control it (Shah et al., 2007). However, it cannot be denied 
that improved communities’ social status helps combat TB. 
The problem of TB appears to be greater in urban areas, where the social composition 
is diverse with multi-cultural, multi-ethnic groups, and complex community settings. 
Also rapid urbanization with increasing migration, homelessness, urban slums and 
unemployment in urban areas make TB control efforts more fragile, as these factors 
have considerable impacts on the spread of TB disease, its service provision and 
completion of its treatment. In addition, the diverse socio-cultural profile of health 
service providers and TB patients in urban areas has been an important factor 
influencing interactions and relationships between providers and patients thus 
affecting treatment outcomes. However, inadequate understanding of the ways urban 
complexity and socio-cultural structures impact on TB control programmes limits 
effective ways of overcoming these barriers.   
In Nepal, the persistent legacy of interconnected caste, ethnic and gender-based 
exclusion, a complex social hierarchy and socio-cultural diversity continues to 
influence health, with low service utilization and poor outcomes among socially 
excluded groups (NDHS, 2006; MoHP 2010). For further details see chapter two, 
section 2.7.1. In the recent past there has been massive cultural transformation in 
Nepal along with rapid urbanization, migration from rural to urban areas (both within 
Nepal and internationally), and creation of new settlements with blends of various 
socio-cultural groups. This will continue to pose problems in provision of health 
services including for TB, especially in urban areas. TB has been a taboo and 
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traditional home remedies and care-seeking from traditional healers have been 
common practices rooted in cultural beliefs. The association of TB with various socio-
cultural beliefs such as TB being a consequence of past wrong doing, association of 
TB with low caste, and TB being linked with impurity, dirt and bad habits like 
drinking and smoking, have implications for the delivery of TB services; and being 
required to visit a TB centre for daily treatment makes TB services more difficult to 
access (Harper, 2005). However, we have limited knowledge on how and why social 
and cultural concepts help or hinder TB services, preventing the development of 
effective ways of addressing negative impacts of socio-cultural beliefs and practices 
(NTP 2007). In the absence of such knowledge, improvements in TB control through 
ensuring successful treatment completion will be difficult, especially in complex 
urban contexts. 
It has been widely recognised that socio-cultural barriers present threats to successful 
TB treatment completion, and thus accomplishment of TB control goals will not be 
feasible if the socio-cultural phenomena of TB disease are kept in isolation from the 
programme. Until now, attribution of the impacts of socio-cultural factors on TB 
treatment completion has been measured in quantitative terms, thus limiting wider 
understanding of how and why socio-cultural beliefs and practices help or hinder 
treatment behaviour of TB patients. This suggests the need for an explicit 
investigation rather than just reiterating issues which have already been identified. 
Sumartojo (1993) supports the need for further research, saying ‘social and 
behavioural research is particularly important at this time because of changes in the 
epidemiology of the disease TB’.  
3.4.3 Stigma and discrimination 
Although stigma can be classified as a socio-cultural issue, I discuss it separately 
because of its impact on successful TB treatment completion. The two words stigma 
and discrimination are often used interchangeably, which can lead to confusion about 
cause and effect. Defining stigma is not simple because explanations and concepts 
vary and it is difficult to establish cut-off points between what is stigma and what is 
not (Maco and Martinez, 2006). Goffman (1963) defines stigma as an 'attribute that is 
deeply discrediting' and that reduces the bearer from 'a whole and usual person to a 
tainted, discounted one'. Goffman classified stigma into three different types: 
‘abominations of the body’ (the various physical deformities); ‘blemishes of 
individual character’ perceived as weakness, domination, and rigid beliefs and 
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dishonesty; and ‘tribal stigma of race, nation, religion and castes’. In simple term 
stigma is a negative attitude whereas discrimination is negative behaviour resulting 
from stigma. Stigma is therefore important because of the way it causes discrimination 
(Baral et al., 2007).  
Fear of stigma and discrimination is a major reason why people with TB delay seeking 
proper care and fail to complete treatment (Meulemans et al., 2002; Khan et al., 2000; 
Kelly 1999; Nair et al., 1997; Liefooghe et al., 1995; Liefooghe et al., 1999; Auer, 
2003; Kelly, 1999; Jaramillo, 1998; Johansson, 2000). The association of TB with 
poverty, itself stigmatized, further increases TB stigma and makes TB control even 
more complicated (Johansson et al., 1997; Meulemans et al., 2002). The consequences 
of TB stigma are social isolation, rejection, shame, blame, and self-isolation, all of 
which can lead to severe stress, loneliness and hopelessness, which have direct 
implications for treatment. As a result of social stigma, discrimination against people 
with TB occurs in workplaces, healthcare facilities, communities and families. The 
consequences of such discriminatory behaviours on TB patients can be devastating as 
they cause feelings of isolation, disgrace and shame (Mason et al., 2001; Johnson, 
1995) and can eventually lead to non-completion of treatment. However, stigma 
attached with TB varies from country to country and therefore addressing TB stigma 
and discrimination requires a comprehensive understanding tailored to local contexts 
(Baral et al., 2007). 
The effects of stigma are clearly seen in the community. Women seem to be more 
vulnerable. Married women may be divorced by their husband and unmarried 
women’s marriage prospects may be jeopardized because of TB (Long et al., 2001; 
Khan et al., 2000). Moreover, women TB patients’ loss of physical strength, inability 
to perform household jobs, and financial loss are important contributors to 
stigmatization in the community (Meulemans et al., 2002). Similar results have found 
in Vietnam, Pakistan and India where women TB patients are more worried about the 
social consequences of the disease than men, as women with TB fear they could be 
isolated or expelled from home (Long et al., 2001; Khan et al., 2000; Nair et al., 
1997). In India, mothers have been observed attending clinics claiming to be suffering 
from TB, although in reality it was their daughters that had the disease: the mothers 
were protecting their unmarried daughters (Nair et al., 1997). This further highlights 
how TB stigma and discrimination can make women’s lives extremely difficult.  
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In Nepal, issues related to stigma and discrimination provide substantial barriers to 
care-seeking and treatment completion. TB patients generally isolate themselves from 
community, friends and family for fear of transmitting TB to others (Baral et al., 
2007). One study suggests that because of TB stigma, a higher proportion of women 
than men that remain undiagnosed in the community (Connolly and Nunn, 1996). 
Anecdotal evidences from the field suggest that there are still many people who hide 
their disease due to fear of stigma, taking treatment in the private sector to avoid being 
seen in the DOTS programme.  
In summary, TB is stigmatised for both men and women, though to different degrees, 
causing discrimination in the community. Such discriminatory behaviour influences 
TB care-seeing and treatment, leading to poor treatment completion and disrupting TB 
patients’ positions within their societies. It is therefore vital to gain wider 
understanding of how stigma causes discrimination and affects TB patients at various 
stages of their treatment and identify ways TB control programmes can effectively 
address these issues.  
3.4.4 Gender and TB 
The term sex is used to distinguish men and women based on their biological 
characteristics whereas gender is used to distinguish men and women based on 
features that are socially constructed. Gender influences the control men and women 
have over the determinants of their health, for example their economic position and 
social status, and their access to resources (WHO, 2005c). In this section, I consider 
knowledge on TB and its treatment from a gender perspective.  
TB researchers have looked at gender differences in infection and disease progression, 
health-seeking behaviour, treatment completion and many other social aspects. 
Interactions between society, culture and TB control raise important questions about 
the role of gender and discrimination in all aspects of the disease, from case finding to 
diagnosis, treatment and eventual outcome. In most countries, men carry more of the 
TB burden as the estimated male to female ratio of TB cases reported worldwide is 
two to one (Borgdorff et al., 2000). A similar scenario is seen in Nepal. However, TB 
poses a major threat to women’s health security: in 2008, 3.6 million women had TB 
and 700,000 women died from TB, making TB the third leading cause of death 
worldwide among women aged 15-44 years (WHO 2009). TB makes women more 
vulnerable than men because of their low status in society and because of relatively 
high stigma and discrimination by families and communities (Johansson et al., 2000). 
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In Bangladesh, women have poorer access to public out-patient clinics and are less 
likely to undergo sputum examination than men (Begum et al., 1994). Moreover, 
women see themselves and are seen by others to be more sensitive to poor service 
conditions (Johansson et al., 2000).  
Health care providers often treat women as being inferior and therefore women are 
hesitant to seek treatment and interact with health care providers (Vlassoff, 1994), 
particularly when the health workers are male. In Mumbai, India, women’s household 
responsibilities made it impossible for them to continue TB treatment, and women 
kept their disease undisclosed for fear of rejection (Nair et al., 1997). Men with TB 
seemed more worried about financial implications of TB disease, and thus paid less 
attention to completing their treatment (Johansson et al., 1999) whereas women were 
more worried about social implications of TB such as rejection by their husband and 
in-laws and reduced chances of marriage (Nair et al., 1997). Studies from other 
developing countries by Long et al. (2001) and Khan et al. (2000) support these 
findings. Most women who defaulted from treatment said concerns about interactions 
with health-care providers and social stigma were the main reasons for their default. 
Weiss (2003) reported that for 70% of women in Maharashtra, India, consuming 
medicines in the presence of a health-care practitioner was unacceptable. If they were 
forced to take their medicines under direct observation, these women preferred to do 
so under the supervision of a female nurse. These findings support those of an earlier 
study by Balasubramanian et al. (2000), which also indicate that women are less likely 
to accept DOT than men because of concerns about social stigma. These findings 
clearly suggest that the imposition of DOT forces people towards non-completion or 
prevents people from starting treatment in the programme. Getahun and Aragaw 
(2001) identified clinical improvement during treatment as the most common reason 
for treatment discontinuation, followed by long distance to the treatment facility. 
Support from family and community was found to be a critical element in promoting 
treatment adherence. It is therefore suggested that if TB programmes wish to achieve 
high treatment completion, the TB treatment delivery modality needs to be developed 
and implemented within a wider understanding of patients’ needs and tailored to local 
context (Newell et al., 2006).  
In Nepal, the male: female TB case detection ratio is 2:1. More women complete TB 
treatment than men (NTP 2008/09). As in other countries, there are significant gender 
differences among TB patients, including in treatment seeking behaviour, overall 
knowledge on general aspects of TB, social problems faced by patients, and treatment 
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completion (NTP, 2008/09; NTP, 2007; Asbroek et al., 2008; Yamasaki et al., 2001; 
Baral et al., 2007). Women have lower access than men to health services in both rural 
and urban areas. Women have been historically deprived in Nepali society, adding 
further complications, since women have little or no control over household resources. 
Women have very few decision-making roles in the family. Such unequal division of 
roles and responsibilities makes it more difficult for women than for men to seek 
proper health care. Thus, gender roles not only affect illness reporting but also 
decisions to choose a health care provider and how much to spend on the sick woman 
or man: gender affects all steps of health-care seeking behaviour (Pokhrel, 2005; 
Smith, 1994). A TB case-finding survey showed that health facilities were less utilized 
by women than men, as women continue to hide their illness until it severely affects 
their routine life, and mobile clinics were particularly attractive to women in rural 
areas (Harper et al., 1993).  
In summary, gender inequality is an issue in TB control influencing TB treatment 
completion, with women tending to have worse access to TB services than men. 
Women seem to be more receptive to TB treatment, but the sufferings women face 
due to TB is enormous. There is a need for further in-depth investigations into the 
impact of gender differences on TB control. 
3.4.5 Economic factors 
The poor are at high risk of developing TB as poverty makes people more vulnerable 
to ill health, and reduces their capability to cope when these illness occur. The 
association between TB and poverty has been discussed in chapter one. This section 
mainly focuses on the economic consequences of TB disease on TB patients and their 
households at various stages of the care-seeking process; and patients’ financial ability 
to continue TB treatment in the context of developing countries and specifically 
Nepal.  
TB is more common among the poor and disadvantaged, and low economic status is 
an important predictor of non-completion of TB treatment (Meulemans et al., 2002; 
Barnhoorn & Adriaanse, 1992). This presents a major challenge to TB control as the 
disease is most prevalent among the poor. The situation is complex as TB severely 
affects the financial status of patients and their families because many TB patients lose 
their routine income, and are forced into poverty from which there is no escape (Khan 
et al., 2000; Liefooghe et al., 1999; Barnhoorn & Adriaanse, 1992; Comolet et al., 
1998; Khan et al., 2005; Jaiswal et al., 2003; Johansson at al, 1999; Johansson et al., 
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1996; Johansson and Winkvist, 2002; Liefooghe et al., 1995). Although anti-TB drugs 
are provided free in the public sector, other direct and indirect costs born by TB 
patients (such as transportation for multiple clinic visits, loss of wages and opportunity 
costs of time spent) put these so called free services beyond the reach of many poor 
people (Kemp et al., 2007; Johansson et al., 2000; Barnhoorn & Adriaanse, 1992; 
Rubel &Garro, 1992; Comolet et al., 1998). Nair et al. (1997) found that TB caused 
on average a loss of 60% of monthly income among wage-earning respondents in 
India. Similarly, Kemp et al. (2007) found that in Malawi the cost of TB diagnosis 
(direct and indirect) for poor could be as high as 574% of their total monthly income. 
They highlighted that the poor and women pay more for TB diagnosis. It is clear that 
poor people need to divert scarce resources to seek the TB care that is claimed to be 
free of charge for all. 
For many TB patients there is a conflict: should they choose to support themselves 
and their family and die with disease; or attend the clinic for treatment and die of 
hunger? Men, as head of households and often the sole wage earner, tend to raise this 
dilemma more frequently than women (Liefooghe et al., 1995; Greene, 2004; Khan et 
al., 2005; Johansson et al., 1999; Coleman et al., 1998; Demissie et al., 2003): it is a 
difficult choice, as many patients are not able to afford to both feed the family and 
attend the TB clinic (Khan et al., 2000; Jaiswal et al., 2003; Johansson et al., 1996; 
Nair et al., 1997). This situation forces many TB patients to abandon treatment. Many 
TB patients interrupt TB treatment citing an inability to afford the cost of care 
(Watkins and Plant, 2004; Greene, 2004; Johansson et al., 1996) and express guilt that 
they are unable to stop TB forcing their entire family into difficulties (Sanou et al., 
2004; Johansson and Winkvist, 2002; Demissie et al., 2003). Despite evidence of 
enormous financial consequences to TB patients and their families due to TB, health 
care providers in some settings do not acknowledge the fact, merely stating that TB 
treatment is provided at no cost (Greene, 2004). This shows a lack of health care 
providers’ understanding of patients’ suffering due to TB, which may contribute to 
poor TB treatment completion rates. However, in some cases providers did 
acknowledge patients’ financial constraints (Sanou et al., 2004).  
In Pakistan, almost 32% of patients did not complete treatment due to lack of financial 
support during their treatment (Liefooghe, 1997). This finding is supported by a 
literature review of TB in India performed by Ogden et al., (1999). Mull et al., (1989) 
pointed out in their study on Pakistani leprosy patients that economic and social 
support appears to be a valuable tool in reducing the number of treatment defaulters.   
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In summary, TB pushes the poor deep into poverty and places a massive financial 
burden on TB patients and their families, severely damaging their likelihood of 
completing TB treatment. Although TB patients receive free treatment from national 
programmes, other costs (e.g. opportunity costs, income loss, and costs of care, 
transportation and additional food) give a high financial burden to patients, creating 
problems of TB treatment continuation. Although TB patients who successfully 
complete treatment may have gone through the same difficulties but overcome 
financial problems by applying coping strategies, there is little or no mention of this 
issue in the literature. The conclusion must be that national TB programmes have not 
paid sufficient attention to reducing financial barriers among TB patients and TB 
control strategies are not addressing the needs of the poor. There is a clear need for 
further research to better understand how to establish ways of addressing financial 
problems patients face. 
3.4.6 Physical access to treatment 
Access to health care may be examined from three major perspectives: availability 
(physical access); acceptability (social access) and affordability (economic access). 
Social and economic factors have already been discussed above (see sections 0 and 
3.4.5): this section focuses on physical access to TB treatment. 
Availability of TB services is generally measured using the distance from the patient’s 
home to the TB diagnosis and treatment centre (the DOTS centre). It is an important 
factor that may lead to poor utilization of TB services. Studies in Pakistan, India, and 
many other parts of the world have reported that patients who live close to DOTS 
centres are more likely to complete their treatment than those who live a long distance 
away from the DOTS centre (Khan et al., 2000; Liefooghe et al., 1999; Al-Hajjaj & 
Al-Khatim, 2000). Comolet et al. (1998) found that patients who live more than half 
an hour away from the treatment centre interrupted TB treatment and then defaulted 
from treatment more often than those who live closer. A similar situation can be noted 
in Nepal, especially in rural areas where DOTS centres are far from patients’ homes. 
In many settings, DOTS clinic opening times are not convenient for many patients, 
causing patients major problems in receiving daily DOT from DOTS centres. In Nepal 
this issue is mainly raised by daily wagers in urban areas who often work long hours, 
leaving their rented room early in the morning and not returning until late. The 
problem also occurs for people who have positions such as office bearers and students. 
However, good physical availability of TB services under DOTS does not mean that a 
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DOTS programme will be accessed by many patients. There may be other reasons for 
the low use of DOTS programmes like socio-cultural constraints, economic 
constraints, inappropriate behaviour of health workers, and quality of services, as 
discussed earlier. Studies have also pointed out that private practitioners are popular 
not only because of the respect shown to patients by private doctors but also the 
convenience of their location and opening hours (Uplekar et al., 1998; WHO, 2001; 
Newell, 2002).  
In summary, access to health facilities is an important area which determines 
treatment completion. Patients with easy access are more likely to take treatment 
regularly. However, there is limited understanding in the context of urban areas how 
factors such as distance, clinic opening hours, and the presence of other services in the 
public and private sectors contribute to non-completion, and further studies are needed 
that look explicitly at links between access to TB services and treatment completion.  
3.4.7 Knowledge and attitudes to disease and treatment among 
TB patients 
Knowledge of disease and treatment plays an important role in completion of 
treatment. Treatment interruption has repeatedly been related to perceptions about TB 
as a disease; some patients did not believe that they had TB, only wanting a cure for 
their symptoms and stopping treatment once they lessened. TB patients with poor 
knowledge of their disease and treatment are less likely to complete their treatment. 
Barnhoorn & Adriaanse (1992) found that TB patients who had an active orientation 
and adequate knowledge of TB and its treatment were more likely to complete 
treatment than patients who had less understanding about the disease and treatment 
approach. In contrast, Liefooghe and Muynck (2001) found knowledge of TB itself 
did not have a clear impact on defaulting but attitude towards treatment did. Many 
studies have found that after some months of TB treatment, many patients feel better 
or cured and discontinue their treatment due to lack of clear knowledge about their 
disease and treatment (Tekly, 1984; Barnhoorn & Adriaanse, 1992; Liefooghe et al., 
1997). In TB control, ‘on and off treatment’ is well known; but there is a tendency to 
blame patients where in reality they are unable to continue treatment due to factors 
outside their control.  
Positive and negative beliefs of patients’ regarding disease and efficacy of treatment 
may affect treatment continuation, as noted by Munro et al. (2007) in their review. 
The efficacy of drugs, especially pills, is normally a concern to many TB patients: 
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some think that injectables may do better than oral drugs. Belief in treatment efficacy 
appears to be related to patient confidence in the medical system (Singh et al., 2002; 
Johansson and Winkvist, 2002). Patients ask for medicine if they feel unwell and drop 
out of treatment when they feel better (Barnhoorn & Adriaanse, 1992).  Liefooghe 
(2000) observed in Pakistan that many patients want to have quick relief once they 
start taking drugs: if there is no significant improvement at the initial stage this may 
lead to dissatisfaction with treatment and medical shopping, a trend seen in most 
developing countries. This finding was confirmed in a second study, which found that 
non-satisfaction with treatment was the main reason for defaulting (Dataline Service, 
1998). A similar situation exists in Nepal (author’s personal experience). It has been 
found that many TB patients fear and deny a diagnosis of TB, and some patients do 
not accept their diagnosis: such feelings and behaviour could lead to non-completion. 
Conversely, though, some studies noted that patients’ desires to be cured acted as a 
motivator for completing treatment (Watkins et al., 2004; Marra et al., 2004; Wares et 
al., 2003).  
In many developing countries TB is still perceived as an incurable disease (Liefooghe 
et al., 1997; Khan et al., 2000), and my experience from Nepal shows that patients 
who have little information about TB and its treatment are more likely to stop their 
treatment (informal consultation with TB patients and care providers in DOTS 
centres) and feel more stigmatized (Baral et al., 2007). A study in a teaching hospital 
in Malaysia found that improved knowledge of TB by TB patients and families helps 
to improve treatment completion (Liam et al., 1999).  Similarly Meulemans et al. 
(2002) found in Pakistan that patients with higher professional rank and with 
reasonable knowledge about TB and its treatment had more belief in the curability of 
disease and were more likely to be compliant compared with unemployed and 
illiterate patients.  
Completion of treatment requires the active participation of the patient. Patients’ 
treatment literacy, and knowledge of TB disease and its treatment, therefore plays an 
important role. A study in the Wardha district of India found that for TB treatment to 
be successful, patients must see themselves as vulnerable to the illness, believe that it 
is of a serious nature, be convinced that treatment will be efficacious and experience 
external or internal motivation to complete the prescribed course of treatment 
(Barnhoorn & Adriaanse, 1992). For their motivation, knowledge about disease and 
treatment is vital. Other authors recommend further research to help understand this 
issue. Other factors contributing to non-adherence include language barriers and lack 
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of awareness about the existence of TB treatment programmes. This is especially true 
among migrants who have arrived in cities (Daniela et al., 2009). A study conducted 
in New York City on Chinese immigrants enrolled in TB DOT programmes (Ho 2004) 
revealed that new immigrants are unaware of TB treatment programmes and 
consequently waste a significant amount of time and money seeking treatment from 
multiple providers (e.g., hospitals, general practitioners and traditional Chinese 
practitioners). Lack of on-going patient-provider communication, inadequate 
treatment supervision/support from health care workers and the perception that 
treatment facilities are unwelcoming are also potential barriers to treatment 
completion especially in urban areas where there are multiple providers and multiple 
users.  
In summary, patients’ knowledge and attitude influence treatment behaviour thus it is 
imperative that health care providers working in TB programmes give patients 
adequate information. Approaches to providing the right information at the right time 
within the treatment process with an appropriate approach to treatment literacy need to 
be well embedded in routine programme activities: health care providers need to be 
sufficiently equipped with relevant education materials to help communicate 
information to patients and address any negative attitudes to TB treatment. 
3.4.8 Health care provider and patient relationships 
Successful treatment requires an understanding between patients and providers in 
order to develop their treatment plan and mutually execute the plan. The role of health 
care providers is crucial from the beginning to the end of treatment: health workers 
who are well informed about patients’ needs will help patients to implement their 
treatment plan to cure their TB. In this regard, health workers’ behaviour and 
relationships with TB patients and their family members cannot be overlooked: they 
can contribute to non-completion of treatment by their behaviour (Grange & 
Festenstein, 1993). When TB patients have good knowledge of the nature of the 
disease, treatment requirements and effects of drugs, they are more likely to follow the 
treatment required to achieve cure. Success of TB treatment is related not only to 
biomedical factors: there is a web of social, psychological and behavioural factors 
which influence patients’ and providers’ relationships and overall treatment. The 
relationship developed between the patient and the provider is key to achieving 
success in treatment, and requires investment of time and energy from both sides 
(Enarson et al., 2000; Liefooghe et al., 1999). Studies in this area have not assessed in 
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depth how health care providers’ behaviour and relationships influence TB treatment 
completion. However, some studies have found that the relationship between 
providers and patients performs a key role in treatment completion. The Centres for 
Disease Control (CDC) also echo the above statement. Furthermore, the CDC 
identifies other key factors that sway relationships and have direct or indirect 
influence on treatment outcomes: personal and social characteristics of patients and 
providers; culture, knowledge and beliefs of patients and providers; health care 
infrastructure; and quantity and quality of information available to patients (CDC, 
1994). However, limited research in this area inhibits understanding of how good 
relationships can be developed by addressing issues related to both patients and 
providers.  
Several studies have noted that a substantial number of TB patients seek care from 
private practitioners, one reason being that they have gained popularity among TB 
patients and their families. Most authors agree that poor relationships between patients 
and government sector providers is a factor in increased use of private practitioners 
(Uplekar et al., 1998; WHO, 2001; Newell, 2002).  
If patients trust health care providers, they are more likely to visit the health facility 
regularly and discuss their problems (Barnhoorn and Adriaanse, 1992). Trust cannot 
be established unless there are good relations and sharing of treatment decisions by 
patients and their families. Thus the problem of treatment non-completion could be 
reduced by improving relationships between providers and patients (Nuwaha, 1999; 
Meulemans et al., 2002). Furthermore several authors (Khan et al., 2000; Liefooghe et 
al., 1999; Nuwaha, 1999; Meulemans et al., 2002; Barnhoorn and Adriaanse, 1992) 
state that effective health care delivery is possible if the health care provider does not 
provide support, love and respect and is just concerned with providing drugs without 
showing any feelings or providing adequate information. 
In summary, inadequate or poorly established relationships between patients and 
providers deters continuation of TB treatment, which is not good neither for patients 
nor for the health system; thus good relationships and trust are vital from both sides. 
Several studies have identified that mutual confidence between service providers and 
patients has to be established, tailored to each patient. Fears and misunderstandings 
differ from patient to patient, and should be considered for each individual – an issue 
which is not properly addressed in TB control (Nuwaha, 1999; Meulemans et al., 
2002). 
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3.4.9 Therapy related factors 
The TB treatment regime is complex, including several drugs, some of which can have 
substantial side effects. This complexity, real, anticipated, or culturally interpreted, 
has often been mentioned as a common cause of treatment interruption (Liam et al., 
1999; Jaiswal et al., 2003; Greene, 2004). The number of medications prescribed, the 
difficulty associated with swallowing the medication, the frequency of dosing and the 
occurrence of side effects (e.g., skin rash, hepatitis, stomach upset) can all contribute 
to higher non-completion rates. Chaulk et al. (1998) noted that the higher the levels of 
these factors, the lower the adherence to treatment. 
Poor management of drug side effects can result in patients stopping taking drugs. In 
national TB programmes, health workers receive training on identification and 
management of drug side effects. However, health workers’ and patients’ 
interpretations of side effects and their severity can vary. This often results in poor 
management of issues reported by patients, and in many instances, patients are badly 
informed about side effects and their potential impacts on their illness. Patients say 
that health workers pay little heed when they report drug side effects: in some cases 
they have responded with derision (Nair et al., 1997; Greene, 2004; Jaiswal et 
al.,2003; Singh et al., 2002; San & Bothamley, 2000). When side effects occur, 
continuing treatment can sometimes be fatal. Poor management and inappropriate 
responses to reports of side effects also shows a lack of responsiveness by health 
workers and can deter treatment continuation. 
In summary, side effects during TB treatment are caused neither by patients nor health 
workers, but if not promptly managed can deter treatment continuation. It is important 
that health workers are sufficiently skilled and responsive to issues reported by 
patients, and provide information on potential drug side effects in advance. Cultural 
perceptions of TB drug effects need to be explored properly. 
3.4.10 Other factors affecting TB treatment completion 
Other factors also influence TB treatment completion. These include migration; 
patients’ satisfaction with treatment; quality of service and delivery of care; ethnic 
differences; occupation; age differences; and floating populations. Limited 
information based on good research is available on these factors. Patients who are 
migrants have poor access to treatment. Most are not aware of the availability of 
treatment services (Kirwan et al., 2009). Patients from low castes may have 
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difficulties continuing TB treatment. Some occupations may interfere with patients 
continuing TB treatment: such occupations include drivers, trekkers, contracted 
labourers, the police and the army, who often move from one place to another during 
their work. However, issues related to these groups have not been investigated in 
depth. It is difficult to predict who is going to complete treatment and who is not, 
based on the characteristics of the patient. However, some groups have been identified 
as high risk of non-completion: these include substance abusers (drug users, 
alcoholics), homeless people, migrants, people with mental illness, and residentially 
mobile people (Coleman et al., 1998; Nair et al., 1998; Jaiswal et al., 2003).  
3.5 Responses to lateness or non-completion in TB treatment 
This section presents various responses put in place to enhance TB treatment 
completion in different settings. Experts have noted that even with accessible and 
appropriate health care, some patients still face various obstacles and do not always 
complete treatment (Volmink, Garner, 1997). It is well documented that establishing 
effective TB control is an enormous task for health systems, especially in developing 
countries.  
3.5.1 DOT to improve TB treatment completion 
DOT is seen by many as a good method of ensuring that patients continue treatment, 
but continues to be contentious. The Stop TB strategy emphasizes patient-centred 
‘supervision and patient support’ which may include DOT but tailored to the local 
context. However, the strategy lacks detail on approaches to supervision and patient 
support, and what is meant by patient-centred. As a result, many countries have not 
yet come with well-designed mechanisms to translate the strategy into practice. More 
detail is given in section 0. 
3.5.2 Support from family and community 
Several studies have found that family support greatly improved treatment completion, 
yet in general NTPs do not appear to try to mobilise families. Instead, many 
programmes include various forms of community support, but the effects of this 
support within the social context have not been properly evaluated. Many national 
programmes (including Nepal) have a DOTS committee in most DOTS centres, the 
role of which is to address public awareness, community advocacy and education, 
provide treatment observers and patient tracers, identify local solutions and encourage 
cooperation (Macq et al., 2003). These committees (where active) have helped TB 
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patients and their families by encouraging them and facilitating a local social 
environment for TB treatment. The provision of identified late patient tracer 
volunteers, especially in urban areas, has contributed significantly in raising 
awareness and helping TB patients when they are late in TB treatment (Thomas et 
al.,2007; Newell et al.,2004; Baral et al., 2009; Harper, 2006). Nepal has an extensive 
network of female community health volunteers who provide help to TB patients by 
acting as their treatment observer (Newell et al., 2006), removing the need for patients 
living in remote areas to travel long distances to get TB drugs. Munro et al. (2007) 
noted that positive community and family attitudes helped TB patients to overcome 
TB-related stigma and discrimination and also offered support in maintaining 
treatment taking. On the contrary, negative community and family attitudes can act as 
strong barriers to taking TB treatment. In such circumstances, community-based TB 
treatment programmes and stronger involvement of local social networks to support 
TB patients are well justified (Newell et al., 2006).  
3.5.3 Financial incentives 
TB patients’ poor financial situations and additional financial stress due to TB are two 
of the major barriers to completing TB treatment. In the light of this issue, financial 
incentives, either in cash or as vouchers, have been used to help TB patients continue 
their treatment. Several authors have commented on the effectiveness of financial 
incentives and the sustainability of these measures in different settings.  A review 
performed by Volmink and Garner (2000) found that some forms of incentives like 
free food and clothes were effective. Many interventions using financial incentives 
performed in developed countries were effective to bring continuity in TB treatment 
(Bock et al., 2001; Davidson et al., 2000). However, there are relatively few studies 
investigating financial interventions in developing countries, suggesting that 
programmes are not sufficiently established or financed to consider financial 
incentives to TB patients.   
3.5.4 Different forms of late patient tracing mechanisms 
including reminders 
The term ‘late patient tracing’ is generally defined as any action by the programme or 
individuals to contact patients when they are late for their treatment. What is meant by 
‘late’ varies from two days to several weeks. Another approach is reminders, defined 
as any action to inform patients to take their medication at any stage of treatment. 
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Reminders are commonly used when patients are late to collect drugs on their due 
date.  
Mechanisms such as telephone reminders, reminder letters and cards, and home visits 
by health workers or community volunteers have been used in many programmes to 
enhance treatment completion among TB patients. In Saudi Arabia patients who failed 
to collect TB drugs for two weeks were traced using home visits by social workers and 
a telephone call where possible, but no data is given to assess the effectiveness of this 
method on increasing treatment completion rates (Al-Hajjaj & Al-Khatim, 2000). A 
similar tracing system was applied in rural Uganda but no measure of the effectiveness 
of this system was given (Nuwaha, 1999). Volmink and Garner (2000) mention that 
tracing of late TB patients has been a major part of many programmes applied in local 
settings and their effectiveness vary. In Nepal, tracing using volunteers in an urban TB 
programme in Lalitpur gave good results (Thomas et al., 2007; Newell et al., 2004 
and 2005). In contrast, Lonnroth et al. (2001) found in Vietnam that tracing of 
defaulters had potentially negative effects on patients’ willingness to attend DOTS 
clinics.  
In a Cochrane review, Liu et al. (2008) reviewed reminder and late patient tracer 
interventions in the diagnosis and management of TB. The authors reviewed nine 
trials, six of which assessed reminder systems and three the use of late patient tracers. 
They concluded five of the six studies assessing a reminders system showed benefits 
in increasing adherence in TB treatment, as did all the trials of late patient tracers. 
They further noted that the use of letters appeared to be effective in encouraging 
patients to return to treatment who were late even in those who were illiterate. 
However, all interventions assessing reminder systems were conducted in developed 
countries (USA and Spain), so may not be relevant to developing countries.    
3.5.5 Health education 
Continued education of TB patients is part of national TB control programmes. 
Effective education provision to individuals and to society appears to be a logical 
solution to problems of treatment completion. All the literature reviewed agrees that 
health education is important in TB control. However, in many countries national TB 
programmes seem to focus on identification of cases to the exclusion of good 
management of cases through an effective health education network. Several authors 
(Liefooghe et al., 1999; Nuwaha, 1999; Meulemans et al., 2002; Barnhoorn and 
Adriaanse, 1992) from many countries have stated the importance of health education 
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in reducing problems with non-completion in TB treatment, but most have not 
assessed its direct impact on TB treatment completion.  
A randomized control trial in Pakistan found counselling in TB treatment is effective 
in improving adherence if it is provided one-to-one (Liefooghe et al., 1999). Several 
studies have recommended effective health education to help to decrease social stigma 
and discrimination of TB, which will lead to better treatment completion (Lonnroth et 
al., 2001; Baral et al., 2009; Harper, 2006; Jaiswal et al., 2003; Frieden and Sbarbaro, 
2007; WHO 2009b). In Nepal, health education for TB patients at DOTS centres and 
other awareness programmes is part of routine national TB programme activity. 
However, the effectiveness of health education in increasing treatment completion has 
not been assessed and concerns have been raised about its effectiveness as the 
programme uses conventional ways of delivering education to patients and 
communities. A review of the NTP in 2007 also highlighted this and recommended 
innovative approaches to health education in the programme; however, the programme 
has not yet developed an effective health education and communication strategy. The 
NTP recently started implementing a patient-to-patient education programme, in 
which successfully treated TB patients provide information to new TB patients. This 
programme seems likely to be effective if implemented well, but its effectiveness in 
improving continuation of TB treatment is yet to be assessed. A similar approach to 
educating TB patients and families was found to be effective in Pakistan, and also 
increased social and family support to TB patients (Liefooghe and Muynck, 2001). 
Balasubramaanium et al. (2000) also believe that use of trained community 
volunteers, religious leaders, NGO members, cured TB patients and shopkeepers as 
treatment supervisors help to ensure treatment completion. However, identifying a gap 
in the current health education process, Kelly (1999) urges changes in the current 
system of providing information to patients. She proposes alternative ways of working 
with patients by replacing the current one-way flow of information from health worker 
to patient towards a process of negotiation between provider and patient.  
Previous reviews have shown that interventions directed at staff in TB clinics rather 
than patients were key in improving patient treatment completion. Patients with TB 
attending health centres with intense staff supervision were more likely to complete 
treatment than those attending health centres with routine staff supervision (Volmink 
and Garner, 2003). A subsequent review by Volmink et al. (2000) provided a 
summary of 15 programmes with intensive and personalized management 
interventions to motivate staff. Interventions included lectures and role playing which 
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provided staff with in-depth training in various areas, including communications, 
confidentiality, outreach techniques, and management of TB. External funding for 
health education was also seen as an important and necessary component of effective 
DOT programmes. Salihu et al. (2001) remind us that factors such as adequate 
training and commitment by care providers and those involved in TB control 
programmes, as well as overall administrative efficiency, are important factors that 
help patients to continue their treatment. 
In summary, various measures have been proposed to combat the problem of non-
completion. They include increased service access, mass media campaigns, 
decentralization and integration of the TB programme into the primary health care 
system, intensive supervision of clinic staff, mailed or telephone reminders of 
appointments and follow-up of missed appointments, giving medicines in well-
organised containers and maintaining good relationships between TB patients and care 
providers (Meulemans et al., 2000; Barnhoorn and Adriaanse, 1992). 
3.6 Successful treatment completion remains an issue 
Studies have found successful completion of treatment is associated with multiple 
factors including social, behavioural and economic factors, health systems, and 
structural factors such as poverty and gender. The route to successful TB treatment 
completion is difficult for many patients, as studies have shown that TB patients often 
take their TB medication under difficult circumstances and experience significant 
challenges, many of which are outside their direct control (Munro et al., 2007). 
Undergoing treatment lasting a minimum of six months, and an unbearable period of 
DOT, in combination with many individual constraints, compel patients and their 
household to take difficult decisions at various stages of the care process, sometimes 
at substantial personal and social cost. The factors affecting TB treatment are 
intricately linked: see Table 7 below for a summary of factors affecting treatment 
completion. To achieve successful treatment completion requires affordable, 
accessible and appropriate health services, designed and delivered with a greater 
understanding of patients’ needs and the wider socio-cultural context. Progress 
towards successful completion of TB treatment can be seen to involve a chain of 
responsibilities involving various actors and factors such as patients and their 
behaviour, patients’ families and their cooperation, health service providers and their 
conduct, policy makers and their understanding of issues, and the community’s values 
and norms (Wares et al., 2003).  
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Munro et al. (2007) presented a model to understand factors affecting adherence to TB 
treatment which involves structural, personal and health service factors, as well as the 
social context in which TB patients take their treatment. All but one of the studies 
included in the review concurred with this model. The final article reviewed envisages 
three layers of barrier that TB patients experience in TB treatment: attending the 
health care facility initially; attending repeatedly; and experiences while there. These 
layers were often interlinked and exacerbated by structural factors such as geographic, 
economic, and gender inequalities. Most importantly, patient decisions in relation to 
treatment taking were thought likely to shift during the treatment course, for a variety 
of reasons (Sanou et al., 2004).  
It is important that PLTB are sufficiently motivated to continue their treatment, and a 
range of approaches has been used to encourage patients. However, even though 
PLTB are sufficiently motivated, other social and structural factors may create barriers 
(Munro et al., 2007).  
There are several other factors affecting TB treatment completion which TB patients 
have little or no control over, such as poverty, social exclusion, gender, stigma and 
discrimination, organizational factors, therapeutic factors and other societal factors 
that influence patients’ treatment-taking behaviour (Sumartojo, 2000). TB patients 
need to have flexibility and choice in their treatment plan including choice of 
treatment observer if required by the programme. However, patient autonomy in 
treatment taking seems to be contrary to conventional TB service delivery (WHO 
2003a; Diwan & Thorson, 1999; Cuneo & Snider, 1989). It is also important to note 
that patient choice in taking treatment is influenced by the social and cultural 
structures in which the person lives and physiological and psychological phenomena 
of the disease (Lienhardt et al., 2003). However, a common notion found among 
programme managers and health care providers is that completing treatment is the sole 
responsibility of TB patients, and care providers are only there to ensure that they 
follow the recommended way of completing their treatment plan. This approach puts 
TB patients in a difficult position, and when they fail to complete their treatment, they 
are the ones who get the blame. This tendency among care providers and managers 
can lessen patients’ motivation towards treatment and fail to create a supportive 
environment for treatment. Health workers and programme managers therefore require 
an explicit understanding that beyond the patients’ control there are several other 
factors that play important roles in to determining treatment completion among TB 
patients; their role is to minimize those negative factors by understanding patients’ 
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needs and providing them with support. However, there are few studies looking at this 
issue in depth.  
There are several factors related to health system or organization of TB service 
delivery that pose enormous difficulties to patients and thus may prevent them 
continuing their treatment plan. For instance, treatment taking behaviour of TB 
patients is greatly affected by poor access to DOTS centres, DOT, health worker 
behaviour and inadequate information about the disease, treatment and TB service 
availability, travel distance and transportation costs, and other costs of care associated 
with TB treatment. Sumartojo (1993) suggested that interventions to enhance 
treatment completion should focus not only on the patient but also on the wider 
context and the health care system. A clear shift is therefore needed from a limited 
biomedical approach to a wider social, contextual and structural understanding of 
issues in TB treatment completion which will broaden knowledge and experiments in 
designing patient-centred pro-poor strategies in addressing this complex issue. 
Lienhardt et al. (2003) and Munro et al. (2007) have also noted that a shift in 
perspective is needed in order to give greater attention to both the social and economic 
environment in relation to TB infection: stirrings in this direction can be seen in the 
international policy arena. 
Several measures have been used to address poor completion of TB treatment. Some 
(training, motivation and supervision) aim to change the behaviour of health staff. 
Others are directed at patients and include education, reminders and prompts to re-
attend, financial incentives to return, contracts between patient and provider, 
supervision of tablet taking, and tracing of patients who are late or default. All have 
documented success stories but vary greatly. However, studies have also 
acknowledged the inadequacy of interventions to address issues of non-completion 
and suggested investigating new ways of interventions tailored to local contexts.  
  
68 
 
Factors  Themes Issues 
Health 
systems  
- TB service 
delivery 
modality 
- Patient 
education, 
treatment 
literacy 
- Clinic opening 
time 
- Poor access to treatment services 
- Availability of drugs and quality of care 
- Infeasible daily DOT 
- Inconvenient opening hours 
- Long waiting hours at clinics 
- Unfriendly health workers, poor relationships 
between service providers and patients 
- Attitude of service providers towards TB patients 
- Maltreatment of patients 
- Poor management of patient issues 
- Inadequate information to patients on their disease 
and treatment 
- Poor management of drug side effects 
- Poor follow up 
- Lack of specific approach and flexibility in 
treatment  
Social and 
family  
- Stigma and 
discrimination 
- Cultural beliefs 
 
- Social and family rejection, isolation  
- Support from community, friends and family 
- Challenging traditional beliefs and practices related 
to TB (incurable disease; disease of poor and 
unhygienic people; result of bad deeds) 
- Women – family rejection, difficult to find husband 
- Weak social network and broken relationships 
Economic  - Diagnosis cost 
- Cost of 
treatment and 
care 
- Unemployment  
- Loss of income and job 
- Financial stress to individual and household 
- Inability to support family – increases stress and 
frustration 
- Diversion of other resources to TB care – 
compromises with other family needs 
- Relatively high diagnosis cost affects treatment 
continuation  
- High transportation cost  
- Food costs – routine and additional  and other cost 
Individuals - Knowledge 
- Beliefs  
- Behaviours 
- Personal 
motivation 
- Inadequate information about disease and treatment 
- Limited understanding about treatment duration  
- Lack of information about service availability 
- Denial of TB 
- Feeling good after initial treatment 
- Willingness to complete treatment 
- Substance abuse (drug users and alcoholic) 
  
Table 7: Summary of factors affecting TB treatment completion - current knowledge 
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Factors  Themes Issues 
Therapeutic 
factors 
- Treatment 
duration 
- Treatment 
regimen  
- Long treatment duration 
- Complex regimen with many tablets at a time 
- Side effects of drugs 
- Taste of drugs  
Structural 
factors 
- Geography 
- Gender 
- Urbanisation 
- Migration 
- Difficult geographical terrain – hard to reach health 
facility  
- Lack of gender-friendly approach in TB care 
- Urban complexity (slums, homelessness, 
overcrowding) 
- Increasing migration, vulnerable to ill health 
3.7 TB treatment completion and gaps in current knowledge 
Studies show that TB patients were burdened with a wide array of social, economical, 
and medical problems. Often TB patients take their medication under a complex 
environment and pressure, which severely affects their ability to complete the full 
course of TB treatment. In TB control, understanding treatment completion is a 
complex science as several factors hinder treatment completion, many beyond the 
control of individual patients. Non-completion of TB treatment is the largest issue in 
TB control, and is made more complex because TB is prevalent among people with 
low socio-economic status and TB makes individuals and household vulnerable 
financially, socially and physically. Considering the complexity of the issue and the 
relatively poor measures applied to tackle this issue, Addington (1979) stated 
‘treatment completion is the greatest unmet public health challenge in TB control’, a 
view that still remains valid today. 
Many factors affecting TB treatment completion and their responses have been 
identified (and have already been discussed above). However, economic burdens to 
patients and families, feasibility, accessibility, acceptability and affordability to TB 
treatment, migration, caste, support from society and families, and health beliefs 
among individuals, and their direct and indirect impacts in TB treatment completion 
have not been rigorously researched. People with TB are frequently disadvantaged 
members of the society and face numerous problems fighting their disease.  Patients 
who have successfully completed treatment may have faced many difficulties during 
their long course of TB treatment but most studies have ignored this group and their 
problems. The strategies they have used to overcome the many financial, social and 
managerial difficulties they encounter during their treatment have not been properly 
addressed in any study. Most importantly, studies have not considered issues of TB 
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treatment completion in urban areas where TB is more prevalent and urban 
complexities challenge its control. Explaining the urgency of dealing with TB in urban 
areas, Weiss and Addington (1998) in an editorial mentioned that ‘TB definitely is an 
urban health penalty’. This further emphasizes the urgency of gaining in-depth 
insights into issues that affect TB treatment completion in urban areas especially in 
developing countries. In order to improve TB treatment completion, health service 
providers need to be well aware of the factors that affect and facilitate treatment 
completion for individual patients, a complex task in urban areas.  
Most studies have used quantitative approaches to measure the magnitude of problems 
in treatment completion. Some researchers have used social science approaches 
applying qualitative methodologies but have not addressed in depth the issues of 
treatment completion from patients’ and communities’ perspectives. Dick (1998) 
raised the issue of the use of inappropriate research methodologies to address the 
problem of non-completion. She further stated that to investigate and obtain a clearer 
insight into the barriers to completing TB treatment and to develop a unified approach, 
current research has to move from quantitative to qualitative techniques. Similarly, 
Munro et al. (2007) in their review article advocated looking at wider social, 
economical, and structural issues. In the context of Nepal, to my knowledge, there are 
no published studies looking in depth at issues related to TB treatment completion. 
However, other studies conducted in Nepal have highlighted the need for better 
understanding of the interrelated factors affecting TB treatment completion (Baral et 
al., 2009; Newell et al., 2006; Newell et al., 2004; Harper, 2005; Bam et al., 2006).  
The potential solutions to the problem of non-completion discussed above have also 
not been very well studied. Most of the studies reviewed in this chapter have not 
considered in any depth issues of patient autonomy, and the importance of patient-
centred approaches to increasing TB treatment completion. Various support 
mechanisms have been proposed to address non-completion, but information on 
whether and how they were tailored to patients’ needs is not well documented. 
Similarly, various social networks exist in communities where patients live but there is 
limited understanding of how these social structures and networks influence TB 
treatment continuation. I found only a very few interventions that were designed to 
map social and family support to Tb patients, and they were not assessed using 
treatment completion or other outcome measure. I also found that gender inequalities 
in TB treatment have not been well studied despite their obvious importance.  Most 
studies and trials have not considered the effects of DOT in TB treatment completion, 
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although most studies infer that DOT affects TB treatment completion in many ways 
and state that further investigation is required. Approaches such as late patient tracing 
mechanisms have not been effectively investigated. There is a gap between 
implementation of such processes and measurement of their effectiveness. Issues of 
non-completion must be addressed from a social perspective rather than purely from a 
biomedical standpoint. In order to do this, qualitative information must be gathered 
from TB patients on their definitions of treatment completion, beliefs about the 
consequences of and reasons for non-completion and successful completion, and 
explanations of how and why treatment behaviour may have changed over time. It is 
also important these issues need be understood within the local context and complex, 
day-to-day living conditions of TB patients. Some studies have investigated treatment 
completion using social perspectives, but rather superficially. There has been little 
assessment of approaches like financial incentives to patients, resource mobilization 
for late patient tracing, improved education and peer assistance to overcome problems 
of non-completion. These gaps concur with the gaps highlighted by Munro et al. 
(2007) in their systematic review of patient adherence to TB.     
Most of the relevant literature I have reviewed in the area of TB treatment completion 
seems to be somewhat superficial in terms of identifying ways of addressing these 
issues effectively. Based on this literature I conclude that there is a need to gain an 
explicit understanding of factors associated with non-completion of TB treatment and 
future investigations should consider and relate their findings with the local context. 
Furthermore, while investigating these factors there is a need to use appropriate 
qualitative techniques to bring clearer insight into the problem. 
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3.8 Theoretical understanding of TB treatment outcomes and 
treatment completion 
A theoretical framework is a structure that presents the theory underpinning a research 
study, whereas a conceptual framework (discussed in the next section) is the approach 
used to operationalise the theory. In this section, I present a framework to aid 
understanding of pathways to potential TB treatment outcomes and thus TB treatment 
completion in the context of national TB programmes. The framework explains the 
problem under study, and thus serves as a basis for conducting this research work.  
As discussed at length above, not all people living with TB will be able to complete 
the full course of TB treatment for a variety of reasons, despite their best efforts to do 
so. People who complete their treatment are required to follow a difficult treatment 
pathway, along which many factors may help or hinder progress. This section 
describes the standard pathway through TB care, and the potential treatment outcomes 
in the context of a national TB control programme. 
As shown in Figure 7, the national TB programme receives people with TB from a 
variety of sources who commence treatment using an appropriate treatment regimen. 
However, some people with TB do not come to the national TB programme for 
treatment and the programme will not know their treatment status. Generally, such 
people take their treatment from the private sector (Newell et al., 2004; Uplekar, 
1998; Hurtig et al., 2000) or are left untreated. It is important for the programme to 
understand why many people do not come into the programme for treatment and know 
the treatment status of such people. However, this study focuses on people registered 
for treatment in the programme and does not include people who get treatment outside 
the national TB programme.  
Some people living with TB registered for treatment into the programme will 
complete the full treatment course without any interruption and their outcome is 
classified as Treatment Success (treatment completed or cured) as shown by the 
straight line A in the figure. In Nepal, the national TB programme claims 85% of 
people fall into this category (Annual NTP report 2007) which indicates that the 
programme is highly successful. Although these people complete their full course of 
treatment, it does not mean that they did not have issues during their treatment. Some 
people complete treatment but with some interruption of treatment doses as shown by 
line B with straight and dotted lines: these people are also classified as treatment 
success. In terms of outcome category in the programme there is no difference in the 
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two outcomes shown by lines A and B. However, experience suggests that many of 
the treatment success cases will have experienced some irregularities during the 
course of their treatment. Many people in this category were at risk of discontinuing 
treatment if they failed to address the causes of irregularities or lateness. What is 
unreported, and what the figure does not present, is how people who completed 
treatment managed during their treatment; what coping strategies people applied, and 
what factors might have helped or hindered their treatment pathways. However, it is 
important for the programme to understand the critical relationships between 
treatment success and individual strategies that people applied in order to complete 
treatment. This will help the programme to develop effective ways to advance TB 
treatment completion.   
Not all people who start TB treatment will complete their full course of treatment. 
Several factors that can interfere with their treatment continuation as discussed earlier 
in this chapter. People who start treatment, and then discontinue treatment at least for 
two months, classified as Defaulters, are shown by the straight and dotted lines (C). 
This is an undesirable treatment outcome for the programme. In Nepal’s context, 
around 10% percent will default from treatment during the treatment course (NTP 
Annual Report 2007/8). People of this type could be late or irregular in treatment at 
any stage during the period during which they are taking treatment. Some such 
‘defaulters’ will come back to treatment, either on their own or after tracing by the 
programme, are classified as Returned After Default. People who default from 
treatment are often difficult to identify especially in urban communities where 
settlements are complex and people, especially migrant workers, do not record a 
proper address or change their address frequently. It is crucial for the programme to 
understand the reasons for lateness/default in their treatment, to be able to address 
such effectively.    
People may die during the treatment course, whether due to TB or other causes. They 
are classified as Died in the programme as shown by line D. This is another 
undesirable outcome and can happen at any stage of treatment. People of this type 
could be late or irregular in treatment before they die. The same is true for people 
whose sputum status is positive at 5 months of their treatment or later, classified as 
Treatment Failure in the programme. In the NTP, treatment management and 
allocation of treatment regimen is based on disease site, type of TB disease and history 
of previous treatment.    
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People who are on TB treatment can transfer from one centre to another as shown in 
line F. Their treatment outcome is categorised and recorded as Transferred Out at the 
centre from which transfer occurred. This study does not investigate this category of 
people and outcome, as they are difficult to trace within the study area.  
Some people have a confirmed diagnosis of TB but are not put on treatment. The 
programme needs to find these people and register them for treatment. People may 
reappear or start treatment elsewhere but this information is not available. The study 
assumes there are only a small number of people in this type, but this may be untrue. 
Line G shows such people who are diagnosed but never get into the treatment process. 
Thus lines A to G depict the main potential pathways and hence treatment outcomes 
that can occur after being registered in the programme. In addition, the figure includes 
factors that affect taking regular TB treatment, and may lead to treatment disruption at 
any stage.  
Most people with TB want to be cured – this is why they seek treatment. Studies have 
shown that people with TB are burdened and take their treatment in complex 
environments. The study assumes that while going through the treatment people apply 
different mechanisms to comply with defined treatment procedures and overcome 
barriers in treatment. These ‘coping strategies’ are included in the figure. Failure to 
identify and follow effective coping strategies can result in treatment discontinuation 
and may lead to non-completion. It is important for the programme to gain explicit 
understanding of these strategies in order to understand barriers and enabling factors 
and minimize the burden on people with TB and their families to achieve high 
treatment success rates. Thus, this study also intends to investigate the coping 
strategies that people apply during their treatment course: this knowledge will 
contribute to the design of patient-friendly approaches to delivering TB treatment 
services. 
It is also important to take into account relevant context which can influence treatment 
completion. Relevant context includes national and international policies and TB 
control guidelines; the local context of each individual with TB, including where they 
live, their occupation, caste and ethnicity, status in society; and potential reforms in 
the health sector. 
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Figure 7: theoretical framework to understand potential treatment outcomes and 
treatment completion in TB 
Context 
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The theoretical framework (figure 7) presented the various treatment pathways and 
potential treatment outcomes that a person with TB could experience once enrolled for 
TB treatment in the NTP. The majority of those with TB are poor and live in difficult 
socioeconomic circumstances. They often work in an unhealthy and hazardous 
environment. Hence the determinants of ill health are not just biological. Evidence 
indicates that success in TB treatment is influenced by multiple factors. When the 
delivery of health services uses a ‘patient-centred approach’, adverse influences on 
treatment outcomes are diminished, suggesting that TB treatment outcomes can be 
improved in this way. 
The basic principle of the patient-centred approach to health care promotes the 
concept of putting the patient at the centre of his/her health care. Definitions vary and 
are context specific (Stewart et al., 2003; Laine and Davidoff, 1996; Mead and Bower, 
2000). Stewart et al (2003) in their book Patient-Centred Medicine: Transforming the 
Clinical Method present a patient-centred model with six interacting components:  
(i) assessment of both the disease and the illness experience, 
(ii) integrating the assessment with an understanding of the whole person, 
(iii) finding common ground between the service provider and the patient, 
(iv) incorporating prevention and health promotion, 
(v) building up a long-term relationship between the provider and patient, and, 
(vi) being realistic about allocating resources in practice.  
There is a growing trend away from provider-centred care towards patient-centred 
care in health service delivery. Although in developed countries the patient-centred 
care approach is increasingly viewed as a core component of the management of 
illnesses including long term treatment therapies, and is widely advocated (Law and 
Britten, 1995; Barry et al., 2000; Britten et al., 2000; Kennedy et al., 2007), it has not 
been recognised to the same degree in developing countries. 
Studies show that patients strongly prefer a patient-centred approach to health care 
(Little et al., 2001), particularly when long term treatment is needed, such as for TB 
disease. The traditional biomedical approach fails to recognise the influence of 
psycho-socio-economic factors in disease and its management. TB is not merely a 
biological phenomenon, and hence successful TB treatment requires an accurate initial 
diagnosis plus an integrated patient-centred approach, support from family, relatives, 
community, and health care providers. I therefore developed a conceptual framework 
for this study putting TB treatment completion at the centre (see section 3.9).  
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3.9 Conceptual framework 
A conceptual framework is a group of concepts that are broadly defined and 
systematically organized to provide a focus, a rationale, and a tool for the integration 
and interpretation of information in research (Reichel & Ramey, 1987). The use of 
predefined concepts through a conceptual framework in qualitative research is argued: 
however, not rejected. In my study, I used the conceptual framework in Figure 8 to 
outline the research approach at initial stage of my research which helped 
understanding the research context and also guide the research process. The 
framework well interacted as the research progressed, and ultimately refined in line 
with the study findings (Guba & Lincoln, 1989). As discussed by Smyth (2004) the 
conceptual framework strengthens the study in following ways: providing clear links 
from the literature to the research goals and questions; informing the research design; 
providing reference points for discussion of literature, methodology and analysis of 
data, and; contributing to the trustworthiness of the study.  
 
Figure 8: Conceptual framework 
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I developed the conceptual framework considering a theoretical understanding of TB 
treatment pathways, reviewing current understanding and knowledge about factors 
that help or hinder people with TB taking TB treatment, potential treatment outcomes, 
and treatment completion in the context of a national TB control programme. My 
framework identifies three main actors: health services/NTP; PLTB; and the family of 
PLTB and community. These three actors can influence TB treatment completion by 
either facilitating or hindering progress towards the treatment outcomes. The 
framework shows relationships among these players. The framework considers that 
TB control programmes are guided by global and national policies and guidelines; 
they determine the TB treatment process under programme conditions, often designed 
from a biomedical approach with little consideration for the needs of PLTB and the 
local context. I plan to try to understand how these policies and guidelines contribute 
to successful TB treatment completion in local context of Nepal’s NTP. Similarly, the 
organization of TB service delivery, resources, settings, existence of multiple service 
providers will also influence TB treatment completion and I plan to gain an explicit 
overview of these contexts. 
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3.10 Study aim and objectives 
3.10.1 Aim 
The aim of the study is to gain a better understanding of experiences and issues faced 
by People Living with TB (PLTB) and their responses during the course of TB 
treatment; and to identify appropriate ways of addressing the identified issues in a 
specified context. This study will contribute to the body of knowledge relating to TB 
treatment completion and facilitate the design and implementation of patient-centred 
care in Nepal’s National TB Programme (NTP) and similar settings elsewhere. The 
study focuses on factors that influence TB treatment completion among PLTB taking 
TB treatment under the NTP in urban settings in Kathmandu Valley, Nepal.  
3.10.2 Objectives 
The following study objectives were developed; 
• to understand the issues underlying the successful and unsuccessful 
completion of TB treatment from the perspective of PLTB in the context of 
the NTP in urban settings in Kathmandu, Nepal; 
• to understand responses to the factors influencing the successful and 
unsuccessful TB treatment completion from the perspective of health systems, 
communities and PLTB in the context of the NTP in urban settings in 
Kathmandu, Nepal; 
• to identify appropriate ways of addressing the issues identified leading to the 
successful and unsuccessful TB treatment completion in the context of the 
NTP in urban settings in Kathmandu, Nepal. 
3.11 Conclusion  
This chapter provided an understanding of the context relating to the issue of TB 
treatment completion considering the existing knowledge into account. Based on the 
understanding it set out a theoretical framework which then developed to a research 
tool – a conceptual framework – based on which I formulated study aims and 
objectives in this chapter. The next chapter describes research design and methods. 
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CHAPTER 4 
RESEARCH DESIGN AND METHODS 
I have presented the context, problem analysis, problem statement, aims and 
objectives of the study in previous chapters. This chapter describes the research design 
and methods that I used in the study. It also describes the basis for my selection of the 
study approach, data collection methods and analysis of data along with a description 
of issues that arose while conducting the field research and analysis. The chapter also 
describes the trustworthiness of the research process and findings along with 
limitations of the study and ethical considerations. 
4.1 Setting up the study 
Only very limited prior information on TB treatment completion in the context of 
Nepal’s urban TB control programme was available, so my intention was to seek a 
greater depth of understanding. To do so, a well thought-out research design and 
application of methods was vital. A review of relevant literature on study approaches 
used by other researchers, my experience of more than fifteen years working in 
Nepal’s health system including in the NTP, and a general overview of the study 
context helped me to shape my thinking as a researcher. In early days of my research, 
my involvement in the NTP as a research assistant, primarily working on a 
randomized controlled trial (Newell et al., 2006), provided an opportunity to develop 
concepts about TB treatment completion in Nepal and elsewhere. It also gave me 
opportunities to interact with various researchers involved in TB control and social 
sciences in Nepal and elsewhere, as well as health service providers and policy 
makers. I was also engaged in formal and informal discussions with the NTP and its 
stakeholders, including people with TB and their families, who were central to my 
research area. It also helped me understand the context of how TB services were 
delivered in urban areas of Nepal and general characteristics of urban populations, and 
in particular migrants. All these processes at the initial stages of my research helped 
me to understand major issues related to TB service delivery in Nepal and other 
developing countries, particularly in the context of South Asia. These initial 
understandings helped me to give shape to my research design and methods in line 
with the study aim and objectives.   
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4.2 Research approach and design 
My research sought explicit understanding of issues in TB treatment completion in the 
context of urban TB control in Nepal. Considering the nature of the study, involving 
personal experiences of people with TB, their families, members of the community 
and health workers, I thought appropriate to use a qualitative research approach. I 
considered a research ‘approach’ is to help researcher to shape research at various 
stages to conduct research systematically in relation to its aim and objectives. 
Ethnography; phenomenology; grounded theory; biographical, life history and 
humanistic; ethnomethodology; interpretivist; conversational analysis and discourse 
analysis; psychoanalytic approaches are some of the key approaches to qualitative 
research. I do not intend to present a comprehensive explanation of various qualitative 
research approaches. Instead, I emphasise that the qualitative researcher can apply a 
range of methodological techniques and practices and present a range of philosophical 
underpinnings in their areas of enquiry (Mason 2002). No matter what the approach or 
approaches are, qualitative researcher need to engage actively in making decisions at 
throughout their research, which need to be grounded in relation to their research 
questions/objectives, and changing context (Mason, 2002).   
Qualitative research is multi-method, interpretative, exploratory, flexible, analytical, 
and context-specific in its nature (Manson, 2002; Maxwell, 2005; Denzin and Lincoln, 
1994; Flick, 2007). Uses of a qualitative research approach in health care have 
gradually increased; however, arguments on its theoretical underpinnings and mode of 
operating continue to exist (Marshall, 1996). Many researchers have used this 
approach in designing and validating quantitative research i.e. to inform development 
of hypotheses and survey questionnaires, to help wider interpretation and 
understanding of quantitative data, to ensure validity of data, to probe or provide 
different perspectives to quantitative research (Pope and Mays, 2006). Besides the use 
of qualitative research approach in complementing quantitative research, its 
independent use to unveil the varied nature and essence of things in the social world 
has been widely acknowledged and used in many disciplines of social sciences 
(Mason, 2002) including studies related to human health and well-being (Pope and 
Mays, 2006). I therefore thought it appropriate to use this approach in my study to 
allow me to be able to address the diverse social phenomena influencing the issue that 
I was interested in, and in which I could modify or reconsider the research design and 
methods as research progressed and respond to new knowledge and changes in the 
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study as they emerged (Hammersly and Atkinson, 1995; Mason 2002), thus allowing a 
greater understanding of the issue that I was investigating.  
In the study, I intended to uncover social world and phenomena related to TB disease 
and its treatment completion primarily from the point of view of the people involved: 
individuals or groups including various social actors, their various behaviours and 
experiences, emotions, beliefs, thoughts, ideas, perceptions, knowledge, feelings, 
motivation, interpretations of happenings, attitudes in particular to illness and affected 
people, identities and views, social positions of individuals and family, cultural and 
social practices and constructions, and events and reactions to them. The use of a 
qualitative approach allowed me to understand the study respondents and their social 
world in their natural settings. This concurs with the use of a qualitative research 
approach in social sciences to gain understanding of subjects, meanings and 
metaphors and their causal relationships to context and knowledge (Neuman, 1997; 
Mason, 2002; Brink and Wood, 1998). This approach is useful to explore issues, 
refine research questions/objectives, conceptualize them considering the context, and 
to increasingly focus the study as it progresses (Hammersly and Atkinson, 1995; 
Creswell, 1998). Using a qualitative research approach, researchers can distinguish 
and develop understanding on factors behind observed behaviour (Strauss and Corbin, 
1998), modify researchers’ prior assumptions (which are often little explored), and 
provide an in-depth analysis of ‘what, how and why’.   
In the field of social science, qualitative research in the form of an inquiry of human 
behaviour was initiated in the late 1920 and 1930s (Denzin and Linclon, 2005). Since 
then, various attempts have been made to define qualitative research. During the 
1960s and 1970s, qualitative research was considered as an alternative to quantitative 
research (Flick, 2007; Strauss and Corbin, 1998). Qualitative research has a long 
history of use in many disciplines, especially studies related to social sciences 
(Silverman, 2000; Manson, 2002), as it studies people in their natural settings and 
focuses on understanding events and the meaning people make of their social world 
(Denzin and Lincoln, 1998).   
Qualitative research aims to gain an explicit understanding of social phenomena. In 
doing so, it emphasises exploration of: peoples’ experiences and perspectives; their 
day-to-day behaviour in the areas of investigation; social constructs of the issues 
under investigation; situational constraints; the reality of natural world in which 
people live, and intimate relationships between researchers and what was studied 
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(Strauss and Corbin, 1998; Silverman, 2005; Manson, 2002; Flick, 2007). However, in 
designing a qualitative research study, it is important to choose appropriate research 
method(s) to be able to best understand the area under investigation. Denzin and 
Lincoln (2005) provide an initial generic definition of qualitative research in the third 
edition of their qualitative research handbook: 
‘Qualitative research is a situated activity that locates the observer in the 
world. It consists of a set of interpretive, material practices that make the 
world visible. These practices transform the world. They turn the world 
into a series of representations, including field notes, interviews, 
conversations, photographs, recordings, and memos to the self. At this 
level, qualitative research involves an interpretive, naturalistic approach 
to the world. This means that qualitative researchers study things in their 
natural settings, attempting to make sense of, or interpret, phenomena in 
terms of the meanings people bring to them.’ (p.3)    
Although my study’s research design began to take shape as I defined my research 
objectives, it was obviously vital to have an appropriate research design taking into 
account the issue(s) and context where I was going to conduct my research. However, 
I found there were inconsistent views among qualitative researchers as to whether or 
not qualitative research should have a research design (Miles and Humerman, 1994; 
Maxwell, 2005). Figure 9 presents the overall research design of the study. I adapted 
this design from Maxwell (2005), who named it ‘an interactive research design’. 
Maxwell further elaborated that this design captures various aspects of a qualitative 
research approach, retaining sufficient flexibility to allow researchers to deepen their 
understanding on the areas under investigation. It provides opportunities to travel back 
and forth in terms of refining methods and research objectives/questions along with 
assuring their validity and credibility.  The design includes various components, all of 
which interact with each other. Each component has multiple reciprocal relationships, 
rather than being in a linear relationship with only one component. Another 
characteristic of this research design is flexibility to respond to emerging knowledge 
and changes during the course of research – thus allowing the researcher to move back 
and forth between, and interact with, methods and issues under investigation. The 
relationship between research aim and methods and conceptual framework and 
research validity is shown using dotted lines: interactions among these components 
and their implications were found to be of less importance than other components, 
although a certain degree of interaction was still expected during the course of 
research.   
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While adopting the research design, I fully considered the research context and 
findings from the literature review; both demonstrated a clear need for a flexible and 
interactive research design, which could enable me to understand relationships 
between issues by visiting and revisiting the various research components shown in 
the design. Thus, the research design has carefully considered details of issues of TB 
treatment completion, local context, and the study aim and objectives.  
 
Source: adopted from Maxwell, 2005, p.5 
This study was unique. The nature of the data I intended to generate through discourse 
in the study was rich in explanations, for example knowledge of people with the 
disease and undergoing treatment, experiences of PLTB in natural or constructed 
situations during illness and treatment, how and why the social and cultural world in 
which PLTB and their family lived were constituted, and their interactions with TB 
and its treatment. I therefore concluded that the research design and methods would 
need to be interactive and continually refined, as informed by fieldwork (Jacobs, 
1987; Goetz and LeCompte, 1984; Erlandson et al., 1993).  
The research design I adopted (Figure 9) not only allowed me to investigate important 
new issues and questions as they arose, but also helped me to drop unproductive areas 
of research from my original research objectives. I started with the general idea of 
exploring issues in areas of my investigation then gradually focused on specific issues 
as they emerged. A similar approach is found in other qualitative research (Silverman, 
Figure 9: A representation of the interactive research design 
Research 
goal/aim 
Conceptual 
framework 
Methods Validity 
Research  
Objectives 
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2000; Manson, 2002; Lincoln and Guba, 1985). For example, I started exploring some 
basic questions relating to TB treatment completion, such as ‘what happened or was 
happening?’, ‘why did it happen the way it did?’, ‘how did it happen?’, and ‘what was 
its effect?’. Then, as concepts and relationships emerged during the research process, I 
gradually narrowed my study focus to specific issues, developing ‘theory’ by closely 
understanding interactions of issues with people and context. A key characteristic of a 
qualitative research approach is that the researcher does not start with a 
comprehensive understanding of the issues under investigative at the outset of the 
research, but rather provides deep understanding at every step of the research, thus 
leading to modifications of the research design as the study progresses (Maxwell, 
2005; Manson, 2002; Silverman, 2005). 
4.3 Methods 
This section describes the research methods I used, giving a detailed explanation of 
why I choose these methods and how I implemented them during the course of my 
study. I considered research methods as a process of identifying potential data sources, 
generating data from the sources, and techniques of conceptualising data and thus 
building a concept (Strauss and Corbin, 1998; Mason, 2002). Thus, in this section I 
provide a description of potential data sources, study respondents and their selection, 
techniques used in data generation, processes of conceptualization and data structuring 
to facilitate in-depth analysis of phenomena, ethical issues in research and my 
experiences while undertaking this study.  
4.3.1 Study sites 
The study was conducted in the urban areas of Kathmandu Valley. The valley consists 
of three cities: Kathmandu, Lalitpur (also known as Patan) and Bhaktapur. The study 
sites were urban DOTS centres in Kathmandu and Lalitpur.  Kathmandu is the capital 
and largest metropolitan city of the Federal Democratic Republic Nepal, and Lalitpur 
is a sub-metropolitan city located in southeast of Kathmandu. More than 40 DOTS 
centres providing TB services in these cities including public, private and NGOs 
(Figure 10). Due to confidentiality reason I have not identified the DOTS centres 
where I conducted the study.  
  
86 
 
 
4.3.2 Identifying potential data sources 
Keeping my study aims and objectives and the local context in mind, the first step I 
considered was identifying potential data sources. They were: 
• People: individuals or groups with an association (direct or indirect) with TB 
disease i.e. PLTB; family members, relatives, friends and colleagues of PLTB; 
health workers working in DOTS centres; community volunteers and members of 
DOTS committees; 
• Organizations and institutions providing TB services in the study area (both 
private and public): DOTS centres, laboratories, NTC, District and Municipal 
health institutions; 
• Published and unpublished documents: for examples TB registers; TB 
treatment cards; media reports; NTP reports; NTP training materials;  
• Events and happenings i.e. TB trainings, workshops, meetings related to the 
NTP and others as relevant; 
• Local settings and environments 
Figure 10: Map of urban DOTS centres, Kathmandu Valley 
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Categorising the potential sources was not merely a theoretical exercise; it provided an 
insight into whether the data sources existed and how they could be accessed as per 
the study requirements. It also helped me to engage creatively with the potential 
sources as and when relevant to the study context (Mason, 2002). The list of potential 
sources not only highlighted data generation options, but also helped me to define and 
consider ethical aspects of data generation among various sources. The categories 
above were indicative; thus data generation were not limited to these sources, but were 
extended taking into account of issues that emerged during the course of study.  
4.3.3 Methods of generating data from sources 
I used data generation methods to explore respondents’ subjective understanding and 
on experiences of the issues I investigated. There are various approaches to generating 
data in qualitative research studies and qualitative researchers use them according to 
the research theme and the nature of the study, the participants involved and the 
context of the research. Despite differences in their use, a common focus can be seen 
among many researchers in the use of data, as qualitative studies focus on talk, 
actions, interpretations and meanings to human beings to make sense of the social 
world they live in (Pope and Mays, 2006). I used the following methods in my study; 
• Individual interviews: I conducted open-ended and discovery-oriented in-
depth interviews with respondents; 
• Focus group discussions (FGDs): involving around 6-8 people in a group, 
which focused on and explored in depth a specific topic; 
• Observation: I observed interactions, actions and behaviours, and peoples’ 
interpretation of these acts especially in DOTS centres in the study area and 
formal meetings of the NTP. I recorded observations as field notes; 
• Document review: I reviewed published and unpublished literature related to 
my research area, including NTP policy and guidelines, and NTP training 
materials; 
The next sections describe the process of implementation of each technique that I used 
in generating data, the context in which I used these techniques, and whether and how 
the process and the context influenced the data generating process. 
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4.3.3.1 Qualitative interviews 
Qualitative interviewing is a creative art, and doing it well is a difficult task, which 
demands active engagement and creative work by the interviewer (Holstein and 
Gubrium, 1995), not only at the start but also throughout the process. Various 
adjectives are used to differentiate interview methods in qualitative research – in-
depth; semi-structured; open-ended; and unstructured. Mason (2002) believes that the 
term ‘qualitative interview’ refers to an in-depth interview with a semi-structured 
nature. Rubin and Rubin (2005) suggest that each qualitative interview is unique, 
because questions are constructed in the light of the interviewee’s responses. They 
also termed qualitative interviewing as ‘responsive interviewing’, urging that the 
interviewer should consider as a person rather than merely as a research subject, so 
should listen to the interviewee and ask questions carefully to generate deep 
understanding of issue(s) being researched rather than superficial breadth (Rubin and 
Rubin, 2005). Rubin and Rubin (2005) define qualitative interviewing as follows; 
‘Qualitative interviews are conversational in which a researcher gently guides a 
conversational partner in an extended discussion. The researcher elicits depth and 
details about the research topic by following up on answers given by the interviewee 
during the discussion’. (Rubin and Rubin, 2005, p 4) 
I considered in-depth interviewing as the main method of generating data in the study, 
because it can produce rigorous and rich data through talking and listening carefully to 
the people being researched in the settings where they live; eliciting peoples’ 
perspectives, knowledge and behaviour, personal experiences and opinions, and 
interactions with socio-cultural contexts of the issue under investigation (Bogdan and 
Biklen, 1992; Burgess, 1994; Mason, 2002; Lincoln and Guba, 1995; Rubin and 
Rubin, 2005). In in-depth interviews, the researcher starts the conversation in a 
relatively informal style and listens to the interviewee’s perspective on the research 
topic (Burgess, 1994), eliciting the interviewee’s knowledge about the issue under 
investigation (Rubin and Rubin, 2005).  
I used a semi-structured approach in interviews without compromising on depth and 
flexibility (Rubin and Rubin, 2005). For this purpose, I used an interview guide with a 
set of flexible worded questions to keep the conversation guided, which helped 
interviews to be more focused on specific issues but did not limit the emergence of 
new ideas (Annex 1). I found this technique appropriate to gather knowledge on how 
TB affected the lives of PLTB and their families, and to understand PLTBs’ 
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interpretations of causal explanations and relationships in the context (Mason, 2002), 
keeping TB disease and treatment completion as a central theme.   
There are different ways of conducting interviews in qualitative research, including 
one-to-one interactions, large group interviews, face-to-face interviews and telephone 
interviews. I decided to conduct face-to-face interviews in a relatively informal style, 
one interviewee at a time. I started interviews by posing open questions in a neutral 
manner, listened carefully to the responses, and asked follow-up questions and probed 
based on the responses and issues raised. I started all interviews with open-ended 
questions: during the conversation my questions became more structured or focused 
on specific issues raised by the interviewee (Merton et al. 1990). In subsequent 
interviews, I focused on issues raised by previous respondents. Interviewees were 
given maximum opportunity to discuss new issues as they emerged and encouraged to 
construct contextual knowledge by focusing on relevant specific contextual issues. For 
example, I asked participants to talk through their specific experiences with regard to 
their disease and treatment rather than framing questions about what they ‘generally 
did’ under certain circumstances.  
I conducted the majority of interviews. There were a few instances where I considered 
using another appropriately trained researcher as an interviewer. For example, I 
trained two female researchers, who had already had some prior experience in 
qualitative research, in qualitative interviewing techniques. They interviewed some 
women respondents in the study. In the initial stages of my fieldwork, I thought that 
women respondents would feel less comfortable if they were interviewed by me, 
considering the Nepali cultural context where, in general, a woman would prefer to be 
served by a female health worker, so I thought they would be more open about their 
views and issues with a woman interviewer. The female interviewers performed some 
interviews with women respondents; at the same time, I also conducted some 
interviews with women respondents. I went carefully through the interviews 
conducted by the women interviewers and the ones conducted by myself, but did not 
find any differences with regard to issues explored and the depth with which they 
were explored. In contrast, a woman I interviewed communicated her experiences 
without any hesitation, even though some of the information she provided crossed my 
preconceptions about cultural boundaries, such as her concerns regarding her sexual 
relationship with her husband since she had TB. I thought women would not share 
such issues when interviewed by a male interviewer: however, I found this was not the 
case. I became convinced that using female interviewers to interview women 
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respondents would not maximise intellectual richness in data generation. However, in 
one instance, I used a female interviewer when a woman respondent preferred to be 
interviewed in her local language
3
4.3.3.2 Focus Group Discussions 
, which I did not know. Apart from these few 
instances, I interviewed all respondents, regardless of sex, transcribed the interviews 
and analysed them.  
Unlike one-to-one interviews, focus group discussions (FGDs) involve a group, 
typically 6 to 8 participants, in discussion. FGDs are useful to explore peoples’ 
experiences, opinions, wishes and concerns related to the issue under investigation. 
Their use in qualitative research has enabled researchers to understand the 
perspectives of people as they operate within a social network, and are particularly 
suited to the study of attitudes and experiences around specific topics (Barbour and 
Kitzinger, 1999). Use of FGDs varies depending on the nature of the research. 
However, in general, all FGDs are used for similar purposes. Morgan (1998) presents 
three fundamental strengths of FGDs in qualitative research – (i) exploration and 
discovery; (ii) context and depth; and (iii) interpretation. Employing one or more of 
these strengths would further enrich data generation. I specifically focused on 
interpretation, for example of policy and practice of institutional DOT; opinions of 
participants on opening hours of DOTS centres and their convenience or otherwise; 
perspectives on diversity and complexity in delivery of TB services in urban areas and 
what they meant to PLTB; different behaviours of people with TB during the course 
of treatment and what that meant to PLTB and their family; and opinions of members 
of the community regarding TB disease and the effects of such constructed beliefs to 
PLTB and their family. In the above areas I primarily looked at interpretations of 
people on how things happened; why they happened they way they did; could they 
have happened differently, and if so what, how and why. Similarly, I also considered 
the second strength – context and depth – during FGDs.  
Six FGDs were conducted, with six to eight participants each. Four were conducted 
with PLTB and two with frontline health workers. In each group, participants were 
recruited purposively. PLTB were recruited in consultation with health workers of the 
DOTS centres where the PLTB were taking treatment, after I described the purpose of 
                                                 
3
Newari, a local language of Newar ethnic groups, which is commonly used among 
Newars. 
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doing FGDs with PLTB and what kind of participants I was looking for. I consulted 
with health workers because they dealt with the PLTB on a daily basis and I therefore 
assumed that they had an understanding of the background of the PLTB e.g. in one 
FGD I looked for migrants, factory workers, daily labourers, and identifying such 
PLTB without consulting health workers was difficult. However, selection bias was 
minimised as far as possible. Similarly, when constituting FGDs with frontline health 
workers who were working in DOTS centres run by public, private and NGO 
providers, I approached individuals who had been taking a lead role in delivering TB 
services, as I wanted to gain their experiences with PLTB. Each FGD lasted 
approximately 1.5 hours.  
I moderated four of the six FGDs and a woman researcher trained in qualitative 
research and FGDs moderated the other two. She had conducted FGDs in a research 
project I had been involved in on TB stigma and discrimination in Nepal, so I had 
good knowledge of her skills as an FGD moderator. She conducted FGDs with women 
with TB and their family members. The role of the moderator was to raise specific 
topics and encourage participants to talk freely and spontaneously about them. In each 
FGD, a public health graduate working as a research officer in various qualitative 
research projects acted as rapporteur. In addition to her field experience as a 
qualitative researcher, I trained her in FGD with specific focus on the role of 
rapporteur. We requested permission in advance to record the discussion in all FGDS: 
in three FGDs there were no objections, while in the remaining three FGDs, we did 
not use a recorder, as the participants did not feel comfortable with their discussion 
being discussed. In particular, front line health workers did not want to be identified 
when making critical comments about NTP policy and its implementation. However, 
the rapporteur captured all proceedings in the form of anonymous discussion notes in 
each FGD. Efforts were made to create a favourable physical environment in all 
FGDs.   
A thematic guide was used in each FGD, giving a general outline of areas to be 
covered as well as specific themes and questions, and potential probes (annex 2). The 
moderator followed the guide although allowed wider discussion, particularly when 
new issues pertaining to the research area emerged and were discussed and explored 
by the participants. All areas given in the guide were well covered in discussion, even 
if not precisely in the order stated in the guide. Based on the guide, all processes and 
roles of facilitator, participants and rapporteur were clearly explained before the actual 
FGD started, helping to make the FGD more informative.   
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4.3.3.3 Observation method 
I used observation in the study to broaden the range of data generated (Manson, 2002; 
Coffey, 1999). By ‘observation’ I mean me, as a researcher, being physically present 
in a research setting and observing and experiencing a range of happenings e.g. 
actions and interactions between health workers and PLTB and their family members; 
behaviours and relationships; social interactions among and between PLTB and 
others; and management of events, in particular TB treatment management. The 
research setting in my study was: health institutions i.e. DOTS centres, NTP meetings 
and trainings, and in few instances residences of PLTB.  
At the DOTS centres, I observed many routine activities. I particularly focused my 
observation on the process of DOT with a focus on the health worker who was 
providing the service (also known as a DOT provider or treatment supervisor), and the 
PLTB who was being served. I observed verbal and non-verbal communications, 
actions, relationships and behaviours of PLTB and health workers in natural settings 
from the sidelines. In DOTS centres, I also concentrated my observation on events 
related to health education/communication, which took place between health workers 
and PLTB at various stages of TB treatment. In a few instances I also visited 
residences of PLTB. My visit to their homes was mainly for the purposes of the 
interview: however, I also observed what was happening in the family, especially the 
behaviours of PLTBs’ family members. I also observed various meetings, orientations 
and training programmes organised by the NTP, such as meetings with urban DOTS 
stakeholders, and reporting and planning meetings; and various interaction events in 
urban TB control, such as awareness campaigns targeting communities and PLTB. I 
made many visits to the sites; some observation was made during visits to the DOTS 
centre to interview health workers and PLTB. Information obtained from various 
observations was recorded in the form of field notes. In many instances, I recorded my 
findings after I completed my observation, because in many settings it was infeasible 
to observe and record the observations at the same time, as in many instances I was 
standing in a corner or talking to people other than the actors I was observing. 
However, on few occasions, I did observe and record my observation, especially at 
events such as training, meetings and orientations. All information was recorded in the 
form of field notes, which were subsequently analysed. 
I was equally aware of the fact that my physical presence in the observation setting 
could distort the naturally occurring interactions between and among the actors and 
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events that I observed. However, I made efforts to minimise this distortion by not 
taking notes while I observed the events; making friendly relationships with the actors 
and being part of their group instead of presenting myself as an external observer. 
Nevertheless, it was difficult to assume ‘zero or no influence’ due to my presence in 
the setting especially when I visited resident of PLTB.   
4.3.3.4 Document review 
I also reviewed relevant published and unpublished documents, including unofficial 
reports of the government of Nepal including the Ministry of Health and the NTP. I 
also reviewed NTP manuals, guidelines, strategies, training modules for different 
groups, case studies, NTP annual reports, locally published newspaper articles related 
to TB, advocacy and IEC (information, education and communication) materials 
developed by the programme as per their relevance to the study.  
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4.3.4 Study participants and their characteristics 
Although TB affects a wide range of people in the community, I restricted my study to 
the participants stated in section 4.3.1: (i) people living with TB (PLTB); (ii) family 
members of PLTB; (iii) frontline health care providers; (iv) NTP authorities; and (v) 
members of the general community. Table 8 and 9 provides brief characteristics of 
study participants (in-depth interview and FGDs) with a focus on PLTB.    
Table 8: General characteristics of in-depth interview respondents  
In-depth Interview  
Participant Approached 
for interview  
Participated in 
interview 
Total 
interviews  
   Male Female   
People living with TB 43 22 9 31 
Family members  
(age: 22 to 55 years) 
8 1 5 6 
Health care providers 14 5 3 8 
Community people  
(age: 22 to 42 years) 
4 2 2 4 
Total 69 30 19 49 
General characteristics of PLTB participated in interview (n=31) 
Local resident 7 3 10 
Migrant 15 6 21 
Occupation of PLTB participated in interview (n=31) 
Housewife/Homemaker 0 3 3 
Factory worker, labours 14 3 17 
Unemployed 2 0 2 
Student 1 1 2 
Local business (e.g. small shops) 1 1 2 
Others  4 1 5 
Median age of PLTB respondents (n=31) 36 years 
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Focus Group Discussion 
(FGD) FGD 1  FGD 2 FGD 3 FGD 4 Total 
Participant/Characteristics M  F  M  F  M  F  M  F  M  F  
 A. People living with TB (PLTB) 
Homemaker 1 0 0 2 0 0 0 0  1 2 
Factory worker, labours 4 0 0 5 2 0 4 0  10 5 
Unemployed 2 0 0 0 1 0 1 0  4 0 
Student 1 0 0 0 2 0 1 0  4 0 
Local business (e.g. small 
shops) 
0 0 0 1 2 0 1 0  3 1 
Others  0 0 0 0 0 0 2 0  2 0 
 B. Health Service Providers 
DOTS clinic staff 3 3 4 2         7 5 
District supervisor 0 1 1 1         1 2 
Lab technician/assistant 1 0 0 0         1 0 
DOTS clinic volunteer 0 0 0 1         0 1 
NTP officials 1 0 0 0         1 0 
 
People Living with TB (PLTB): a person diagnosed with TB is normally known as a 
‘TB patient’ in both the NTP and the community. However, I started naming them as 
‘people living with TB’ (PLTB), because a young male patient told me that being 
named as a TB patient grossly undermined his position as a normal member of his 
family and community. Other people, and especially members of the community, 
(except other PLTB) who already perceived them as ‘different’, further stereotyped 
them by naming them as TB patients. In many instances, such stereotyping further 
demoralised them. According to this interviewee, members of the community (and 
many health workers as well) started seeing them only as a TB patient, with no 
autonomy, and a burden and a risk to others, thus completely overlooking their role in 
their family and community. I therefore decided to use the phrase ‘people living with 
TB’ in my thesis and in my work.   
PLTB in the study area were from various strata of the population: however, the 
majority of my study respondents were migrants4
                                                 
4For the purpose of this study, migrants are defined as people coming to the city area 
(Kathmandu Valley) from other parts of the country. A majority of migrants were from 
rural areas of the country. 
, presented as ‘migrant’ or ‘migrant 
Table 9: Characteristics of FGD participants 
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worker’
5
as appropriate. The magnitude of TB burden among migrants in the study 
area was unknown as there was no official estimate available in the NTP. However, 
discussions with DOTS centre staff, and other anecdotal evidence suggested that a 
majority of registered TB cases in the study area were migrants with low 
socioeconomic status and very limited social networks as most had come to the city in 
search of work. At the start of the study, I did not plan to focus only on migrants and 
people with low socioeconomic status, but as I proceeded with interviews, I found 
many issues were related to these groups. However, I also sought information from 
PLTB who were local residents 6
Family members of PLTB: For the purposes of the study, family members were 
defined as those who had biological and cultural relationship with PLTB and were 
living as co-residents. In general, the family consisted of a father, mother and their 
children (i.e. a nuclear family). Some PLTB had an extended family structure (a joint 
family). In joint families, at least two generations of family members were living 
together in one house: members often comprised grandparents, their sons and their 
sons’ families. Generally, the oldest man headed the family. I found that family 
members of PLTBs were important sources of information who could provide a depth 
of understanding on experiences of TB and its treatment, and their management of 
consequences at home and in the community, because family members were with the 
PLTB from the start of illness to treatment completion, and shared the journey of 
sorrow and happiness together. My interviews with PLTB clearly demonstrated the 
crucial role in their treatment of family members as supporters, not only 
accompanying them to DOTS centres, but also assisting them at home and work, and 
in financial and social areas. In the study, I interviewed the husband, wife, mother or 
father of the PLTB as I found these were the family members who generally assisted 
the PLTB during their treatment. However, in some cases, where appropriate I also 
interviewed brother and sisters of PLTBs.  
 and other non-migrants. The occupation of 
respondent PLTBs varied, but the majority among migrants were workers and daily 
labourers in factories producing products such as carpets and bricks, and in building 
construction. Respondent PLTBs were from a variety of caste and ethnic backgrounds 
with a median age of 36 years. 
                                                 
5In the study, migrant workers were those who had temporarily migrated to the city and 
were working in factories and small private firms or were daily labourers.  
6For the purpose of this study, local residents were defined as indigenous people living 
permanently in the study area. 
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Frontline health care providers: In the study, frontline health workers were those 
working in DOTS centres who had direct interaction with PLTB on a regular basis as 
part of their role in TB service delivery. They included government, NGO and private 
health sector employees who were working in one of the identified urban DOTS 
centres in the study area. I wanted to explore their practical experiences in 
implementing TB services in the local context and their first hand experiences with 
PLTB during their treatment. It was important to investigate their understanding of TB 
treatment policy, feasibility of implementation of policy options, policy relevance and 
awareness of problems in the urban TB control programme. Their knowledge and 
behaviour towards the TB disease and PLTB, and their opinion regarding patient 
centred TB service delivery were crucial components of the study. All frontline health 
workers working in TB had received five days basic TB training provided by the NTP.  
NTP authorities: NTP officials were defined as government officials working for the 
NTP in various roles at central, regional and district level. These officials were staff of 
general health services under the Ministry of Health and Population. Many, 
particularly those working at central level, were involved in policy development and 
providing technical and operational guidance to front line health care providers 
involved in TB control. Those interviewed included the Programme manager, senior 
officials, regional TB officers/coordinators, district health officials including district 
TB officers, and programme supervisors. TB programme supervisors in districts, also 
known as District TB and Leprosy Assistants/Officers were responsible for ensuring 
effective implementation of TB control policies including DOTS in the districts. Other 
major areas of urban TB control they were engaged in included monitoring and 
capacity development. Issues discussed included their roles and areas of engagement 
in urban TB control. I had several formal and informal interactions with these people 
during the course of the study while enabled me to understand NTP policy and 
implementation aspects related to TB treatment management.   
Community members: For the purposes of the study, I considered members of the 
community to be people who were living in the community and were not directly 
affected by TB: such people had roles in shaping support or otherwise to PLTB and 
their families. I did not include any PLTB or their families in this group, even though 
they were also members of the community in which they were living.  
Evidence showed that the socio-cultural understanding and perceptions of community 
members regarding TB disease and PLTB greatly affected PLTBs’ lives, including 
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their treatment continuation. It was therefore important to document such perceptions 
and understand how differing knowledge and perceptions affected the social lives of 
PLTB and their treatment behaviour. The community included various people and 
groups, but I focused on community volunteers who had a degree of involvement TB 
control in various roles such as late TB tracers and members of DOTS committees. 
The late TB tracers were volunteers identified by the programme who had mostly 
received orientation on TB including DOTS. They were not salaried. Their 
involvement in DOTS was visiting PLTBs when they were late coming for treatment, 
educating them and their families, and providing support to the DOTS centre in 
delivering TB services in their local area. The DOTS centre coordinated these 
volunteers. As one focus of the study was to understand why PLTB are late for or 
discontinue treatment and how this is managed, it was important to better understand 
the experiences and practical understanding of late TB tracers. Likewise, it was 
important to gain insight on whether and how the late tracing mechanisms worked in 
different contexts. These people also interacted with PLTB and their families during 
the course of their treatment so it was important to document their perceptions and 
behaviour towards them. 
The DOTS committee is a voluntary community group formed to gain community 
support in implementing DOTS. Formation of committees was perceived as a means 
of community participation in TB control in Nepal, the NTP encouraged all DOTS 
centres to do so when DOTS was established. Most of the DOTS centres in urban 
areas had formed a DOTS committee comprising members from the local community 
including local political leaders. However, their level of involvement in DOTS varied 
greatly thus their knowledge of and opinions in the study. 
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4.3.5 Sampling strategies 
Unlike quantitative research, which aims to generalise study findings to a larger 
population, the purpose of qualitative research is to provide in-depth insight into the 
issues under investigation, eliciting human experiences and interactions and 
illuminating meanings, rather than making general statements (Glaser and Strauss, 
1968). Although use of qualitative research in health care has increased over the years, 
it faces some challenges, including in particular how to justify sampling strategies and 
recruitment of study participants (Marshall, 1996). See Table 10 for some examples 
of sampling in qualitative research. Marshall suggests that the use of various complex 
terms in qualitative research, frequent changes in views and interpretation of these 
terms and ambiguous sampling strategies in qualitative research have fuelled 
confusion, especially among quantitative researchers who question the generalisability 
of findings from qualitative studies. Patton (1990) recommends that qualitative studies 
focus on understanding the conceptual links between the issues under investigation, 
emerging themes from the data, and research subjects and their selection process, 
instead of numerical considerations in selecting research subject and size.  
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Scholars   Proposed sampling strategies 
Strauss & Corbin (1990) Theoretical sampling – three stages 
• open sampling 
• relational and variational sampling 
• discriminate sampling 
Patton (1990) All sampling is purposeful – 15 strategies 
• extreme or deviant case sampling 
• intensity sampling 
• maximum variation sampling 
• homogeneous samples 
• typical case sampling 
• stratified purposeful sampling 
• critical case sampling 
• snowball or chain sampling 
• criterion sampling 
• theory-based or operational construct sampling  
• confirming and disconfirming cases 
• opportunistic sampling 
• purposeful random sampling; 
• sampling politically important cases 
• convenience sampling 
Morse (1991) Four types: (i) purposeful sample, (ii) nominated 
sample, (iii) volunteer sample, and (iv) total population 
sample 
 
Sandelowski et al. (1992) • selective sampling  
• theoretical sampling 
Sandelowski (1995) All sampling is purposeful – three kinds  
• maximum variation 
• phenomenal variation 
• theoretical variation 
Marshall (1996) Three types 
• Convenience sample 
• Judgmental sample 
• Theoretical sample 
Ulin et al. (2005) • theoretical 
• priori 
Source: Adapted (with some additions) from Coyne 1997 
Overall, however, there are three broad approaches in qualitative sampling strategy: 
convenience sampling; purposive sampling; and theoretical sampling (Rubin and 
Rubin, 1995; Marshall, 1996; Silverman, 2005).  
Convenience sampling refers to the selection of research subjects who are easily 
accessible to the researcher. In this technique the researcher puts comparatively little 
effort into finding research subjects, either individuals or groups. In contrast, 
purposive sampling is the recruitment of research subjects guided by their relevance to 
Table 10: Examples of qualitative sampling 
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specific research objectives/questions. This is one of the most commonly used 
sampling techniques in qualitative research. Patton (1990) considers that the broad 
term ‘purposeful sampling’ can define all types of sampling in qualitative research. 
Theoretical sampling is based on a continuous interplay between the researcher, the 
ongoing data gathering process and its simultaneous analysis, which guides the 
researcher in selecting the next research subject, to help further examine and elaborate 
emerging concepts (Ulin et al. 2005). When the researcher decides the next research 
subject according to emerging codes and categories, this is described as a theoretical 
sampling process (Coyne, 1997). This sampling technique is particularly used when 
research focuses on an explicit construction of theories grounded in real circumstances 
(Strauss and Corbin, 1990).   
There is considerable overlap between these sampling strategies, and especially 
between purposive and theoretical sampling, and in fact the phrases purposive 
sampling and theoretical sampling are often used interchangeably in the literature. In 
practice, qualitative researchers are generally guided by their research 
objectives/questions as well as the theoretical framework of the research when it 
comes to identifying sampling techniques and recruitment of study participants (Ulin 
et al. 2005), and use of such techniques usually demands a flexible approach. 
Silverman (2005) suggests that all methods are acceptable as long as the researcher 
takes a flexible approach, considering the study objectives, context, research subjects 
and emerging concepts in data, and provides a deeper understanding of social 
phenomena related to the issue under investigation.   
In the study, I used a mix of convenience and purposive sampling strategies. Study 
participants were drawn from the various groups discussed in section 4.3.4. It was 
important to identify study participants who could candidly explain their experiences 
with TB and its treatment, perspectives, and behaviours and their consequences in 
successful completion of TB treatment. I therefore focused on a specific subset of 
people who had direct experience with TB and its treatment and who could talk 
openly. I developed an initial plan to recruit potential study participants: however, at 
the start of data collection, I was unclear about who to recruit and how many 
participants would be sufficient to best answer my study objectives. I therefore 
initially used convenience sampling: however, study participants were identified in 
consultation with frontline health workers in DOTS centres. Once I had interviewed 
some study participants, issues started to emerge. In the light of the study objectives 
and issues emerging from the data, I identified subsequent participants to broaden my 
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understanding on the issue emerged. For instance, once it emerged that the fixed 
opening hours of DOTS centres hindered many PLTBs’ treatment, I chose some 
participants who had jobs with fixed hours, to understand whether and how the 
centre’s opening hours influenced their treatment continuation and their coping 
strategies. In deciding sampling strategy, I not only took the research participants into 
account, but also considered the local context, willingness to participate, 
trustworthiness, my relationships with key informants, interview location and many 
other factors that could influence data generation. I also looked for participants who 
could be critical of ideas emerging from the data, to elicit opposing views if they 
existed. For example, in my sampling I sought health workers who were critical of the 
DOT policy and of overall service delivery in urban areas. I stopped collecting data 
once no new issues emerged and no additional insight was forthcoming. 
4.3.6 Recruitment of participants 
This section describes the process that I followed in recruiting study participants, with 
special focus on in-depth interviews, as recruitment for FGDs has already been 
discussed in section 4.3.3.2. First, I considered identifying PLTB who were willing to 
be interviewed and to detail their experiences with regard to TB disease and their 
treatment processes, the central focus of the study. The following steps were 
performed in selecting PLTB for in-depth interviews.  
First, I visited each DOTS centre and met the frontline health care providers there. I 
explained about my study area, aim and objectives, potential study groups and 
methods. I sought their verbal approval for the study to be conducted in their centre. I 
assumed that frontline health care providers would have an idea about general 
characteristics of the PLTB who they were serving: i.e. social, cultural and financial 
background; occupation; behaviour during treatment; openness and willingness to talk 
about their experiences etc. The visits helped me to understand the basic 
characteristics of PLTB who were undergoing treatment at the centre; the feasibility of 
conducting in-depth interviews there; the willingness of the service providers to 
cooperate in the study; and the feasibility of recruiting PLTB into the study.  
Next, I went through the main TB register of all PLTB taking treatment from the 
centre. I obtained the details of the PLTB available there: registration and treatment 
start date, full name, age, sex, address, disease classification and registration category, 
and result of sputum examination (initial and follow-up). I also reviewed the TB 
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treatment cards of the PLTB and obtained information about their treatment history 
i.e. whether there was any lateness and retrieval; side effects of drugs; and history of 
disease (current and previous). After a rigorous process of information collection, I 
selected some names and discussed them with the service providers.  
Finally, I individually approached the PLTB who I had identified. I briefed them about 
my identify, the study purpose, their expected role in the study and voluntary 
participation, any implications to them and their treatment if they chose to 
participate/not participate in interviews, use of information and its confidentiality and 
the interview process. After a few interviews, I pursued issues raised in previous 
interviews and identified appropriate participants who would provide greater insight 
into the issues identified. I also selected participants who had specific characteristics 
and experience in order to understand typical conditions and their influence in TB 
treatment completion, such as people who were frequently late in their treatment; 
people who had stopped TB treatment due to side effects of TB drugs; people who 
frequently had to travel as part of their occupation; migrants; people residing in slum 
areas and daily labourers. I did not take this approach to generalise knowledge gained 
from specific cases, but to enhance understanding of various characteristics. 
In total, I approached 43 PLTB for interview, of which 31 agreed to participate. It was 
a very time consuming process. Reasons for non-participation included lack of time 
for interview; did not get approval from household (especially women and young 
girls); not willing to talk about their disease; did not want to participate because this 
was the first time they had talked to an interviewer; did not see any benefit of talking 
to an interviewer; did not think they have anything special to tell.  
During the process of identifying PLTB for interview, I considered potential selection 
bias: however, I was interested to know the issues in-depth rather than trying to cover 
all groups in the study. It was likely that service providers suggested those PLTB that 
they thought easy i.e. people with whom they had a good relationship, who would not 
talk negatively about them and the services they were receiving from the centre; and 
people who had never complained about their treatment. I was concerned about such 
potential bias, so used not only discussions with service providers but other 
approaches when selecting study participants. My multiple visits to the centres and 
careful observation of the services provided helped further to minimise bias. 
Another group I recruited for in-depth interviews was family members of PLTB. For 
convenience, the majority of family members selected were accompanying PLTB to 
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the DOTS centre either for daily DOT or follow-up. In some cases, PLTB were also 
present during the interview with family member, as the context did not make it easy 
to ask PLTB to leave the family member. However, responses were obtained from the 
family members and by making clear that I wanted to interview the family member 
about their experiences, possible interferences in the interview were minimised. In 
such conditions I also assumed that the family member who accompanied PLTB to the 
DOTS centre had a good relation with PLTB and provided support. However, on a 
few occasions during interview family members were critical about the PLTB, 
especially on their personal habits i.e. smoking, dietary habit, and negligence in taking 
TB drugs. Such comments confirmed my assumption that I had created an 
environment where family members could air their views openly. Not all family 
members were interviewed with the PLTB. I also visited PLTBs homes and 
interviewed the family members there, in agreement with PLTBs. In some cases, I 
interviewed a family member who went to the DOTS centre to collect drugs without 
the PLTB. In most cases, family members were spouse (in the case of a married 
couple), or a parent of the PLTB (in the case of children). Young unmarried girls were 
mostly accompanied to the DOTS centre by their mother, who was thus identified for 
interview. However, I could not interview PLTB who did not support the PLTB in 
their treatment, or those family members who discriminated against the PLTB in the 
family, as gaining access to them was not feasible.  
I also interviewed frontline health care providers. I mainly approached service 
providers working in identified DOTS centres, because their role was to facilitate TB 
treatment; hence, I assumed that they had frequent interactions with PLTB throughout 
the various stages of care seeking. According to NTP policy, their role was identified 
as a DOT provider, which means they were the one implementing the NTP’s DOT 
policy at service delivery level thus had firsthand experience in DOT and its feasibility 
in the context. The service providers were also an important source of information to 
PLTB regarding TB disease and treatment management, which had a big role in TB 
treatment completion. Moreover, most of the providers were local residents and were 
aware of the complexity of the urban environment, especially regarding essential 
health care services. I conducted in-depth interviews and FGD with this group (see 
more on FGD in section 4.3.3.2). The service providers were purposively selected for 
in-depth interviews. Fourteen frontline health care providers were approached for 
interview, of which 8 (5 men and 3 women) agreed to participate. The reasons given 
for non-participation were: no prior experience of giving such interviews; concerns 
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about jeopardising their job by describing differences between policy and practice; no 
approval from organization; and personal unwillingness to participate. Interviews 
were conducted in DOTS centres. 
Similarly, NTP officials were identified as key informants, because NTP senior 
officials, in particular at national level, were involved in policy formulation, providing 
technical assistance to districts including to the urban TB control programme and 
overseeing overall implementation along with engagement in monitoring of NTP 
activities. TB programme supervisors also worked in district public health offices. 
They played a key role in setting up and managing the urban TB control programme in 
collaboration with other stakeholders in the study area. The purpose of key informant 
interviews with NTP officials was to gather information as they had particular 
knowledge and understanding about the NTP policy and its implementation, especially 
in TB treatment management, thus I assumed that they could provide insight on the 
issues identified from field data collection, from policy and programme 
implementation perspectives. NTP officials were identified purposively based on their 
roles and responsibilities in the NTP. I also interviewed senior members of the public 
health division of the municipality in Kathmandu as they were the key partners 
providing TB services in collaboration with the NTP in the study area.  
Another group I interviewed in the study was community members. DOTS committee 
members and volunteers (late TB tracers) were identified for the interview after 
discussion with DOTS centres staff. Lists of volunteers were obtained from the DOTS 
centres, from which I identified volunteers who had experience of tracing late PLTB. 
(Not all tracers had traced PLTB, nor were all of them actively involved in TB control 
activities.) I did not consider interviewing non-active TB tracers, even though they 
could have provided reasons of not getting involved, because the focus of the study 
was to understand their experiences with TB and PLTB while performing their role as 
TB tracer. However, it could be an area of further research to understand how and why 
TB tracers engage or do not engage in TB control. I recruited members of DOTS 
committees to gain community perceptions towards TB disease and PLTB. 
Participants from this group were identified after discussion with staff members of the 
DOTS centre with which the DOTS committee was associated. As with the tracers, I 
only identified DOTS committee members who had had involvement in TB control.  
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4.3.7 Interview location and context 
The purpose of in-depth interviewing was to gain a clear understanding from 
individuals regarding their experiences during treatment, how and why those 
situations occurred, and their relationships to the study aim and objectives. It was 
important to ensure interviews occurred in places where participants could feel 
comfortable to talk openly. However, in the study setting, it was hard to find good 
locations where all external disturbances could be prevented. Nevertheless, I made a 
considerable effort to find the best environment for interviews. I initially discussed 
with frontline TB service providers and obtained ideas about the context and possible 
locations where interviews could take place. Below, I describe how I worked with the 
participants to find interview locations.  
PLTB and their family members: Once a participant had agreed to be interviewed, we 
discussed the location and time for the interview. I made it clear that I could be 
available at any place and time they proposed, at their convenience. Initially, I did not 
propose any location and time but it was not easy for them to suggest a preferred 
location and timing. For the ease of participants I then suggested some potential 
locations i.e. participant’s home or rented room, their work place, and the DOTS 
centre where they were taking treatment, but made it clear that I could be available at 
any location they chose. Some participants proposed a different location. Preference of 
location and time varied among individuals: the most common were DOTS centres 
where they were taking treatment; their home or rented place; a restaurant; and public 
places such as parks, temples, and other holy premises.  
The majority of PLTB and their family members choose DOTS centre where they 
were taking treatment. Their preferred time was when they visited the centre for DOT 
or drug collection. First, they took or collected their drugs, then started the interview. 
Many DOTS centres in the study area had limited rooms, so it was difficult to find a 
good location there for interview. DOTS centre staff made a room available for the 
interview (e.g. office room or drug store room). No interruptions occurred. 
Three participants chose their home or rented room for interview. People who 
preferred to be interviewed at home lived 15 to 20 minutes from the DOTS centre. (I 
recorded the travel time when I walked with the participants from DOTS centre to 
their home for interview: participants perceived this as nearby.) All participants I 
interviewed at home had rented one or two rooms for them and their family or friends 
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and relatives. People who were living with friends choose a time when others were not 
in the room; most were out for work or visiting their village.  
Three young men with TB, all migrants living with friends, identified a restaurant near 
the DOTS centre for interview. The restaurant owner or worker was a friend of the 
participant or from the same village and knew about their disease: some provided 
support for their treatment. I found that they had a good trusting relationship, which 
was the reason they preferred that place for interview. The restaurant was open to 
everyone but we sat in a corner and did the interview with a cup of tea. There was 
some external interference such as movement of people and talk, but the participant 
did not seem bothered.  
Five participants choose public places, four inside the temple premises, and one in a 
public park near the DOTS centre. I found that these people often visited these places 
to rest on the way to and from the DOTS centre, and were familiar with surroundings.  
All family members chose to be interviewed at DOTS centres, except one who chose 
to be interviewed at home.   
Frontline health care providers and NTP authorities: All interviews with health 
service providers took place in their office, in accordance with their preferences. The 
environment appeared conducive during the interview, as the participants were open 
to frank discussion about the issues that arose. Similarly, NTP officials were 
interviewed in two locations: their office premises and at DOTS centres when they 
visited for supervision or monitoring purposes.  
Community members: Participants from this group also given the option to choose the 
location of their interview. All preferred to be interviewed at the local DOTS centre.  
4.3.8 Data management and storage 
Qualitative data often consists of a collection of unorganised notes, transcribed 
conversations, audio-taped interviews, documents, matrices, hunches of ideas, maps 
and diagrams, photographs, field notes, etc (Mason, 2002). It is a difficult task to 
organise the data and use them to generate theory in line with the study objectives. In 
my study, I gathered a great deal of data as discussed in section 4.3.3. In this section, I 
describe my data management, referring specifically to primary data which I collected 
in the form of recorded interviews, transcripts, field notes and discussion notes.  
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Regarding recording of qualitative interviews, three different ways are commonly 
used: notes written at the time of the interview; notes written after the interview; and 
an audio recording of the interview. There are pros and cons to all these methods. A 
researcher who writes notes at the time of interview needs to do two things at once, 
which can interfere with the process of interviewing and thus compromise the quality 
of the interview. A researcher who writes notes after completion of the interview is 
likely to miss out details of the conversation, as remembering a long interview and 
documenting information afterwards is a challenge for most researchers. In many 
cases researchers prefer audio-taping, but not all respondents will are comfortable 
with this, especially when the topic under investigation is sensitive (Britten, 1995): 
some respondents do not speak openly when their interview is recorded, limiting the 
quality of data obtained.  
In the study, I used two ways of recording qualitative interviews that were appropriate 
to the context: audio recording and note taking during the interview. I clearly 
explained the recording options to respondents before the interview started. The 
majority of interviews were audio recorded. Interviews with those respondents who 
preferred not to be audio-recorded were recorded using notes taken at the time of 
interview. Reasons given by respondents who did not agree to use audio recorder 
included feeling uneasy; first time to be interviewed; concerns about confidentiality; 
unwilling to be recorded because some interview questions and answers critical of 
policy and practice could be related to other people in the team; did not want to be 
recorded as voice is not good (one woman respondent commented, ‘my voice is like a 
buffalo cry, I don’t want to be recorded’). Most people with a formal role in the NTP 
were reluctant to use audio recording. Similarly, women including unmarried girls 
were hesitant to record their conversation. I found that despite ensuring confidentiality 
some respondents did not seem to be comfortable to be recorded, but still consented to 
be interviewed. All interview records, interview notes and audio recordings were 
given a code and kept locked away in a place only I had access to.  
The audio-recordings of the initial fifteen interviews were transcribed and then 
translated into English, as the interviews were conducted in Nepali. For the remaining 
interviews, I only translated the major concepts and issues, because in the initial full 
translations, I found much of the information was not relevant or had already been 
covered and did not bring additional insights. However, in this process, there was the 
possibility of missing some relevant information, so decisions on relevancy were 
carefully considered. 
109 
 
Data generated from observation was recorded in the form of field notes. I recorded 
notes in Nepali and then translated them into English during analysis. I used my 
notepad to record field notes in brief, depending on the context and time available and 
kept the notes separately.  
Data generated from FGD was recorded in writing, as the group participants did not 
agree to audio-recording. A trained rapporteur took discussion notes, which were then 
translated into English. Consideration was given during translation to maintaining the 
originality of the data; I later checked this myself.  
4.3.9 Qualitative data analysis 
Qualitative data analysis is a rigorous process. In many qualitative studies, data 
collection and analysis complement each other, with analysis occurring in parallel 
with data collection (Silverman, 2005; Huberman and Miles, 1994). Data collection 
and analysis is a cyclical process: collecting, noticing, thinking, rethinking and 
inferring in qualitative research (Jorgenson, 1989; Krippendorff, 2004; David and 
Sutton, 2004). In his book Doing Qualitative Research, Silverman (2005) identified 
four ways to develop the analysis of qualitative data within a context where data 
analysis and data collection go hand in hand: (i) focus on data which is of high quality 
and easiest to collect; (ii) look at one process within that data; (iii) narrow down to 
one part of that process, and (iv) compare different sub-samples of the population (p. 
173). He encourages qualitative researchers to develop provisional ideas of analysis 
and comparison categories between groups in order to maximise depth of data 
collection focusing on high quality data.  
It is clear that qualitative data analysis requires a rigorous process of critical thinking 
at various stages of the research process on whether and how the data could be used to 
construct meaningful themes, common and/or divergent ideas and relationships 
relating to the phenomena under investigation. Scholars have defined various methods 
of qualitative data analysis e.g. grounded theory, narrative analysis, conversation or 
discourse analysis, and content analysis along with use of inductive or deductive 
approaches – either independently or using a mix of approaches (David and Sutton, 
2004; Silverman, 2005). In their book Social Research David and Sutton (2004) 
suggest that two forms of qualitative analysis dominate: content analysis and discourse 
analysis. These two approaches complement each other and may be combined.  
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4.3.9.1 Process of analysing data 
I used a content analysis approach. This is a scientific tool to analyse textual data. 
Krippendorff (2004) presents a definition of content analysis as: ‘Content analysis is a 
research technique for making replicable and valid inferences from texts (or other 
meaningful matters) to the context of their use.’ (p. 18)  
In this definition the word technique emphasizes active engagement of the researcher 
in data analysis through application of appropriate scientific tools thus gaining greater 
insight of the context and issue under investigation. The use of specialised 
technique(s) in research is expected to be reliable: hence, findings derived using 
scientific procedures are replicable regardless of circumstances, when researchers 
apply the same technique to the same data. Application of scientific procedures in 
research studies including analysis of data should yield evidence that is valid and 
independent. Similarly, the use of word text in the above definition is not limited to 
written scripts only, but covers unwritten forms of data e.g. photographs, art, signs, 
symbols etc. However, eventually all qualitative data become text when they come to 
the analytical stage. In defining content analysis in qualitative research, researchers 
have configured their definition within three essential points: content to be inherent in 
a text; content to be a property of the source of a text; content to emerge in the process 
of a researcher analysing a text relative to a particular context (Krippendorff, 2004).  
However, use of content analysis is questioned by some qualitative researchers, who 
see it as the imposition of arithmetical quantification in qualitative research. 
Researchers who reject content analysis prefer to use discourse analysis; thus the 
debate seems to revolve around content analysis versus discourse analysis (Silverman, 
1993; David and Sutton, 2004). However, some qualitative researchers believe in the 
value of content analysis to maximise depth of analysis of qualitative data (Berg, 
1998; Huberman and Miles, 1994), and urge that the researcher using content analysis 
needs to construct a context within which the text makes sense and can answer the 
researcher’s questions relating to social phenomena.    
I used content analysis within which I applied detailed and inductive approach. Figure 
11 outlines the components of my interactive approach to data analysis, which I 
adapted from Huberman and Miles (1994).  
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Source: Adopted from Huberman and Miles 1994, p. 429. 
In the figure, I focus on the process that I used in data analysis in parallel with data 
collection, and the interactive relationships between data collection steps and analysis: 
reading; coding; reducing; displaying and interpreting. I emphasise that I did not 
precisely use a grounded theory approach in the study as defined by Glaser and 
Strauss (1967).  
Interim analysis: I considered data analysis as an ongoing and frequentative process. I 
made an interim analysis (not in-depth and explicit at this stage) during and after each 
event of data collection, based on reading the content of the data. Reading through 
data helped me to understand whether the responses were full and detailed, or 
superficial. At this stage I also reviewed whether other aspects, such as context, 
location of interview, selection of study participants, and broadmindedness of 
participants and health care providers influenced the study: I also gave these aspects 
repeated consideration throughout data collection. At this stage of interim analysis I 
also looked at new issues emerging from the data and started to assess linkages. I 
continued doing this until I had understood the issues or areas emerging during data 
collection. The interim analysis helped make sense of the data and focus subsequent 
data collection events on emerging themes and the study aim and objectives. This also 
helped me avoid being overwhelmed by data as my data collection was guided by 
issues arising from the data, thus omitting unrelated data which were outside my study 
area, while permitting widening of the scope of data collection to admit new issues. 
My continue reading of data as they were collected helped me to assess the quality of 
Figure 11: Qualitative data analysis- steps-by-steps 
 
Reading Coding 
Reducing Displaying 
Interpreting 
I. In the field 
Verifying Questioning
 
II. At your desk 
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my notes and transcripts, the data collection process, my observation methods and my 
interactions with study respondents.  
Although there are several software packages for qualitative data analysis, I chose to 
record and analyse data manually, as my previous experience as a qualitative 
researcher gave me a degree of confidence in this approach. 
Coding: Coding is a process where codes (key words, themes or phrases) are applied 
to textual data which highlight similarities and differences within and between text 
(David and Sutton, 2004). I found that coding was a major step in data analysis as it 
starts the data analysis and prepared me for further in-depth analysis. Although most 
qualitative researchers use some form of coding exercise in qualitative research, no 
standard rules exist on how coding should be done. It is up to the researchers to decide 
what types of code to formulate and how they should be used (Ulin et al., 2005): 
however, coding in line with research objectives/questions helps researchers to see the 
association of data with the objectives and thus advance further analysis. I assigned a 
code to each meaningful segment of text as it occurred: I call this first level coding. I 
used an inductive coding approach: codes were generated after initial reading of data, 
known as open coding. While selecting codes, I primarily considered original ideas, 
concepts, and words used by study participants during the interview. In doing so, I 
found it appropriate to generate various codes keeping the original concepts within the 
conversation recorded in the data. Reoccurring segments of data were coded several 
times (but with the same code) as they appeared and eventually clustered under one 
theme after verification. It was unmanageable to have too many codes, so after the 
initial coding I reviewed the coded data and reduced the codes to a manageable level 
without losing data and keeping the original sense intact. I personally coded all data.  
Data grouping, categorization and theme identification: After coding each segment of 
data, I clustered the codes and used them to develop themes and categories. Extracting 
and combining of information from the data under various themes allowed me to look 
at the data more closely and examine them separately and jointly. I repeatedly referred 
back to my study objectives. This also helped me to identify linkages between and 
among categories to deepen my understanding of issues identified. 
Data reduction: The data reduction process started when I fully finalised coding and 
grouping of data under themes. Before reduction, I was well acquainted with all major 
themes and subthemes and various categories that I generated from the data, and had 
an understanding of various links and meanings of themes and sub themes (Ulin et al., 
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2005). In the data reduction stage, I carefully considered the identified themes and 
their linkages to the research objectives. I also looked at why some unrelated themes 
occurred, and hence whether they had any connection to other themes. I found some 
interesting things in the data that were not related to my study objectives: such 
irrelevant segments were dropped during the final analysis process. I used handwritten 
flow charts and matrices to understand whether and how the data segments I wanted to 
drop from the final analysis had any association with the study objectives.  
Comparisons: After clustering data segments under various themes I extracted 
commonly understood meanings, then used constant comparison of features of the 
evidence emerging from the data analysis process. This helped me to understand 
patterns of similarities and differences, and enablers and barriers. It also helped me to 
understand the robustness of issues and to avoid misleading interpretations of data. 
However, comparison was often not easy as multiple themes were derived from the 
data and comparing them to events and features of certain groups or individuals was a 
challenge. I also found various commonalities as well as differences in responses, so 
that in a few instances comparisons and their interpretations were rather mystifying. 
Interpretation: Interpretation is considered to be the establishment of a concept 
through identification and appropriate explanations of the core meaning of data (Ulin 
et al., 2005). In the study, I considered interpretation not just as an act of providing 
interesting notions about the data: I was more interested in explaining what all the 
identified themes and subthemes in the data meant and how they related to individuals 
or groups of individuals and their social interactions under different circumstances. In 
the study, interpretation was not made only at the end of study (i.e. after collection of 
all data): but at various stages including during observation and interviews and while 
reading interview transcripts. Essentially, my interpretation of the data was based on: 
the categories and themes produced from the data and their originality; concepts and 
ideas that emerged from data grouping; contextual meaning of data relevant to the 
study setting and the people studied; my best judgment related to the issues that 
emerged without manipulating the essence of issues; previously documented 
knowledge on issues in the local context and elsewhere; and the study’s aim and 
objectives. However, before arriving at the final interpretation of the data’s core 
meaning I frequently revisited the data, the concepts that emerged from the data and 
their relevance to the context and the study objectives. Similarly, I also considered the 
key questions put forward by Silverman (2005), which he suggested that qualitative 
researchers should take into account before they actually plunge into data analysis and 
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revisit them during analysis: what are appropriate method(s) of data analysis? Do the 
analysis methods suggest interesting questions? Is the analysis method likely to 
generate interesting generalisations? Do previous research findings seem to apply to 
the study data? How do particular concepts from the preferred social research model 
apply to the study data? Which concepts work best and are likely to be most 
productive? (p.152) 
Nevertheless, in some instances it was difficult to make appropriate interpretations, 
particularly when respondents were reticent about an issue, either due to perceived 
risk of being explicit or lack of understanding of the issue. I also experienced 
challenges while interpreting core nuances from the data when there were multiple 
dimensions in the data indicating multiple meanings of an issue or finding – either in 
similar or in different contexts. This happened generally when contradictions were 
observed on the same issue with the same group. However, I found that further 
thought and comparison between themes and subthemes and emerging concepts, with 
greater understanding of the context, helped my interpretations in such circumstances. 
4.3.10 Contribution of different data sources 
The purpose of this study was to develop an in-depth understanding of TB 
treatment completion – problems, issues, responses and ways to address them in 
the specific contexts in which they arose – mainly from the perspective of PLTB.  
I used the following qualitative research methods: (i) in-depth interviews, (ii) 
FGDs, (iii) observations, and (iv) document review, which are discussed above. 
These methods were equally important and complementary in the study, enabling 
information to be triangulated and validated. It is not appropriate to quantify the 
relative contribution of different data sources when judging the merits of the study 
findings, developing arguments and building theory. Comparative weighting of 
methods used in evaluating qualitative research is complex (Elder and Miller, 
1995; Krik and Miller, 1986), especially when multiple methods are used. 
However, considering the frequency of methods used and adequacy of responses 
gained on the issues and complexities of the phenomena that I researched, I found 
that in-depth interviews, FGDs, field observation and document review all 
contributed substantially to the study findings. 
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4.4  Validity and reliability 
The definition of validity varies among qualitative researchers since there is not a 
single, fixed or universal definition of the term. Hence, use of the term in qualitative 
research paradigm is often subject to controversy, unlike in quantitative research. 
However, many qualitative researchers have given their own concepts of validity and 
presented terms that they considered appropriate, such as: ‘trustworthiness’, ‘worth’, 
‘quality’, ‘rigor’, plausible’, ‘representative’, ‘confirmable’, ‘credible’, and ‘relevant’ 
(Denzin & Lincoln, 1998; Guba & Lincoln, 1989; Hammersley, 1987; Mishler, 1990; 
Wolcott, 1990).  
Hammersley (1990) relates his concept of validity to the account of truth that a 
researcher needs to represent correctly while interpreting phenomena in his/her study. 
He stated; ‘By validity, I mean truth: interpreted an account is valid or true if it 
represents accurately those features of the phenomena, that is the extent to which an 
account accurately represents the social phenomena to which it refers.’ (p. 57). 
Hammersley (1992: 67) also defines reliability from the point of view of consistency 
in the research: he notes, ‘reliability refers to the degree of consistency with which 
instances are assigned to the same category by different observers or by the same 
observer on different occasions.’ In contrast, some researchers do not use the term 
reliability, stating that the term is not applicable in qualitative research. Rejecting the 
concept of reliability in qualitative research, Stenbacka (2001) stated; ‘the concept of 
reliability is even misleading in qualitative research. If a qualitative study is discussed 
with reliability as a criterion, the consequence is rather that the study is no good’ (p. 
552). Thus, the understanding of reliability among qualitative researchers is found to 
be as complex as the understanding of validity. Table 11 is a summary of 
Hammersley’s (1987) reviews of reliability and validity as defined by various authors 
from different methodological positions. 
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Validity ‘An agreement between two efforts to measure the same thing with 
different methods’ – Campbell and Fisk (as cited in Hammersley, 1987) 
‘The measure that an instrument measures what it is supposed to’ – Black 
and Champion (1976, pp. 232-234) 
‘Accuracy’ – Lehner (1979, p. 130) 
‘Degree of approximation of ‘reality’ – Johnston and Pennypacker (1980, 
pp. 190-191) 
‘Are we measuring what we think we are?’ – Kerlinger (1964, pp. 430, 
444-445) 
‘to the extent that differences in scores yielded … reflect actual 
differences’ – Medley and Mitzel (as cited in Hammersley, 1987, p. 150) 
Reliability ‘An agreement between two efforts to measure the same thing with the 
same methods’ – Campbell and Fisk (as cited in Hammersley, 1987) 
‘Ability to measure consistently’ – Black and Champion (1976, pp. 232-
234) 
‘Reproducibility of the measurements … stability’ – Lehner (1979, p. 
130) 
‘Capacity to yield the same measurement … stability’ – Johnston and 
Pennypacker (1980, pp. 190-191) 
‘Accuracy or precision of a measuring instrument?’ – Kerlinger (1964, 
pp. 430, 444-445) 
‘To the extent that the average difference between two measures obtained 
in the same classroom is smaller than … in different classrooms’ – 
Medley and Mitzel (as cited in Hammersley, 1987) 
Source: adapted from Winter G. (2000). Retrieved from www.nova.edu/ssss/QR/QR4-
3/winter.html 
Expectations of highly consistent ‘high reliability’ in qualitative studies can result a 
systematic bias in data generation and interpretation, as reality is dynamic in social 
phenomena and changes constantly, so that attempting to attain high reliability will 
grossly compromise validity. Therefore, in qualitative research, many researchers 
focus on validity and some of them also consider validity as the combination of 
‘validity’ and ‘reliability’ (Hammersley, 1987). Mason (2002) argued that the terms 
validity, reliability and generalisability, which he named ‘scientific criteriology’, often 
do not fit comfortably with the essence of qualitative research – the way qualitative 
research conceptualises, designs, implements and interprets – and thus discussion on 
how qualitative researchers measure the significance of ‘scientific criteriology’ should 
not be the primary debate; instead, researchers should focus on the bigger picture of 
qualitative research; that is quality and rigor.  
Table 11: Hammersley’s review of validity and reliability - definitions by various 
researchers 
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In my study, I looked at two aspects of so-called validity: data generation methods 
and interpretation (Manson, 2002).  
In general, validity in research is largely determined by the use of research 
instruments based on which interpretations are made. As Patton (2001) pointed out, in 
qualitative research ‘the researcher is the instrument’ (p. 14), thus the validity and 
credibility of qualitative research depends largely on the ability and effort of the 
researcher.  
Threats to the validity of the research techniques that I used emerged from the outset 
of my research; I constantly addressed these threats through rigorous thinking at 
various stages of my research. An important approach that I instigated at the 
beginning of my research was – who could contribute to answer my research 
objectives; how I could recruit them into the study; what alternatives did I have in 
identifying potential data sources and methods of generating data from the identified 
sources; and how and whether the context was conducive for the kind of research I 
was conducting. Such thinking forced me to learn more about methodological stances 
that I took in the study. In the overall design of my research approach (see section 
4.2), including selection of study participants and data generation methods, I 
consistently looked at the relationships between selection of methods, potential study 
participants, selection of research sites such as DOTS centres and my research 
objectives and the kinds of theory and explanations that I sought in the study. I put 
every effort into generating trustworthy data in the field. I conducted the great 
majority of qualitative interviews and moderated all FGDs, constantly checking and 
verifying data, asking myself questions such as: Does this data make sense? Can I 
trust the data source? Does this segment of require verification from the source? Was 
the respondent fair in his/her answers? Had there been any pressure on the respondent 
to answer questions in a particular way? It was not easy to get answers to all these 
questions but I constantly retained my stand to search for the best through 
understanding of the context and establishing a good rapport with the respondents. In 
a few instances, I used other researchers in qualitative interviews, but I judged their 
skills as researchers to be good and I provided training to further enhance their skill 
before they actually commenced fieldwork. Similarly, a well-trained rapporteur in 
FGDs also ensured quality of FGD discussions.    
Interpretation of data and inference were achieved through content analysis using a 
flexible approach in which constant comparisons and triangulations were ensured. 
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Comparisons of categories to understand similarities and differences between two 
constructs were important to enhance richness of data interpretation and thus 
trustworthiness. Comparisons were made not only between categories of data, but also 
between study participants and their responses to the issues emerging from the data. 
Broadly, triangulation refers to the combined use of more than one method of 
investigation to look at the study findings – that is, methodological triangulation. 
However, in qualitative research, triangulation is not limited to methodological 
triangulation, but is also used to seek explanations for similarities and differences and 
record the construction of reality, considering respondents, theories, investigators, and 
data generation (Denzin, 1970). The purpose of triangulation in qualitative research is 
to enhance confidence and credibility of data interpretations and thus reduce 
uncertainty and increase the plausibility of inferences. The use of multiple methods in 
data generation, such as qualitative interviews, observations, FGDs and key informant 
interviews further helped to yield more valid, reliable and diverse construction of 
realities in the study. 
Similarly, during data generation, especially in qualitative interviews and FGDs, a 
probing strategy was adopted which helped to avoid misleading conclusions during 
data analysis. At the end of each interview I verified with respondents the key issues 
that emerged during conversation. I considered performing a full validation of data 
interpretations with the study respondents but concluded this was not feasible because 
of problems accessing respondents, especially PLTB and their family, as they were 
not in touch with the DOTS centres after they completed treatment and many of the 
respondent PLTB were migrants and thus mobile.  
Chapter 6 touches further on validity and reliability related to the generalisability of 
my findings.  
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4.5 Ethical issues and considerations 
I obtained ethical clearance for the study from the Ethical Review Committee of 
Tribhuvan University, Institute of Medicine, Nepal. As per my research proposal and 
the guidance of the ethical review committee, I used an information sheet and consent 
form (see annex 3 and 4) written in Nepali (Nepali was the common language of all 
participants). The ethical review committee reviewed and cleared the form. Obtaining 
written consent from participants was explored and rejected, as it was not deemed 
feasible within the Nepali culture and the local context where people had reservations 
about signing any documents. Thus, I decided to gain verbal informed consent from 
all research participants, an approach approved by the ethical review committee. The 
information and consent form was read out to the participants before the interview 
started. All participants were clearly informed about their right to withdraw their 
consent at any time during the study and assured that a decision to withdraw would 
not affect the treatment that the PLTB was receiving. All participants were also 
informed if they did not wish to answer any question(s), they had the right to do so at 
any stage of the research process. I also informed the participants that data generated 
from interviews would be used for my doctoral thesis and publication as seen relevant 
but no identification of participants would be made. Before each interview, potential 
study participants were clearly informed about the purpose of the study and the 
interview, and their role in the study.  
In addition to the information and consent form, I developed an information sheet 
containing other related information regarding the study and provided it to the 
participants. Sometimes I read the consent form and information sheet, while in other 
cases I helped participants to read them. Some study participants took the information 
sheet with them after the interview. I encouraged participants to ask any questions 
they had regarding their participation and the study. 
I was fully aware of the need to preserve the anonymity and confidentiality of 
participants’ identities and information. All information obtained from individual 
participants was recorded using either audio taped or written notes, only for the 
purpose of the study, and no names were used on these recordings, as code numbers 
were used instead of participants’ names. I or my team (the additional interviewer and 
the rapporteur) did not and will not disclose names or any other information that could 
be used to identify study participants, either in this thesis or in any other 
circumstances.  
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It was also explained to participants that all data would be destroyed after the purpose 
of the study was achieved: a completed PhD thesis and associated publications. I also 
mentioned to study participants that I would provide feedback of the major findings to 
participants through using available means. Considering the context I thought it 
appropriate to use local radio stations to provide this feedback. I will also use the 
DOTS centres and staff members involved in the study to communicate findings to 
PLTB and their families. I did not take any biological samples of any kind in the 
study. I also obtained permission from the NTP to conduct the study in their 
programme setting, having presented how I was going maintain ethics standards and 
protect the rights of study participants throughout the study.  
4.6  Limitations in data collection 
In this section, I focus on limitations that I experienced in the data collection process. 
Limitations were observed during data collection: however, throughout the process I 
made efforts to understand limitations and then overcome or minimize their 
implications as the study progressed.  
One limitation was that I planned to interview some specific groups of people as 
guided by the issues emerging from the data, but could not do so. For instance, there 
were some young unmarried girls receiving TB treatment under DOTS in the study 
area. I approached them but most refused to participate in the study because their 
parents did not give permission for them to be interviewed, mainly because of 
concerns about being identified as a TB patient by the community.  
Data collection may have been affected by external factors such as interview 
locations. Although the interview location was decided after discussion with research 
participants, there were not many options available where interviews could be 
conducted without external interference. In some instances, I noticed that research 
participants were not willing to share specific information, such as how they were 
treated in health institutions, and especially health workers’ behaviour towards them. 
Such reluctance was mainly observed when the interview took place in a DOTS 
centre. Considering this limitation, I encouraged PLTB to choose an alternative 
interview location but had limited options available.  
Some women participants from the Newari ethnic group preferred to talk in Newari, a 
common language among Newar community in Kathmandu, but at the initial stage of 
data collection, I was not able to address this issue. Once I became aware of this issue, 
I trained a female researcher who then did interviews in Newari.  
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There was a perception that women would not talk openly when interviewed by a 
male interviewer. Initially, I interviewed a few women, and then used a trained female 
researcher to interview female respondents. I found that there was no difference 
openness about issues experienced during TB treatment. However, I used both to 
avoid limitations. Use of an audio recorder was not acceptable to some study 
participants and it was difficult for the researchers to note all conversations, so some 
important points from conversations may have missed. Similarly, one interview was 
not properly recorded due to a problem with the recorder, and had to be excluded from 
analysis, as it was not possible to redo the interview.  
Selection of research participants for interviews and FGD may have had some 
limitations as it was done largely in consultation with DOTS centre staff. It can be 
assumed that they may have proposed research participants who they thought would 
respond favourably when asked about their experiences with TB service providers.  
One of the tools that I used in data collection was observation. My physical presence 
during observation at the DOTS centre may have influenced the service delivery 
environment and the behaviour of health care providers and PLTB. However, I tried to 
minimize this limitation by creating a good relationship through several visits and 
interaction with health service providers, so as they could see me not a ‘quality 
assessor’ of services they provided to PLTB and others.    
One limitation in data collection could be the cultural understanding or perception of 
the Nepali people. In Nepali culture, people often try to please by not saying negative 
things even though there could be many negative issues that occurred. This might 
have happened in this study: however, I considered this and tried to avoid it by 
developing informal relationships through many meetings and visits before obtaining 
data from participants.  
Wider limitations observed in the study are described in chapter 6. 
4.7  Conclusion  
This chapter described the research approach and design, and approaches to ensuring 
validity and reliability of the study findings, along with a rationale of the methods and 
approaches used during the various stages of my research. The chapter further 
discussed ethical considerations throughout the research process and some observed 
limitations in data generation in the study. The next chapter presents my study 
findings and initial discussions.  
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CHAPTER FIVE: 
STUDY FINDINGS AND INITIAL DISCUSSIONS 
The previous chapter described the research design and methods used in the study. 
This chapter presents the study findings and initial discussions. The chapter broadly 
examines the issues that hindered or helped TB treatment completion from the 
perspectives of PLTB. I have divided the chapter into three major sections inline with 
my study objectives: issues in successful and unsuccessful treatment completion; 
organisation of TB service delivery as a response to the issues related to successful 
and unsuccessful treatment completion; and, factors enabling successful treatment 
completion. The third objective of my study - identify appropriate ways of addressing 
the problems and issues identified – is discussed in chapter seven.     
To broaden understanding of successful and unsuccessful completion of TB treatment, 
I have primarily considered perspectives gained from the three major stakeholders: 
PLTB and their family members; the health system (which includes the NTP and 
health workers); and the community (general members of communities, and friends 
and colleagues of PLTB). However, the perspectives of PLTB and their family 
members have been my priority, because I wanted to gain first hand experiences of 
PLTB to understand whether and how TB service delivery in urban areas hindered or 
helped TB treatment completion.  
I found that the many issues relating to TB treatment completion were interrelated. 
Objectively understanding their impact on TB treatment was complex. Hence I have 
presented the study findings, initial discussions and my interpretation as they emerged 
during data analysis. However, I considered the following areas while making my 
interpretation: the original views expressed by various study respondents; local 
context including organisation of TB service delivery in the study area; my 
observations throughout the study, in particular during field research; information 
obtained by reviewing relevant documents; and my experience as a researcher during 
the research process. I note at the outset that there were multiple health care providers 
providing TB services in the study area. The findings and initial discussions presented 
in this chapter are within the context of Nepal’s NTP in an urban area: thus I have 
presented implications of findings considering this local context. I fully acknowledge 
that many people with TB receive treatment outside the NTP (i.e. in the private sector) 
but this was not the focus of my study. 
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5.1 Understanding pathways to TB diagnosis and treatment 
Although the study focused on problems and issues arising during the treatment period 
(the period from the start of anti-tuberculosis treatment until treatment outcome was 
available), many PLTB stated that they experienced barriers before they embarked on 
treatment (i.e. in the period between the start of illness until diagnosis of TB), causing 
considerable suffering. I found that some such issues started in the diagnosis phase 
and continued into the treatment phase, thus affecting TB treatment completion. I 
therefore also discuss major issues that arose during diagnosis in this section.   
5.1.1 Health care seeking among PLTB 
Health care seeking behaviours among PLTB varied, making it difficult to identify a 
unique pathway through TB diagnosis to appropriate care. Figure 12 compiles the 
main TB care seeking pathways, and major issues that PLTB experienced before and 
during diagnosis including continuation during treatment phase. I found that many 
PLTB decided to seek initial care only when symptom(s) disrupted their routine work: 
this was especially prevalent among people with limited knowledge about health care 
and low socio-economic status. Similarly, a tendency to ignore illness for as long as 
possible was found among some PLTB. People describing this behaviour gave several 
reasons: PLTB did not suspect TB when they noticed symptom(s); cough and fever 
were considered as symptoms of mild common cold; PLTB used home remedies to 
address the symptoms; PLTB were unable to seek care from formal health care 
providers/institutions for financial reasons, or because they believed costs of care 
would be unaffordable; their illness was tolerable as it did not disturb routine 
activities; and because they were not aware of health service availability in the city. 
I found that ignoring illness till it disturbed routine activities was a common 
phenomenon which was supported by a culture of practicing home remedies, for 
instance, using hot water with turmeric powder to treat cough. Another major reason 
PLTB delayed care seeking was the cost of care: this was more common among those 
facing difficulties to maintain their livelihood. I discuss costs of diagnosis of TB in 
section 5.1.5. In addition to the high cost of care, I found that not knowing the cost of 
care was another reason for delaying care seeking, as many PLTB were not sure how 
much it would cost them to seek care from formal health workers and feared it could 
be so high that they could not afford it.  
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I found that delayed care seeking by PLTB was often linked to their knowledge and 
perceptions about the disease and its symptoms, and use of traditional practices to 
overcome their illness and cost of care. Although initially related to care seeking, 
these issues continued further into the treatment phase and had consequences for 
continuation of TB treatment. 
In conclusion, Figure 12 provides an understanding on pathway to TB treatment. 
During the pre-care seeking phase I found that many PLTB either ignored their illness 
or used home remedies to treat their illness. Only when illness started disrupting 
PLTBs’ routine work did they seek care from a health care provider. Many PLTB 
switched care provider during diagnosis as discussed in 5.1.3. As shown in Figure 12 
I found some issues that hindered care seeking during diagnosis: for instance, cost of 
care; access to care; lack of support; poor referral mechanisms among care providers; 
and poor information of service availability. These barriers contributed to diagnosis 
delay, which ultimately increased cost of care to PLTB and households. As shown in 
the figure, some issues experienced during diagnosis continued to hinder TB care 
during the treatment phase: to address them, PLTB and their families used various 
coping mechanisms in order to stay in TB treatment. In subsequent sections I discuss 
the major issues that delayed TB diagnosis that had implications for TB treatment.  
  
125 
 
Figure 12: Pathways of TB care seeking and issues 
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5.1.2 Use of multiple care providers during diagnosis 
I found that the providers most often visited by PLTB during the initial stages of 
illness, were private health care providers, especially pharmacies or drug retailers. The 
reason stated were that they were trustworthy, easily accessible, were the same 
providers used for other illness, were thought to provide good quality care, were 
recommended by family members, relatives and friends and were easily accessible 
(i.e. close to home and convenient service hours). I also found that many PLTB were 
unaware of availability of health services in the city. Migrants had difficulties locating 
health facilities as they were new in the city and information about health facilities 
was not readily available, so they simply visited the nearest health workers, mostly 
pharmacies, as advised by friends, relatives and neighbours. A male migrant with TB 
said; 
‘I arrived a few months ago and the city is new to me. I did not know where to go for a 
health check-up. I looked for clinics nearby then found a pharmacy, which I visited 
first.’ 
One the other hand, not initially seeking care from the public sector was due to poor 
access to services; perceived poor quality of care in public sector and inconvenient 
opening hours of health institutions. Some PLTBs stated that the lengthy care seeking 
process in public hospitals was another reason why they sought services from private 
providers. I found that the decision to seek care from a specific provider was not only 
guided by costs or physical access, but also by types of information about providers 
and the health care process that PLTB would receive. Such information was generally 
obtained from people around the PLTB, mainly family and friends. Thus, family 
members, friends and relatives played a major role not only in selecting the health 
workers during the diagnosis phase but also in choosing treatment services and 
continuation of treatment.  
In contrast, some PLTB directly went to public hospitals. PLTB who choose this 
approach had suspected their symptom(s) could be related to TB and preferred visiting 
the specialized centre i.e. the NTC. In addition, some PLTB who had problems 
affording the cost of private care visited government hospitals. Similarly, people who 
had been affected by TB in the past sought care from the government hospital where 
they had previously been treated. 
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I found that some PLTB also sought care from traditional healers before they used 
allopathic health workers. This was more common among migrants when they became 
ill while in their village home. The reasons they cited were that they preferred 
traditional practice; were advised by family members especially elderly member of the 
family; had seen improvements in other people with similar symptoms who sought 
help from traditional healers; and felt there was no harm in visiting them. I found a 
tendency among some PLTB to visit traditional healers at the same time as using 
modern health services: this happened frequently when other forms of care were not 
making an impact on their illness. Information and advice PLTB received from 
traditional healers was influential: in some cases, it led them to change their care 
seeking practice including treatment prescribed by the health workers. A 22-year old 
unmarried girl with TB said; 
‘I had feeling that my disease was not TB and so did my parents. We went to a faith 
reader. He gave me a religious ring and some herbal medicines and asked me to stop 
other medicines because the medicine he gave would not work if the modern 
medicines continued.’ 
5.1.3  Switching health workers during care seeking 
PLTB often switched from one provider to another (see Figure 12). The main reasons 
stated were: no improvements in health; unaffordable cost of care; suggestions from 
others (relatives, friends and colleagues); behaviour of service providers; negative 
effects of drugs prescribed by the provider; delay in diagnosis of disease; moved  
house; and to find a more qualified provider. However, shifts from private to public 
providers were due largely to financial constraints such as inability to pay the cost of 
care – the doctor’s fee, and investigation, drug and other charges.  
I found that switching from one provider to another was more common during the 
diagnosis stage than in the treatment phase. The PLTBs who switched more often 
during diagnosis were also likely to seek alternative providers during treatment. This 
was more likely when the PLTB was not making a quick recovery or the health 
worker was not trusted by the PLTB. Advice from family members, relatives and 
friends also played a vital role in whether PLTB switched providers during the 
diagnosis and treatment phases. Importantly, I found it was common that the decision 
of the PLTB was greatly influenced by those who were close to them: in such cases, 
the knowledge of the PLTB had little role to play in decision-making.  
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5.1.4  Referral for TB diagnosis and treatment 
I found there was relatively poor referral linkage from the private sector to the public 
sector and vice versa. My interaction with care providers revealed that private health 
care providers had little trust in the quality of services provided in the public sector 
and were thus not interested in referring their clients. Although some PLTB stated that 
private pharmacies referred them to the TB hospital when their medications did not 
work and they suspected TB, it was not the case with private practitioners, who almost 
never referred people to public hospitals for diagnosis.  
Some referral practices were found within the public sector. A few PLTB stated that 
when doctors in public hospitals suspected they had TB, they referred them to the 
NTC. I found that PLTB rarely mentioned referral by public hospitals for TB 
diagnosis, whereas referral for treatment after diagnosis was common practice, with 
many big hospitals referring PLTB to DOTS centres for treatment.  
5.1.5  Cost of TB diagnosis 
Although the NTP has a policy of free TB diagnosis nationwide, many PLTB stated 
that they had to pay fees for diagnosis that were high relative to their individual and 
family income thus being unaffordable for many. I found that the cost of diagnosis 
varied among individuals, ranging from 1000 to 150,000 Nepali rupees7
I found that the NTP’s free provision of TB diagnosis was only for sputum 
examination in some DOTS centres and public hospitals. Many PLTB stated that the 
high cost of care affected timely care-seeking as they did not have savings and 
depended largely on daily wages or monthly salary. For many PLTB it was difficult to 
 (US$ 14 to 
2,142). The upper end of this range was an extraordinarily highly cost for diagnosis of 
pulmonary TB. The PLTB who spent that amount said that his diagnosis took more 
than a year and involved visiting several places including India. I found that spending 
such a high amount for the diagnosis was rare: other PLTB who I interviewed had 
spent approximately US$ 40 for diagnosis. However, this exceptionally high cost of 
diagnosis cannot be overlooked as many PLTB stated that the cost of diagnosis was a 
problem that also affected TB treatment, as money borrowed for diagnosis had to be 
repaid during the treatment period.  
                                                 
7US$ 1 was equivalent to Nepali rupees 70 (2007/2008)  
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pay even nominal costs of care so that they remained untreated for a long time. A 
woman with TB said; 
‘I did not have money. My husband took loan and went to Qatar for work but he was 
not able to send money back. I was ill but did not go to hospital because had to pay 
charges. I stayed at home for 2 month without consulting any doctors. My husband 
sent some money then only I sought care.’ 
Not knowing the approximate cost of TB diagnosis in advance was an issue which 
delayed PLTBs’ decision to seek care. 
In contrast, PLTB who visited the NTC paid relatively low costs and were rapidly 
diagnosed. Those whose first point of contact with a health care provider was the NTC 
had suspected their cough as a symptom of TB. This clearly showed that community 
awareness of TB led to choice of a proper health care provider: thus TB was 
diagnosed early with low cost to the PLTB and their household. Although the cost of 
diagnosis varied among individuals, managing the cost was a problem for many 
PLTB, and a cost that adversely affected their TB treatment.  
5.1.6  Motivation for TB treatment in NTP 
PLTB stated several reasons why they chose treatment under DOTS even though their 
diagnosis was made in the private sector. One major reason stated was the provision of 
‘free antiTB drugs’ in NTP, which seems to be an encouragement for many PLTB to 
start treatment in the NTP. This encouragement was more appealing to the people with 
low economic status (especially migrants and daily wage labourers) and the people 
who spent a considerable amount of their income and savings for TB diagnosis, 
whether in the public or the private sector.  
Information about ‘free drugs’ seemed to be widely known. PLTBs’ sources of 
knowledge of free drug provision varied: they included family members and relatives, 
friends, colleagues, television, FM radio and health service providers where PLTB 
sought diagnosis. The most common sources of information were family, friends and 
relatives.  
PLTB mentioned that before treatment they knew very little about the process they 
needed to go through to get the ‘free’ drugs in the DOTS programme, or about other 
hidden costs associated with free treatment. Some PLTB stated that if they had known 
that they would be required to spend a considerable proportion of their income to 
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access the free drugs, they could have chosen another provider. A 46-year old man 
with TB (a shopkeeper) said; 
‘Before I came here [the DOTS centre] I was not aware that I need to come daily. I 
pay twelve rupees every day to get to this clinic. Sometime I think that with the money 
I am spending on travel I could have brought drugs from medical hall with less 
hassles every day.’ 
Another reason PLTB used the NTP for treatment was because they had seen other 
persons cured after taking DOTS treatment. However, they were unaware of issues 
that these cured persons faced while undergoing DOTS. Some PLTB perceived the 
free drugs in the public sector to be of low quality, though they were continuing their 
treatment as they feared using the private sector due to the high cost of drugs there. I 
discuss the issue of quality of care and drugs in subsequent sections.  
In conclusion, there were multiple health care providers and users with differing 
characteristics in the study area, so that pathways to TB diagnosis and treatment 
varied. Although PLTB initially sought care from a variety of providers, eventually, 
many of them were diagnosed in the public sector and started DOTS in the NTP. 
However, delays in diagnosis occurred whether the provider was private or public. 
Although the diagnosis of TB sounds simple as described by the NTP, in reality, not a 
single PLTB I spoke with had gone through a smooth process of diagnosis, regardless 
of whether they used public or private providers. Issues during the pre-treatment 
period had an enormous impact on successful completion of TB treatment. The next 
section provides an in-depth analysis of the issues experienced by PLTB during 
treatment which affected the TB treatment completion.  
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5.2  Issues in TB treatment completion 
In this section and subsequently, I discuss issues and problems that hindered TB 
treatment completion. Since there is substantial overlap and interrelations between 
issues, some overlap in the analysis and discussion is inevitable.  
5.2.1 Understanding of TB disease: knowledge and 
perception 
Among PLTB I found mixed knowledge and perceptions about TB and its treatment. 
People used various synonyms, described in Error ! Reference source not found., for 
TB disease. This indicated that TB is a complex social phenomenon, and 
understanding of the disease was greatly influenced by social and cultural beliefs, 
most of which contradicted ‘scientific’ evidence. It also reflected general community 
views of TB and people with TB. It is clear that developing an understanding of TB 
and its effects using only a biomedical lens could misrepresent social consequences of 
the disease and its control, thus undermining successful TB treatment completion.  
 
In general, PLTB regarded TB as a communicable disease. This is for two major 
reasons: they heard that TB can transmit from one person to another; and they 
perceived that their disease was transmitted from others. Some PLTB who had been 
exposed to a known TB case before they were diagnosed, strongly believed that they 
Box 1: Synonyms of TB disease in the community 
- a disease of poor: poor are more affected 
- a distant making disease: makes relationship fragile 
- a wasting disease: makes people skinny 
- a disease of cough: person coughs persistently 
- a killer disease: it kills people 
- a communicable disease: people can infect others 
- a disease of bad doings: it affects person who does unsocial behaviour 
- a disease of divine cruse: it affects people who disobey god, a punishment of 
disobey 
- a disease of dirty people: it affects people who are unhygienic and work in 
such conditions  
- a disease of pollution: dust and air pollution cause the disease 
- a disease of malnutrition: it affects people who eat less 
- a simple and curable disease: disease is treatable with drugs 
- an incurable disease: once person gets the disease it stays lifelong 
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got the disease from that person, thus strongly believing that TB is a communicable 
disease. A young man working in a carpet factory mentioned: 
‘When doctor told me I have this disease [TB], I got surprised and later I came to 
know that a colleague working in the factory had TB but he never mentioned to me. I 
think I got the disease from him.’ 
I found that PLTB who believed in the communicability of TB thought that they could 
transmit TB to others until they were cured. Consequently, most of them kept a 
distance from others in the household, and especially children and spouse, throughout 
the course of treatment. Many, and especially women, stated that keeping a distance 
from their love ones was painful, and influenced continuation of their treatment. A 
woman with TB who had two children said; 
‘I may transmit my disease [TB] to children thus I have sent them to my parents’ home 
since I was diagnosed with this disease.’ 
On the other hand, some PLTB were uncertain whether their disease was 
transmittable. Although they had heard that TB is a communicable disease, their 
experience did not correspond with this, as they had been living with their family and 
none of their family members had TB. I found varying understanding among PLTB of 
the causes of TB, including germs; smoking; hard physical work; unbalanced and 
spicy food; excessive consumption of alcohol; not enough sleep at night; the worst 
consequence of pneumonia; frequent sex with sex workers; sex with multiple partners; 
and not enough food. I found a link between such understanding and continuation of 
TB treatment as some of them thought that their disease would be cured if they 
avoided such causes: thus they focused on avoiding the causes they thought relevant to 
them, rather than organising regular TB treatment. A primary school teacher in the 
hills but who was staying in Kathmandu for TB treatment said; 
‘The doctor told me that my disease was due to less eating so I am trying to eat more 
food with protein but it costs a lot of money.’ 
I found that PLTB often construe their understanding about the disease based on what 
they experienced in the real world: but in many instances knowledge and experience 
conflicted, and experience dominated over knowledge. However, not all PLTB 
experiences were the same leading to differing understanding. In several instances, I 
found that the PLTB who were suspicious about the communicable nature of TB had 
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problems accepting their TB diagnosis (although they were continuing their 
treatment): most PLTB were curious to know how they got the disease. It is therefore 
important to understand misunderstandings and negative experiences that influence 
PLTBs’ knowledge and determine treatment behaviours. However, I found that the 
health system had little consideration of such practical aspects of health 
communication: PLTB were often not satisfied with the responses to questions that 
they put to the health workers. See section 5.2.4 for further analysis of 
communication.  
In addition, I found some common beliefs that PLTB, health service providers and 
community members often stated when describing their understanding about TB as a 
social disease. The sections below describe such beliefs and their link to TB treatment 
completion.  
5.2.1.1 TB: a disease of poor and marginalised 
I found that many people associated TB with poor people and conditions of poverty. 
The health workers very often stated that the majority of PLTB undertaking treatment 
in the NTP were from poor and marginalised groups. In this context, the poor and 
marginalised groups were defined as people working in factories (producing for 
example carpets, bricks, metalwork and garments), vegetable sellers (people who fetch 
vegetables and sell them door to door by bicycle), daily labourers, porters, 
construction workers, people working in motor garages, garbage collectors, transport 
workers (drivers and helpers), and slum dwellers. People living in such conditions 
were not only vulnerable to TB, but also to other illnesses for which they required care 
from other health care providers, and the cost of care was unaffordable for many 
people. It was found that TB was often not the only illness PLTB (and especially poor 
PLTB) were dealing with, as TB invited other illness, which further reduced the 
ability of PLTB to stay on TB treatment. A DOTS clinic staff mentioned: 
‘We receive many poor people suffering from various illnesses and TB is the most 
common among others. Sometime TB patients get seriously ill due to other illness 
which creates further problem for them to visit the DOTS centre.’ 
PLTB confirmed that their TB treatment became more complicated when combined 
with other illnesses. They often associated their TB with their poverty, which they 
described as not having enough to eat; hard physical labour and long working hours; 
working in poor environments such as brick factories; and performing low-grade 
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jobs
8
In contrast, a few PLTB stated that TB does not only affect poor people and nor was it 
only the result of hard physical labour and limited food. This belief had two roots: TB 
affected the PLTB even though they were eating well and had a decent job without 
much physical hardship; and they had seen other people affected by TB who they 
thought were not poor. Some PLTBs further stated that the disease was more visible 
among the poor because they could not afford to hide their disease as rich people did 
by taking treatment in confidence, generally from the private sector. It was felt by 
many PLTBs that only poor people accessed DOTS and those who could afford to pay 
took treatment in the private sector unnoticed by others. Some PLTB also mentioned 
that TB treatment under DOTS was of poor quality. They thought so because the main 
. They also thought that the illnesses accompanying TB were largely due to poor 
socioeconomic conditions and their inability to seek proper care, which was 
precipitated by TB. A young man who had undertaken three months treatment said; 
‘I was well and doing my work, since I was diagnosed with this disease [TB] one after 
other illnesses made my conditions [financial and physical] worse.’ 
While there are obvious links between TB and poverty, PLTBs were generally 
subsequently labelled as of low status, further disadvantaging them, and affecting their 
morale and ability to live as a normal member of the community. Consequently, not 
only the individual with TB, but the family suffered with psychosocial problems such 
as anxiety, feelings of guilty and depression. A spouse of a PLTB revealed how she 
felt when she discovered her husband had TB:  
‘When doctor said he [her husband] had TB I felt like the land I was standing on has 
gone down. I felt helpless because he is the only hope of our family wellbeing. People 
think TB is not a simple disease, how can I survive with two children, how to respond 
questions from people if they know about his TB.’ 
In a similar vein, an educated young local resident, maintaining a decent job but who 
had been diagnosed with TB three months previously, said: ‘I know TB can be cured. I 
can convince myself but it is very hard to convince others such as relatives and friends 
as TB is known as a disease of low status people and holds bad reputation in the 
community.’ 
                                                 
8In this context, PLTB referred to low-grade jobs which required heavy physical work 
such as portering, and other jobs that many people in the community did not want to 
perform such as metal working, garbage collection, cleaning safety tanks etc. 
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users of DOTS were poor people who had no alternative (i.e. treatment in private 
sector) and there was a feeling that the poor generally accept anything, even of low 
quality, when provided free of charge. In contrast, some PLTB whose health had 
gradually improved after taking TB treatment did not question the quality of drugs and 
services they received under DOTS. Similarly, some PLTB stated that their perception 
that TB only affects the poor had gradually changed after they saw other people (who 
they thought were not poor) taking treatment under DOTS. 
5.2.1.2 TB: a disease of sin 
Respondents reported that there was a belief in society that TB disease was a 
consequence of wrong doings
9
PLTB also stated various other common community beliefs about causes of TB, 
including not fulfilling secret promises
 and a divine curse. Many PLTB stated that they feared 
revealing their disease to others as people with TB generally had bad reputations in 
the community especially among elderly people. This perception has considerable 
implications in Nepali society where culture, religion and livelihood are strongly 
embedded and interlinked. A woman homemaker continuing her second month of 
treatment mentioned:  
‘I visited a temple during the second day of my menstruation, may be the God became 
unhappy and as a curse I was caught with this disease [TB].’ 
She thought this because in the past she had heard women (mostly elderly) referring to 
such incident happening to a girl in her neighbourhood who had TB. Because of fear 
that she could be labelled as uncivilized, the women did not disclose her disease to 
others: this was not easy for her.  
10
                                                 
9
 In the study context wrong doing referred to an act that violates the moral norms of the 
community 
10
 In Nepali society, there is a practice of making secret promises – if as a result something 
happens, something will be offered to god. 
 that people made to God; engaging in 
socially unacceptable behaviour; and sexual relationship within the extended family 
relations. Many PLTBs were afraid that people who hold such beliefs would link them 
to one of these behaviours if they knew they had TB. Although PLTB did not 
experience any direct impact from such beliefs, they affected their treatment seeking 
behaviour, as some PLTB did not go to the nearest DOTS centre for fear that local 
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people would see them visiting the TB clinic and link them with such behaviours. It 
was clear that such negative cultural beliefs prevented PLTB seeking care from the 
nearest TB centre and forced them to take medications in fear and isolation.  
In contrary, some PLTB stated that, although such beliefs regarding TB existed in the 
community, they did not take them seriously. Young men with TB in particular were 
less bothered by such beliefs. However, the majority of PLTB stated that TB-related 
stigma existed in the community, and that this was often linked to such beliefs; on the 
basis of such beliefs, people with TB were discriminated against in the community 
thus creating a barrier to accessing TB treatment. I give more analysis of TB-related 
stigma and discrimination in section 5.2.2.1.   
5.2.1.3 TB: a lifelong disease 
One of the most common beliefs among PLTB was that once a person has TB, the 
disease remains in their body forever. This belief arises from doubts about a complete 
curability of TB – some PLTB thought that TB gets partially cured but not 
completely; and they saw the disease reoccurred in some people who had been cured 
in the past; a belief that TB badly damages the lungs and healing damaged lungs 
without surgery was not possible. Such beliefs further worried PLTB when friends and 
community members mentioned that TB could reoccur anytime as it remains in the 
body and weakens human.  
Many PLTB also had a belief that the reduction in physical strength caused by TB 
could not be recovered even when the TB was cured. PLTBs’ main reasons for this 
belief were that TB can severely damage the lungs, which will not heal even after the 
TB is cured; TB makes people vomit blood as a result of permanent damage inside the 
body that will remain forever; TB can become chronic and untreatable; and powerful 
anti-TB drugs damage body cells while killing the TB bacilli. It is important to note 
that the belief about damaged lungs and oral TB drugs was closely linked to TB 
treatment, which often made PLTB question continuation of treatment. PLTB 
continued to take their treatment but seemed to be at greater risk of discontinuing 
treatment when these concerns were not well addressed.  
Many PLTB further believed that TB drugs are so powerful that they can make both 
men and women sterile by weakening their body cells - this made some PLTB 
vulnerable to discontinuation of treatment. An educated young man who had been 
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continuing treatment for one month was seriously concerned when he heard from his 
friends that TB drugs could cause impotence.  
‘When I think the consequence [impotence] that TB drugs can have on me, I cannot 
concentrate on my work and can’t sleep too. My friend told me about the bad effect of 
the drugs that I’m taking. Though it is hard to believe but I’m worried.’ 
Similarly, a woman with TB mentioned that she and her husband were worried that 
she may not be able to bear a child as consequence of the powerful drugs. Health 
workers also mentioned that PLTB, especially young people, often asked questions 
about the effect of anti-tuberculosis drugs, concerned about their fertility. It was found 
that such beliefs among PLTB sometimes caused them to consider discontinuing 
treatment. Such PLTB were taking their treatment under very difficult and fearful 
circumstances. PLTB stated that health workers did not take these concerns seriously, 
even though they were raised several times during their treatment, and responses were 
not convincing. A lack of good information presented in a convincing manner put the 
PLTB caused fear and uncertainty 
I further discuss communication between PLTB and health workers and its 
effectiveness in subsequent sections.  
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5.2.2 Socio-cultural issues in TB treatment 
This section is closely related to sections 5.1 and 5.2.1 above and overlaps with some 
of the issues that I have already discussed, because the issues are interdependent. This 
section describes how societal and cultural context and practices influenced TB 
treatment completion. I discuss social and cultural issues independently considering 
the roles of the community and culture, and their impact on PLTB and his/her 
household during TB treatment. I have configured this section under three major 
themes: stigma and discrimination; gender related issues in TB; and the social system, 
including caste and ethnicity.  
5.2.2.1 Stigma and discrimination due to TB 
A majority of PLTB stated that they experienced some level of stigma and 
discriminatory behaviour based on their disease. According to them, stigma and 
discrimination existed at multiple levels: among the community; at workplaces; in 
institutions such as hospitals, DOTS centres, schools and colleges; and at home. 
Stigma and discrimination not only prevented PLTB seeking care for diagnosis but 
also affected their ability to continue TB treatment in many ways. However, the 
magnitude of stigma and discrimination varied among PLTB, depending on individual 
discriminator’s and sufferer’s knowledge, and local contexts such as social status, 
financial well-being, treatment duration, and severity and visibility of disease. The 
discriminators were defined as people who had negative attitude and behaved 
unfavourably towards PLTB and their family members on the grounds of TB whereas 
sufferers were those who affected by discriminatory acts of people.  
In the study, I focused on the causes of stigma and discrimination and their impact on 
treatment completion rather than merely a description of what happened to PLTB and 
their family due to TB in general. However, it was complex to pin down the causes of 
stigma and discrimination as they varied amongst PLTB and understanding of 
individuals had a significant role to play. Stigma and discrimination can be described 
in many ways. Here, I present findings and discussions in the ways which PLTB and 
their family members perceived and experienced them. Considering the study findings 
and the nature of stigma and consequent discrimination, I have grouped them under 
four major themes: (i) stigma and discrimination in community, (ii) self-stigma (iii) 
stigma and discrimination in family, and (iv) stigma and discrimination in institution. 
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I considered presenting stigma under these themes based on respondents’ experiences 
and their perceptions in line with the study aims and objectives. However, although all 
these themes are interrelated, for simplicity I have attempted to describe them 
independently as I thought appropriate, based on the data that I gathered in the study.  
(i) Stigma and discrimination in community:  
In this section, the word ‘community’ refers to general members of the community 
who may or may not be directly associated with PLTB and their family: neighbours, 
friends, and colleagues of PLTB and their families. I found various reasons why 
stigma existed against TB, PLTB and their families. The major reasons were: 
- associated social and cultural beliefs on the causality of TB; 
- fear of disease transmission; 
- TB disease often being linked to people with ‘low-grade’ in the community; 
- immoral behaviour of a person and association with TB disease in the 
community; 
- association between poverty and TB. 
As consequence of the reasons mentioned above, many PLTB and their family 
members were frightened to disclose their disease status, as they thought that the 
reasons above were enough to humiliate them if community members behaved 
unfavourably as a result of knowing their disease status. Below I describe the reasons 
and experiences of PLTB and their families due to TB in the community.  
I found that one of the causes of stigma and discrimination against PLTB and their 
family was linked to the causality of TB and associated social and cultural beliefs, 
which I have discussed in section 5.2.1 of this chapter and will not repeat here. The 
strongly held socio-cultural beliefs on the causality of TB, which were often 
scientifically unverified, have made TB a taboo subject within the community, putting 
many PLTB and their families in difficult positions, although such beliefs varied 
among individuals. As an example, there is a belief in the community that a person 
who visits sex workers and frequently has sex with them could get TB. A male college 
student, who had been taking treatment for two months, and was victimized on the 
basis of this misbelief, said; 
‘I disclosed my disease to friends and they asked with negative deed whether I visited 
prostitute women because they thought that maybe my disease is a consequence of that 
act. I was so upset to hear such allegation then I stopped visiting friends and did not 
disclose my disease to others.’ 
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PLTB stated that another reason why they and their family members were seen and 
treated differently in the community was due to the widespread fear of transmission of 
infection. They gave this as the reason community members kept a distance from 
PLTB and their family members. People with children in the community were the one 
who often kept a distance from PLTB as they perceived that children would more 
easily get infected than adults. Some PLTB perceived the distance kept by community 
members was reasonable, as they might have done similarly to protect themselves. 
However, the unfavourable behaviour associated with fear of disease transmission was 
seen as discrimination by some PLTB. Consequently, PLTB hid their disease because 
of fear of being seeing as ‘an unwanted social element’ in the community where they 
live. PLTB and their family members thought this was not only linked to fear of 
infection but also that community members often saw TB as a disease of ‘low-grade’ 
people and thought such a label could damage their social status.  
According to PLTB, ‘low-grade’ was defined considering the PLTB’s social status 
including caste and ethnicity; financial status; occupations perceived to be physically 
demanding and in an unhealthy environment; poor education shown by poor manners; 
physical visibility indicated by wasting; engagement in immoral social behaviour such 
as unsafe sex, alcoholism and drug use; and poor housing and living standards. In 
many instances, I found that PLTB and their family members had a strong 
apprehension that people in the community would link them to one or many of the 
above-mentioned ‘low-grade’ statuses if they knew they had TB: thus disclosing their 
disease to others was a concern for many PLTB. I found that, due to such beliefs in the 
community, PLTB see themselves as vulnerable – socially, financially, physically and 
psychologically – which had an impact on treatment continuation. A few PLTB stated 
that not all community members would think this way; but it was hard to ascertain 
who would think differently. A migrant worker, a woman who had been undergoing 
treatment for one month, with a small child, said; 
‘We live in a rented room. I am worried if my neighbours come to know my disease, 
especially women living in the same flat because I heard them talking bad things 
about other person affected with TB in the past. I’m worried that they could think the 
same on me if they know my disease.’ 
Some PLTB stated that not disclosing their disease was the only way they could avoid 
being linked with such negative community-held beliefs. However, they also stated 
difficulties in doing so as TB was visible with cough and wasting so people in the 
community could easily guess they had TB. Living with TB in the face of such 
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negative beliefs in community was even harder for woman, which not only prevented 
them disclosing their disease but also made them psychologically vulnerable and 
abashed, severely affecting care seeking. A young woman respondent who decided to 
take treatment far from her local community said; 
‘I am afraid I could be perceived as a bad girl in the community thus I have not 
disclosed my disease to others. There is a DOTS centre nearby my house but I came to 
this place because local people do not know me here.’ 
PLTB also stated that there was widespread feeling in the community that poor people 
get TB and disclosing their disease to others would make them be seen as inferior with 
in their community and group. A young male respondent said; ‘People think TB only 
affects poor people. Sometime people call me kshayarog birami [TB patient], it hurts 
me and I feel so embarrassed.’ 
This issue had particular implications for people living in slum areas, migrant 
labourers, vegetable sellers and factory workers as they were perceived as threats to 
the community, consequently increasing stigma among the poor. Health workers in 
DOTS centres also mentioned that poor people were the ones most affected by TB and 
they often hide their disease from others as they thought the community would avoid 
them. The care providers further stated that other people (perceived by them as 
wealthy local residents) who were visiting the clinic with their children for 
immunization complained about PLTB taking treatment from the same clinic, as they 
feared bringing their children to a place where people with TB were being treated. I 
discussed with members of the community to understand how they perceived links 
between poverty and TB. A local community resident said; 
‘We have a slum near to our community where many poor people reside.  They suffer 
from many health problems and I heard that TB is a common disease. They could be a 
threat to local people.’ 
Some PLTB also commented on differences in TB related in urban and rural areas. In 
focus group discussions most PLTB stated that people with TB and their families were 
more stigmatised in rural areas than in urban areas. Consequently, some PLTB came 
to an urban area for their treatment. PLTB thought there would be less stigma and 
discrimination in urban areas because in urban areas PLTB had less contact with other 
members of the community; urban people were unconcerned about others; in urban 
areas there are many people with mixed cultures so it is easy to keep a low profile; in 
urban areas people were well educated and aware. In contrast, in rural villages 
everyone could easily guess that a person has TB as such people lose weight and have 
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a continuous cough. A few PLTB stated that because of these reasons they came to 
Kathmandu for their treatment. However, some PLTB had different experience. They 
found no difference in rural and urban area regarding the way people thought about 
PLTB and TB-related stigma. A young migrant male said; 
‘I find no difference in terms of what people think about me in my village and here 
[urban] as people I know here did not like me visiting their room and no one comes to 
see me. I want to go to village but I was told by health worker TB drugs were not 
easily available in the village.’ 
Similarly, an old man who came to the city for his treatment and was staying with his 
son said in a focus group discussion; 
‘People in city are not welcoming and have less sympathy to people like us. We know 
we have TB but when someone says unpleasant it touches our heart. If someone say 
good such as take medicine and get cured we feel so good but in the city it is difficult 
to find people with good heart.’ 
On the contrary, a few PLTB stated that they had positive experiences when they 
disclosed their disease to others, as people subsequently helped them. Community 
members helped them in several ways, encouraging them to continue their treatment; 
assuring them that taking regular treatment would cure their illness; said TB is a 
normal disease; demonstrated sympathy towards them and their illness; and supported 
them financially when they were in difficulties.  
In many instances PLTBs felt older people held stronger negative beliefs than the 
younger generation. They also stated that some young people who behaved badly 
towards PLTB were influenced by older people with negative beliefs. However, this 
should be interpreted with caution, as the study did not find stigmatising behaviour 
only among the older generations. Nevertheless, cultural beliefs about causes of TB 
seem to be changing gradually: people of younger generations had less belief in 
scientifically unproven arguments.  
I found that many PLTB had problems due to TB such as physical weakness and 
financial hardship. TB-related stigma and discrimination added yet another challenge. 
However, many PLTB stated that their family members and some relatives, friends 
and colleagues supported them in difficult situations, which helped them to boost their 
morale and stay on treatment. For example, a young woman homemaker said she was 
worried when she was diagnosed with TB and did not disclose her disease to her 
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neighbours but after two weeks she became very weak and her neighbours came to see 
her and they came to know her disease. She described her experience thus; 
‘I was wrong that I did not discuss my illness to my neighbours earlier as I was not 
sure how they would react but they know many things about TB and showed sympathy 
towards me and said that TB occurs to all people, no need to worry.’ 
Although some PLTB stated positive responses from friends, and relatives, a few 
experienced avoidance after disclosing their disease. A young woman said; 
‘We used to share many things with friends when I was well and our children used to 
play together. I called my friend a few weeks ago and she said she does not want to 
come to my house because I have TB. I felt so embarrassed. My daughter wants to go 
to her house but I afraid how they will behave her so I didn’t send.’ 
I got a mixed response when I asked what PLTB thought about such behaviour from 
friends. Some PLTB thought the behaviour was legitimate if they did so to protect 
themselves and their children, whereas others thought it was discrimination because in 
their experience, some relatives and friends used this as an opportunity to claim PLTB 
were inferior on the basis of their disease. However, not everyone had the same 
experience.  
I found a contradiction between what PLTB interpreted as the perception of TB in the 
community (mostly stated negative perceptions), and positive experiences of some 
PLTB who gained support from friends and relatives after disclosing their disease. 
PLTB who received support or were not stigmatized in the early days of their 
treatment were encouraged to share their disease status with others and they were 
likely to receive support from friends and community. On the other hand, PLTB who 
did not receive support in early days of treatment were more inclined to hide their 
disease, where possible they wanted to hide throughout the treatment period, which 
affected their treatment continuation as often they had to continue treatment under 
perceived social pressure, even though sometimes such pressure did not actually exist.  
I also found that the sharing of support received during treatment was not common 
practice among PLTB even though they frequently met in the DOTS centres. Rather, 
they often talked about problems and negative experiences they had during the 
treatment. When I asked them why they did not share the support they received, their 
responses were: they had many more experiences of problems and concerns than of 
receiving support; they felt relived sharing problems with other PLTB; PLTB listened 
well to each other, unlike others in the community; and PLTB felt free to share 
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problems which they fear sharing with other community members. However, not all 
PLTB had shared their experiences, positive or negative, in their group. Some 
mentioned that they did not find the environment in DOTS centres conducive to 
talking freely with other PLTB, as there was limited space, waiting rooms were small 
and only few of them knew each other, although they were taking treatment from the 
same DOTS centre. Although it could take long time for the NTP to change cultural 
disbeliefs through interventions, a way forward could be to address negative thoughts 
of PLTB by providing an environment in DOTS centres that enabled sharing good 
experiences and support provided to PLTB by friends, relatives and community 
members. However, I found that the programme had not taken such opportunities to a 
great extent in DOTS centres.  
(ii) Self stigma 
I found that often PLTB felt undeserving and had lack of self respect which often led 
them to depression and self isolation from others – a determinant of self stigma and 
discrimination. Many PLTB isolated themselves from others, especially family and 
friends. The reasons behind self-isolation were to avoid disease transmission to others; 
fear of discrimination; fear of losing their identity among friends; concerns about 
relationships; and feelings of guilt and depression. I found that beliefs of individuals 
played a major role in isolating them from others and the major reason cited was fear 
of transmitting disease to others. For example, a recently married young female stated 
that she wanted to protect her husband thus had kept her distance since she noticed her 
disease. She did so despite her husband telling her she was no longer infectious as her 
sputum had become negative.  
Most PLTB were struggling to continue their treatment as they had to manage not 
only the treatment but all other problems. Inability to do so made them 
psychologically weak and damaged their confidence. Many of them felt lonely and 
depressed, except some who had good support from family and friends. Due to their 
disease condition other responsibilities were grossly compromised: many felt guilty 
and some PLTB had a tendency to self-blame. A young migrant worker said; 
‘I have two small children and wife has no job. I am not able to feed them well, 
sometime they ask me to bring meat but I cannot afford as I lost my job and have no 
savings. I feel so embarrassed and sometime do not want to live life anymore seeing 
my family in difficult situation.’ 
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I found that PLTB who isolated themselves were self-stigmatised and had difficulties 
to maintain relationships within the family. This led to self-imposition, social and 
physical distance, and restricted participation in the family and in society. A young 
woman with TB said she sent her children to her parents’ house when she was 
diagnosed with TB and had hardly seen them during her treatment. Similarly, self-
isolation was an issue in husband and wife relationships. A young woman said; 
‘I was told that my disease transmits while breathing so I don’t share bed with 
husband. He [husband] asked several times but I avoided. I fully understand his 
desires and one day I told him I don’t mind if he fulfils his desire with others because 
I’m ill at the moment.’ 
I also found that some PLTB were worried that they would face an identity crisis if 
they disclosed their TB to others. They feared that they could become known as a ‘TB 
patient’ rather than their original identity as a businessman, teacher, social worker, a 
nice women, etc. The fear that TB would erode their existing status in society was 
another reason PLTB hesitated to disclose their disease. A school teacher who was 
taking TB treatment expressed his concern; 
‘I know TB is a normal disease and it will cure but community people do not think so 
and often call Mr …with TB or that person with TB, thus I am also concerned that 
people in community and my mates will call me Mr …..with TB ……a teacher with TB, 
which I feel awkward.’ He further said that this was not only his judgment: he had 
seen other people who were labelled with TB.  
PLTB also stated that they preferred to be in isolation because they thought if 
community members became aware of their disease then the family would have a 
taboo in the community and they would be victimised. Such feelings were especially 
found among PLTB who were local residents of the city. 
It was evident that self-isolation and thus self-stigmatisation existed, which often 
decreased morale of PLTB, thus putting them in a difficult situation. I found that such 
low morale affected the confidence of PLTB, and thus their individual power to 
negotiate with service providers on their treatment protocol, so they became passive 
recipients throughout the duration of treatment. It was found that even though PLTB 
had knowledge about their disease and treatment, translating this into practice was 
difficult due to low morale.  
Similarly, PLTB stated that they could have received support from others if they had 
disclosed their disease to friends and relatives, but they feared negative consequences. 
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I found that self-isolation was used as a coping mechanism by many PLTB in order to 
protect their family from infection and stigmatisation in the community. Although 
they had a difficult journey to travel, many remained in isolation throughout the 
treatment period. It was clear that some PLTB who disclosed their disease, either 
knowingly or by accident, had less suffering from isolation phobia than non-
disclosers. I also observed that the individual contexts were different as some did 
experience discriminatory behaviour when their disease was disclosed and some 
discrimination had a direct impact on their treatment such as job loss, broken 
relationships, or rejection from community and family. A young male factory worker 
said; 
‘I disclosed my disease to supervisor as I thought he will allow me some time to visit 
DOTS centre but he dismissed me from the job.’ 
(iii) Stigma and discrimination in family  
PLTB participating in the study came from two different family structures: small and 
big families. For convenience, in the study, I have defined small families as those with 
two to five members, generally comprising husband, wife and children; and big 
families, commonly known as joint family as those comprising more than six blood 
relatives.  
I found that many PLTB were supported by their family at different stages of their 
treatment, which gave a strong indication that stigma and discrimination within the 
family was less strong than in the wider community. However, a few PLTB had a 
different experience: they reported stigma and discriminatory behaviour by some 
family members. This was mostly observed in big families and was often linked to 
some other dispute with family members before the TB developed. In such cases the 
family members who had disputes with PLTB used the TB to demoralise the PLTB 
within the family. Similarly, some elderly family members discriminated against the 
PLTB; in-laws were the most common discriminators.  
In most cases, I found that family members asked PLTB to stay in isolation, guided by 
fears of disease transmission. Although isolation was intended to protect other family 
members from infection, the act was hurtful to the PLTB, although not in all instances. 
In many cases, PLTB themselves wanted to be isolated from their family members, 
reasons cited being to avoid transmission of disease to others; fear of discrimination 
by other members especially in a big family; concern about relationships; fear of being 
blamed if things go wrong in the family (mostly in big families); and avoiding 
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burdening the family. PLTB therefore found various ways to keep at a distance from 
family members, even though there was no stigma and discriminatory behaviour in the 
family. A young man with two children staying in a big family said; 
‘I use separate utensils and do not give contaminated food [jutho] to my children and 
wife. I do not watch TV together with my family as I fear of infecting others.’ 
However, most PLTB who isolated themselves from the family stated that it was a 
difficult experience. Although a fear of infecting others was found to be the main 
concern among PLTB at home, a few PLTB also had a fear of being seen as inferior 
within the family if they disclosed their disease to other members. Some members of 
the family insisted they be isolated and not disclose their disease even within the 
family. A young woman from a big family stated; 
‘My husband took me to hospital and I was found TB then he [husband] asked me not 
to disclose my disease to his parents and brothers. He was worried that I may be 
treated differently in family because of my disease.’ 
The woman also stated that she was suffering to maintain such conditions as she had 
to find suitable times to visit the DOTS centre so that others would not notice her 
disease.  
A few PLTB stated that they could have received more support from the family 
members during their treatment, but did not, because some family members especially 
in-laws perceived that TB is a dangerous disease and incurable. I found that compared 
with men, women with TB were more stigmatized within the family and discriminated 
against by other members and especially in-laws. A female respondent said; 
‘My mother-in-law always gets angry with me because I have TB and she mentioned 
with other women that I am a witch in her family.’ 
Similarly, another woman respondent stated that her husband behaved well in the 
early days of her disease, but his behaviour had changed and he had started to hate 
her. Because of her husband’s behaviour she did not get good support from other 
members of the family. Another woman respondent also stated that her husband 
physically assaulted her because she had TB. The husband blamed her for ruining his 
life. Since then, she had gone to her parents and was staying apart from husband. 
Similarly, another female respondent stated that her family members including her 
husband became disloyal once she was diagnosed with TB.  
I found that some PLTB were reluctant to talk openly about having no support and 
discriminatory behaviours they received within the family: they thought talking about 
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their own family was insulting their own position in society. However, I found some 
PLTB talking about their family problems with other PLTB who they trusted in the 
DOTS centres. Many PLTB found stigma and discrimination from family members 
difficult to cope with, even though the family stigma was relatively minor compared 
with what they experienced in the community. However, it was clear that support from 
the family was a strong determinant of their treatment outcome and stigma in family 
had reduced the support thus make the PLTB vulnerable in their TB treatment. This 
was particularly the case for women in big families.  It is to be noted that the majority 
of PLTB stated that they received good support from their family during the course of 
their treatment.  
(iv) Stigma and discrimination in institution  
Institutional stigma and discrimination occurs when the PLTB and their family 
members are labelled or linked to undesirable stereotypes resulting in unfair treatment 
by an institution or person(s) affiliated to an institution on the grounds of TB. PLTB 
gave examples of institutional stigma and discrimination at the workplace, and in 
health institutions, college and schools. I found that migrants with TB and PLTB 
working in factories often experienced institutional stigma, and as a consequence 
some stated that their job was vulnerable. Consequently, their TB treatment was 
affected, as it not only reduced their financial ability to continue treatment but also 
damaged their social network. A young man, a migrant worker in a factory, narrated 
his experience as; 
‘The disease made me so weak but my friends were helping me thus I was continuing 
my treatment. It was hard for me to come everyday to this [DOTS] centre as I had 
only half an hour break. I thought my supervisor would allow me more time if I tell 
him my condition. I talked to him but after two days I was dismissed from the job.’ 
Other respondents stated similar experiences. Institutional stigma occurred more for 
poor PLTB who were less empowered to claim their rights and had weaker social 
networks outside their workplaces. A young unmarried woman who had worked about 
six months in a factory said that she was doing well in her job and her owner promised 
to increase her salary. Since she developed TB her work had been compromised. She 
had to disclose her disease as it was difficult to continue the job and visit the DOTS 
centre daily and in consequence she was dismissed from her job. She regretted that she 
had disclosed her TB to the owner. She thought that she could have managed her 
treatment with help from friends and kept her job.  
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Similarly, a young woman working in a travel agency said;’ My job was to help the 
clients. My boss did not like me continuing the job since I had TB. Now I’m jobless.’ 
Apart from job loss due to stigma linked to TB, PLTB had faced other consequences 
in the institutions where they were working, such as reduced pay, inferior treatment, 
and undermined capacity to perform tasks. However, not all PLTB had similar 
experiences. Some PLTB mentioned that they received support from the employer 
during treatment including time off work to visit the DOTS centre for treatment; 
salary advances; leave to rest when they were weak. A young man working in a 
private shop said; ‘My owner gave me leave for a week when I was very weak. It 
helped me to continue my treatment.’ 
Similarly, a female respondent working in a factory said she had received good 
support from her employer when she disclosed her disease status.  
I also found that children with TB were treated differently in school because of their 
disease. A mother of a girl with TB said; ‘My daughter was asked to leave the 
classroom because she had TB. The teacher asked my daughter not to come to school 
until her TB is cured.’ 
Similarly, a young woman respondent who discontinued her study due to TB shared 
her TB status with her teacher and was told not to disclose the information to others.  
It was found that PLTB were given a label that set them apart from other normal 
people in various institutional settings. PLTBs’ experiences revealed that they were 
treated unfairly on the grounds of their disease, affecting their social and financial 
well being, and thus their continuation of TB treatment. 
Stigma and discrimination in health institutions  
I found that some PLTB experienced discrimination in health care settings on the 
grounds of their disease. Since health institutions are the place where PLTB seek care 
and hope to cure their disease, any forms of stigma and discrimination in these 
institutions would directly affect TB treatment. I found that a few PLTB were treated 
unfavourably in health institutions compared with people with other general illnesses. 
The unfavourable behaviour that PLTB experienced included; 
• Ignorance by care providers: for example, in some cases PLTB felt that they 
were ignored by health workers as they did not respond well to their concerns 
during treatment, whereas they saw health workers engaging well with other 
(non-TB) patients;  
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• Health workers behaved in a hostile way while serving PLTB: PLTB observed 
health workers being aggressive and irritated while serving them although this 
was not the case when they served other (non-TB) patients;  
• Health workers maintained a distance with PLTB: for example, in some 
instances PLTB stated that the health workers asked them to keep at a distance 
while providing TB care although their sputum had converted to negative; 
• PLTB were asked to wear a mask all the time in the DOTS clinic: I found that 
some PLTB did not like wearing a mask as they thought it would identify 
them as a TB patient in the community.  
• Health workers directly asked PLTB not to cough during communication and 
while injecting: this demand was embarrassing for many PLTB who became 
fearful while in the DOTS centre. A woman said; ‘I pray to god not to produce 
cough while I’m in front of health worker.’ 
• In some instances, health workers asked PLTB to leave the clinic as soon as 
they had taken their drugs, whereas other clients were not asked to do so.  
• A few PLTB stated that they were treated badly because of their origin (local 
or migrant) and language they speak: for example, some PLTB noted health 
workers employing different behaviour (in terms of politeness and caring) to 
PLTB who migrated to the city compared with that shown to local people who 
spoke the local (Newari11
The points mentioned above illustrate some PLTBs’ experiences in DOTS centres. 
However, despite this, a majority of PLTB stated that they received good care in 
DOTS centres.  
With regard to the language and discriminatory behaviour, a young migrant working 
in a factory said; ‘The Nurse is a Newar and she behaves well with people who talk 
in Newari. I can’t speak Newari language thus I felt that she often ignored me.’ 
) language; 
I found that the use of Newari among Newars was common both in the community 
and in institutions. However, when I asked Newari-speaking health workers to 
comment on the issues raised by PLTB, they did not agree. They denied any 
discrimination to PLTB based on the language they used in DOTS centres. However, 
                                                 
11
Newari is a local language used by the Newar ethnic group in Kathmandu and some 
other parts of the country 
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they stated that Newari-speaking PLTB preferred the use of local language in 
communication. Some Newari-speaking health workers did say that the PLTB who 
did not know Newari may have felt uneasy seeing us communicating in Newari. A 
health worker working in DOTS centre said; 
‘So far we are doing our best to help TB patients, sometime their concerns may not 
have been well addressed as we often have busy work schedule but it was not due to 
the language they used in communication.’ 
Despite some issues with regard to stigma and discrimination in health institutions, 
many PLTB stated that they had support from health workers: I discuss this in 
subsequent sections. During my fieldwork I also discussed with senior NTP officials 
to get their views on the stigma and discrimination that PLTB experienced in health 
institutions, and especially in DOTS centres. It was hard for them to agree that 
institutional stigma exist in DOTS centres. However, they did mention that in spite of 
the NTP’s best efforts there were some issues, as in urban areas, DOTS centres were 
run by multiple stakeholders and they had not been able to provide support to these 
centres to maximise TB service delivery and effectiveness.  
In conclusion, I found various forms of stigma and discriminations against PLTB and 
their families, with varied consequences. Socio-cultural beliefs about TB, especially 
about causation of the disease, which was often based on little or no scientific 
evidence, had a major role in stigma and discrimination. Although incorrect cultural 
beliefs were changing as TB control measures became widely available, they still exist 
in the community and contribute to stigmatisation of PLTB and their families. 
Varying understanding of the disease influenced the perceptions of PLTB and their 
families and determined their behaviour with regard to their disease and treatment. 
PLTB often took into account the cultural beliefs and anticipated attitudes of 
community members towards them, and modified their behaviours in response, for 
instance hiding their disease, isolating themselves, feeling unworthy, having a lack of 
trust in others and feeling ashamed. So stigma worked as a chain which affected 
PLTBs’ treatment behaviour and PLTB and their family used various coping strategies 
to tackle the stigma and discrimination. It was clear that the sets of factors causing or 
influencing stigma against PLTB were interconnected. However, it was evident that 
PLTB who perceived TB as a normal disease were often less influenced by cultural 
beliefs and experienced less stigma and discrimination compared to PLTB who 
followed traditional socio-cultural beliefs.  
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5.2.2.2 Gender inequality in TB treatment 
This section presents findings on how the wide variety of socially and culturally 
constructed roles and responsibilities of women and men influenced their treatment 
behaviour. I found that gender-related inequalities affected TB treatment completion 
in many ways in the Nepali cultural context. In this connection I found four major 
themes occurring in the study related to gender inequality in TB treatment: 
• socio-economic position;  
• culturally defined values and customs;  
• stigma and discrimination;  
• health beliefs and the health service delivery model.  
These themes often determined differences in the treatment experienced by women 
and men with TB. However, it should be noted that gender inequality appeared in the 
study as a crosscutting issue as it affected TB treatment in many ways. Thus, where 
relevant I have discussed gender and its influence on TB treatment in other sections. 
Stigma and discrimination has already been discussed in section 5.2.2.1 and will not 
be revisited here. 
Regarding socio-economic status, there were differences among and between women 
and men. The impact of TB was found greater on women as they were the most 
deprived members of the household and community, both economically and 
culturally. I found that almost all men were involved in some economic generation 
activities outside the home before, during and after diagnosis with TB, whereas 
women were mostly confined at home doing household chores such as cooking, 
cleaning, and washing. In addition, they were also looking after their children and 
helping other family members, a further responsibility of a homemaker. Thus men 
were working outside the home, doing ‘proper’ money-earning jobs, while women 
worked inside the home, doing jobs not considered to have financial value. I found 
that women had little or no power to access financial resources within the family as 
they were not directly generating money. The implications for women were massive, 
as in many cases women were compelled to put other things first and make their 
treatment a low priority. I also found differences within the group of women and men 
as their characteristics varied. Therefore I realised it would not be reasonable to 
present issues of gender inequality in TB treatment as though they were homogenous.  
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I found that most women respondents considered household work as their assigned 
duty and intended to continue despite illness and physical inability. They thought that 
failure to continue household jobs would make them more vulnerable in the family 
and would have a negative impact on their treatment. I found that in the face of 
mounting pressure of household chores, a big problem that many women with TB 
faced was finding time for treatment. Although men also stated similar constraints, it 
was even hard for women, especially in joint family. A woman respondent described 
her difficulties; 
‘I am the only one handling kitchen work at home. My family is a big family in size, I 
need to start early in the morning to prepare everything in kitchen, sometime even 
harder when there is no water supply. I only come here [the DOTS centre] after 
finishing all my work and need to do the same when I go back in the afternoon.’ 
I found that it was even harder for many women to manage their treatment and 
household chores when the DOTS centre had short, inconvenient opening hours. 
Section 5.2.5.2 further analyses the effects of DOTS centres opening hours on both 
women and men. 
I found that men were somehow better off than women as they received support from 
other family members, especially parents and wives. Women were compelled to 
continue their job inside or outside the home despite their physical inability to do so. 
Women respondents stated that there were few ways to cover work at home when they 
were ill, whereas men’s jobs could be covered by women by finding another job 
outside the home. A young migrant man with TB said; 
‘I have not been able to go to work since I got this disease [TB]. My wife had to find a 
job and now she is working as housecleaner and taking care of children and me. 
Sometime she comes here [DOTS centre] to collect drugs for me. I feel so repent as 
she is taking a trouble.’ 
In contrast, a woman with TB said; ‘I am very weak but have to do job at home as 
there is no other person to help, my husband goes for work and comes late evening.’ 
Fears and worries were major reoccurring themes in interviews and FGDs. Women 
were found to be more psychologically distressed and thus more vulnerable during 
their treatment, than men. A few women stated that their in-laws often assaulted them 
due to their disease. In some cases, husbands disliked them and fear of rejection 
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further contributed to their distress. A married woman with two children, a local 
resident, said; 
‘It has been three months since I was diagnosed with TB, my husband and in-laws do 
not behave as before, they talk to me very less. Recently my in-laws took all my 
jewelries that I received in wedding. I have a feeling that she [mother-in-law] wants 
me to go out from home.’ 
Similarly, relationships between husband and wife can become fragile due to TB. A 
woman from a village who migrated with her husband to the city and was undergoing 
treatment said; 
‘My husband scolded me many times. He thinks all wrong happenings in the family is 
because of me. We did not have good relation since last one year which became 
further worst since I was diagnosed with TB. He always blames me and dislikes me at 
home.’ 
I found that many women who did not receive support and were discriminated against 
by family members struggled to continue their treatment. They stated that they could 
tolerate and fight against discrimination by others but when it happened within the 
family, their spirit was completely broken, affecting their ability to continue treatment. 
However, despite such difficulties women continued their treatment, and were more 
compliant than men. I discuss more on stigma and discrimination in the family in 
section 5.2.2.1. 
I found that unmarried girls and women had more support from their parents and were 
thus less troubled than married women who had a big role in looking after their 
family. A 22 - year-old student said; ‘All my family members are very helpful, my mum 
comes along with me when I come to this centre. They always remind me to take 
drugs.’ 
However, unmarried women had other worries due to TB. I found that their parents 
were restless and had put every possible effort to hide their daughter’s TB, as they 
stated a fear of having difficulties arranging their marriages.  
Although I found both married and single women had issues, women with small 
children faced more difficulties continuing treatment than single women. Most women 
with children stated that despite their worries they were not able to care for their 
children properly, because of fear of infection and physical inability. It is likely that 
things would have been even more difficult for lactating mothers with TB but I was 
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unable to find any to interview. However, my discussion with health workers who 
served lactating women in the past revealed that they often had difficulties continuing 
their TB treatment. Such women not only feared infecting their babies but also 
thought TB drugs that they were taking would cause physical deformity in their 
children.  
Many women with TB stated that their children had to suffer more than others in the 
family as a consequence of their illness. In several instances, their children were 
forced to work to generate money for the household, deeply affecting their study. In 
many cases, their children replaced them in their work when they were unable to 
attend due to TB. This situation was found mostly among poor women who were 
working in small factories, and especially migrants. A woman migrant worker said; 
‘Sometime when I feel very weak I send my daughter to replace me in my work. This is 
how I am managing to keep my job in the factory. I feel sorry that she missed her 
school but will continue her studies once I feel better.’ 
In this case, I asked the woman whether she would send her daughter if her husband 
was ill. She said that she would do the work instead of her daughter to help her 
husband to continue treatment. Such findings clearly indicated that the impact of TB 
on women not only affected the individual but others in the family, especially 
children.  
I also found an array of issues among migrant women with TB which affected their 
ability to continue treatment. Most migrant women arrived in the city with their 
husband and children and did household chores as well as working outside. They 
already had problems to earn and live in the city. TB further damaged their 
economical and social ability as the disease made them jobless and spoiled their social 
networks in the city as well as in the village.  
I found that, in addition to concerns about the harmful effects of TB drugs (see section 
5.2.1.3), women and men who were single and married with no children were more 
distressed about their fertility than women and men who had children. Their 
apprehension was not only whether they would be able to bear children but also the 
risk of not finding a marriage partner and being rejected by the family. The effects of 
such emotions in their treatment were clear as they often visited different health 
workers during their treatment and even thought about discontinuing treatment. A 
mother of an unmarried girl with TB who visited the DOTS centre with her daughter 
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said; ‘We consulted several doctors to find whether these [anti-tuberculosis] drugs 
causes impairment on her.’ 
She further stated that she heard in the community that TB drugs are very powerful 
and they dry and shrink the uterus, and cause infertility. Similarly, a young single man 
studying in college asked me during an interview whether the TB drugs that he was 
taking really affect his ability to be fertile. In contrast, married women and men with 
children found to be less concerned about this issue: however, some male respondents 
mentioned that the TB drugs have reduced their sexual strength. A lady health worker 
also stated in her interview that a woman who had her pregnancy test positive after 
diagnosis of TB was extremely concerned about her pregnancy status and had fears 
about negative impact on her foetus due to TB and TB drugs.  
I found that the TB services were not gender friendly. Most women respondents stated 
various inconveniences in receiving TB treatment from designated DOTS centres. 
Such as women had difficulties sharing their problems with health workers due to lack 
of privacy in DOTS centres. Many women respondents stated that they had to wait for 
a conducive environment in the centre to discuss their concerns with health workers. It 
was more difficult when they had some personal and family issues hindering their 
treatment. I also found that women with TB were more inclined to visit the DOTS 
centre when there were fewer men there. Women also stated that they wanted to be 
served by woman health workers instead of man but there was no choice in many 
DOTS clinics. The reason they stated was they could discuss their problem openly 
with female care providers; in contrast, whereas men stated they saw no difference in 
the service provided by men or women care providers.  
Similarly, I found that, unlike men, women tend to visit faith healers during TB 
treatment. I also found that health workers believed women were more stable and 
continued treatment from the same centre where they initiated treatment whereas men 
were more mobile. The mobile nature of men was mainly due to their job and family 
responsibilities. Health workers also stated that women were more compliant to advice 
given by them and more committed to their treatment despite hardships.  
In several instances, I found that wives accompanied husbands to the DOTS centre but 
husbands hardly accompanied wives. This indicated that women and their illness were 
less of a priority for husbands. It could be also that men did not want to be seen with 
women, as this is not common in Nepali society. However, in interviews men stated 
that it was due to their busy schedule as they do care about the illness of women. 
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In conclusion, I found that gender differentials exist in TB service delivery and 
treatment: thus gender inequality was an issue in the NTP. Both men and women face 
difficulties continuing their treatment. However, women with TB were more 
vulnerable to TB treatment due to their positions in the family and society, which are 
further determined by socially constructed roles, and a wide variety of behaviours and 
expectations. Women faced several barriers at home, in the society and in health 
institutions. Despite such hardships, women tend to follow TB treatment better than 
men. I also found that the existing TB service delivery mechanism was not gender 
sensitive: thus revisiting the existing modality needs to be a priority to address the 
gender-based inequalities in TB services. However, despite gender differences both 
men and women continued their treatment.  
5.2.2.3 Social system, caste, ethnicity and TB 
Nepal has a multifaceted social structure with a number of traditionally defined social 
layers generally based on caste, ethnicity and language as described in section 2, 
section 2.7.1. The study area was not untypical, as it included people from different 
ethnic origins, castes and languages, so that my respondents were mixed (see chapter 
4, section 4.3.4). In this section, I discuss findings related to people with TB from the 
socially disadvantaged classes (so called lower cast groups known as Dalits) as I 
found them to be more vulnerable. I present their experiences with TB and TB 
treatment with a view to understanding whether there were caste and ethnicity 
differences in factors affecting TB treatment completion.  
Most of the Dalits with TB I interviewed shared concerns about whether their caste 
identity would be disclosed, even despite my initial guarantees of confidentiality 
within the study, because they thought that the community perceives Dalits as low 
caste people, and disclosing their caste identity would make them further vulnerable in 
accessing TB services from the DOTS centre. They also stated that in DOTS centres 
so called higher caste PLTB may not like them, and they may receive poor behaviour 
from health workers, who mostly belong to the higher castes. A young man, working 
in a factory said; 
‘I don’t mind letting others know that I’m from a Dalit but not all people in the 
community have same respect to all castes therefore sometime I fear whether people 
would treat me differently knowing that I am a Dalit.’ 
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In the Nepali social system, caste can be identified from a person’s surname. 
According to health workers, Dalits with TB, especially women, often hesitate to give 
their surname during registration for treatment. I found that Dalits with TB were 
anxious about unfavourable behaviour from people in the community and at the 
DOTS centres, over and above fear of discrimination on the grounds of TB. 
Consequently, some Dalits with TB had changed their surname when they registered 
for treatment in a DOTS centre. I found that Dalits’ intention to hide their caste 
identity was nothing more than to avoid situation of discrimination against themselves 
and their family on the ground of their caste and the disease.  
I found that the false names and addresses given by Dalit TB patients during 
registration had implications for treatment, if they missed treatment doses and health 
workers tried to trace them to encourage them to continue treatment, they could not be 
found at the address given. In addition, health workers stated that some Dalits with TB 
often carried drinking water themselves, as they were reluctant to use the water jar 
provided in the DOTS centre. They were worried whether others would say something 
unpleasant because they thought that PLTB from higher castes would not use the 
water touched
12
Identifying clear links between TB and specific caste groups was hard: I found that the 
socially disadvantaged groups, especially the Dalits, saw an association between their 
TB and the job they were performing, which was generally considered a low-grade 
job. Dalits also said that their perceptions of association between TB and the kind of 
job they were engaged in became stronger when health workers told them that the 
 by them. This showed that Dalits with TB wanted to avoid any 
situation of potential discrimination by others, but doing this throughout treatment 
caused them additional problems.  
I found that Dalits often had a perception of being less empowered to demand 
services; and this was exacerbated when Dalits had TB. A young woman who 
migrated to the city with her husband said; 
‘People do not care our problems because we are Dalits and having TB is a suicide 
for us.’ 
                                                 
12 Historically Dalits were considered to be untouchable and were therefore culturally restricted in 
many ways. In many instances, food or water touched by Dalits was considered to be contaminated 
and therefore unacceptable by so-called higher castes. However, things are changing since the 
government reinforced anti-discrimination legislation 
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causes of their TB was very much associated with their job. (It should be noted that 
not all Dalits were engaged in the type of work that was perceived as low-grade.) 
Although TB flourishes in conditions of hardships and poverty, it made Dalits with 
TB feel that their disease was a consequence of the work they were involved every 
day, which further humiliated them, and their feeling of being inferior in the society 
became stronger. I found that such perceptions among Dalits affected continuation of 
treatment as they often isolated themselves and blamed themselves for being Dalit and 
having TB. In addition, the poor social and economic status of Dalits made them more 
vulnerable to the disease and created further hurdles to treatment continuation.  
On the other hand, a Dalit with TB working as a teacher stated that there was no 
discrimination against low caste TB patients in the DOTS centre where he was treated. 
In addition, he said; ‘Things have changed a lot in the society as these days people do 
not take caste business seriously.’ 
I found that people in urban areas perceived caste as less high profile and less 
important for them in their public life, clearly indicating a changing scenario. A health 
worker said; 
‘It is not much important in cities as many people do not care whether a person is 
from lower or upper castes, the only matters is how people behave with each others.’ 
From my findings it can be said that the caste issue is no longer taken seriously in the 
cities whereas it still exists to a certain degree in rural areas. However, from the point 
of view of Dalits with TB, unfavourable behaviour against Dalits based on caste still 
exists, which in some instances was made worse by TB.  
I then interviewed NTP officials to obtain their opinion on the matter of discrimination 
based on caste. First, they denied that there was any form of discrimination in TB 
service delivery. Second, they perceived that TB was common among socially 
marginalised groups, although they said that the NTP has no specific evidence for this 
opinion, but has planned research on this topic. Third, they mentioned that the NTP 
has been considering designing some specific interventions taking into account the TB 
burden among socially marginalised groups and their difficulties accessing TB 
services, especially in urban settings.  
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A 28-year Dalit woman arrived in the city with her husband and two children in search 
of financial improvement. She had no big dream in the city being an uneducated Dalit 
woman, so she started a job in a brick factory. She started earning 95 rupees (US$1.3) 
per day. She registered in the factory with a non-Dalit surname and enjoyed her new 
social identify. While in the city, she wanted to avoid prejudices based on her Dalit 
status. Such prejudices had caused her substantial suffering in her home village: for 
instance, she did not have privileges to access the temple, water sources, eating places 
and other public places.  
Unfortunately, the joy of being away from discrimination did not last for long as 
within two months another tragedy hit her life when she was diagnosed with TB. 
Diagnosis cost her all her savings. Survival in the city became difficult for her due to 
financial constraints and access to the distantly located DOTS centre. Consequently, 
she had to return to the village. Her brother helped to get drugs from a health post, 
which was 6 hours distance from her home. Despite several efforts to hide the disease, 
other women in village became aware of her illness. The prejudice mounted after her 
disease became public. It was more difficult to continue treatment when her brother 
had to come to the city to earn money.  
These consequences weighed heavily on her and she stopped treatment for a month. 
She thought life had come to an end. Meanwhile her husband came and rescued her 
back to the city. She had to go through all the TB tests again and restarted her 
treatment at a new DOTS centre. Now her nine-year-old daughter helps her at home, 
her husband has a job and her little boy stays with her. She is getting help from her 
brother who came to the city to earn money. She has regained her hope in life but is 
worried whether she can continue the treatment. Now she has left everything to God. 
(The women was a participant of focus group discussion) 
Box 2: Case study of a Dalit woman with TB 
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5.2.3  Attitudes and behaviour of health workers 
In this section, I present my findings about attitudes and behaviour of health workers, 
as a follow-up to a question I asked to most PLTB: ‘how do you think you have been 
treated by health workers during the process of your TB treatment?’ The initial 
answer most respondents gave was in line with the statement; ‘most health workers 
were good but they generally keep their distance’.  
In the interviews, I sought further explanations of the word ‘distance’. I found that it 
did not mean only the physical distance between PLTB and health workers during TB 
service delivery, but also the distance in the DOTS centres in everyday practice such 
as behaviour, communication, providing TB drugs, and examining PLTB. In most 
cases, PLTB were disinclined to discuss the attitude and behaviour of health workers, 
despite my assurances of confidentiality, because many PLTB feared that negative 
comments about aspects of health workers’ behaviour would endanger their treatment; 
they assumed there would be no change in health workers behaviour towards them so 
what was the point of raising the issue; many PLTB were unclear on the role of health 
workers towards them and what should they expect from a health worker, so they 
could not comment on whether what they received from health workers was good or 
bad; PLTB had a feeling of so far, so good, as things were moving despite problems 
thus why comment on health workers. However, not all PLTB had the same feeling 
and fear: I found a few were critical of health workers’ attitude and behaviour. A 
woman with TB who had also volunteered in a DOTS clinic in the past said; 
‘Health workers in this centre are good. It is not to blame them but often they consider 
us only as a patient then a human thus they have difficulties to understand our 
situations. This makes me to feel that they do their job but not serving us from their 
heart. I feel sometime they may have ill feeling towards us or some kind of fear with 
TB disease, but they don’t show in general’.  
Similarly, a few PLTB stated that their health care workers were not friendly towards 
PLTB and in many instances did not respect them. Examples they gave included: 
PLTB were scolded by workers during the course of their treatment, especially when 
PLTB were late, even by a few hours, in collecting TB drugs; uncooperative 
behaviour of health workers such as not supplying TB drugs even for a few days when 
PLTB were in desperate need; responding with an insolent tone of voice when asked 
questions; and unresponsiveness to PLTB shown when health workers sometimes 
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asked PLTB to wait while they chatted with friends. A young migrant with TB 
working in a factory, who used his lunchtime to visit the DOTS centre said; 
‘I wish I could have money to buy drugs in pharmacy as the health workers here 
[DOTS centre] are so unresponsive to my needs. I told them I have limited time to 
come for drugs, despite so, they keep me waiting and they engage in chat with each 
other. Seeing their behaviour makes me so upset but nothing I can do as they don’t 
like if I complain.’ 
On several occasions, PLTB stated that they felt uneasy discussing problems, 
especially personal and social issues, with health workers, because health workers 
often did not show any interest in listening to problems other than those directly 
related to health; health workers did not encourage PLTB to share their problems; and 
in a few instances health workers said to PLTB that they cannot help. A rural woman 
who migrated to the city in search of work but who developed TB, and who tried to 
share her problems with her care providers, said;  
‘Staff here [the DOTS centre] are nice but they were often not interested to listen 
issues other than treatment and I feel odd when I wanted to talk about my other 
problems. I thought she [a nurse] would not listen to me, as she never asked how I was 
managing my treatment. She may not like if I push her to listen my problems.’ 
A tendency was seen among some health workers to view PLTB as a ‘TB patient’ 
rather than a human being with roles in the community and family; and thus such 
health workers treated TB, not people. PLTB said that health workers did their routine 
duty but were less sympathetic to PLTB as they viewed them differently from other 
people in the community. A young man said; 
‘I missed drug for a day as my father came from village and he was ill. My wife took 
him to hospital. I was very weak and not able to come here. I was waiting my wife to 
return home and get drugs from the centre but it was too late by the time she arrived 
home. Next day I came to this centre she [a Nurse – the respondent pointed to her] 
scolded me as if I am not a human and only an ill desired person. I tried to explain my 
situation but she did not listen to me.’ 
However, most health workers said that they did listen to PLTB and tried to 
understand their difficulties, but were unable to help PLTB in addressing non-medical 
issues such as financial and social problems. A health worker working in an NGO 
clinic said; 
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‘We are aware that TB patients have concerns other than medical. We listen them but 
cannot address the especially their financial inability, accommodation needs and so 
many others. Although we listen them, not able to provide help may have annoyed TB 
patients thus they may have felt that we do not consider them seriously but it is not 
what we think.’ 
There was therefore a mismatch between the health workers’ and PLTBs’ perceptions 
regarding non-medical support. PLTB thought most of the problems they suffered 
during TB treatment were as a consequence of TB, and therefore it was legitimate to 
ask for advice and support form health workers; while health workers believed that the 
PLTBs’ non-medical problems, had nothing to do with them, as they could only 
address medically related issues such as drug side effects.  
In contrast, some PLTB stated that they had a good relationship with health workers, 
who supported their treatment continuation in various ways. Examples included: 
health workers accepted PLTB and put them on treatment; they tried to be flexible in 
DOT as they supplied drugs when requested; they provided assurance that their 
disease would be cured; they opened the DOTS centre on time and called PLTB when 
they were late for treatment; they were polite and informative in their dealings with 
PLTB. A woman with TB who had family problems which meant she faced 
difficulties continuing her treatment said; 
‘I shared my problem with the nurse and she suggested me how to deal with problems. 
She presented like my sister and worried that I may discontinue my treatment. All her 
support and encouragement helped me a lot.’ 
I observed that, in general, health workers attitudes and behaviour towards PLTB were 
good; and when health workers respected PLTBs, this provided considerable 
motivation to continue TB treatment. 
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5.2.4 Information and communication 
I have already discussed my finding that TB-related knowledge and perceptions 
among PLTB, their families and the community played crucial roles in proper 
diagnosis and treatment of TB. The knowledge, perceptions, attitudes and behaviours 
of both health workers and PLTB were closely linked to information and information 
communication. Information communication was an important activity of the NTP, 
the main examples being: 
- Interpersonal Communication (IPC) between health workers and PLTB 
dur ing treatment, where appropriate including family members, friends or 
relatives of PLTB. 
- Programme communication to communities: aiming to change socio-cultural 
norms, thus improving community understanding of TB and perceptions of PLTB, 
expanding community support and solving social problems at community level. 
- Communication with politicians and policy makers to advance policies and 
guidelines and secure required financial resources.  
In this section, I mainly focus on IPC between health workers and PLTB (and where 
appropriate PLTBs’ family members), because information and communication, when 
delivered effectively, can have a profound impact on changing individuals’ attitudes 
and behaviour. I will not discuss the other communication activities explicitly as the 
focus of my study is on health workers and PLTB.  
In this section, I discuss my findings on IPC with a specific focus on information as a 
‘resource’ and communication as an ‘activity’. I developed a framework (Figure 13) 
to aid understanding of IPC based on the three major themes that emerged in the 
study: context, process and outcome. Context refers to the physical and socio-cultural 
environment; process to information relevancy, means of communication, 
understanding and respect for each other’s views; and outcome to satisfaction, 
problem solving and knowledge enhancement and hence to successful treatment 
outcome.  
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I found that a various elements had a role in shaping the IPC. The subsequent sections 
focus on context for IPC, its process and outcomes.  
  
Figure 13: Framework for understanding interpersonal communication in successful 
completion of TB treatment 
Context 
• Environment of the DOTS centre 
• Socio-cultural and economic status 
• Age, sex, gender, education, occupation, social networks, family 
• Support and encouragement 
 
 Process 
• Means of communication 
• Information and relevancy 
• Encouragement and support 
• Understanding PLTBs' views/opinion/expectations 
• Interpersonal communication skills of care providers 
• Language and behaviour 
Outcome 
• Satisfaction 
• Reduction of anxiety, improved psychological status 
• Solution of problems 
• Encouragement and support 
• Updated knowledge about disease and treatment literacy 
• Better utilisation of services 
• Successful treatment outcome 
Interpersonal communication 
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5.2.4.1 Context for interpersonal communication 
In this section, I mainly focus on the following areas that influenced IPC: the 
environment of DOTS centres, the cultural diversity of PLTB and health workers, and 
socioeconomic differences of PLTB and health workers.   
5.2.4.1.1 Environment and other context for communication 
I found that IPC between health workers and PLTB was influenced by the atmosphere 
at the DOTS centres (external and internal); institutional settings and service delivery; 
privacy; comfort; and support and encouragement provided. The DOTS centres in the 
study area were heterogeneous in terms of infrastructure, internal settings and services 
they provided. A few centres were located within the premises of a general hospital 
and offered a wide range of TB services, but the majority operated in a limited 
physical setting with no designated room for communication services (although a few 
centres had a general consultation room, which was also used for TB services). 
Generally, communication took place in an area where other services
13
                                                 
13
In the study area, many DOTS centres were also providing other health services such as 
general health check-up, immunization, antenatal and post-natal care, family planning 
services, child health etc. 
 were being 
delivered, so that frequent interruptions occurred. Health workers commented that 
limited physical facilities at the DOTS centre, especially rooms, not only affected 
communication but also challenged delivery of basic TB services and quality of care.  
I found that communication events were also often interrupted by frequent phone calls 
(and particularly mobile phone calls) to the health worker involved in communication; 
lack of concentration by health workers; untidy rooms and disorganized and cluttered 
working environments (e.g. the health worker’s desk was messy with papers and 
drugs); external noise such as pressure horn of cars and loud music from nearby 
shops; and frequent comings and goings of people in the room during communication. 
Moreover, many DOTS centres were poorly equipped with furniture and other 
essentials such as water supply, power, curtains, toilet etc. The absence of a minimum 
standard in the centre not only affected IPC but also lowered the motivation of PLTB. 
A woman respondent said,  
‘This centre even does not have provision of drinking water and sufficient chairs to sit 
and, how can they provide good service to us.’ 
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Likewise, the majority of PLTB stated that confidentiality was an issue in DOTS 
centres: a lack of privacy meant many of them did not discuss important issues with 
health workers and affected trust and curtailed relationships between both parties. I 
found only a few centres that had good physical facilities with a separate consultation 
room. However, PLTB receiving treatment in the centre stated that health workers 
were often busy and thus had little time for communication. This indicated that PLTB 
required more than merely good physical facilities.  
On the other hand, I found that a few PLTB were not concerned with the environment 
of DOTS centre when it related to information and communication. This was not 
because they did not require information, but because they did not consider the DOTS 
centre as an information source, because they had not been satisfied with 
communication at the DOTS centre; because they satisfied their information needs 
from other sources (e.g. family members, friends, colleagues, books and the internet); 
and exceptionally because as they did not want to look for additional information.  
Exploring information from various sources, especially the internet, was common 
among young PLTB with a good educational background and who are familiar with 
modern information technology.  
Despite insufficiencies in physical environment and other contexts, I found that a 
degree of communication between PLTB and health workers was happening. Most 
health workers felt that they delivered effective communication within the limited 
resources provided to them. I found a strong feeling among health workers that high 
treatment success rates indicated that PLTB were satisfied with the services provided 
by them: thus they thought communication with PLTB was effective and contributed 
to good results. A health worker said; 
‘Despite the resource constrains, we have been providing good services to patients as 
a result we have achieved a high rate of treatment success which indicated that TB 
patients were satisfied with our services.’ 
Such understanding among care providers did not acknowledge that, despite 
completing treatment, PLTB suffered greatly due to TB. The claim of health workers 
directly contradicted with what PLTB experienced, as many PLTB stated that the 
environment in DOTS centres did not allow them to discuss their issues and problems 
with health workers.  
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To summarise, a degree of communication took place between health workers and 
PLTB in DOTS centres, despite communication hurdles due to inadequate physical 
and other environments of DOTS centres and other contextual issues. Although the 
environment in the DOTS facilities is hard to change, there are opportunities which 
could minimize the effects of some contextual factors on IPC if health workers take 
the trouble to take them; but many health workers seen unbothered. 
5.2.4.1.2  The need to understand socio-cultural diversity  
I have already discussed in sections 5.2.1 and 5.2.2 my finding that PLTB had varied 
understandings and interpretations of their disease and treatment, most of which were 
influenced by locally-held cultural norms and the socio-economic status of the PLTB. 
In addition, the varying socio-cultural, economic, and occupational status of PLTB 
greatly influenced the support and barriers encountered during their treatment. It is 
therefore important to assess knowledge, attitude and beliefs of PLTB, and where 
applicable their family members, regarding TB and its treatment. Better understanding 
of PLTBs’ knowledge, attitudes and beliefs would enable health workers to 
understand their views and information needs, and tailor information and 
communication accordingly. However, in many instances, health workers started 
communication without assessing the views of the PLTB, hence ignoring their views 
and failing to respect the PLTB’s beliefs during the communication process.  
For example, a woman strongly believed that taking drugs on an empty stomach 
would causes stomach erosion, but her health worker asked her to take all her TB 
drugs on an empty stomach. This information that conflicted with her beliefs not only 
confused her but made her worried whether the drugs would work for her, because she 
decided to take the drugs after a meal. I found many instances where beliefs of a 
PLTB and information given by a health worker were contradictory, and as a 
consequence the PLTB became anxious, fearful, or distanced him/herself from the 
health worker.  
Such contradictions/mismatches often occurred when health workers gave generalised 
information to all PLTB without being aware of their views and information needs, so 
that the information was not tailored to the PLTB’s needs. I found in many instances 
that the health workers started communication with a set of pre-determined 
information discussed in largely bio-medical, with little or no consideration of the 
PLTB’s social and cultural background. It was often the case that TB messages were 
technical rather than contextualised to locally-held socio-cultural beliefs.  
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For example, the first information provided to PLTB was about the requirement for 
DOT, in line with national policy. Health workers could have communicated the 
policy after assessing the status, knowledge and behaviour of PLTB and motivated 
them by detailing the importance of DOT in treatment. Similarly, health workers often 
emphasized the need for continuation of TB treatment. Clearly, this was important 
information that all PLTB needed to know, but PLTB perceived that health workers 
focused only on treatment continuation without understanding the problems that 
prevented the PLTB continuing treatment. For example, a young migrant worker 
working as a carpenter was told to come daily for his treatment without the health 
worker having sufficient understanding of whether and how he had any issue that was 
affecting his treatment. He said; 
‘I know continuation of my treatment is very important for me and not doing so my 
disease will not be cured but there are other problems preventing me to do so. They 
[health workers] do not understand how much pain I am carrying due to this disease 
[TB].’ 
I found that only providing important information to PLTB would not change their 
behaviour as desired: it was equally important to know how and when to provide such 
information, to ensure that their knowledge was enhanced and they changed their 
behaviour to that needed to ensure cure.  
I found that many PLTB had a difficult journey getting to the treatment stage. 
Notification of the disease itself was a shock for many PLTB, and by the time they 
arrived at the DOTS centre for treatment, they had many personal and family 
problems and frustrations in addition to TB. A woman running a small street shop 
said; 
‘I know TB is curable, sometime I feel it is better to die instead of facing hardship in 
life. It [TB] is not only the problem that I am facing, there are many others but who is 
going to listen them.’ 
Although to some extent health workers seem to be aware of the fact that PLTB were 
living with many other difficulties, they were rarely considered during 
communication. In absence of such considerations, exchanging information through 
IPC was often ineffective. 
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5.2.4.1.3  Socioeconomic differences between health workers and PLTB 
I found that the difference in status, and especially socioeconomic differences, 
between health workers and PLTB played an important role in shaping the context for 
IPC. I often found that PLTB saw the health workers as being in a high position in the 
community, because of the respect they commanded and the power they held. Respect 
was largely due to the health worker’s social position (they were often high caste 
people with education), economic well-being (having a high standard of living 
compared to the PLTB), their identity as a health professional, all influenced by a 
traditional mindset (health workers, especially doctors, save lives and are thus 
respected in the community). I found this respect often helped establish good 
relationships, contributing to good communication. On the other hand, power often 
hindered effective communication. Many PLTB strongly felt that health workers 
‘control’ their treatment in many ways, because health workers make the decisions 
with regard to their treatment and PLTB have to comply. Consequently, many PLTB 
thought that the health workers were less approachable to them because of the power 
they hold translated into control during TB treatment. I found that the health workers 
further dominated the communication when they used their power to control the 
treatment process by showing no flexibility, especially in implementing DOT. 
Although DOT was mandatory in DOTS, it could have been properly explained and 
discussed with PLTB and their family members before being imposed:, PLTB would 
then have seen the health worker as a facilitator, rather a ‘treatment controller’. The 
power of control and such non-negotiated decisions often meant that PLTB were 
unable to challenge health workers. A teacher with TB said; 
‘Coming here [the DOTS centre] every day is like visiting the court as if I have done a 
crime. Several times, I asked health workers to supply drugs for a week but they say it 
is restricted by the policy.’ 
Some PLTB believed that decisions made by health workers were unquestionable. 
Such perceptions not only restricted PLTB from challenging the decisions but also 
made them reluctant to seek the health worker’s advice on other issues. A woman who 
had continued treatment for two months said; 
‘I do not question them [health workers]. I simply try to comply with their decision. I 
fear that asking many questions would annoy them and I may get problem getting 
treatment from this centre.’ 
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Similarly, I found that the words that health workers used to address PLTB during 
communication indicated less respect to PLTB. For instance, ‘timi’ is a Nepali word 
which indicates ‘you’ in English but when pronounced with more stress, it is 
considered as less respectful. I found that many health workers used such words, 
which devaluated the PLTB in several ways. A young man working in a private firm 
had a bad experience with a health worker when he asked for drugs for few days. He 
said; 
‘The doctor behaved me so badly. He said you (timi) all people [PLTB] are 
uneducated thus, you do not understand us [health workers]. He said angrily that it is 
not possible to educate people like us, if I wanted to cure my disease I should listen 
what he said if not I should buy drugs from private.’ 
This was an extreme example and I did not find any other examples of health workers 
behaving in such a grossly intolerant way towards PLTB. There were other examples 
which indicated that PLTB were scolded by some health workers during their 
treatment but not to the same extent.  
I also found that many PLTB were not comfortable to talk about negative experiences 
that they had with the health workers from their DOTS centre, indicating that PLTB 
were worried whether their treatment would be affected if they talked about bad 
experiences they had with care providers. Such feelings were prevalent despite my 
reassurances about the confidentiality of information in the study. It was clear that 
there was a lack of mutual trust in the relationship between PLTB and health workers. 
Despite this PLTB showed respect to care providers.  
Of course, not all health workers had negative attitudes and behaviour towards PLTB. 
I found health workers respecting PLTB on many occasions: some health workers did 
help PLTB during their treatment because of a strong commitment to make the 
treatment a success. In doing so, some helped address non-medical problems, leading 
to good relationships throughout the treatment. A young migrant worker working as 
supervisor in a carpet factory described the help he received from a health worker, 
which enabled him to continue treatment without losing his job; 
‘I had problem to come every day to the centre which I discussed with health worker. 
She [nurse] phoned the factory owner and asked him to support my treatment.’ 
I also found that gender differences between care providers and PLTB affected 
information exchange. This was more common among women PLTB, who were often 
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reluctant to share their problems with male providers. Similarly, age and literacy 
status also affected communication. However, NTP TB training modules clearly state 
that such factors must be taken into account by health workers when communicating 
with PLTB. However, not all health workers put into practice the theoretical 
knowledge that they gained during basic TB training. 
I also found that PLTB acquired information from their social networks – relatives, 
friends, neighbours, and colleagues – which played an important role in determining 
their treatment behaviour. The information that PLTB received from their social 
networks was of mixed reliability: some of them were incorrect, for example ‘TB 
drugs cause impotence’. Such misconceptions could reduce PLTBs’ ability to continue 
treatment if not properly addressed by the health system. However, I did not see health 
workers carefully considering information that PLTB received from their social 
networks. Likewise, I found that many PLTB received encouragement and support 
from family members. However, health systems did not pay sufficient attention to 
engaging PLTBs’ family members despite many opportunities to bring family 
members into the treatment process.  
5.2.4.2 Process of information and communication 
In this section, I define process as a particular course of action in communication 
intended to achieve a desired outcome. Although the process of information 
communication started when PLTB sought care, in this section, I only consider 
communication during the course of TB treatment.  
I found four major actors/agents that shaped the information and communication 
process: health systems (the NTP and its policies); health workers (who though part of 
the health system are also individuals); PLTB and their family; and members of the 
community such as friends, relatives and colleagues. Although all four were 
important, I focus on two major actors: health workers; and PLTB along with their 
family where applicable, because these actors were more often engaged in 
communication during the treatment phase than the other two. Important areas 
influencing the communication process and thus its effectiveness were: information 
content and relevancy; means of communication; and involvement of PLTB and their 
family members in the communication. Below, I describe each independently. 
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5.2.4.2.1  Information content and relevancy: 
The NTP had a pre-defined information package, designed for all PLTB. This focused 
mostly on the technical aspects of the disease and treatment with less consideration of 
socio-cultural implications of the disease (see Box 3). Although this technical 
information was important for the PLTB, it was hard to expect successful treatment 
completion when socio-cultural aspects of the disease were ignored. During 
interviews, many PLTB raised concerns regarding their disease and treatment which I 
have discussed in subsequent section. I found that most of the specific concerns 
(Table 12, the second column) were not fully addressed in the NTP’s information 
package. Examples of such issues include TB-related stigma and discrimination; the 
impact of TB drugs on fertility; dietary restrictions during treatment; relationships 
between TB and poverty; life-long implications of TB; and physical relationships 
between husband and wife during TB treatment. Such issues are discussed in section 
5.2.4.3. It is clear that the NTP information package did not fully addressed the 
concerns PLTB had during TB treatment. However, health workers had a strong 
feeling that they addressed needs of PLTB because they observed high treatment 
success rates. 
 
  
Box 3: NTP’s predefined TB information package 
All PLTB must know that; 
i. they need to take the full course of prescribed drugs under the direct observation of a 
treatment supervisor 
ii. treatment should not be interrupted throughout the treatment period 
Information that health workers should inform PLTB at the start of TB treatment 
iii. PLTB need to take their treatment everyday under DOT; 
iv. The duration of TB treatment; 
v. TB will not be cured if treatment is interrupted; 
vi. Information on minor side effects of drugs (e.g. red urine). If PLTB have other 
difficulties they should contact health facility as soon as possible; 
vii. TB drugs are available free of charge; 
viii. About TB: cause; regular treatment cures the disease; once treatment is completed 
the disease will not infect others etc; 
ix. Cover mouth while coughing, where possible use handkerchief or use hand  
Source: Translated by author from the NTP training module ‘treatment management, 
health education and skill development’ page 48 and 49. NTP Nepal 
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The DOT element of DOTS is emphasized in the information package. Although use 
of DOT was part of policy, it was not suitable to all PLTB as discussed in section 0. It 
was stated by a majority of PLTB that the emphasis placed on the requirement for 
DOT overshadowed other information needs that were equally important to PLTB. I 
found that selection and individualisation of information taking into consideration the 
PLTB’s personal circumstances was not common practice, and greatly affected 
communication. 
Some information in the NTP information package was outdated (Box 3). The Box 3 
point number VII says a PLTB becomes non-infectious only after completion of TB 
treatment, whereas evidence suggests that PLTB will be non-infectious within two 
weeks of starting regular TB treatment. Such unverified information provided to 
PLTB compelled them to be in isolation from family and friends throughout the 
treatment period, which was difficult for many PLTB. Similarly, I found that in some 
cases, although information was correct, how and when it was delivered to PLTB had 
a big impact on whether the information contributed to its purpose. For instance, point 
V in the box says that the disease will not be cured if treatment is interrupted. The 
information is technically true, but the way it was communicated to PLTB created 
unnecessary fear among those who missed only one or two doses of TB drugs during 
the course of treatment. A woman with TB said; 
‘I missed two days treatment because the DOTS centre was closed due to bandh [a 
strike caused by political instability]. Health worker told me at the start of treatment 
that I should not miss even a single dose. I am worried whether my disease will cure.’ 
It was important that health workers needed to understand the context and the 
relevance of information to each individual, instead of generalising to all PLTB. 
However, it was rarely considered during communication, so that information 
provided to PLTB often conflicted with their individual beliefs.  
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Areas of general concern Specific concerns of PLTBs 
Disease-related 
 
- Symptoms  
- Communicableness 
- Cause of TB 
- Types of TB 
- Is my disease really TB? 
- I have no bad habits (smoking, drinking alcohol): how did I get TB? 
- When will I stop being infectious? 
- Will TB remain in my body for life? Does it permanently damage my lungs?  
- Does TB reduce physical ability even after cure? 
- Misbeliefs regarding the cause of TB: e.g. I got TB because secret promises 
to god were not addressed; TB was a result of bad deeds.  
- Can my TB turn into a chronic disease? 
Treatment- and drug-
related 
 
- Treatment duration  
- Side effects of drugs 
- Why does treatment take so long? 
- Some people have said TB needs to be treated for at least 2 years: why will 
my treatment only take 6 months? 
- Can my TB actually be cured? Why does TB treatment fail? 
- How do these drugs work on me? Why do I need to take a lot of drugs? 
- Should take supplementary drugs (e.g. vitamins) during treatment? 
- Will TB drugs affect my fertility? Will TB drugs make me physically weak? 
- TB drugs are very powerful: will they damage my body? 
- Can TB drugs be taken after meals? 
- Are TB drugs of quality 
- Will TB drugs damage body cell while killing TB bacilli 
DOT and treatment 
management-related 
 
- DOT  
 
 
 
- Is DOT compulsory for free TB treatment? 
- Why am I forced to undergo DOT? 
- Should DOT happen only at the DOTS centre? 
- Can the treatment be supervised by family or friends at home? 
- How long is DOT required? 
- If sputum is positive in 2 months, should DOT extend for another month? 
- Can I travel out of town during treatment: if so, how can I get my drugs? 
- Can I be referred to my village for TB treatment? 
- If I take TB treatment at my village, should I come to the city? 
- Are TB drugs the same and the same quality in the city and the village? 
Food habits 
 
- Diet  
- I can’t afford additional nutritious food: will this affect my treatment? 
- If I am vegetarian should I switch to a non-vegetarian diet? 
- What shouldn’t I eat?  
- How frequently should I eat meat? 
Disease precautions 
- precautionary 
measures  
- Should I be in isolation? How long should I be in isolation? 
- Can I share a bed during TB treatment? 
- Should I use a mask all the time? How can I protect others from being 
infected? 
Table 12: Information needs of PLTBs 
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Social, cultural and 
financial aspects of TB 
 
 
- Why is TB perceived as a dangerous disease in the community? 
- Why do people avoid PLTB? Is TB only a disease of the poor? 
- Can PLTB transmit their disease to others? 
- Why do people discriminate against PLTB? 
- Will people marry a person with TB? 
- Will TB and TB drugs shrink the uterus? 
- Is TB is a disease of people who do bad things? 
- Does TB occur when a person engages in sexual relations with other family 
members? 
- Does TB often occur in people who have had sex with prostitutes? 
- Does TB only affect people who do low grade job e.g. garbage collector? 
- Are women who visit a temple during menstruation at risk of TB?  
Source: Compiled by the author from interviews and FGDs with PLTBs and their 
family members  
5.2.4.2.2 Techniques used in communication:  
I interviewed some PLTB along with their family members immediately after 
interaction with health workers, I found that they had several concerns that they 
wanted to discuss with the health workers but had no opportunity to do so. The PLTB 
said that;  
‘He (the health worker) could have given drugs as I’m very weak and coming every 
day is a problem for me’.  
Similarly, his (the PLTB) wife stated; ‘I am not sure how he will come every day. Now 
I’m worried how we will protect our children as his disease transmit to other. We 
have only one room where we all stay. He [husband] is not working since he got ill, 
it’s difficult for me to come along with him every day as I need to go to work. I wanted 
to ask whether we can go to our village and take drugs from nearby health post.’ 
It indicated some important shortcomings in the communication process: it was very 
much one-way; the health worker did not acknowledge the fact that PLTB was unable 
to come to the centre every day because of his physical inability although this was the 
PLTB’s and his wife’s main concern; several messages were given to the PLTB and 
his wife all together; and the health worker did not ask whether the PLTB had any 
concerns. Although the health worker communicated important messages, some of 
them worried the PLTB e.g. isolating himself from his children and wife.  
I also verified my observation during interviews with PLTB who had been through the 
communication process in DOTS centre once or several times. Some stated that they 
often listened to health workers but had little opportunity to ask what they wanted to 
know about their disease and treatment. For example, a woman continuing TB 
treatment who was a local resident of the city said; 
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‘The health worker said many things about my disease but I hardly remember few of 
them’. When asked whether she had opportunity to ask any questions to the health 
worker, she said; ‘I wanted to ask what precautions I should take, what can I eat and 
what should I avoid but I did not have time.’ 
Other PLTB had a similar experience. I observed that many communication events in 
DOTS centres were poorly organised as the process followed was rather traditional 
and largely dominated by health workers. In many instances, I found that the health 
workers did not consider the physical and psychological ability of PLTB to acquire 
information, and the environment where communication took place, so that 
communication was not very effective in achieving its purpose.  
In contrary to what was stated by PLTB, and my observations, the health workers 
thought that their communication was effective, as they believed that they applied a 
good process and ensured active participation of the PLTB. A health worker who had 
recently communicated with a woman with TB while I observed, said, when asked 
what he thought about how the communication went; 
‘It is my duty to make TB patients aware about their disease and treatment. I told [my 
emphasis] what she needed to know about her treatment.’ 
However, I hardly noticed any two-way interactions. The health worker did not ask 
the woman whether she understood or had any questions. I found similar occurrences 
in my observations and discussions with PLTB.  
I found that most health workers were aware of the technical facts of TB. However, 
the context of the PLTB and his/her needs were rarely considered during the 
communication process. Issues included: how the health workers communicated facts 
to PLTB; whether the facts were understood by the PLTB in absence of a two-way 
dialogue; whether, in the absence of proper response to queries of the PLTB, the 
communication helped to change the knowledge and behaviour of PLTB to make 
successful treatment completion likely; whether the health workers considered the 
status of the PLTB and made adjustments to enable communication; whether a 
relationship and trust was developed before and during the process of communication; 
whether the PLTB had opportunities to share his/her opinions and ask questions. I 
found that none of these issues were taken fully into account. 
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In some instances, I found that the health workers often assumed an educated person 
would already have good knowledge about his/her disease and treatment and thus 
have less need of information. However, this was not always the case. Some well-
educated PLTB I interviewed knew some information about their disease and 
treatment, but not enough to help them during treatment. For example, a health worker 
considered a well-educated young man working in a government office to be a person 
with sufficient knowledge about his disease, so she felt no need to provide detailed 
information to him. The young man narrated his experience; 
‘In my first meet with her [the nurse] she said that I am well educated thus I must have 
known many things about my disease thus no need to repeat them again. But it was 
not true, I did not know many things about TB. ’When asked whether the educated 
person asked the nurse any questions, he said; ‘It was hard for me to ask her again as 
I did not feel comfortable. I simply listen her and walk out.’ He stated that asking 
questions to the nurse again would undermine his image of being a well-educated 
person, so he did not do so. 
In contrast, PLTB with little or no education felt overloaded with information 
provided by the health workers, especially in the early days of treatment. They stated 
that the care providers told them many things at once, making it difficult for them to 
remember everything. A male migrant worker said; 
‘The nurse told many things about my disease but I hardly remember few of them. 
Recently a sir [health worker] in the lab told me several things about my result and 
asked to bring another sample but it was hard for me to understand all information 
provided.’ 
I found that it was important to individualise the content of communication taking into 
account the educational level, information needs and ability to understand 
information. However, the findings demonstrated that there was little consideration of 
choosing an appropriate communication process and the status of the PLTB while 
exchanging information, consequently the purpose of communication was not fully 
achieved. 
In addition, the relevance and prioritization of information according to needs of 
PLTB at various stages of their treatment was another important area that determined 
the effectiveness of communication. However, it was often the case that health 
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workers were more inclined to provide a set of pre-defined information to the PLTB 
regardless of its relevance to individual needs. During interviews, health workers often 
said a lack of sufficient time for communication limited their ability to understand the 
needs of PLTB and prioritise information accordingly. However, I observed that the 
majority of PLTB visited the clinic on a regular basis, and there were ample 
opportunities that health workers could have used to educate PLTB. In response to a 
question regarding how frequently PLTB were educated in the DOTS clinic, a woman 
respondent visiting the clinic every day said; 
‘The nurse gave me several information when I started my treatment. Then after she 
provides information when I ask questions.’ 
This and other experiences did not match what health workers said about limited time. 
Since PLTB visited the clinic on a regular basis, health workers could have prepared a 
list of PLTB who they could communicate with at each visit. However, this did not 
happen in many DOTS centres as communication was not a routine activity delivered 
in an organized fashion. 
I found a lack of communication tools in DOTS centres. Most of the communication 
events between care providers and PLTB were based on verbal discussions or lectures 
with little or no use of audio-visual tools. Health workers also raised the lack of 
communication tools as a barrier in exchanging information. I also looked at the basic 
NTP TB training module used to train health workers. The combined module had a 
section on ‘Health Education, Communication and Skill Development’. The section 
contained exercises, role-plays, games, some examples of good communication, 
pictorial exercises and communication theory. Communication was a half-day course 
within a five day training package. During interviews with health workers, I asked 
about the training they received with regard to communication. Responses were 
mixed. Some health workers said that a half-day course was insufficient to enhance 
their skills in communication whereas others said that the content and exercises were 
sufficient, but they were insufficiently focused on during the training course.  
In the central store of the NTP I found some educational materials related to TB (see 
Table 13). I found that most of the communication materials were developed 
considering the programme perspective with limited understanding on the needs of 
PLTB. In addition, the materials were also limited in quantity so that they were not 
available in many DOTS centres in the study area. In my discussion with NTP 
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officials they also highlighted the lack of educational materials in the programme. A 
NTP official said; ‘We have developed few communication materials and realized that 
these are not sufficient thus we are in process of developing new materials 
considering the needs of the programme.’ 
Tools Contents  Target groups Comments  
TB leaflet TB in general 
(cause, 
symptoms, 
treatment and 
prevention) 
General population - Too much information with no 
prioritisation 
- Lack of content to address 
misconceptions about TB  
- Not useful for illiterate people 
TB poster  TB general General population 
and PLTB 
- Traditional design  
- Unfocused messages 
Banner  TB in general 
DOTS 
General population 
and PLTB  
- General TB messages 
- Only used during certain 
occasions i.e. world TB day 
Flip char t 
(cloth) 
TB in general, 
diagnosis, 
treatment, DOT 
Community health 
workers, PLTB 
- Designed with focus on DOT 
(institution and community) 
- Useful to educate PLTB on 
disease and treatment 
- Limited availability 
Pamphlets TB in general Community people, 
volunteers, PLTB 
- Too many messages 
- Hard to read 
- Not useful for illiterate people 
5.2.4.2.3  Involvement of family members of PLTB in communication:  
I observed that PLTB were often accompanied by a family member, friend or relative 
while visiting the DOTS centre. This was more common during the initial two months 
of TB treatment when PLTB were asked to visit DOTS centre daily and when the 
PLTB was physically weak. In several instances, the family members wanted to know 
more about the disease and treatment. Thus, a woman who accompanied her husband 
to the DOTS centre showed her desire to know more about the disease and treatment; 
‘I want to know more about his [her husband’s] disease. Since he started taking drugs 
he became very weak and sometime vomits blood. This makes me so worried and 
seeing him in such condition, I feel helpless. It may be due to these strong drugs or 
may be due to other disease he may have. I wanted to know whether the treatment he 
is currently taking is correct for his disease.’ 
Table 13: Communication materials of NTP for various target groups 
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In DOTS centres, I often observed that the family members who accompanied the 
PLTB were present during discussions with health workers. However, family 
members’ participation in communication process was passive. In discussion with the 
family members, I found that they were unclear about their role in treatment, as it had 
not been clearly explained by the health workers. PLTB and their family members 
commented that although health workers ensured family members were engaged in 
discussions on the requirement for DOT in TB treatment, otherwise their engagement 
was overlooked. Regarding the requirement for DOT, family members were mostly 
seen as witnesses to ensure that the PLTB visited the DOTS centre every day. A 
family member who accompanied her daughter to the DOTS centre said; 
‘I come here with my daughter every day. It has been few weeks I have been doing so. 
I asked the nurse whether I can take drugs and feed at home but she said my daughter 
needs to come every day for initial two months then after she can supply drugs for a 
week.’ 
In my discussion with the health workers, they clearly stated the importance of 
engaging family members in the treatment process. They believed that without the 
help of family members many PLTB would have difficulties continuing their 
treatment. However, they also stated that lack of a clear understanding in the 
programme on the role of family members, especially during DOT, limited 
opportunities to engage family members in the treatment process. Despite this, the 
health workers thought that they often appropriately engaged family members of 
PLTB. The health workers also stated that some family members proactively engaged 
in discussion with them. However, not all family members of PLTB were the same. 
It was clear that the family members of PLTB had been playing an important role in 
TB treatment. However, a lack of clearly defined roles and responsibilities was an 
issue. This clearly demonstrated a need to maximize involvement of family members 
in the treatment process by engaging them at various stages of TB treatment. 
5.2.4.3 Outcomes: unresolved concerns of PLTB 
I found that a degree of communication was taking place between the health 
workers and PLTB at various stages of TB treatment. However, it was not an easy 
task to measure its contribution to enhancing PLTBs’ knowledge and changing 
their behaviour as the responses varied among PLTB and information needs were 
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different. I also found that the amount and type of information communicated to 
PLTB differed, however, to a certain extent, the NTP’s set information package 
was communicated to all PLTB. 
I found that some PLTB and their families were not fully aware of the treatment 
regimen, the reasons for the long duration of TB treatment, potential side 
effects of drugs and what to eat and avoid during the course of treatment. 
Similarly, some PLTB had strong personal or cultural beliefs about the disease 
and treatment, and who they could turn to for help. In some instances, I found 
that the treatment process that PLTB were asked to follow in DOTS conflicted 
with those beliefs. As a result, PLTB and their family members became fearful 
and anxious, and distanced themselves from their health workers, negatively 
affecting communication and thus the desired outcome. Such incomplete 
knowledge and unchanged traditional thoughts resulted in an inability or lack 
of motivation to stay on TB treatment. A young woman with TB said; 
‘It has been more than three months I’m taking drugs but the drugs are not 
responding well. Instead, my health is getting worse as I’m losing my weight, 
my head spins all the time and I can’t sleep as I see dreadful dreams. I think it 
is happening on me due to Boksi [she-devil], she may have been following me 
all the time. If it was a disease then these drugs should work on me.’  
Despite such conflicting thoughts, she was continuing her treatment. 
In contrast, I found that some PLTB were happy with the basic information they 
had received. They stated that the information they gained greatly helped them to 
enhance their knowledge. Some also said that the communication they had with 
care providers helped to reduce their psychological stress and motivated them to 
stay on treatment. A woman with TB said; 
‘It gave me a pain when my children used to cough though the cough was simple. 
It made me to feel that I may have transmitted disease to them. I discussed with 
health worker and he told me that chance of transmitting disease is rare once I 
started taking TB drugs. He also checked my children and their sputum was 
negative. I was a big relief to me.’ 
I found that the NTP set of information was communicated to PLTB despite 
hindrances in the communication process. Some PLTB stated that the communication 
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helped them to understand technical aspects of TB treatment, as the majority of them 
said they were aware of basic information of the disease and treatment. However, 
most of them were also concerned about other than technical aspects of TB and its 
treatment which were taken less into account during communication: information 
needs with regard to socio-cultural aspects of the disease and its treatment were poorly 
addressed. Table 14 presents a summary of concerns frequently raised by PLTB 
during interviews and FGDs. I found that some if not most of them remained as 
concerns of PLTB throughout the treatment process. 
Key questions Areas of concern 
Is it true my disease is TB? How did I get this disease? 
Can it be transmitted to others? 
What happens if my sputum remains positive after two months? 
What makes me vomit blood? Why it does not stop? 
Disease related 
Why do I need to come here every day? How do these drugs work? 
Are there other options available for TB treatment? 
I cannot sleep at night, is it due to these drugs? 
How long do I need to take drugs? 
I missed drugs for a day; do I need to restart drugs from the beginning? 
Drugs and 
treatment related 
How long do I need to be in isolation? 
What should I eat and what not during treatment? 
How frequently should I eat meat? 
Precautions and 
other concerns 
How long should I not conceive after completion of my treatment? 
My job requires taking heavy boxes from one place to another; can I 
restart my job while on treatment? 
Will I be cured after six months? 
Do these drugs reduce my sexual potency forever? 
People say once a person has TB it stays in the body forever; is it true? 
Will my disease really be cured? Will my disease relapse? 
Can I establish a physical relationship with my husband/wife while I 
am on treatment? Do these drugs affect my fertility? 
Will I regain my health? 
Psychological 
stress, anxiety 
I also found that PLTB did seek information from various other sources such as 
family, friends, relatives and the internet and updated their knowledge about the 
disease and treatment. In such a context it was hard to pin down the effectiveness of 
the communication events which PLTB had in DOTS centres.  
Table 14: Frequently raised concerns by PLTB during data collection 
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5.2.5 Access to TB services in DOTS 
NTP policy clearly states that TB diagnosis and treatment should be as close as 
possible to PLTB. However, I found conflicting views among study respondents 
including NTP officials in what was meant by access. NTP officials at national, 
regional and district level generally defined access to TB services by geographical 
coverage only – the distance from PLTBs’ homes to DOTS centres – whereas I found 
that the access to TB services, especially treatment services was not merely limited to 
physical access to DOTS. Many PLTB and some frontline health workers stated that 
other factors presented barriers to access TB services as they hindered day-to-day TB 
treatment under DOTS. The study respondents, especially PLTB and their family 
members, noted the following barriers that curtailed access to TB treatment services in 
the given context; 
- Geographical: inequitable distribution of health services including TB 
- Health care systems: poor infrastructure supporting TB control activities; 
long care taking process; long waiting hours; inconvenient opening hours 
of DOTS centres; provision of mandatory DOT for all PLTB; non-
availability of basic services for other illnesses in DOTS centres; no 
provision of follow-up sputum examination in DOTS centres; complex 
referral mechanism; attitude and behaviour of health care providers 
towards PLTB 
- Financial: poor financial status of PLTB; high cost of TB diagnosis 
resulting in high financial burden during TB treatment; opportunity costs; 
job loss resulting in difficulties living and continuing TB treatment in the 
city especially for poor migrants; unemployment; other associated costs to 
TB treatment; other priorities such as survival opportunities perceived to be 
more important than TB treatment; lack of savings resulting in a lack of 
money for TB treatment;  
- Social and cultural: cultural misbeliefs; stigma and discrimination; 
traditional practices (see section 5.2.2)  
- Educational, information and knowledge: lack of information among 
PLTB on TB and its treatment (see section 5.2.1); poor information on 
availability of TB services; lack of information on location of DOTS 
centres; 
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- Environmental: external environment such as frequent strikes; 
- Personal habits: alcoholism, lack of motivation for TB treatment; drug 
abuse. 
Some of the barriers stated above have been discussed in earlier sections (see 5.2.1, 
5.2.2, and 5.2.4). In this section I therefore focus on barriers related to geography, 
health systems, finance, environment and personal habits.  
5.2.5.1 Geographical barriers to access to TB treatment services 
The number of DOTS centres in the study area has increased over the years. NTP 
officials’ view was that since the coverage of TB services had increased, the problem 
of limited physical access had been addressed in the programme. A District Health 
Official said; 
‘Over the years we have increased the number of DOTS centres fourfold thus TB 
services is widely accessible in urban area therefore service utilisation has 
increased.’ 
In contrast, the frontline health workers in DOTS centres stated that they had been 
receiving PLTB from a far distance in their centres, and dealing with their problems 
regarding long distance travel was an issue for them. I found that the geographical 
expansion of TB services in the study had been prioritised by the NTP, and as a result, 
a number of new DOTS centres were established. Although expansion had taken 
place, it was inequitable, as it did not consider the distribution of populations who had 
poor access to TB services. I found that migrants and factory workers faced more 
difficulties accessing TB services from designated DOTS centres than other PLTBs, 
as they lived and worked far away from the nearest centre. This was especially the 
case for those working in factories such as those making bricks and carpets. A migrant 
woman who was helping her husband continue TB treatment, and who lived in a slum, 
said; 
‘There is no health institution in our area, we need to travel far even for minor illness. 
It takes about an hour [one-way] to reach to this centre and coming everyday here 
with an ill person sometime it takes longer as he [her husband] cannot walk as I do.’ 
I found that access to the DOTS centre on a daily basis during the initial two months 
of TB treatment was a major problem. Although this problem did not resolve 
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completely after the initial phase of TB treatment, it was reduced as the PLTB were 
given a weekly supply of TB drugs. Likewise, women with TB and students also cited 
the distance they had to travel everyday to the DOTS centre was hampering their other 
routine activities. It demonstrated that had the TB drugs been supplied to PLTB during 
initial months, it would have greatly reduced access barrier to PLTB. 
5.2.5.2 Health systems barriers to access to treatment TB services 
I found only limited public health infrastructure available for implementing essential 
health care services (EHCS) including TB care in urban areas. There were three major 
health care types of provider delivering EHCS in urban areas as described in Figure 
14, the public sector (central and local government); the private for-profit sector 
(mainly private hospitals and medical colleges, private pharmacies and  private 
practitioners); and the private not-for-profit sector (Non-Governmental 
Organisations). Unlike the other health services in the study area, I found that the NTP 
had established a level of partnership with non-governmental organisations and a few 
private health institutions as presented in the figure. The public sector comprised 
central and local government was the main TB service provider under the NTP. I 
found that the private sector, both for-profit and not-for-profit, was relatively large in 
terms of services and numbers in the urban area. However, only limited providers 
were engaged in providing TB services under the NTP. Although a level of 
collaboration existed, TB service coverage was limited in areas where most of the 
urban poor and marginalised groups lived (slums and peri-urban areas). I also found 
that coordination among these providers was poor (shown by dotted lines in the 
figure), because it was unclear whether these institutions had any responsibility to 
provide EHCS including TB services, so that services were uncoordinated and 
unregulated. Similarly, inadequate institutional setup and human resources in existing 
DOTS centres provided only limited TB service delivery. Health services provided by 
the private for-profit health sector were not readily accessible for many urban poor 
due to the high cost of care.  
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I found various other institutional barriers that hindered TB services. They included no 
DOT: no TB treatment (if PLTB was unable to comply with DOT requirements, s/he 
was not eligible to start TB treatment under the NTP); inflexible opening hours; 
limited information available on the location of DOTS centres; long waiting hours in 
DOTS clinics; unavailability of basic health care for other minor illness in DOTS 
centres; limited number of care providers in DOTS centres; no facility for follow-up 
sputum examination in some DOTS centres. These barriers particularly prevented 
migrants from accessing TB services from the designated DOTS centres. 
Particularly important among these institutional barriers, were the inconvenient 
opening hours of DOTS centres. The normal working hours of government offices is 
10 am to 5 pm, except Friday, which is 10 am to 1 pm. However, most of the DOTS 
centres opened from 10 am to 2 pm with the exception of a few which opened from 9 
am to 4 pm. The DOTS centres’ opening hours conflicted with the work schedule of 
many PLTB, resulting in difficulties continuing work and treatment simultaneously. 
The unsuitable service hours particularly affected jobholders, job seekers, 
homemakers and women with children: many PLTB fall in such categories. I also 
found that a few PLTB left their job because they had to attend the centre for DOT; 
and some PLTB who wanted to start job could not do so because of inappropriate 
TB services in 
urban area 
Private-for-profit 
sector 
Hospital / Medical 
College 
Pharmacy 
Private practitioners 
Laboratory  
Public Sector 
Central Government 
Central hospital 
Primary Health Centre 
Local Government 
Municipal Urban Health Clinic  
 
 
 
Private not-for-profit  
Sector  
NGOs 
Figure 14: TB services under NTP – an example of urban area 
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opening hours of the DOTS centres. A male respondent who was working as an 
electrician said; 
‘I did not work for two months as I had to come here daily. Now I get week supply, 
even it is not enough as I need to start my work at 6 in the morning and it lasts till 7 in 
the evening.’ 
A young man with TB who left his job because he had to visit the centre daily said; 
‘There should be provision in the programme, either they need to extend service hours 
or supply drugs to patients who are not able to come daily.’ 
I found that migrants who had come to the city for work and were mostly working in 
factories and surviving on daily wages suffered a lot. Most had working hours from 
before 10 am until late in the evening, conflicting with the opening hours of DOTS 
centres: managing time in between was a problem for most if not all. A migrant 
worker with TB said; 
‘My major problem is time as I am obliged to come here leaving my work. It is not 
possible to take two hours leave everyday from my work, need to take whole day off as 
my work is far from this centre. If the centre had opened early I could have taken 
drugs first then go to work but who is going to listen our voice here.’ 
Some PLTB stated that they requested the care providers to open the centre early as 
the majority of people who were receiving TB treatment from the centre wanted it. 
However, the care providers refused their request by citing official policy.  
I found that it was not only opening hours that hindered PLTB: some PLTB also said 
that they needed to spend a considerable time in the centre to be served. Similarly, 
some PLTB said that the DOTS centres did not open on time and sometimes they 
closed early. A student who had taken treatment for one month said; 
‘Every day I come here at 10 am then I go to college but they [the health workers] take 
so long time to give drugs. Once I asked the nurse here to serve me a bit quick but she 
did not like my saying.’ 
Some PLTB said that they had to take the day off from work when they had to go for 
follow-up sputum examinations, as some DOTS centres did not have provision of 
sputum microscopy. Similarly, PLTB were sent to either National TB Centre or other 
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hospitals to seek advice from doctors when they noticed drug side effects: even minor 
side effects were not well managed in the DOTS centres. I also found that PLTB had 
to visit other health care providers for other illnesses, even minor ones. Lack of 
comprehensive delivery of essential health care from DOTS centres caused difficulties 
for many PLTB taking TB treatment, especially for migrants who had limited 
knowledge about other health care providers in the city.  
I found that some PLTB, especially migrants, wanted to be referred to a DOTS centre 
near their village for the course of TB treatment, mainly because they could not afford 
to stay in the city. However, health workers were reluctant to refer them. As PLTB 
stated, at the time of registration for treatment they were strictly scrutinized by health 
workers and asked to commit to completing the entire treatment from the centre where 
the initial registration took place. Because of such conditions, PLTB feared asking 
health workers to be referred to other places. I also found that the health workers were 
not fully aware whether TB drugs were available in the village where PLTB wanted to 
be transferred to, as they did not have a list of DOTS centres providing TB services 
across the country. This issue affected not only PLTB who wanted to be referred: 
PLTB who needed to travel out of the city for a few days also had difficulties, so their 
mobility was restricted due to the complex transfer process in the NTP. In a few 
instances, I found that PLTB were transferred to other centres in their district during 
TB treatment but did not get drugs from the health facility nearest to where they were 
transferred. Although the NTP treatment guideline gave clear procedures for 
transfer/referral during TB treatment, it was poorly managed in practice.  
5.2.5.3 Financial barrier to access TB treatment services 
The poor financial status of PLTB appeared to be a major problem in accessing TB 
services: it was a particular issue among migrants and factory workers who had come 
to the city for economic opportunities. I found that existing poor financial status 
became catastrophic due to the appearance of TB, and consequently many PLTB 
became engulfed in a vicious cycle of abject poverty. Major causes were that many 
PLTB had to pay a lot for TB diagnosis (see section 5.1.5); loss of opportunity costs
14
                                                 
14
The opportunity cost is the cost incurred because of inability to do other activities due to 
TB or the engagement of the PLTB and family members in the TB treatment process. 
This is not restricted only to monetary or financial costs.  
 
many PLTB stated that they had to discontinue their work due to TB; and job loss due 
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to TB resulted in difficulties living and continuing TB treatment in the city especially 
for poor migrants. A health worker working in an NGO-run DOTS centre said; 
‘I have seen many TB patients in this centre who have been facing difficulties to 
continue their treatment. Most of them are factory workers and labourers. Some of 
them left job due to their disease and often tell us that they have problem to pay the 
rent, buy food, travel to the centre and look after their children. Despite such financial 
difficulties they have been taking TB treatment.’ 
Although TB drugs were free of charge in the NTP, managing other costs associated 
with TB treatment such as travel to the DOTS centre, additional food and 
accommodation was an issue for many PLTB. I found that many PLTB had spent a 
considerable sum on travel compared with their monthly income, especially during the 
initial intensive phase (the initial two months) of TB treatment when PLTB had to 
visit the DOTS centre at least six days a week for DOT. A migrant worker told me his 
income was around US$ 70 per month and he spent around US$ 8 in travel for DOT, 
which was around 12 percent of his monthly income. Many other PLTB described 
similar problems regarding travel costs to the DOTS centre. Only a few PLTB lived in 
walking distance of the DOTS centre.  
I also found that some PLTB had difficulties to cover basic costs for other illness such 
as diarrhoea, dysentery, gastritis, fever of unknown cause etc. during the course of TB 
treatment. Although the government had a policy of ‘free health care’ under which 
essential health care services were provided free from government institutions, it was 
not the reality in urban areas as there were insufficient government institutions 
delivering essential health care services. PLTB therefore had to seek care from private 
health care providers even for minor illnesses, which was expensive for many PLTB. 
This placed an additional financial burden on PLTB and their household during the 
TB treatment.    
I found in many cases that TB was not only a disease of one individual in the family: 
rather, it destroyed the entire household financially and put other family members in 
jeopardy. This was mostly observed among migrants who had come to the city to earn 
money and help their family. It was even more devastating when TB attacked the head 
of the household, when all members of the household were affected, especially the 
children who then had to search for a job or accompany their parents in their jobs. The 
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wife of a migrant with TB who started seeking a job once her husband was not able to 
continue work due to TB said; 
‘We had problem to manage our day-to-day life, which became complicated from the 
day he stopped working due to the disease. Since then, I started searching job but I am 
not educated and hard to find a job. My friend helped me and I worked for few days 
and managed some food and travel for him [travel costs for the husband to visit the 
DOTS centre] but there was no work after a few days. I got some work but not 
everyday. When I had no work, many days we lived in absolute dry with no food, we 
had only water to drink. We are adult; we can manage somehow but cannot see 
children suffering. Now my daughter [aged 12] started working as a house cleaner. It 
is not good for her future but instead of keeping her hungry we thought sending her 
for work.’ 
5.2.5.4 Environmental and personal barriers to access TB 
treatment services 
On the environmental context, I found that frequent unplanned strikes in the city, 
largely due to political instability, hindered access to TB treatment, especially to those 
who needed to visit DOTS centres daily during initial intensive phase of TB treatment. 
A man with TB said; 
‘I was in the clinic but it was closed, later I came to know that there was general 
strike and it lasted for four days. I went to a medical hall to buy drugs but I did not 
know which drugs I was taking.’ 
Similarly, I found that the personal habits and behaviours of PLTB influenced their 
TB treatment. Health workers told me that some PLTB often failed to keep 
appointments thus missing some doses of their TB treatment. This often happened for 
alcoholics. I also found that a few PLTB who had a weak social network and support 
from family and friends were poorly motivated to complete their TB treatment. 
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5.2.6 Supervision and patient support: an issue in TB 
treatment 
Supervision and patient support emerged as a key issue in TB treatment as it deeply 
influenced the treatment process and outcome. This section describes various ideas 
that study respondents had on the meaning of supervision and patient support, and 
how and whether it facilitated the successful completion of TB treatment.  
As per the Stop TB strategy, supervision and patient support refers to helping PLTB to 
identify and address issues in TB treatment through developing a partnership and 
mutual understanding between health care providers and PLTB (WHO 2006). 
However, in the study context, the various understandings among NTP officials, 
frontline health workers and PLTB about supervision and patient support contradicted 
each other and the essence of supervision and patient support as envisaged in the Stop 
TB strategy.  
In general, I found that the NTP viewed supervision and patient support as two 
separate elements: ‘supervision’ and ‘patient support’. Supervision was defined as 
supervision of health workers and supervision of PLTB during treatment. Supervision 
of health workers was considered as a routine activity of the NTP where senior 
programme officials supervise their subordinates. Supervision of PLTB was largely 
linked to daily DOT, in which treatment supervisors often asked PLTB what they 
were supposed to do, regardless of their needs and contextual feasibility. I observed 
some instances of supervision at the DOTS centres where NTP officials and district 
supervisors performed their routine supervision. The visits largely focused on cohort 
recording and reporting and verification of TB treatment cards to see whether the 
DOTS centre had been providing DOT to all PLTB. Although the PLTB were present 
in the centre during the time of supervision, supervisors did not have any meaningful 
interaction with them. This clearly showed that the views of PLTB were not taken into 
account during programme supervision, although the NTP supervision checklist 
encourages supervisors to do so. Box 4 presents a summary of the NTP supervision 
checklist; every supervisor should have discussed relevant points with PLTB during 
their supervisory visit to DOTS centre. 
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I found that the NTP considered supervision largely from the clinical aspect of 
treatment management. Although clinical management was important, on its own it 
was inadequate to achieve the desired outcome of successful treatment completion 
without also addressing the social and cultural aspects of the disease and treatment. 
The NTP’s emphasis on clinical management often encouraged health workers to 
control the treatment process rather than facilitating it. Hence, they often overlooked 
other important aspects of the social and behavioural context in treatment management 
which ultimately contributed to creating a distance between the health workers and 
PLTB, and hindered development of trust and good relationships.  
Similarly, the NTP viewed free diagnosis and free drugs in the programme as 
sufficient means of patient support. The provision of free TB drugs was welcomed by 
a majority of PLTB. However, it was evident that they had to pay a considerable sum 
for diagnosis (see section 5.1.5), treatment and unnecessary additions such as 
vitamins, other investigations (e.g. routine blood tests), which was difficult for many 
PLTB. Moreover, I found that the PLTB linked the free drugs with DOT, as they 
thought that the DOT was compulsory because the programme provided free drugs to 
them.  
[This box presents on the patient section in the NTP supervision checklist] 
Interview with patients 
- Distance of the treatment centre from home  
- Attitude of family member/community people having TB 
- Awareness of treatment and medicine 
- Time between the first symptom and contact with the health services 
- How long between the first contact with the health services and diagnosis 
- Family history of TB patient 
- The types and colour of prescribed drugs 
- The duration of the treatment 
- Common side effects of drugs 
- The importance of directly observed treatment 
- Any payment for treatment  
- Any home visit by the health workers 
- The importance of sputum examination  
- Does anyone observe them taking their medicine 
- Which disease were they suffering from? 
Source: NTP supervision checklist 
Box 4: Summary NTP supervision checklist 
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It was clear that the understanding of supervision and patient support varied. The 
PLTB had relatively little power so simply followed instructions, whereas health 
workers were in control and regulated the entire treatment, often without providing 
facilitation and support to PLTB. However, neither was the NTP able to convince the 
PLTB what the treatment supervision meant in the programme, nor could the PLTB 
challenge the NTP despite mounting difficulties posed by inappropriate policy 
regarding their treatment, especially mandatory DOT. Taking into account the views 
of the NTP officials and health workers and the PLTB, it was clear that the 
‘supervision and support’ component was ill-defined in the NTP. Moreover, the 
NTP’s perception of DOT and availability of free anti-tuberculosis drugs as sufficient 
supervision and patient support was limiting and eventually, in several instances, it 
failed to facilitate treatment thereby negatively affecting the treatment process.  
I found that DOT had enormous implications for defining supervision and patient 
support during TB treatment. Understanding and implementation of the DOT policy 
varied between NTP officials, health workers and PLTB, as some DOTS centres 
applied it as per the NTP policy and some applied a degree of flexibility. However, 
DOT was seen by many PLTB as a major barrier to continuing TB treatment. In 
subsequent sections, I analyse and discuss DOT with a focus on its implementation, 
acceptance, convenience, and whether and how it helped or hindered successful 
treatment completion in the local context. In doing so I consider the views expressed 
by the NTP authorities, front line health workers and PLTB.  
5.2.6.1 NTP’s guideline and views on DOT 
The NTP’s long term plan states that TB diagnosis and treatment services should be 
fully integrated into general health services and all PLTB taking rifampicin should 
receive DOT (NTP, 2004). DOT was therefore regarded as a major operational policy 
of NTP, and was considered an adequate tool for both treatment supervision and 
patient support. A NTP official said; 
‘DOT is to ensure that patients take drugs regularly thus applicable to all TB patients 
at least during the initial two months of TB treatment.’ 
Figure 15 presents the NTP guideline on implementing DOT in the programme. 
Hospitalization of PLTB for DOT is the first option, but was not applicable in the 
study area, as the majority of DOTS centres did not have in-patient facilities and 
hospitalisation was not deemed a requirement for the majority of PLTB. Talking to 
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NTP officials, I found that the NTP never encouraged hospitalization of PLTB unless 
the person was seriously ill and required treatment in hospital. A NTP official said.  
‘NTP does not encourage health workers to admit TB patients for DOT which is not 
the programme’s strategy. It is in the guideline just to make sure that seriously ill 
patients get admitted in the hospitals.’ 
However, the instructions in the NTP guideline and understanding among NTP 
officials and health workers were contradictory. My observation was that since 
implementation of DOTS, I did not find PLTB hospitalized for DOT, except in a few 
in rural areas.  
The second option in the guidelines was DOT by health worker, under which PLTBs 
had to visit a health facility. Following the guideline, health workers stated that they 
ask all PLTB to attend the DOTS centres on a daily basis (except holidays and 
weekends) during the initial two months, after which they supply drugs for a week. A 
majority of PLTB were treated under this option.  
The guidelines further state that, if a PLTB had problems visiting the DOTS centre for 
DOT, the health workers should identify a trained person in the community and start 
treatment under direct supervision. However, I found that health workers were unclear 
what ‘trained person in the community’ meant, as no such people were identified. In 
this situation, health workers assumed that the ‘trained people’ could be community 
volunteers; but I did not find any PLTB receiving DOT by community volunteers in 
the study area. A health worker said; 
‘We do not have people in community trained as treatment supervisor except some TB 
volunteers who generally used for late patient tracing but not as DOT provider.’ 
The last option given in the guidelines was to identify a reliable person and provide 
them with training as a treatment supervisor, and then administer treatment through 
the trained person. I found this option was rarely used, because the programme had 
not clearly defined what type of person was seen by the NTP as ‘reliable’; how the 
person could be identified and trained; the role of the trained person in treatment; how 
the treatment should be observed and where; who should be accountable to whom; 
how long drugs could be supplied to the trained person; who should come to collect 
the drugs from the centre to give to the supervisor; and how long the trained person 
should supervise the treatment. I therefore found that health workers were not sure 
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how to identify a treatment supervisor. When I asked health workers how they 
managed PLTB who had problems attending daily DOT at the centre, many said that 
they simply asked PLTB to manage daily visits to the centre despite their difficulties. 
A health worker said; 
‘We have many people who cited difficulties in visiting the centre every day but we ask 
them to manage visits for their treatment. We face problem to start treatment for such 
cases but the guideline is not clear how we should be managing such patients and they 
are many.’ 
The health workers stated that finding a reliable person other than a family member of 
PLTB was difficult in their settings but the programme did not encourage them to use 
family members as treatment supporter.  
Although I did not find a clear statement in the programme guidelines which 
prohibited using a family member as treatment supervisor, my discussions with NTP 
officials and frontline health workers clearly revealed that the use of the family 
members as treatment supervisor was not considered appropriate by the NTP, as it 
always promoted institutional DOT and unofficial communication from the NTP 
authorities on various occasions (e.g. during supervision and reporting and planning 
meetings) discouraged the use of family members as treatment supervisor despite a 
large number of PLTB saying visiting the centre for daily was a problem hindering 
their treatment. This unofficial policy not only created additional difficulties for PLTB 
but also failed to make the most of the opportunities created by engaging family 
members in treatment process. Such notions and practice in the NTP contradicted the 
provision made in the Stop TB Strategy that DOT could be done at home, which 
meant a reliable family member could supervise treatment at home.  
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Can patient be hospitalized 
during intensive phase? 
Can patient visit DOTS 
centre daily? 
If patient is unable to 
visit daily to the DOTS 
centre for any reason  
Admit in hospital and start 
DOT 
1. Start treatment under DOT 
by health worker 
2. Ask patient to come 
everyday to DOTS centre 
3. Supply drugs for weekend 
and public holidays 
Is there any trained person 
in the community? 
Start treatment under DOT 
by the trained person in 
community 
Identify a reliable 
person as treatment 
supervisor and train the 
person as DOT provider 
Start treatment under 
DOT by the trained person 
Yes 
No 
Yes 
No 
Yes 
No 
Figure 15: NTP guideline to identify DOT provider 
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5.2.6.2 DOT: views of frontline health workers 
The previous section described NTP’s guidelines on DOT. Although frontline health 
workers are also part of the programme, in this section I present their views separately 
because, in some instances, I found policy and practice were confused or contradicted. 
The illustrations in this section were derived from my conversation with frontline 
health workers working in various DOTS centres (government, non-government and 
private). I found in my initial conversations that people were disinclined to express 
critical opinions about the DOT policy, although it was obvious they had some 
reservations. However, after several discussions, they opened up and elaborated on 
their experiences. I have anonymised the illustrations as the respondents did not want 
to be identified when being critical about the DOT policy.  
As briefly discussed above, there were two different views among frontline health 
workers on DOT linked to supervision and patient support: DOT was a sufficient 
means of treatment supervision thus should be provided for all PLTB; and DOT could 
be a means of treatment supervision but should be implemented with a degree of 
flexibility depending on the context of the PLTB. These views contradicted so 
implementation differed.  
Some frontline health workers perceived that the success of the NTP was largely due 
to DOT (i.e. institutional DOT supervised by health workers), so that DOT was seen 
as the cause of success of the DOTS strategy as the other components of DOTS were 
ignored. As some frontline health workers stated;  
‘DOT is a national policy therefore it should be implemented to all TB patients.’ 
‘TB patients do not take drugs if supplied to them at home thus DOT is essential.’ 
‘Today DOTS is successful because of DOT. If had no DOT, DOTS would not have 
achieved high success.’ 
Although the NTP adopted the ISTC and showed commitment to implementing it 
nationwide, I found the standards for TB treatment were barely considered when it 
came to implementing DOT. ISTC standard nine clearly states the need to establish a 
patient-centred approach in TB treatment through understanding the needs of PLTB 
and tailoring TB treatment to individual circumstances; but I found that the NTP had 
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not communicated this ISTC standard to health workers or ensured effective 
implementation of a patient-centred approach in TB treatment.   
‘As a person, I disagree with the DOT policy. I would not accept it if I were a TB 
patient because it undermines patients and simply increases other problems such as 
travelling everyday to the centre and increased cost. I think we are becoming 
irresponsible to patients’ needs and problems by forcing them to visit the centre daily 
but as a health worker we are bound to follow the government policy.’ 
‘DOT may be required for some patients but not for all. I feel embarrassed to force 
patients to come everyday after knowing their problems.’ 
‘DOT is a national policy and the programme demands strict implementation but it is 
unwise to think that all TB patients can adhere to it, as TB patients have several other 
issues and the programme should consider them if the success of the programme need 
to sustain.’ 
‘The DOT at health facility restricted many TB patients to commence their treatment 
under DOTS. We the health workers face problems implementing it because of 
inappropriately designed policy.’ 
‘We understand the DOT policy and ask patients to come every day but they raise 
many questions and ask drugs at least for a week citing their problems. It is difficult 
implementing DOT to all TB patients.’ 
‘I think the NTP communicated DOT as the important component of DOTS thus there 
is big emphasis on DOT among us [health workers]. The increased emphasis on DOT 
actually deterred the other important components such as sputum microscopy and 
drug supply. Similarly, coordination among DOTS centres is another issue but these 
are less discussed in the four-monthly programme meeting.’ 
These illustrations clearly show that some health workers had disagreements with the 
blanket provision of institutional DOT for all PLTB. However, these disagreements 
were rarely raised in public. Some felt compelled to follow the DOT policy despite 
difficulties and infeasibility for the great majority of PLTB.  
In contrast, some health workers stated that DOT was important but it should be 
tailored to the needs of PLTB, and implementation required exploring a full range of 
alternative options that were acceptable to the PLTB. I found that a few frontline 
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health workers implemented a flexible approach to DOT taking the context into 
account. Some health workers supplied TB drugs for a week to fifteen days even 
during the initial two months. They did so after a few weeks of treatment when the 
health worker and the PLTB started to get to know each other and developed a level of 
trust between them. I also found that they engaged family member of PLTB to ensure 
the PLTB took the drugs regularly. The health workers strongly believed that this 
flexibility helped PLTB in their treatment, and as a result PLTB continued treatment 
supported by good relationships and an atmosphere of trust. I also found that some 
health workers provided some financial support to a few PLTB using money from 
their own pocket to provide food, cost for travel, clothes etc. However, these were 
individual initiatives, as I did not find such practices across the programme. However, 
the practice of flexible DOT and individual support provided to PLTB was not 
officially documented. A health worker said; 
‘Although it was intensive phase [initial two months of treatment], I supplied drugs for 
a week to ten days as some patients were unable visit daily. If drugs had not been 
provided, they would have problem to manage their work and treatment.’ 
Some care providers did not like DOT at all because it increased their workload. They 
stated that their job had become difficult since the institution started DOTS, as they 
were supervising several PLTB, so daily DOT resulted in them having more work and 
needing to stay for longer hours at the centre. Consequently, some health workers did 
not implement the DOT policy.  
‘The increased number of TB cases every year resulted more work to us but number of 
staff remained the same. If we call all TB patients daily we cannot manage them so we 
provide drugs weekly. It reduced our workload and may have helped TB patients.’ 
When asked whether the increased caseload of PLTB in their centre was due to the 
flexibility in DOT implementation that they practiced, the health workers did not 
disagree. They also stated that there were other DOTS centres that also supplied drugs 
to PLTB on a weekly basis but would not discuss the practice publicly.  
I also found that some health workers were unsatisfied with the NTP and its officials, 
as some health workers in the study area stated that they were not receiving adequate 
support from the NTP and opportunities were not provided to frontline health workers. 
Some of them felt exploited as acknowledgement of their contribution in DOTS was 
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not linked to other benefits such as higher-level training, international visit, incentives 
etc. As a result, health workers did not implement the DOT policy to indicate their 
dissatisfaction to the NTP.  
‘We do the hard work in the field and people at National TB Centre enjoy all benefits 
of the programme, when opportunity arise we do not get informed.’ 
I found that some health workers did not feel comfortable implementing DOT due to 
lack of basic infrastructure at the centre. For instance, they stated that lack of a water 
supply in the centre made them embarrassed to ask PLTB to visit daily for DOT. I also 
observed that at some centres PLTB had to bring their own water as there was no 
provision of drinking water. PLTB also complained about lack of drinking water in 
the centres. 
Some health workers stated that DOT was not easy to deliver to all PLTB as their 
contexts were different. They said that the people who need to go to work were the 
ones who often had problems complying with the requirement for DOT. They also 
said that if DOT is required for PLTB, it could be implemented in several ways and 
the programme was not exploring other ways of supervising TB treatment. They had 
raised the issue of the difficulties with DOT in their four-monthly meeting but did not 
get a clear answer from the NTP officials. Given this situation they thought that they 
could apply some flexibility taking the local context into account. However, they also 
blamed the NTP for not being clear on the issues they raised.  
‘It is difficult for us to implement the DOT as it stands because in the clinic we face 
lots of questions from TB patients and it is true that many of them are genuine as they 
have problems. I raised this issue with the NTP but they simply asked to implement 
DOT citing the policy document. They were not very clear when I said the 
implementation of the policy was an issue. Since then I look at the patient and do as 
appropriate to them.’ 
 ‘I heard that family members can be a treatment supervisor but the programme does 
not talk about it thus not sure whether it can be considered.’ 
When I asked health workers about alternative ways of ensuring DOT, most stated 
that family members of PLTB could be used as a treatment supporter at home. They 
recommended use of family member as DOT provider because the family 
accompanied the PLTB during their treatment; they often visited the DOTS centre to 
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collect TB drugs; and some family members had regular discussions with health 
workers and showed their concerns. Health workers thought the family members 
could do a good job of supervision if they were properly informed of the importance 
of taking regular treatment. When asked whether family members could be considered 
as treatment supervisors, health workers said; 
‘They are the one we should trust because they are member of their family.’ 
‘We cannot ignore their role in treatment.’ 
‘If I had TB I would expect the same, to be looked after by my family member.’ 
‘It is important that we need to monitor them [the family member] effectively. We need 
to change the training manuals and have more information on how to use the family 
members to make sure that they do the business as a responsible person.’ 
‘There are several other problems every family faces these days such as financial, 
social, unemployment and when a person diagnosed with TB it is a pain in the family 
but we are bound to follow the policy which restricts to supply drugs. I think we 
require to change our approach and use family members in TB treatment.’ 
The above illustrations clearly indicate that the health workers acknowledge the 
potential role of family members as potential treatment supporters. However, health 
workers commented on a lack of clear policy on the use of family members as 
treatment supporters. Despite this, a few health workers stated that they had been 
using family members of PLTB as treatment supervisor.  
‘It was not possible for some TB patients to visit the centre on a daily basis. I asked 
patients to bring their family member and I supplied drugs for a week. They have been 
taking care of patients and had not missed a single dose of treatment.’ 
‘I believe on practical things. We, the field worker, know better than the NTC people 
as we interact with TB patients everyday. It is true that many TB patients have 
problem to visit daily this I supplied TB drugs after explaining all procedures to their 
family member, mostly head of household as I found they were trustworthy.’ 
‘It was nonsense not to use family members in TB treatment process as I found they 
were very concerned and always worried about their beloved.’ 
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In contrast, some NTP officials and health workers were of the opinion that using 
family members as treatment supervisors instead of a person accountable to the health 
system would jeopardise the current achievements of the NTP in achieving high 
treatment success rates. In a question about engaging family members of PLTB in 
treatment they said; 
‘Before we had DOTS, the programme used to supply TB drugs to patients and result 
was not good, many TB patients stopped taking treatment. But it is not the case since 
the programme introduced DOTS. The DOT provided by the health workers is the way 
to achieve the success in TB control.’ 
‘The family members can be involved in the treatment but giving responsibility to 
supervise everyday treatment at home would ruin the success of the programme.’ 
‘In our culture family is important but they do not watch actual drug taking. Since TB 
patient need to take many tablets at once, sometime they do not take all which can be 
dangerous for them and develop resistant to drugs.’ 
‘Out past experience tells that using family member as DOT provider will increase 
default rate and may invite drug resistant TB.’ 
However, before DOTS the programme did not have adequate focus on providing 
appropriate guidance, training and supervision to the family members of PLTB when 
the drugs were supplied to them, so that comparisons before and after DOTS may be 
misleading. Nevertheless, some officials still hold traditional thoughts when it comes 
to using family members as treatment supporters.  
Similarly, some people were of the opinion that, instead of family members, the 
programme should involve community volunteers as treatment supervisors. Some 
stated that the TB is deeply rooted in the community and myths about TB had put 
PLTB in difficulties, so the use of community volunteers could not only help PLTB 
continue treatment but also help address unsocial behaviour towards PLTB. In 
contrast, some care providers stated that although using community members as DOT 
supervisors was a good idea, it would not be sustainable.   
‘People are busy always and most of them search for paid work these days. 
Community people can volunteer on certain occasion but DOT provider requires 
everyday task and volunteer will not do this role without money.’ 
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Considering the views of the frontline health workers I found that institutional DOT 
was controversial, as it was impractical for many PLTB in the local context, but 
programme policy enforced its implementation. Similarly, health workers experienced 
difficulties due to lack of clarity by the programme on the use of people other than 
health workers as treatment supervisors, especially the family members of PLTB. 
However, despite being bewildered due to obscure explanations about DOT, some 
health workers applied a degree of flexibility and engaged family members as 
treatment supporters. However, some health workers and NTP officials were 
unsympathetic to using family members as treatment supervisors and were concerned 
that the achievement of NTP would be limited.    
5.2.6.3 DOT: views of people with tuberculosis 
In this section, I analyse views of PLTB and their family members on institutional 
DOT and its convenience or otherwise in TB treatment. PLTB and their family 
members often used phrases such as the following when expressing their experiences 
with DOT: an obligation; a non-negotiable option; an imposed task; an additional 
burden; no obvious reason for it; a symbol of lack of trust; no choice; an act inflating 
the costs of care; the health system’s negligence of their needs; the health system’s 
control in treatment; unsympathetic to PLTB. Many other terms were also used which 
reflected PLTBs’ concerns that DOT was burdensome for them and greatly affected 
their treatment continuation. Below I looked at some specific areas in order to gain an 
in-depth understanding on the impact of DOT on PLTB and their treatment. 
• Lack of clarity on DOT requirement in TB treatment  
I found that almost all PLTB were unclear why DOT was required. Although PLTB 
were adhering to DOT requirements, they were unaware why they had to do it, which 
made them dissatisfied. It was clear that the reason for DOT was not fully explained to 
PLTB. Despite a lack of clarity on why DOT was mandatory in TB treatment, the 
programme expected all PLTB to comply with its requirements irrespective of the 
difficulties it caused PLTB. I found that many PLTB regarded DOT as a indication of 
the health system’s lack of trust in them. This further contributed to creating a distance 
between health workers and PLTB. A migrant worker with TB who was continuing 
his second month of treatment said; 
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‘Health workers said it [DOT] is a policy thus we need to comply....what kind of 
policy is this which complicates life of a patient who is facing a lot of trouble 
already....this is nothing other than no trust of health workers on patients.’ 
• DOT was a compromise for free treatment 
I found that a majority of PLTB thought that DOT was imposed on them because the 
drugs were given free of charge. PLTB considered it as non-negotiable if they took 
treatment under the programme. PLTB often said that DOT was a burden they had to 
undergo to obtain free TB drugs. A migrant worker with TB recently completed his 
two months treatment said; 
‘I could have taken drugs at home if I had been given. Despite problems I had to come 
to this centre daily because I had no other options as I could not afford to buy drugs 
in private.’ 
I found that by the time PLTB started treatment they had faced several other problems, 
which often made them socially, psychologically and economically vulnerable. In 
addition, the severity of the disease made them physically and mentally very weak. 
Many of them said that they wanted to start treatment as early as possible after their 
diagnosis, so they accepted DOT without realizing the difficulties it might cause 
during the treatment process. A migrant man with TB described his experience thus; 
‘When I came here [the DOTS centre], the very first day, he [the health worker] asked 
whether I can come daily to the centre. I simply accepted it as I wanted to start my 
treatment. After two weeks I had difficulties to continue everyday visit and requested 
drugs for few days so I could do other things and seek some light job but he [the 
health worker] did not give drugs. I have no other choice and managing my treatment 
anyhow up to this point.’ 
• DOT an additional burden to PLTB  
The DOT requirement in TB treatment compelled some PLTB to leave their job, and 
consequently their financial conditions worsened, making them more vulnerable to 
discontinuing their treatment. A man who had completed two months DOT said; 
‘At the beginning health worker asked me to come everyday for initial two months. I 
felt it would be difficult then I asked the doctor right there to arrange me giving 
medicines for a week or 15 days. He told me that he couldn’t give me drugs then I 
discontinued my job for treatment, since then my financial problem has increased. The 
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company hired another person in my position and now I am not finding any job. I 
regret why I left my job.’ 
Some PLTB found that DOT was manageable at the start of treatment. They simply 
accepted it because their priority was to recover from the disease. As treatment 
progressed, people started feeling better and wanted to resume their work. Then they 
realized that coming every day to the centre interfered with their ability to work, and 
wanted drugs to be supplied to them. A respondent said; 
‘It has been a month I am having treatment. I want to start my work but cannot do so 
because I need to come here daily for another month. I do not want to discontinue my 
treatment even a single day but I am not sure how I can continue my treatment without 
earning money. I am in problem.’ 
Similarly, another respondent who had been taking treatment for one month said; 
‘I used to work for a trekking agency which I stopped due to this disease [TB] as I was 
very serious and coughing all time. Now I have recovered and want to go back to 
work but the doctor asked me not to go to work as I need to come here every day.’ 
• DOT and increased vulnerability  
I found that DOT was a difficult choice for many PLTB, especially migrants, daily 
labourers and women. In many instances, it increased vulnerability of PLTB and their 
family, because daily travel to the centre for DOT was such a problem. Although 
travel distances varied, some PLTB had to travel a long distance every day. Some 
PLTB said that the DOTS centre and their workplace were in opposite directions and 
continuing DOT and getting to work on time was a matter of concern. The long travel 
distance meant they had to use public transport, which they needed to pay for every 
day and the costs increased their economic vulnerability, particularly for those who 
had lost their job due to TB and had no other income. Similarly, some PLTB said that 
they had difficulties accessing daily DOT at the centre due to their physical weakness.  
Women with TB were vulnerable in many ways, because they had to take care of 
other tasks at home and thus faced difficulties finding time for DOT. I found that they 
had to compromise with other work in order to allocate time to visit the centre. 
Women often stated in interviews that DOT affected not only them but also other 
members of the family, especially their children, because women had to visit the 
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centre every day and could not give time to their children. I also found that sometime 
children were used for collecting drugs for their parents. A woman respondent said; 
‘I don’t want coming here everyday anymore. For this [DOT] I need to leave other 
things. I have other things to do, I need to prepare my children for school, need to go 
to vegetable market, buy vegetables, and sell them. Then I have to carry other 
household activities, which makes my day busy. Before I was very ill and was not able 
to do all work but now I need to work to survive but not able to sell vegetables for 
long time because I need to come to this centre.’ 
Women with small children had more problems coming to the centre every day, as 
they had to find a carer for their children while they visited the centre. This was 
especially true among migrant families with only two adults, husband and wife, one of 
whom was working. Finding a carer was not easy and taking the children every day to 
the centre was problem as the PLTB were physically weak and often worried whether 
their children would catch TB.  
‘The health worker asked me to come here everyday but I have no other caretaker at 
home. It is difficult for me leaving child alone at the time of visiting DOTS centre. 
Sometime I leave her with my neighbours but often I carry her.’ 
Another woman who had been taking treatment for two months said; ‘I have a small 
child and faced difficulties visiting this centre due to nobody at home to look after my 
child when I need to come for drugs. I used to leave my child at the working place of 
my husband at the time of visiting treatment centre but it was difficult to do so 
everyday.’ 
Similarly, a woman who was a local resident of the city who had been taking 
treatment for one month said; ‘On the one hand I need to go for work and other hand I 
need to fulfil the daily household work and look after my children and their basic 
needs.’ 
In various cases, I found that the vulnerability created by DOT was addressed with the 
help of family members and friends of PLTB. The support PLTB had from family 
members and friends PLTB made a great contribution in helping to continue TB 
treatment.  
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5.2.7 TB treatment therapy related 
I found that PLTB often complained about the long duration of TB treatment. 
Problems were exacerbated when the programme gave only a week’s supply of TB 
drugs even during continuation phase, as PLTB needed to make frequent visits to the 
DOTS centres and increased the costs of care, especially travel costs. It also restricted 
PLTBs’ mobility, which was problematic, because some of them needed to travel 
away from home during their treatment. Although the NTP reduced the treatment 
duration (switching from eight to six month treatment regimen) during the study 
period, the long duration of treatment and weekly supply of TB drugs remained an 
issue for PLTB. Similarly, many PLTB complained about the requirement to take 
multiple drugs together.  
A majority of PLTB also reported side effects of TB drugs which added further 
complexity to their TB treatment. The most commonly reported side effects were joint 
pain, anorexia, nausea, abdominal pain, and burning sensations. These were classified 
as minor side effects by the NTP. Some PLTB spoke to health workers about these 
side effects, but not all received a good response or symptom management, and 
became worried. A few PLTB also reported jaundice, dizziness, loss of hearing, and 
skin rashes, symptoms which the NTP classified as major side effects which required 
immediate attention. According to NTP treatment guidelines, PLTB with major side 
effects should stop TB drugs and seek specialist care. I found that all PLTB who 
reported side effects could not differentiate whether their side effect was minor or 
major, causing them distress. A majority of PLTB stated that they notified their 
problem to health workers. However, in many instances the health workers did not pay 
sufficient attention to manage the problems that the PLTB reported. Consequently, the 
problem became worse and in some cases PLTB stopped taking TB drugs. Because of 
this inadequate management at the DOTS centre, some PLTB sought help from other 
care providers, which had cost implication for the PLTB. A woman with TB who 
suffered from dizziness during her third month of TB treatment said; 
‘I was not able to balance my body, my head was spinning all the time. I reported to 
the nurse but she said it was a minor problem and will go away after a week. I waited 
a week, instead of healing it got worse. Again, the nurse told me to take drugs after 
meal and said I will be fine after a week. My problem got worse and I stopped taking 
drugs. After two weeks, my husband took me to a private doctor and the doctor gave 
drugs. Now I’m fine but worried that I stopped drugs for two weeks.’ 
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I also found that the side effects of drugs were not known by some PLTB, mainly 
factory workers. 
PLTB also stated that their appetite increased once they started TB treatment: lack of 
food and inability to buy food was an issue for them, especially poor people who even 
in normal circumstances had problems managing to get basic food for themselves and 
their household. Similarly, health workers often asked PLTB to take drugs on an 
empty stomach but TB centres opened normally at 10 am, so not eating before they 
came for DOT was an issue. Moreover, for some PLTB, taking TB drugs on an empty 
stomach caused abdominal problems.  
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5.3 Organisation of TB service delivery in the study area 
This section provides an understanding on how TB services under the NTP were 
being delivered and synchronized over the study period in the study area as 
response to the problems and issues. I have structured this section in line within 
the relevant components of the DOTS framework and relevant elements of the new 
Stop TB strategy. However, the new strategy was not fully matured in its 
operational form in the NTP despite almost four years of official endorsement. The 
section also presents responses to the problems and issues identified during TB 
treatment from PLTBs and their family and community members. There are of 
course substantial overlap and interaction between these factors. 
5.3.1 Commitment and partnership for TB service  
5.3.1.1 Commitment 
‘Commitment’ was a component of DOTS that was commonly cited in interviews, 
especially by NTP officials and health care providers. However, its meaning and 
interpretation varied. Most respondents stated that ‘commitment’ in DOTS applied 
only to the ‘higher level’: that is, to government commitment to the NTP in 
implementing the DOTS strategy. Only a few respondents said that it was equally 
important to secure commitment from programme implementers; frontline health 
workers; PLTB and their family members, and community members.  
Government commitment was clear, since TB control is one of the priority 
programmes of the Ministry of Health and Population (MoHP). The majority of 
respondents stated that one of the indications of government commitment to TB 
control was allocation of resources to the NTP. I found that the urban TB programme 
was grossly under-resourced. For example, the study area was the biggest urban area 
of Nepal, where the TB burden was almost four times the national average. In the last 
three years, it had 10% to 12% of the total TB cases registered in the NTP, whereas 
resource allocation was less than 1% of the total NTP budget (see Table 15). In 
addition, within the resources allocated to urban TB control the domestic contribution 
was negligible. Thus government commitment in terms of resource allocation was not 
enough to advance TB service delivery in urban area. A senior official of the 
municipality said; 
211 
 
‘Inadequate resources to the urban TB programme raise a big question on 
government’s commitment. Urban TB control programme should be considered as a 
top priority with adequate allocation of resources otherwise the commitment remains 
in words only.’ 
Fiscal Year NTP Total  Kathmandu and Lalitpur (study 
districts) 
Total budget 
(US$ million) 
Total registered 
cases (National) 
Percentage of 
total NTP budget 
Percentage of 
total registered 
cases 
 2066/67  6.2 35111 0.83% 12% 
 2065/66 3.2 35407 0.93% 11% 
 2064/65 2.6 33419 0.90% 10% 
 2063/64 2.7 33439 0.66% 11% 
Source: data compiled from National TB Centre annual source book 
Commitment to DOTS at the service delivery level varied. In general, it was found to 
be weak, both at organisational and individual levels. Many respondents, especially 
frontline health workers, did not see the relevance to themselves of the word 
‘commitment’, as they generally assumed it referred the higher level. Such 
understanding could weaken service delivery at local level. A frontline health service 
provider said; 
‘We are simply here to deliver services. Commitment should be at the higher level to 
make TB control effective.’ 
However, some respondents stated that individuals need to have ‘commitment’ 
towards their responsibilities: only then could DOTS be effectively implemented. A 
district official said; ‘I think we all need strong commitment to make DOTS a success.’ 
Although people acknowledged difficulties in delivering commitments, in the 
meantime they thought it would help overcome difficulties if individual and service 
delivery institutions knew and had strong commitment to their responsibilities. In an 
urban TB control stakeholders meeting, a senior NTP official said; 
‘Urban TB control is a shared responsibility and all stakeholders should have strong 
commitment to make the services available to people in need.’ 
Table 15:  Budget allocation and burden of TB in the study area 
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Nonetheless, it was found that the tendency of referring to commitment as the 
responsibility only of higher levels was an issue, as it distanced people from their 
responsibility of delivering effective services. This tendency had implications 
regarding creating an environment that was conducive to PLTB to successfully 
complete treatment.  
Likewise, community commitment to DOTS varied, as it was largely associated with 
individual DOTS centres’ initiatives in engaging the community in DOTS. DOTS 
Committees were formed, but were inactive in many places. According to DOTS 
centre staff and district health officials, community support to TB control was difficult 
in urban settings due to the complex composition of urban communities. However, 
this was not the case in all DOTS centres, as some urban DOTS centres recruited late 
patient tracer volunteers who were active in helping TB service delivery and PLTB. A 
volunteer said; 
‘I come here [DOTS centre] everyday for two hours and help drug distribution and 
patients. I go for home visit if some patient do not turn for drugs.’ 
Partnership and coordination 
Partnership for TB service delivery in the urban areas was initiated by the NTP under 
the name of ‘Kathmandu Valley Collation Against TB (KV-CAT)’ with the aim of 
engaging various health care providers in urban TB control. However, some 
respondents believed that KV-CAT could not survive long as it suffered a lack of 
leadership, undefined roles and responsibilities among stakeholders, inadequate 
resources and a lack of collective responses to the issues. However, it instigated a 
momentum in urban TB; in particular, it helped bring public sector providers together 
in one forum. A senior official of NTP said; 
‘TB control in urban area was organised with establishment of KV-CAT. 
Unfortunately, it failed to continue as urban area is complex in many ways thus 
controlling TB requires a greater effort with a sustained partnership from all 
concerned.’ 
Consequently, a public-private partnership (PPP) model for TB was developed, based 
on a PPP initiated in Lalitpur urban area, which demonstrated high treatment success 
rates over several years. However, according to NTP officials, scale up of the model 
was constrained due to lack of adequate resources and a well-designed, costed action 
plan of TB services for urban areas. Despite these constraints, a degree of partnership 
in TB service expansion has been observed in the last few years in the study area. 
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About forty organisations, a small proportion of the total health service providers in 
the area, have been providing TB services in partnership with the NTP. They include 
government-run health facilities; private-for-profit providers such as private hospitals, 
nursing homes, polyclinics and private pharmacies; urban health clinics run by local 
government municipalities; private not-for-profit; and some faith-based organisations. 
I found that a range of TB services was provided depending on the nature of 
institutions and their capacity. A senior NTP official said; 
‘In the last few years with support from various organisations we have managed to 
expand DOTS in urban area. We have good example of partnership and we plan to 
expand further under the new funding arrangement.’ 
I found that coordination among and between the DOTS centres was relatively weak. 
It was unclear who was responsible to enhance coordination in the urban TB 
programme, so most stakeholders seemed to be working independently with relatively 
little coordination with each other. This was an issue highlighted by health service 
providers including district and municipal health authorities, indicating that 
coordination suffered due to undefined roles and responsibilities of stakeholders and 
inadequate resources. It also affected access to services in the programme. A district 
health official said; 
‘Coordinating DOTS centres in urban area is a big task for us because various 
stakeholders have their own institutional boundaries. Sometime difficult to fit with 
each other but we keep on saying that making it [urban TB control] a success is 
responsibility of all.’ 
Although a level of commitment among stakeholders was found, functional 
partnership and coordination in delivering TB services in urban areas was constrained 
due to inadequate resources and unclear roles and responsibility, which was further 
challenged due to the complexity of the urban setting. Such constraints have limited 
programme ability in many ways. Along with institutional commitment, it was also 
found important to secure individual commitments for effective implementation of TB 
services. However, despite insufficiencies, the NTP had made efforts to secure long-
term commitment in the urban TB programme by engaging various service providers.      
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5.3.2 TB service delivery in urban area 
In urban areas, basic health service delivery had relatively weak foundations in the 
public sector. Although the primary health care approach was the main focus of the 
National Health Policy, it was poorly existed in urban areas as there was no defined 
urban health strategy. Access to basic health care including TB services was therefore 
limited, particularly for the urban poor. In addition, I found other complexities in 
urban settings such as multiple health service providers including a large and 
unregulated private sector; multiple users ranging from the rich to the poorest of the 
poor; a rapidly growing urban population and increased unplanned urban settlements 
such as slums; growing social inequalities, and; unhealthy lifestyles among urban 
dwellers.  
I found that within the government framework there was a lack of policy clarity on 
who was responsible – the Ministry of Health or the Municipality – to ensure basic 
health services in urban areas, an issue poorly discussed in policy documents. As a 
consequence, basic health care including TB treatment service delivery was affected.  
District health officials – government employees – stated that because of a lack of 
clear roles and responsibility regarding health service delivery in urban areas, they 
found it difficult to expand TB treatment services to cater the needs of the people. An 
official said;  
‘In rural area we have an established health care network whereas in urban areas we 
lack such provision. Most importantly, there is less clarity on institutional 
responsibility to provide basic health care including TB in urban area.’ 
The study findings make it clear that there is a need for expansion of DOTS as access 
to services constantly emerged as a major barrier among PLTB, only not limiting 
service utilisation but increasing the cost of TB care, thereby affecting treatment 
continuation (see section 5.2.5). However, I found that the district health authorities 
were concerned about their increased workload and said that they were having 
problems maintaining regular supervision and supplies to existing DOTS centres. 
District health officials revealed that they were concerned about the quality of TB 
treatment in the absence of proper supervision and support to DOTS centres. 
Moreover, increasing workloads of district health officials had led to very slow 
expansion of DOTS centres.  
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It was evident that rapid urbanisation in the study area resulted an increased number of 
slum dwellers, factory workers and homeless people, who were often vulnerable to ill 
health. However, the organisation of TB service delivery under the DOTS framework 
was designed to address the need of the general population and had no focus on 
groups vulnerable to TB such as slum dwellers, factory workers, migrants, homeless 
people, internally displaced people and daily wage labourers. I did not find any 
specific attempt by the NTP to reach these groups apart from some sporadic awareness 
activities.  
Consideration of existing TB service delivery in the study area showed that the 
implementation of the DOTS strategy there was not tailored to the local context. The 
TB service delivery structure used a general approach, which ignored socioeconomic 
and other contextual aspects of society. I found that DOTS services were unequally 
distributed; as a result, many poor people faced difficulties. Although it has been 
nearly four years since the NTP adopted WHO’s new Stop TB strategy, which 
advocates increasing access to services among vulnerable populations, I found no 
change in the approach or in services for these groups. 
5.3.3 Logistic management in TB service delivery 
Logistic management under DOTS was a responsibility of the District Public/Health 
Office (D/PHO). District health authorities stated that the programme was 
experiencing difficulties maintaining uninterrupted supplies of TB drugs, laboratory 
reagents, recording and reporting tools, and other items necessary to run DOTS 
effectively. Lack of resources (transport vehicle, cost and human resource) was cited 
as the major barrier. Although the NTP had a logistic management policy that 
included TB drugs, implementation of the policy was a major concern which 
sometimes resulted in stock outs of TB drugs at the DOTS centres, DOTS centre staff 
told me. In contrast, district health authorities did not agree that any centre 
experienced stock outs of TB drugs. They claimed that if they were informed about a 
drug stock out, they could immediately rectify it. However, they agreed that following 
the NTP policy of drug supply and management had been an issue in urban areas, and 
had hampered TB service delivery thus affecting TB treatment completion.   
In conclusion, I found that the current approach towards TB service delivery requires 
considerable attention to respond problems and issues faced by PLTB during TB 
treatment especially required to improve access to services, particularly vulnerable 
population groups such as the urban poor and excluded people. However, this issue 
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does not seem to be prioritised by NTP authorities, because a constant achievement of 
high treatment success rates in urban areas conceals issues of service delivery and 
PLTBs’ needs. It can be seen from the findings that, in line with new Stop TB 
strategy, there was an urgent need for the NTP to design a patient-friendly approach 
within which components of supervision and patient support need to be tailored 
towards greater understanding of local contexts and needs of PLTB. It also became 
clear that poor coordination among various service providers and a weak logistic 
chain, caused by lack of clearly defined roles and responsibilities among stakeholders 
and limited availability of resources, were issues which further weakened the 
programme.  
During my project work I persuaded and engaged with the NTP, in developing an 
urban TB control guideline, which has been piloted in some cities in Nepal. Although 
the guideline exists, it does not negate the need for a fully costed urban TB control 
strategy and operational plan along with adequate resources.  
Remarkably, however, despite many insufficiencies in TB service delivery in urban 
areas, most PLTB continued their treatment under DOTS, and the programme had 
scaled up its services to a limited extent and was achieving high treatment success. 
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5.4 Responses to factors that hindered TB treatment completion  
Various interacting factors were found to influence successful treatment completion. 
As a consequence, many PLTB had faced difficulties during their treatment. 
Nevertheless, the majority of PLTB continued their treatment and completed the full 
course of treatment. Thus, the overall treatment success rate in the urban TB control 
programme remained high. This section describes factors that facilitated PLTB to 
continue their treatment, thereby helping to secure successful treatment completion. In 
subsequent sections I analyse enabling factors in the process of TB treatment in regard 
to the three main stakeholders: PLTB and their family; health systems; and the 
community.  
5.4.1 PLTB and their family 
5.4.1.1 Strong personal commitment and motivation 
Almost all PLTB respondents stated factors that hindered their treatment. 
Consequently, their treatment process was challenged in many ways. However, I 
found that almost all respondent PLTB were highly committed and dedicated to their 
objective of completing TB treatment: this commitment ultimately enabled them to 
overcome many obstacles. A migrant woman with TB said; 
‘Coming to the centre for drugs is a problem as I need to manage my household tasks 
and look after my children. I understand that it is for few months only. If I continue my 
treatment I will be in better condition to do my job thus for me treatment is important 
it is therefore I wake up early and complete my job at home and come for treatment.’ 
I found that PLTBs’ levels of personal commitment and motivation did not remain 
constant throughout the treatment period as the context in which they lived played a 
vital role. In such instances, I found that support from others, and especially family 
members, made a big difference and in several cases I found that PLTB considering 
discontinuation gained support from family members which reinforced their 
commitment to continue their treatment. A migrant worker staying with his family in 
the city and taking treatment of five months said; 
‘I was frustrated because the disease has not only damaged my physical strengths it 
has placed several difficulties to my family. But my wife always says that there will be 
happy days after these sad days will over which makes me to feel that I should 
complete my treatment.’ 
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I found that the knowledge of PLTB regarding their disease and treatment played an 
essential role in making their commitment stronger and motivating treatment 
continuation. PLTB who believed their disease was curable were more motivated in 
their treatment while those who were less convinced or had less knowledge about their 
disease and treatment had much less motivation. Despite this, I found that PLTB from 
both groups continued treatment.  
5.4.1.2 Strong desire of family wellbeing 
I found that a majority of PLTB were concerned about the well-being of their family, 
and especially about their children and their children’s futures, since the majority of 
PLTB I interviewed had been playing an important role in their family, most of them 
being a breadwinner for the family. They therefore had a feeling that the welfare of 
the family had been jeopardized by their disease, as their illness made them unable to 
look after their family, which in turn had destroyed the happiness of the family. Such 
feelings led to a strong desire to continue treatment and regain the lost happiness in 
the family. Such feelings occurred particularly among PLTB who had children: they 
repeatedly stated that their children would face difficulties if they continued to be ill. 
A young man with TB said; 
‘My childhood was a misery in my village but I don’t want the same happening to my 
children. I need to cure my disease anyhow for the sake of my children.’ 
I also found that many PLTB thought that their family was suffering because of their 
illness. Continuing treatment and curing their disease was the only thing they could 
achieve to lessen the stress and burden on the family. Clearly, having such thoughts 
was not sufficient, as tackling the many challenges were difficult, but I found that 
support from family members boosted PLTBs’ hopes and was therefore important at 
all stages of TB treatment. Similarly, I also found that there was a cultural bond 
between illness and family wellbeing: the family would not take part in cultural events 
or other social gatherings if someone was ill in the family. This bond made PLTB feel 
uncomfortable that they were hampering the whole cultural happiness of the family, 
and thus motivated them to complete treatment.   
5.4.1.3 Desire to know more 
I found that many PLTB had a strong desire to know more about their disease and 
treatment which led them to seek more information from the health system, family and 
friends, and other sources. This desire not only encouraged them to gather more 
information, it also led them to disclose their disease to close relatives, friends and 
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colleagues. I found in many instances that disclosure of their disease to others helped 
PLTB to gain support during their treatment: people were sympathetic and provided 
assurance, provided financial support when they were in need, advised them to 
continue treatment, and visited them at home when they were ill. Such kinds of direct 
and indirect support to PLTB and their family enabled them to focus on treatment 
continuation and helped to address the loneliness and psychological stress which they 
experienced due to the disease. A woman with TB said; 
‘Since I was diagnosed with this disease [TB] I was not sure whether to tell about my 
disease to friends. One of my friends relative also had this disease and I thought she 
would know more about the disease then I sought more information about my 
treatment. She was very helpful and she actually suggested me to consult with health 
workers when I had other difficulties. She has been very supportive throughout.’ 
Although some PLTB stated that they received support from others after disclosing 
their disease, a few experienced some level of avoidance from their friends. However, 
a majority PLTB who disclosed their disease had experienced either some form of 
support, or, if no support was gained, at least no avoidance. 
A desire to know more helped PLTB to gain more support from health workers, and 
then decisions they made during treatment were well facilitated by health workers. 
Some PLTB who frequently discussed their problems with health workers stated that 
they had established good relationships and trust between them and health workers. 
Such conditions promoted some flexibility in DOT, as health workers trusted them 
and supplied drugs for a few days.  
5.4.1.4 Acceptance of disease and treatment 
Although PLTB were taking TB treatment, a few had doubts whether they actually 
had TB, so acceptance of the diagnosis was an issue for them. In contrast, PLTB who 
accepted the diagnosis were found to be more committed to their treatment. I found 
that the acceptance of diagnosis gradually increased as the treatment progressed and 
they started to feel less unwell. Good progress in treatment greatly increased many 
PLTBs’ enthusiasm to continue and complete treatment. I found that such enthusiasm 
was well supported by family members, further helping them to continue their 
treatment. In contrast, I found only one respondent who was de-motivated to complete 
the full course of treatment by improvements in his health as treatment progressed, 
because he thought his disease was cured. I found that the link between feeling better 
and motivation to continue treatment was largely determined by how health workers 
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responded to the treatment progress and communicated with individual PLTB – a 
positive and timely response resulted in increased motivation. A young woman who 
was seriously ill and had been hospitalised for a week, said; 
‘I thank health workers who brought me to this stage as now I can walk and do my 
household work. I had lost my hope as my condition was severe but the health workers 
kept on telling me that drugs have responded well and I felt better after a week 
treatment. Now I fully believe that my disease will be cured with full course of 
treatment.’ 
I also found that when PLTB felt better as treatment progressed, they were constantly 
reminded by family members to keep their treatment going. This took place because 
the family members were happy seeing the improvement, and wanted to avoid any 
interruption during treatment that could cause the disease to reoccur or become 
chronic. A wife of a PLTB who accompanied her husband for his treatment said; 
‘When he [the husband] started treatment he kept on saying that his disease will take 
him away from family but now I’m happy to see the treatment has made a difference 
as he started eating well and put some weight. It is really good to hear positive talk 
from him about his illness. Now I fully believe that he will be all right. I keep on 
telling him not to neglect treatment as it has made good progress.’ 
5.4.1.5 Increased support from family in treatment 
I found strong feelings and acts of families of PLTBs’ togetherness throughout their 
illness, regardless of their socioeconomic conditions and cultural norms. Although 
there were a few exceptions where PLTB were isolated in the family, the majority of 
respondents had greater support from the family than from others. I found a variety of 
support and supportive behaviours from family members that helped PLTB to 
continue their treatment. Box 5 below provides key areas of support that PLTB had 
from their family during their illness. 
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The majority of PLTB respondents stated that continuation of TB treatment without 
support from the family was an impossible task, because it would not be possible for 
this support to be provided by any other people.  
5.4.1.6 Management of other priorities 
As discussed in previous sections, PLTB had other priorities which were largely 
determined by their role in the family and by the jobs they were engaged in. In the 
case of women, most held responsibility both as homemaker (managing household 
chores) and for other employment outside the home (mostly income generation work). 
Making TB treatment a priority was not a simple task for many PLTB, and  especially 
women, as it compromised other equally important tasks, particularly jobs directly 
related to their livelihood such as income generation. A young man said; 
‘I come here exactly the time this centre opens then I go to my work. But I lose an 
hour in the morning which I don’t get paid, it is ok because if I’m not well, I will lose 
more than what I’m losing now.’ 
I found that some PLTB had postponed travel to their traditional home because of TB 
treatment. They told me that doing so was difficult for them, but since keeping TB 
treatment was their first priority, they managed.  
• Togetherness throughout the illness 
• Encouragement and psychological support 
• Financial support  
• Good acceptance at home 
• Help to fight against social discrimination 
• Sacrifice of other family priorities to support PLTB in treatment 
• Help as treatment supporter: e.g. treatment supervision, drug collection, 
accompanying care seeking and treatment, reminders to take drugs, help with 
information 
• Provision of nursing care at home 
• Replacement of PLTB in work, to protect employment 
• Help to PLTB to regain lost social identity due to TB 
• Taking on PLTB’s responsibilities in the household 
• Searching for other opportunities during illness and after cure 
Box 5: Examples of family support to PLTB during illness 
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5.4.1.7 Individual tendency of seeking support 
I found that some PLTB had sought help from others when they were in difficult 
times, not considering what others would think about their disease. This was 
particularly true among migrants, who sought help, often financial support, from other 
friends who had come to the city from the same village. However, I also found a 
reluctance among some PLTB to seek help from others when they were dealing with 
their problem anyway, because they feared disclosing their disease. When PLTB had 
no other options they were less concerned about what others would think about their 
disease, and shared their difficulties. In many cases, respondents said the people to 
whom they requested help were positive and supported their treatment. A young man 
who had been receiving treatment for five months said; 
‘I would not be able to continue my treatment more than four months because I was in 
big financial need as I had no money to pay my rent and food. I went to a friend as 
were from the same village, he lent some money and I’m now continuing treatment.’ 
5.4.2 Health systems 
I found many issues related to health systems that generally hindered access to TB 
treatment and thus affected treatment continuation, which I have already discussed in 
previous sections: 5.1, 5.2.3, 5.2.4, 5.2.5, 5.2.5.2, and 5.3. Despite these issues, I 
found some key factors related to health systems and TB service delivery that helped 
PLTB to continue their treatment, some of which I have already discussed. Here I 
focus on a few key factors.    
• Commitment of frontline health workers: Although this was an 
issue as PLTB stated that they did not have good experiences with a few 
health workers, I also found that some health workers were committed to 
providing good care to PLTB and facilitated their treatment. For details see 
sections 5.2.3 and 5.3.1.  
• Visibility of the programme: I found that the NTP had expanded its 
services nationwide and its visibility among the general population was 
generally good, as most respondents knew that TB drugs were free and DOTS 
existed. In interviews many PLTB stated ‘DOTS’ to indicate TB treatment by 
the government, although they hardly knew its meaning. 
• NTP’s partnership and  service expansion: Although TB services 
did not extend to all populations in need, their gradual expansion in 
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partnership with the private sector, NGOs, local government and communities 
(see sections 5.3.1 and 5.3.2) resulted in increased access to TB services, so 
that a majority of PLTB had come to government-provided DOTS services 
and started TB treatment. This is not to say that all PLTB had good access to 
TB services, but I found that a sizable proportion of PLTB were utilising TB 
services under the NTP. In addition, service hours of some NGO run DOTS 
centres found convenient to PLTB as they opened early morning where PLTB 
could take treatment before they head to their work.  
• Free drugs and regular supplies of logistics: Although I found that 
PLTB had paid a considerable sum for diagnosis, the provision of free drugs 
helped PLTB in TB treatment (although, other associated costs during TB 
treatment were an issue for many). Apart from a few exceptions, logistics in 
TB service in the study area were found to be intact, helping TB services to be 
provided for PLTB during TB treatment.   
• Context-specific tr eatment supervision: Although supervision of 
PLTB during treatment and provision of DOT appeared to be controversial 
issues in the study, I also found that some health workers were flexible and 
tailored treatment according to needs of PLTB, especially a level of flexibility 
in DOT. However, this flexibility was applied by individual health workers, as 
it was not a mechanism contained within policy and guidelines. Furthermore, 
some health workers considered the role of family members of PLTB in 
treatment, and engaged them in treatment supervision. Section 5.2.6 has 
already provided a detailed discussion on treatment supervision and patient 
support. 
• Friendly behaviour and positive attitudes of health workers: 
Although section 5.2.3 discussed issues related to health workers’ attitudes 
and behaviour towards PLTB, some PLTB described good partnerships with 
health workers which enabled them to continue TB treatment. Some health 
workers recognised problems that PLTB were facing and tried to modify 
treatment to address them. In many occasions health workers acted as 
supportive friends of PLTB through good understanding of the needs of 
PLTB.  
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5.4.3 Community support to PLTB 
I found that PLTB were somehow linked with their own social network either by 
choice or default. PLTB trusted such networks and gained some support from them 
during treatment: examples included moral support, financial support (lending 
money), information provision, accompanying PLTB to treatment centres, providing 
shelter, and helping in the workplace. All these forms of support were vital for PLTB, 
and especially for migrants who had limited social support in their new urban settings.  
I also found that TB volunteers working as late patient tracers provided help to PLTB 
by visiting their homes when they were late to collect drugs and helped them in DOTS 
centres. Similarly, employers helped PLTB by being flexible while attending DOTS 
centres for DOT (although this was not the case for all employers).  
5.5 Conclusion 
In this chapter I have shown that PLTB had to undergo treatment under very difficult 
circumstances, affected by multiple factors. The interplay of these factors made TB 
treatment complicated for many PLTB. The main issues found affecting TB treatment 
were socio-cultural understanding and practices with regard to TB and PLTB; a TB 
service delivery process that had limited consideration of the contextual reality and 
needs of PLTB; costs of TB care during treatment; inadequate provision of 
supervision and patient support during TB treatment; poorly tailored information and 
communication system in the TB programme; poor organisation of TB service 
delivery in the study area; and little or no consideration of the TB service needs 
among special populations.  
Despite complexities and difficulties in TB treatment, many PLTB were continuing 
TB treatment and completing their prescribed course of TB treatment under the NTP’s 
DOTS framework. The chapter also discussed on various responses to the issues and 
problems that PLTB experiences during TB treatment. However, I found that support 
from PLTBs’ families was crucial in encouraging successful treatment completion.  
The next chapter presents further discussion on the major issues identified in the study 
and investigates the possibility of developing context-specific TB treatment delivery 
services in urban areas to maximise successful treatment completion by reducing the 
burden on PLTB and their households (addressing the objective 3 of the study). 
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CHAPTER SIX 
FURTHER DISCUSSION ON KEY STUDY FINDINGS 
This chapter presents further discussion on the key study findings: barriers and 
supports to successful TB treatment completion. In this chapter, I also revisit the study 
aim and objectives in the light of the study findings and programme context. Finally, I 
discuss limitations in the study and validity and generalisability of the study. 
6.1 The research objectives revisited 
The aim of the study is to gain a better understanding of experiences and issues faced 
by People Living with TB (PLTB) and their responses during the course of TB 
treatment; and to identify appropriate ways of addressing the identified issues in a 
specified context. This study will contribute to the body of knowledge relating to TB 
treatment completion and facilitate the design and implementation of patient-centred 
care in Nepal’s National TB Programme (NTP) and similar settings elsewhere. The 
study focuses on factors that influence TB treatment completion among PLTB taking 
TB treatment under the NTP in urban settings in Kathmandu Valley, Nepal.  
The following study objectives were developed; 
• to understand the issues underlying the successful and unsuccessful 
completion of TB treatment from the perspective of PLTB in the context of 
the NTP in urban settings in Kathmandu, Nepal; 
• to understand responses to the factors influencing the successful and 
unsuccessful TB treatment completion from the perspective of health systems, 
communities and PLTB in the context of the NTP in urban settings in 
Kathmandu, Nepal; 
• to identify appropriate ways of addressing the issues identified leading to the 
successful and unsuccessful TB treatment completion in the context of the 
NTP in urban settings in Kathmandu, Nepal. 
My study findings suggest that various factors and their interplay affected TB 
treatment completion. I was surprised that, despite persisting hindrances and difficult 
circumstances, a majority of PLTB continued treatment: hence the NTP consistently 
achieves a treatment success rate of more than 85% in the study area (NTP 2008). 
This apparent contradiction was an interesting phenomenon, but was largely 
unexplored. I therefore felt it was important to explore why and how PLTBs were 
continuing TB treatment despite the circumstances. The use of a qualitative research 
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approach and an interactive research design allowed me to revisit the research 
objectives and methods as the study progressed (Hammersly and Atkinson, 1995).  
6.2 Summary of key findings of the study 
An understanding of TB as merely a biological phenomenon would misrepresent the 
complexity of the disease and its treatment management. The study findings suggest 
that an interplay of a set of factors (biological, health systems and service delivery; 
PLTB and family; socio-cultural; financial; and structural) had endangered PLTB and 
their families by stopping them addressing difficulties that arose along with TB. This 
finding is consistent with the findings from a study in an urban setting in India 
(Jaiswal et al., 2003) and with what Munro et al., (2007) reported in their systematic 
review of qualitative studies on patient adherence in TB. Although the disease affected 
only one person biologically, it pushed the entire family into great difficulties, and 
their suffering had immediate, mid- and long-term implications throughout and 
beyond the PLTB’s treatment, and especially economic and social implications (Hane 
et al., 2007; Kemp et al., 2007; Harper, 2006; Courtwright and Turner, 2010; Gandy 
and Zumla, 2002; Marra et al., 2004) 
Figure 16 presents an understanding and interplay of factors that hindered PLTB 
during the course of treatment, based on my study findings. In the figure, I summarise 
barriers in TB treatment under four major areas – health systems and service delivery; 
PLTB and family; socioeconomic; and structural – and various sub-areas (presented 
below the major areas), which negatively contributed to successful TB treatment 
completion. However, it is important to be aware that the degree of hindrances and 
complexities and their impacts on TB treatment varied among PLTB, depending on 
their individual status (knowledge and beliefs; disease conditions; severity and 
presence of diseases other than TB); the socio-cultural context (cultural norms and 
practices, community beliefs and perceptions); their economic status (financial ability; 
costs incurred for TB diagnosis) and other local contextual factors (environment, other 
social determinants and urban complexities). The arrows in Figure 16 indicate 
interactions of factors and consequent complexities in TB treatment management. The 
findings suggest that, in many instances, the barriers that PLTB faced became more 
complex as they developed and interacted with each other. The following sections 
summarise and further discuss the key findings in the light of the study findings and 
initial discussions presented in earlier chapters.  
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Figure 16: Factors affecting successful treatment completion and their interplay 
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Note that I have presented the key findings and further discussions based largely on 
the context of urban TB control provided by the NTP, so that I mainly consider my 
findings within the context of the NTP’s existing policies, strategies and guidelines 
including the Stop TB Strategy, the International Standards of TB Care and the Patient 
Charter for Tuberculosis Care. Where applicable, I also discuss the relevance of the 
findings in the South Asian context. 
6.2.1 Key barriers to successful treatment completion 
6.2.1.1 Poor access to essential health care including TB services 
Although my study focused on TB service delivery, my findings demonstrated that 
viewing TB control in isolation from other health care services – essential health care 
services (EHCS) in the context of Nepal’s health system – would grossly underplay 
the reliance of the success of the TB control programme on a functioning general 
health system and services, and the suffering PLTB underwent due to limitations in 
the general health system. The lack of government primary health care setup to deliver 
EHCS in the study area resulted in not only inadequate provision of basic health care, 
but also TB services. This finding indicates that many people living in urban areas, 
especially the urban poor – slum dwellers, migrants, labourers, women, children and 
other people residing in poor urban settlements – were having difficulties accessing 
the EHCS that includes TB care. Consequently, many of the urban poor were forced to 
seek health services including TB care from the private sector, although private sector 
services were unaffordable to many, as noted elsewhere (Uplekar et al., 2001; Newell 
et al., 2004; WHO, 2001). There has been a longstanding issue as to whether the 
responsibility for providing EHCS in urban areas falls to the MoHP or local 
government (i.e. municipal corporations). Although the government of Nepal’s 
Ministry of Health and Population (MoHP) recently introduced an urban health care 
policy (MoHP, 2010), it has not yet taken effect, and it remains unclear who has the 
responsibility to deliver EHCS in urban areas. 
PLTBs were concerned not only about access to TB treatment. I found that many also 
suffered from other illnesses while undergoing TB treatment and the absence of basic 
EHCS in many DOTS centres forced them to seek care for those illnesses from private 
health care providers. In addition to this causing a considerable delay in seeking care 
for other illnesses, it also affected PLTBs’ TB treatment continuation, a major issue 
being the cost of care incurred for other illnesses, in addition to the costs of TB care. 
Although the government has a ‘free health care policy’ (MoHP, 2010a), it was 
229 
 
implemented through the government health institutions under the MoHP, and a lack 
of a government institutional network in urban areas meant the urban poor were 
deprived of free health care provision. According to the MoHP’s definition, the EHCS 
package includes TB care (MoHP, 2010a, p. 18), but implementation of TB services 
has yet to be well coordinated within the comprehensive EHCS package in urban 
areas, unlike in rural areas where TB services are largely being delivered through the 
MoHP’s EHCS network (NTP, 2006/07). The lack of EHCS in urban areas raises an 
important question relating to TB service delivery modality within the existing health 
service delivery context: whether TB services could and should be delivered or linked 
to the EHCS package; and if so how. 
My findings also show that the TB services were delivered in partnership with some 
service providers – public, private for-profit, and private not-for-profit – in the study 
area. The partnership to some extent increased coverage (Newell et al., 2004), 
juxtaposed with other components of EHCS. However, the partnership suffered due to 
lack of a mutually agreed urban TB control strategy; unclear roles and responsibilities 
among partners; lack of stewardship; inadequate resources; and a lack of an 
appropriate TB service expansion plan tailored to the needs of people. This resulted in 
a suboptimal partnership and an ad-hoc expansion of services in the study area. A 
study by Newell et al. (2005) in Nepal also documented a similar finding in terms of 
understanding among health care providers with regard to TB control; however, the 
study was not limited to urban areas. Consequently, TB service was not accessible to 
many vulnerable groups, thus having a profound negative impact on treatment 
continuation (in addition to financial, social and environmental constraints). Many of 
these constraints in partnership and TB service expansion could be addressed through 
scale up of a locally developed PPP model (Newell et al., 2004 and 2005; Hurtig et 
al., 2002). 
Access to existing TB services was also limited by the fixed opening hours of DOTS 
centres. This caused great inconvenience to many PLTB, in particular migrants, daily 
wage workers, students, job holders and job seekers. It was also an issue among 
women PLTB who had a major role in the family as homemaker. A similar finding 
has also been noted in studies elsewhere (Walley et al., 2001; Khan et al., 2002; 
Sanuo et al., 2004; Coleman et al., 1998). I also found that some DOTS centres run by 
NGOs had longer opening hours (early morning to late evening): PLTB taking 
treatment from those centres did not raise opening hours as an issue. However, only a 
few centres made such provision. Extending opening hours of DOTS centres would 
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reduce access barriers and could be done without a major modification in the way the 
centre was run.  
6.2.1.2 No DOT no treatment 
The NTP provided free TB drugs, but contingent upon institutional DOT. There was a 
strong view in the NTP that DOT is the vehicle for TB control and the major pillar of 
the current success of the NTP. This arose from a perception that non-completion is 
caused by PLTB. Another strongly held belief in the NTP was that DOT is a must do 
activity and is designed to support PLTB to complete their treatment, as many of them 
do not take their drugs if given them to take at home. In contrast, PLTBs’ perception 
and practical experience was otherwise – a majority of PLTB criticised DOT and felt 
that the NTP was truly insensitive to the needs of PLTB, and then had to make a 
difficult decision between the public sector’s offer of free anti-TB drugs with DOT 
and the private sector’s offer of expensive anti-TB drugs but no DOT. The NTP and 
PLTB had completely different views and interpretations of DOT, leading to 
controversy (see Table 16). The need for compulsory one-size-fits-all DOT for all 
PLTB was found to be at odds with evidence from Nepal and elsewhere (Newell et al., 
2006; Harper, 2006; Volmink and Garner, 2007), and in addition a majority of PLTB 
viewed DOT negatively (Singh et al., 2002; Jaiswal et al., 2003; Estcott and Walley, 
2005). A large district-randomised controlled trial by Newell et al. (2006) which 
compared treatment outcomes using family DOT and using community-based DOT in 
ten districts of Nepal concluded that family member and community member DOT 
providers were as equally effective as institution-based DOT. Family members were 
found to be accountable as treatment supervisors when the programme engaged them 
appropriately, providing proper education and clarity about their roles and 
responsibilities. The study also found that PLTB preferred family member DOT. 
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Area of 
understanding 
NTP’s understanding of DOT PLTBs’ understanding of 
DOT 
Perceptions, 
Opinions 
about DOT 
• A mechanism of support to 
PLTB 
• Ensures PLTB completes 
treatment  
• PLTB forget to take drugs 
• Success dependent on DOT 
• Prompt management of drug 
side effects 
• Helps solve problems when 
they occur 
• Insensitive to PLTB needs 
• Punitive act imposed by 
programme 
• Non-negotiable option 
• ‘Trade-off’ with free drugs 
• A result of lack of trust by 
programme 
• Unnecessary scrutiny 
• Many problems created by 
DOT 
• Labour-intensive   
Feasibility 
of DOT 
• There are designated DOTS 
centres in urban areas that 
PLTB can access 
• DOTS centres have been 
expanded 
• PPP approach has been adopted 
 
• Unaffordable 
• One-size-fits-all, thus 
infeasible in many ways 
• time consuming 
• high travel costs (time and 
cost) 
• high opportunity costs  
• compromises other priorities  
Implications 
of using 
DOT 
• High cure rate and low drug 
resistance  
• Needed to sustain the NTP’s 
achievements 
• A core element of the NTP’s 
success 
• Discourages PLTB in 
treatment 
• Increases individual and 
family vulnerability  
• Increases financial burden  
• Lost opportunities 
• Treatment completion but 
with major hardship 
• Treatment non-completion 
• Increased stigma in the 
community 
Practice of 
using DOT 
• Policy must be strictly followed 
• Mixed practices with some 
flexibility depending on 
individual health worker 
• Some proxy collection of TB 
drugs for PLTB (i.e. family 
members) 
• No standard practice across the 
programme 
• No direct observation at 
DOTS centre 
• No drinking water supply, so 
no DOT 
• Drug collection by family 
members in a few cases 
• Received 2-5 days supply but 
no standard practice 
Alternatives 
to DOT 
• Use of community volunteers 
• In a few cases, use of family 
members 
• In a few cases, supply drugs to 
PLTB 
• Trust PLTB and supply drugs  
• Use family members as 
treatment supporter 
• Adequate education essential 
• Get treatment in private 
(unaffordable to many PLTB) 
Source: Compiled by the author from study findings 
Table 16: Differences in understanding of DOT between NTP and PLTB 
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The coercive model of treatment management with compulsory DOT does not comply 
with ISTC Standard 9 for TB treatment (ISTC, 2009, p. 38) which calls for a patient-
centred approach to administration of TB drugs based on each PLTB’s needs, and 
based on mutual respect. DOT practice in the study area also contravenes the 
‘supervision and patient support’ element of the Stop TB strategy (WHO, 2006, p. 10) 
and the latest WHO TB treatment guidelines (WHO, 2009, p. 77) which state that 
supervision may have to include DOT but is not mandatory. The documents further 
state that when DOT is used it should be delivered within a broader package of 
supervision and patient support tailored to the needs of PLTB in a context-specific and 
patient-sensitive manner. However, neither document is explicit on what constitutes a 
supervision and patient support package.  
Complying with the requirement of DOT caused huge inconvenience, including 
increased costs for care due to daily travel to and from the DOTS centre; other routine 
activities being compromised; a lack of privacy that exposed PLTB to others, 
increasing fear of stigma and discrimination; restrictions to PLTBs’ mobility; 
increasing the hardships experienced by PLTB and their family members; and loss of 
opportunity costs, since in some cases PLTB had to stop working to be able to comply 
with the requirement for DOT. These findings are consistent with those of other 
authors elsewhere (Thiam et al., 2007; Walley et al., 2001; Khan et al., 2002; Garner 
and Volmink, 2003; Harper, 2006; Newell et al., 2006). Furthermore, the ‘control’ 
caused by DOT made PLTB become passive recipients of treatment (Lienhardt and 
Ogden, 2004), not only making them vulnerable in decision-making and reducing their 
confidence, but also prevented them exerting their rights to receive equitable care, to 
be treated with respect and dignity, and to choose alternative care: a majority of PLTB 
perceived DOT as non-negotiable, causing some to want to start treatment in the 
private sector after facing difficulties due to DOT but being unable to do so due to the 
high costs of private care. This finding was consistent with a study by Johansson et al. 
(1999) in Vietnam. I also noted that DOT was infeasible for a majority of PLTB 
because it grossly compromised other routine activities; in particular it affected job 
continuation and limited employment opportunity, which had a major negative 
implication for treatment continuation. A similar observation has been made in other 
studies (Singh et al., 2002; Gleissberg, 2001; Greene, 2004; Harper, 2006). I also 
found that the initial two months treatment was a difficult period in TB treatment for a 
majority of PLTB; and a major factor was DOT. Difficulties occurred not only for 
PLTB but also for other family members. The study findings demonstrated that family 
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members supported PLTB in many ways to fulfil the requirements of DOT; children 
were most vulnerable as in many instances they were forced to take on a role of the 
PLTB, either by collecting TB drugs from the centre or by replacing the PLTB in 
work.   
6.2.1.3 Supervision and patient support – a need within a state of confusion  
Provision of treatment management along with needs-based supervision and patient 
support heavily influenced the treatment process. However, the programme’s 
supervision and support component has suffered due to varying understanding and 
practices among key stakeholders along with an ill-defined scope, which failed to 
cater for the basic needs of PLTB. There has been speculation on the interpretation 
and practical use of this term since WHO included it in its new Stop TB strategy 
(2006). I have deliberately used the word speculation because I have not seen an 
agreed definition of the approach (if it is seen as an approach) or a set of clearly 
elaborated component(s) (if it is seen as a package). There is a need first to define 
what the supervision and patient support entails, and second, what it implies. 
However, attempts have been made to develop a broad conceptual or theoretical 
understanding of the approach, including helping PLTB to take their TB treatment 
regularly and complete a full course of TB treatment; a different form of treatment 
supervision tailored to the needs of PLTB taking context into consideration; a context-
specific approach to TB treatment; a patient-centred approach to TB treatment 
developed between PLTB and provider based on a mutual trusting relationship; 
encouraging and facilitating a positive partnership between service recipient and 
provider; an approach in which the PLTB and provider work together to improve 
treatment completion by addressing critical factors that hinder TB treatment (WHO, 
2009; WHO, 2006; ISTC, 2009; Raviglione and Uplekar, 2006).  
Although the Nepal NTP has adopted WHO’s Stop TB strategy, ISTC and Patient 
Charter for TB Care, no programmatic understanding has been formed relating to 
supervision and patient support taking the country context into consideration. This 
lack of understanding in the NTP has had implications, as PLTB have had to comply 
with traditional DOT practices. Surprisingly, in several instances, NTP authorities, 
including some health workers, have interpreted the ongoing DOT practice as 
supervision and patient support. This highlights a need to define a patient-centred 
approach within which the role of family members needs to be well defined, taking 
into consideration the results of the trial of family member DOT in Nepal (Newell et 
al., 2006). In the programme, clarity is needed on modes of treatment supervision and 
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support mechanisms to facilitate the overall treatment process. Essential basic support 
mechanisms should not be restricted only to DOT and free drugs; thus a careful 
definition of the scope of various supervision and support mechanisms needs to be 
well explored, with a clear focus on PLTBs’ needs. In subsequent sections, based on 
the study findings, I will attempt to define a patient-centred approach in the context of 
Nepal’s urban TB programme, and develop a revised conceptual framework. 
I note that WHO’s Stop TB strategy (WHO 2006) has also been adopted by NTPs in 
other countries: however, replacing more than a decade-long practice of DOT as an 
essential element of the TB programme by a ‘patient-centred approach’ as a proxy of 
‘supervision and patient support’ – which is yet to be defined – will be a big challenge 
and will require considerable effort to change practices and behaviours of TB service 
delivery authorities.  
6.2.1.4 Health communication exists but is poorly tailored to the context  
Communication between health care providers and PLTB was found to be essential as 
it is an important contributor to successful treatment when provided effectively 
(Liefooghe et al., 1999; Harper, 2006; Jaiswal et al., 2003). Successful completion of 
TB treatment requires a long-term commitment from health care providers, PLTB and 
their family members. The study found that effective communication through a 
meaningful conversation within an established partnership between care providers and 
PLTB provides an opportunity to maximise commitment to successful treatment 
completion. Simply transmitting information from providers to PLTB cannot be 
counted as effective communication. I found that there was a general feeling among 
health care providers that non-completion was due to PLTBs’ poor understanding 
about the importance of TB treatment. This established notion largely shaped the 
interpersonal communication between the care providers and the PLTB, including the 
process of communication, the information content, behaviour of care providers and 
the relationship with PLTB during communication. Communication was shown to be 
an activity genuinely embedded within the programme culture as all PLTB had gone 
through a communication process, starting from the day they registered for treatment. 
However, the effectiveness of communication in relation to empowering PLTB and 
changing socio-cultural beliefs to facilitate TB treatment was an issue (Kelly, 1999). I 
found that it was vital to be able to achieve communication objectives, an 
understanding of PLTBs’ needs and the socio-cultural context within they operated: 
other studies have drawn similar conclusions (Lienhardt et al., 2003; Munro et al., 
2007; Sumartojo, 1993). However, my findings suggest that the communication 
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process was poorly aligned with PLTBs’ needs and socio-cultural contexts. The 
preconceived notions of health workers towards PLTB as non-compliers contributed 
to establishing communication in a top-down and one-way process, as care providers 
fed much information with little or no consideration of the needs and context of 
PLTB: although the information provided was important, the methods used and lack 
of considerations of the contextual facts in communication was an issue, that I 
repeatedly observed and verified with PLTB during interviews.  
In the face of their mounting difficulties – physical, psychological, financial, and 
social – it was ambitious and unrealistic to assume that PLTB would absorb and 
assimilate all the information provided by the care providers. In the study, I also found 
that health care providers did not fully engage family members of PLTB in the 
communication process, even though they were generally present at the event. I 
consider this as a missed opportunity, which could be well utilised with no additional 
cost to the programme; particularly given that PLTB found family members’ support 
to be crucial in TB treatment (Sagbakken et al., 2007; Newell et al., 2006). However, 
it is important and health service providers should obtain consent from PLTB before 
involving family members in communication.  
6.2.1.5 Other key barriers related to health system and services 
The initial two months of DOTS was noted as a difficult period in TB treatment 
because of the need for daily visits to a DOTS centre for DOT (although PLTB living 
nearby DOTS centres did not have the same experience). The long waiting hours in 
DOTS centres due to late opening, long queues, and absent providers also influenced 
treatment continuation.  Health providers needed to know as much as possible about 
PLTBs’ needs, preferences, socio-cultural context, beliefs, knowledge and attitudes to 
be able to offer help and facilitate their treatment. There was no provision to carry out 
a detailed assessment of PLTB apart from filling in the TB treatment card, in which 
limited information was recorded (and most of them had data missing). I did not find 
health workers using open-ended questions by which they could understand PLTB and 
see the differences between PLTBs’ and their own beliefs. This practice had negative 
implications for creating an enabling environment for PLTB at the centre. In many 
cases, the attitude of health workers towards PLTB hindered effective communication. 
In some occasions I observed that the frustration of health workers with the 
programme or higher level authorities was clearly reflected in their behaviour to 
PLTB: this did not help at all. It is equally important that health workers always make 
interactions with PLTB a positive experience: thus institutional or personal issues of 
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health care providers should not lead to victimisation of PLTB regardless of 
circumstances. I also found that health workers’ positive attitudes and behaviour 
helped PLTB to stay on TB treatment: a good relationship and openness between 
PLTBs and providers minimises the burden on PLTB and thus contributes to success. 
Health workers and district TB supervisors raised issues of supply of logistics in the 
programme including anti-TB drugs. However, at the point of service delivery PLTB 
did not mention unavailability of anti-TB drugs, as has been found in other studies 
(Khan et al., 2000; Watkins and Plant, 2004). Likewise, I did not find evidence of 
PLTB being charged for anti-TB drugs, or being asked for under-the-table payments 
in the programme as reported in other studies (Sanou et al., 2004).   
Notwithstanding the evidence of various obstacles in TB treatment, the NTP has 
achieved high treatment success rates among those registered in the programme (NTP, 
2006/07). The NTP uses the term ‘successful treatment completion’ to label PLTB 
who successfully complete the full course of TB treatment: however, it is questionable 
whether this is successful completion in line with the definition I have used in the 
study. The evidence is contradictory: high treatment success rates are achieved despite 
relatively poor access to TB services. This contradiction raises some important 
questions: what proportion of PLTB were treated in the NTP; what were the long-term 
costs to PLTBs of the programme to gaining the benefit of high success rates; and did 
numerical success overshadow the prodigious sufferings of PLTB and their families 
during TB treatment? I will discuss the latter two questions in subsequent sections. 
The first question was not a focus of my study: however, consistently low TB case 
detection rates in urban areas (NTP, 2009/10) suggests that many PLTB are not 
receiving treatment under the NTP, although a public private partnership in TB control 
demonstrated an increase in TB case detection in urban areas (Newell, 2004). 
6.2.1.6 Socio-cultural beliefs, perceptions and knowledge related barriers:  
My respondents came from a variety of socio-cultural backgrounds – a majority were 
migrants who had come to the city from different parts of the country and thus had 
mixed social backgrounds. I found that each respondent, regardless of socio-cultural 
background, displayed culturally constructed beliefs relating to the causality and 
treatment of TB, and to the efficacy of TB drugs. Their behaviour was affected by 
these beliefs, even though the beliefs often conflicted with biomedical understanding 
of the disease and its treatment: similar findings can be found in other studies (Ho M, 
2004; Khan et al., 2000; Long et al., 1995; Courtwright and Tunner, 2010). For 
instance, a community understanding of causes of TB (such as disobeying socio-
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cultural norms; visiting prostitutes; engaging in sexual relation with relatives; wrong-
doing in the past; TB as a disease of dirty people) often prevented people seeking care 
for fear of being labelled, if they were found to have TB. As a consequence, many 
PLTB continued to hide their disease during TB treatment, causing major problems 
for many PLTB. In particular, women and unmarried girls were found to be more 
vulnerable to such beliefs due to their socially constructed positions in the community. 
Such vulnerability was further compounded when they had to comply with 
requirements for DOT by making daily visits to the DOTS centre. I found that the 
repercussion of such beliefs was greater for local residents of the city than for 
migrants, because local PLTB were often worried that such negative labelling would 
jeopardise their social status; as a consequence, some chose to take their TB treatment 
from DOTS centres located a long way from their local community, with implications 
for costs and treatment continuation. I found a mismatch between PLTBs who feared 
disclosure of their disease, and the support and encouragement provided by members 
of the community including friends and colleagues to PLTB who disclosed their 
disease status. Another study conducted in a similar setting produced similar findings 
(Baral et al., 2007). It will be useful for the programme to document such experiences 
of support given after disclosure of the disease and use them as evidence in health 
communication aimed at PLTB who continue to hide their disease from others.   
TB-related stigma and discrimination appeared to be high in the study context; women 
with TB were affected the most. Although health communication included the 
message that after two weeks of treatment TB is no longer infectious, a fear of 
transmission in the community or the family was found to be a major cause of stigma 
towards PLTB. As a consequence, a majority of PLTB practiced self-isolation not 
only for the initial few weeks but throughout treatment. This was particularly difficult 
for women with children and migrants who lived with their family in one room. I 
found evidence that remaining in isolation reduced support from family members and 
close friends. In the cases of drug-resistant TB, multi drug-resistant and extremely 
drug-resistant TB, the practice of isolation may be justified: however, for drug-
sensitive TB, beliefs about the need for isolation need to be addressed through 
effective health communication. There is also a discussion to be held regarding 
whether avoidance of a person with active TB on the grounds of self-protection is 
actually discrimination (Baral et al., 2007), since it is highly unlikely that they pose 
any risk once they start treatment. My findings also suggest that stigmatisation and 
discriminatory behaviour towards PLTB are found more in joint families than in 
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nuclear families; this was particularly the case for women with TB, who tended to be 
discriminated against by their in-laws. However, there was less stigmatisation and 
discrimination by family members than from general members of the community. 
Nevertheless, the findings further emphasis the need for a critical assessment of PLTB 
with regard to their social, cultural and family background to be able to address 
stigma-related concerns that often prevent PLTB successfully completing TB 
treatment.  
Discriminatory behaviours on the grounds of TB in institutions such as schools, 
workplaces and health institutions appeared to be an important barrier to treatment 
continuation. Migrants suffered more than others, because migrants (generally with a 
poor economic status) mostly ended up working in factories, and factory owners were 
often reluctant to continue to employ an ill person, on top of which they believed 
keeping PLTB at work risked infecting others. As a consequence, PLTB were 
dismissed from their jobs, with catastrophic effects as the PLTB found it almost 
impossible to survive in the city and continue TB treatment without a job; a similar 
conclusion was drawn from another study in the same area (Baral et al., 2007). Since a 
majority of PLTB in the study area were migrants, my findings indicate an urgent 
need to develop a strategy aimed at factory managers and owners to address 
discriminatory actions in workplaces (Kirwan et al., 2009). However, not all PLTB 
working in factories had the same experience, as some factory owners supported 
PLTB during their treatment thereby reducing their burden. This suggests that there is 
a possibility to address the issue of institutional stigma in factories. This would require 
a joint approach from local government (municipalities), the office of small business 
industries, garment factory associations, local health authorities, the NTP and others. I 
was particularly surprised to find discrimination on the grounds of TB in health 
institutions. Health institutions provide the last chance for PLTB to be cured, and 
discrimination could seriously hamper PLTB in seeking and continuing TB treatment. 
This suggests there is an urgent need for the NTP to design and implement measures 
to ensure people-friendly TB services in health care settings.  
Similarly, there was a perception that TB remains forever in the body, closely 
associated to the perception that TB damages the lungs and normal physical strength 
can never be restored. These perceptions became stronger when PLTB relapsed or TB 
reoccurred. Such perceptions led to beliefs that TB could not be cured with oral 
medication alone without surgery to repair lung damage, affecting PLTBs’ motivation 
to continue TB treatment, although they continued treatment despite this confusion. 
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Many PLTB were concerned about the potential consequences of TB, especially 
development of chronic TB. They became further worried when they saw some people 
failing to get cure, again affecting their motivation. I was surprised that the health 
system took this issue lightly and in some instances health workers ignored the fact 
that such beliefs existed among PLTB, stating merely that people receive health 
education and TB is now a simple disease to treat. 
My findings suggest that PLTBs’ personal knowledge, attitude and experiences played 
a role in determining their treatment behaviour. PLTB who had a fear of becoming 
impotent as consequence of TB drugs were in a stage of confusion whether to 
continue TB treatment. Likewise, people who were unconvinced that TB is 
communicable had doubts whether they had TB. Such beliefs caused PLTB to have 
psychological dilemmas, some of which persisted throughout treatment. This suggests 
that health communication was poorly tailored to correcting misconceptions. I also 
found that social stigma relating to TB appeared to be more common among local 
resident PLTB than among migrants. Being relatively new in the city, migrants had 
very limited social networks (Kirwan et al., 2009) compared to local people, and were 
thus less bothered being labelled with TB: this however does imply that migrants were 
unaffected by stigma and discrimination. Almost all migrants I spoke in the study 
raised many issues that hindered their treatment continuation: the issues most 
commonly raised were social and financial constraints, on top of which the 
requirements of DOT caused further social, physical and financial problems. Other 
authors also highlight the need to explicitly address the requirements of migrants in 
TB control (Tang and Squire 2005; Long et al., 2008; Wang et al., 2008). The impact 
of stigma and discrimination among respondents varied, depending on the PLTB’s 
knowledge, interpretation and cultural context: importantly, the level of suffering 
experienced was also determined by the level of support the PLTB received from the 
family. The more support PLTB received from the family, the less was the impact of 
community stigma: when stigma existed in the family, support was greatly reduced.  
Gender roles are also important factors in TB treatment. Nepal’s complex social 
structure and culturally defined gender roles influence health care seeking, especially 
when the duration of care is long. I found that women with TB disease were more 
vulnerable than men during treatment. However, women tend to cope better with 
difficulties, whether at home or in the community, and thus stay on treatment (Uplekar 
et al., 2001). Women were more concerned about their children’s future when they 
perceived they were at risk of TB. For example, a woman with TB decided to isolate 
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herself from her children throughout her treatment because she feared that the children 
may get infected; but this isolation caused her substantial and continuing distress. In 
addition, the requirements of DOT made women further vulnerable as it was 
problematic to comply with DOT as well as carrying out household duties with no 
additional help.  
Regardless of socio-cultural beliefs and traditional practices, a great majority of PLTB 
managed to continue treatment. It should not be assumed, though, that PLTB were not 
affected by the difficulties they encountered; rather, the support they obtained from 
their families and their coping strategies enabled them to stay on treatment. I found 
that many PLTB had a strong desire to be cured, despite all the problems they faced. 
They continued to struggle against the barriers, in the hope that their disease would be 
cured and the problems would end. However, although PLTB were committed to their 
treatment, they continued to worry about what they would do after completing 
treatment. Their worries were mainly related to the debts they had incurred to pay for 
treatment, whether they would find a job, and whether TB would reoccur in the future 
if they engaged in hard physical labour, this last concern being particularly prevalent 
among migrant workers engaged in hard labour. Despite the fact that a large number 
of migrants were taking TB treatment in the NTP, no specific strategy exists to 
address their problems in the urban TB control programme. 
6.2.1.7 Therapy related barriers:  
Many PLTB found the long duration of TB treatment and multiple drugs to be taken 
were real problems and led to demotivation. This was further compounded by drug 
side-effects and poor side-effect management by health services: as a consequence, 
some PLTB stopped taking their drugs. Other studies have shown similar findings 
(Jaiswal et al., 2003; Green, 2004; Wares et al., 2003; Watkins et al., 2004). In some 
instances health workers did not pay sufficient attention to the side effects of anti-TB 
drugs that had been brought to their attention by PLTB (Green, 2004): I also found 
disparities in perceptions of the seriousness of side-effects between health workers and 
PLTB, which further hindered the process of side-effect management. PLTB also 
found that once they started TB treatment their appetites increased: lack of food 
became an issue, especially among poor PLTB who anyway had problems managing 
to obtain basic provisions for themselves and their households. This problem was 
further aggravated when health workers suggested that PLTBs needed additional 
nutrition to help cure their disease. Health workers often told PLTB to take TB drugs 
on an empty stomach to improve their efficacy, but this was inconsistent with the 
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opening times of DOTS centres: being unable to eat until after receiving DOT caused 
concerns to PLTB. This further demonstrates the need for health communication 
models tailored to the context, needs and abilities of PLTBs, which are currently 
lacking in the programme.  
6.2.1.8 Structural barriers:  
Sumartojo (2000) defines structural barriers or facilitators as related to organisational, 
economic, social, policy and environmental issues. I have presented other barriers in 
earlier sections; here I focus on urbanisation, the political and organisational contexts 
and poverty-related issues. The infrastructural setup of DOTS centres varied in the 
study area: some had a relatively poor institutional setup with many services delivered 
from a single room. Such arrangements demotivated many PLTB in taking treatment 
from the centre and also raised concerns about the privacy of treatment and the quality 
of services. In addition, PLTB sometimes had to climb multiple flights of steps to get 
to the DOTS centre, causing daily problems to those who were physically weak. Some 
DOTS centres were located within holy premises, causing mixed responses: some 
PLTB who did not want to be seen visiting the DOTS clinic said it was good as they 
could say that they had been to the temple; while others were concerned that people 
visiting the temple could see them entering the TB clinic every day, potentially 
revealing their disease status. It is thus difficult to conclude whether having DOTS 
centres in such premises is good or bad, as preferences depended on individuals and 
contexts. However, in both cases, it is important to ensure the provision of adequate 
space to be able to deliver quality TB services.  
Growing urbanisation has not only resulted in high population growth but also in 
increased unplanned settlements, increased numbers of urban poor and increased 
conditions of poverty in which TB flourishes. In such circumstances TB control is a 
challenge, as it is difficult to provide accessible services to the people residing in such 
areas, hindering not only TB treatment but also TB case identification. There is a 
proliferation of evidence suggesting direct links between poverty and TB (Gandy and 
Zumla, 2002). Archbishop Desmond Tutu’s declaration that ‘TB is the child of 
poverty – and also its parent and provider’ emphasises the vicious link between TB 
and poverty. It has been shown that TB has a disproportionate impact on the poor, 
especially in developing countries. It is estimated that 94% of TB cases and 98% of 
TB deaths occur in developing countries, signifying an imperative need for NTPs to 
address poverty-related barriers in TB control. I was surprised by the complete lack of 
strategies in the Nepal NTP specifically addressing the needs of the poorest population 
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groups, given that in urban areas of Nepal the TB burden is estimated to be four times 
the national average, and TB case notification remains consistently low and default 
rates high. Despite enduring dreadful conditions of poverty, PLTB continued TB 
treatment, applying various coping strategies: selling family possessions; sending 
children to work; borrowing money; and reducing food intake within the family. 
I also found that the ongoing political instability, and frequent unplanned strikes 
across the city, made life difficult for PLTB, not only because they were not able to 
visit DOTS centres but also because they were hampered in their routine work, which 
was the only means of earning enough to stay in the city. These structural factors were 
beyond the control of health workers and PLTB, but health workers could discuss 
such issues with PLTB to find ways to minimise the effects on TB treatment. 
6.2.2 Key factors enabling successful TB treatment completion 
6.2.2.1 Family support:  
Support from family members during the course of TB treatment was one of the key 
factors that helped PLTB to continue treatment. The support gained not only during 
the treatment but from the start of illness greatly helped PLTB overcome barriers in 
care seeking and treatment. Other studies have also found family support to be crucial 
in TB treatment (Newell et al., 2006; Khan et al., 2005; Johansson et al., 1999; Harper 
et al., 2003; Edginton et al., 2002; Nair et al., 1997). For many PLTB a positive and 
accepting home environment was essential. PLTB were generally well accepted at 
home and gained support throughout treatment, with the exception of a few who 
experienced discriminatory behaviour at home, especially in joint families. The 
acceptance of the PLTB within the family not only created a conducive environment, 
but also helped to fight against stigma and stigma-related discrimination in the 
community (Khan et al, 2000; Meulemans et al, 2002).  
Families provided PLTB with various forms of support. The main help was financial 
support during the course of their illness. A majority of PLTB had rather poor 
financial status, even before they contracted TB, so living was a challenge (Liefooghe 
1997), especially for the urban poor and migrants. TB disease further increased these 
challenges, and consequently the large costs associated with treatment weakened the 
PLTB’s ability to continue treatment. Several studies have demonstrated that PLTB 
interrupt TB treatment because of financial pressures (Watkins and Plant, 2004; 
Greene, 2004; Johansson et al, 1996). However, the financial support given by family 
members proved vital in the TB treatment process and helped the PLTB continue to 
243 
 
stay on treatment. Another vital form of support from the family was staying with the 
PLTB throughout their illness. This act of togetherness profoundly helped PLTB in 
reducing their psychological stress, empowered them and increased their confidence. 
(Meulemans et al., 2002; Barnhoorn and Aadriaanse, 1992). 
In many instances, family members provided good nursing care at home, regardless of 
the severity of the PLTB’s illness. They often prioritised care for the PLTB, not only 
at home but also accompanying them to the DOTS centre, collecting drugs from the 
centre, and reminding them to take drugs regularly. Family members often 
compromised their other work to ensure that the PLTB continued with treatment. In 
many instances, they replaced PLTB in their jobs and took over responsibility for the 
PLTB’s household chores. It came as a surprise that despite ample evidence of the 
crucial role of family support in TB treatment in Nepal and elsewhere (Newell et al, 
2006; Khan  et al, 2005; Johansson  et al, 1999; Harper et al, 2003; Edginton  et al, 
2002; Nair  et al, 1997) the formal NTP guidelines relating to TB treatment 
management do not give serious consideration to engaging family members in the 
treatment process (NTP, 2006), despite the fact that family members often come to the 
DOTS Centre with the PLTB during the process of seeking care.  
Although family support played a vital role in determining successful TB treatment 
completion, it was often the case that women with TB had less family and community 
support than men. This observation was also made in other studies: in many societies, 
especially male-dominated societies in developing countries, women are given lower 
priority (Long et al., 2001; Khan et al., 2000; Johansson et al., 2000). However, it was 
noticeable that families provided more support to young unmarried women than to 
other (married) women in the home (Khan et al., 2000).  
6.2.2.2 Personal commitment of PLTB: 
 Almost all PLTB found the journey to TB treatment was not straightforward, as 
unfavourable circumstances hindered them at various stages. Despite mounting 
difficulties, PLTBs’ personal commitment and motivation remained strong, greatly 
facilitating successful TB treatment completion. However, I also observed that their 
motivation did not stay constant throughout treatment: other support and 
encouragement, in particular from family members, played a central role in ensuring 
continuing commitment to treatment. Note that not only personal motivation 
facilitated PLTB to remain on treatment, and individuals’ motivation varied, an issue 
also identified in other studies (Harper et al., 2003; Khan et al., 2005; Menegoni, 
1996).  
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To be able to stay on treatment, it seemed important that PLTBs had adequate 
knowledge regarding their disease and treatment: however, in the majority of 
instances, I found that despite limited knowledge of TB and its treatment and 
unanswered concerns, PLTB continued treatment. This was because many PLTB 
understood that the disease not only affected them but the entire family, so that the 
happiness of the family, and especially the future of their children, relied on their cure 
– a strong motivational spur to PLTB. It was also found that regardless of their 
knowledge about the disease and its treatment, PLTBs accepted their treatment: 
however, there were a few occasions when PLTB seriously questioned whether their 
disease was TB.  
6.2.2.3 Flexibility in TB treatment management and positive attitude of 
health workers:  
My study findings suggest that some health workers applied flexibility in TB 
treatment management and in particular the requirements of DOT, against the NTP 
policy of institutional DOT. However, this flexibility went unrecorded because of fear 
that they might be reprimanded by senior authorities. This flexibility greatly helped 
PLTBs continue their treatment, but raised genuine questions why health workers had 
to fear when they were flexible in response to PLTBs’ needs and the local context. 
There was a strong understanding among some health workers that institutional DOT 
was infeasible for all PLTBs, and therefore they chose to be flexible to achieve the 
NTP aim of successful treatment completion. However, they did not forget the need 
for quality treatment. They educated a reliable family member and often developed a 
good partnership before supplying drugs to the PLTB. The positive attitude of such 
health workers helped further a supportive conducive environment for PLTBs. I found 
that health workers who had a positive attitude towards PLTBs often developed a 
good relationship and adjusted the treatment plan to address the context and the 
PLTB’s needs: such health workers were the ones who practiced flexible DOT. I 
found that ‘flexible DOT’ did not compromise the quality of care: nor did the PLTB 
interrupt treatment, despite the NTP’s assumptions that supplying drugs at home 
would encourage PLTB to miss drug doses. Given such flexible practices secured 
good results, it was a surprise that the NTP has not yet considered documenting such 
practices and revisiting policy in the light of lessons learned in the field. It is 
especially relevant to do so since the NTP has adopted the Stop TB strategy, the ISTC 
and the Patient Charter for TB Care.  
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6.3 Limitations of this study 
In addition to the limitations relating to data generation and analysis discussed in 
chapter 4, I now present further limitations of the study in two broad areas: effects of 
the researcher on the overall research process; and methodological limitations of data 
analysis.  
Effects of the researcher on the overall research process: I consider it important to 
discuss the effect of the researcher on the research process, as in qualitative studies the 
researcher works as an instrument in the research (Patton, 2001). The researcher is 
closely engaged in generating data; performing analyses in parallel with data 
generation; seeing patterns and issues and deciding on respondents to widen 
understanding on particular issues; and reinterpreting issues; all while constantly 
engaging with the data and the process of data generation. Therefore, the validity and 
credibility of qualitative research depends largely on the ability and effort of the 
researcher. 
In the last fifteen years of my professional career, I have worked with the NTP at 
district, region and national level. I was closely involved in setting up TB services in 
urban areas in my capacity of a government employee of the NTP and more recently 
as a researcher providing technical assistance to the NTP. I am therefore well 
acquainted with the TB services in the study area and have a good working 
relationship with the NTP and other key stakeholders. However, it was possible that 
study respondents, in particular health workers and NTP authorities, may have treated 
me primarily as an ‘expert in TB control’ instead of a researcher. Such a label may 
have given some respondents, and in particular health workers and key NTP officials, 
the feeling that I have substantial knowledge about the issue I was investigating which 
may have prevented them discussing some issues in depth. During data generation I 
wondered whether respondents were treating me differently from a researcher, as 
during interviews respondents used phrases such as ‘as you well know’, ‘you are the 
one who faced such issues while working in government’, ‘what’s the point of me 
saying more, as you know more about it than I do’. After realising this fact, I spent a 
considerable time clarifying my stance as a researcher before each interview. I made 
them clearly aware of the purpose of the conversation and the importance of their 
participation in my research, and emphasised their freedom to openly express their 
views. I believe this approach helped them to speak their mind.  
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Methodological issues: In the light of the research aim and objectives, I chose to use a 
qualitative approach, as I discussed in chapter 4. Limitations were observed during 
data collection: however, throughout the process I made efforts to identify and 
understand them and overcome or minimize their implications.  
One limitation was that, guided by issues emerging from the data, I wanted to 
interview some specific groups of people, but I was unable to do so. For example, 
there were some young unmarried girls receiving TB treatment under DOTS in the 
study area. I approached them but most refused to participate in the study because 
their parents did not give permission for them to be interviewed, mainly because of 
concerns about being identified as a TB patient by the community.  
Data collection may have been affected by external factors such as interview 
locations. Although each interview location was decided in discussion with the 
research participant, there were not many options available where interviews could be 
conducted without external interference. In some instances, I noticed that research 
participants were not willing to share specific information such as how they were 
treated in health institutions, and especially health workers’ behaviour towards them. 
Such reluctance was mainly observed when the interview took place in a DOTS 
centre. In the light of this limitation, I encouraged PLTB to choose an alternative 
interview location, but there were limited options available. However, I discussed 
confidentiality of information in depth with respondents, and assured them of their 
anonymity, before I started the interview. Most, but not all, interviews were recorded, 
because some respondents felt uncomfortable recording their interviews. Reasons 
varied: some perceived risks of being recorded being critical of policy and practice; 
for some this was the first time they were interviewed, and thus they felt uneasy in 
front of a recorder; some felt their voice was not good so did not want to be recorded. 
Such interviews were documented by taking detailed written notes. However, I found 
that it was difficult to take detailed notes of the conversation and simultaneously fully 
interact with respondents, maintaining eye contact, listening, moderating the 
conversation and probing (Green and Thorogood, 2009). However, I have had 
substantial experience in qualitative interviewing and used all my skills to maintain 
the conversation without compromising quality interaction with respondents. For 
those interviews where use of an audio recorder was not acceptable it was difficult to 
note all conversations, so it is possible, but unlikely, that some important points from 
conversations may have missed. One interview was not properly recorded due to a 
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problem with the recorder, and the written notes were not comprehensive. It was not 
possible to redo the interview so this respondent was not included in the analysis. 
In some instances, the participant had limited time, so the interview was completed at 
a subsequent time convenient to the respondent. A common limitation of using 
interviews is that they only give accounts of what the respondents say, rather than 
what they do in reality. I addressed this concern by creating an environment for 
conversation in which respondents could describe the practical experiences that they 
faced. I also used observation, which helped to achieve practical understanding, and 
compare findings with what was said in interviews.  
Some women participants from the Newari ethnic group preferred to talk in Newari, a 
language common among the Newar community in Kathmandu, but at the initial stage 
of data collection, I was not able to address this issue. Once I became aware of this 
issue, I trained a female researcher who then did interviews in Newari.  
There was a perception that women would not talk openly when interviewed by a 
male interviewer. I initially did a few interviews with women myself, and then used a 
trained female researcher to do some subsequent interviews with female respondents. I 
found that there was no difference in the respondents’ openness about issues 
experienced during their TB treatment.  
There may have been some limitations in my selection of research participants for 
interviews and FGDs, as it was largely done in consultation with DOTS centre staff. It 
is possible that they may have proposed research participants who they thought would 
respond favourably when asked about their experiences with TB service providers. 
However, in addition to consultation with DOTS centre staff, I also used TB registers 
to identify respondent PLTBs, which may have mitigated this limitation to a certain 
extent. 
One of the tools I used in data collection was observation. My presence during 
observation at the DOTS centre may have influenced the service delivery environment 
and the behaviour of health care providers and PLTB. However, I tried to minimize 
this influence by creating good relationships by making several visits and interacting 
with health service providers, so they would not see me as a ‘quality assessor’ of the 
services they provided to PLTB and others. 
One limitation in data collection could be the cultural behaviour of the Nepali people. 
In Nepali culture, people often try to please by not raising negative issues.. This might 
have happened in this study: however, I considered this and tried to avoid it by 
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developing informal relationships through many meetings and visits before obtaining 
data from participants.  
I collected too much data, which may have compromised depth as I could have probed 
further if I had used fewer respondents. However, I did do substantial amounts of 
probing; and respondents might not have been prepared to spend even more time with 
me. Although I tried to interview PLTB who defaulted from TB treatment, I was not 
successful. This is unfortunate, because getting defaulters’ views could have increased 
my knowledge on the ‘why’ component of non-completion of treatment. 
In FGDs, some researchers have raised concerns about the influence of the 
moderator’s views on the group (Morgan, 1997); and concerns that some participants 
feel uncomfortable presenting their own views (Rice and Ezzy, 1999). As the FGD 
moderator, I was well aware of these possibilities and addressed them by being careful 
not to express my views or influence the group in any other way, and by creating an 
environment where all participants could openly express their views. To keep the 
discussion focused and gain quality data I used a FGD guide and moderated all FGDs.  
6.4 Validity and generalisability 
I have already discussed validity in qualitative research in chapter 4. In this section, I 
discuss how I maximised validity in the study, and to what extent my findings are 
generalisable to other contexts. The comprehensiveness of my data, and the repeated 
inspection of my data that I carried out until I reached in-depth explanations of issues 
suggests my work is credible and trustworthy (Silverman, 2000). I sought to gain in-
depth understanding of successful TB treatment completion in a specific context 
among a limited number of study respondents, so it is difficult to claim that my 
findings are generalisable, except perhaps to broadly similar contexts.  
During the overall design of my research approach (discussed in chapter 4), I 
repeatedly looked at the relationships between selection of methods, potential study 
participants, selection of research sites, my research objectives and the kinds of theory 
and explanations that I sought in the study. I put every effort into generating 
trustworthy data in the field. I interviewed different groups of people, which further 
strengthened my study’s trustworthiness by using multiple data sources to the issues 
under examination. I conducted the great majority of qualitative interviews myself, 
and moderated all FGDs, and constantly checked and verified data, asking myself 
questions such as: Does this data make sense? Can I trust the data source? Does this 
segment require verification from the source? Was the respondent fair in his/her 
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answers? I constantly retained this questioning stance to search for the best through 
understanding of the context and establishing a good rapport with the respondents. In 
a few instances, I used other researchers in qualitative interviews, but I judged their 
skills as researchers to be good and I provided training to further enhance their skill. 
Similarly, a well-trained rapporteur also ensured quality of FGDs. 
Interpretation of data was achieved through content analysis using a flexible approach 
incorporating constant comparison and triangulation. Issues arising from the data were 
investigated among all study participants as appropriate, rather than relying on 
subgroups, which I believe helped to maximise the internal validity of the study. 
Comparisons of categories to understand similarities and differences between 
constructs enhanced the richness of my data interpretation and thus the trustworthiness 
of my study. Broadly, triangulation refers to the combined use of more than one 
method of investigation to look at the study findings – that is, methodological 
triangulation. However, in qualitative research, triangulation is not limited to 
methodological triangulation, but is also used to seek explanations for similarities and 
differences and record the construction of reality, considering respondents, theories, 
investigators, and data generation (Denzin, 1970). The use of multiple methods in data 
generation, such as qualitative interviews, observations, FGDs and key informant 
interviews further helped to yield more valid, reliable and diverse constructions of 
realities in the study. 
Similarly, during data generation, especially in qualitative interviews and FGDs, a 
probing strategy was adopted which helped to avoid superficial and misleading 
conclusions during data analysis. At the end of each interview I verified with 
respondents the key issues that had emerged. I considered performing a full validation 
of data interpretation with the study respondents but concluded this was not feasible 
because of problems accessing respondents, especially PLTB and their family, as they 
were not in touch with the DOTS centres after they completed treatment and many of 
the respondent PLTBs were migrants and thus mobile.  
The NTP could argue that my findings are not relevant to the programme as I did not 
follow the NTP definition of successful TB treatment completion. However, I believe 
that my definition of successful treatment completion encouraged me to look at human 
suffering rather than only numbers; thus I did not disagree with the NTP’s definition, 
but looked at its meaning in the real world. I believe that my study findings can 
provide insight that will encourage the NTP to look beyond numbers and help to 
facilitate TB treatment by reducing the suffering of PLTB and their households. 
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6.5 Conclusion 
In this chapter, I have made further discussion of the key study findings in the context 
of Nepal’s urban TB control programme. The discussion suggests that successful TB 
treatment completion was not straightforward, as many obstacles posed threats to the 
PLTB and their families during TB treatment. Against all the odds, despite mounting 
difficulties faced by PLTB and their families during the course of treatment, a 
majority continued TB treatment: this seemed essentially to be because of support 
from their families. Obstacles with causes related to the health system had a greater 
impact on PLTB and their families than obstacles with causes related to the PLTB. It 
is therefore essential that the health system establishes patient-centred care with 
adequate provision of supervision and patient support: the proposed key prerequisites 
would greatly reduce the burdens PLTB and their family experience during TB 
treatment, and thus facilitate successful TB treatment completion. The next and final 
chapter of this thesis presents the revised conceptual framework and a policy 
framework for implementation of the revised conceptual framework within the context 
for urban areas of Nepal.  
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CHAPTER SEVEN 
STUDY CONCLUSION: THE REVISED CONCEPTUAL 
FRAMEWORK AND ITS IMPLEMENTATION  
This final chapter focuses on conclusions of my study. It presents the revised 
conceptual framework and a policy framework for implementation of the revised 
conceptual framework with a particular focus on urban TB control programme in 
Nepal. This chapter addresses the third objective of my study - identify appropriate 
ways of addressing the problems and issues identified. In addition, I also discuss the 
implications of my study findings and my contribution in influencing the adoption of 
the findings into policy and practice in the Nepal NTP during the course of my 
research. I conclude the chapter with suggestions for areas of research that may further 
advance successful TB treatment completion in the context of the Nepal NTP and 
elsewhere. 
7.1 The conceptual framework revisited 
I have shown that a series of interacting hurdles occurred during the management of 
TB treatment. Despite the infelicitous circumstances that repeated occurred 
throughout treatment, PLTBs continued to fight the threats to their successful 
treatment. The definition of ‘successful TB treatment completion’ I used in the study 
is ‘completion of the full course of treatment in a supportive environment with no 
harmful consequences to the PLTB and his/her family during and after treatment, 
leading to cure and restoration of the pre-existing quality of life and productivity’. 
Although most PLTBs completed the treatment course (and were recorded as 
‘treatment successes’ by the NTP), their treatment was not successful according to my 
definition of ‘successful TB treatment completion’, because no single PLTB I spoke 
with had completed treatment without experiencing harm both to them and to their 
family.  
Taking into account my study findings, the local context and my definition of 
successful TB treatment completion, I revised the conceptual framework (Figure 8) to 
widen understanding of successful TB treatment completion, see the revised 
framework Figure 17. The essence of the revised framework is to promote patient-
centred care in existing NTP services which will reduce (and ideally eliminate) the 
sufferings of PLTBs and their family during TB treatment, thus helping achieve 
successful completion of TB treatment. The revised framework presents the major 
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prerequisites needed to facilitate successful treatment completion in the context hence 
promoting patient-cantered care. The prerequisites identified are:  
7.1.1 Appropriate, affordable access to TB services  
The essence of access is ensuring PLTB are able to receive TB services from 
diagnosis to completion of treatment. It requires that TB diagnosis and treatment 
services are easily physically accessible. My study findings suggest that, more than 
any other cause, access to TB services during treatment was limited by  the 
requirement for institutional DOT; thus, the health system needs to give more 
emphasis to finding appropriate ways of delivering TB services, which may or may 
not include DOT, specific to the context and to needs-based treatment management 
(Maher el al., 2003; Adatu et al., 2003; Thiam et al., 2007; Garner and Volmink, 
2003; Harper, 2006; Newell et al., 2006). When DOT is required, the modality needs 
to be agreed with PLTB and must not limit access to TB care. Other major 
contributors to improving affordable access to TB care would be: reducing waiting 
times in DOTS centres; providing alternatives to requiring PLTB to be physically 
present at the clinic to obtain drugs, when the PLTB’s physical and social mobility 
make attendance difficult; providing easy access to information on service availability 
in the city (addresses and maps of existing DOTS centres to allow PLTB to identify 
convenient clinics); and extending TB service delivery hours in DOTS centres to help 
PLTB align work and TB treatment. The availability of basic health care for other 
illnesses also adversely affected PLTB during treatment. It is therefore important to 
better integrate TB services within basic primary health care (in Nepal, the free 
essential health care service package). 
7.1.2 Affordable care  
This prerequisite addresses the findings that highlighted the negative impact of various 
costs – direct and indirect – born by PLTB and their households. Direct costs entail 
fees for diagnosis and treatment (other than TB drugs); indirect costs are other costs 
associated with TB diagnosis and treatment: costs of e.g. travel, food, an 
accompanying person; opportunity costs; costs of living in the city; etc. The findings 
suggest that both direct and indirect costs were unmanageable as the expenses PLTB 
incurred for diagnosis and treatment exceeded their and their households’ incomes, 
even though TB drugs were provided free of charge – Hane et al (2007) drew similar 
conclusions. I did not estimate monetary values of income and expenses, but PLTB 
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highlighted the high costs of care as major barriers to continuing treatment, with 
catastrophic impacts on PLTB and households. Similar conclusions have been drawn 
in other studies in Nepal (Kirwan et al., 2009; Karki et al., 2007) and elsewhere 
(Jaiswal et al., 2003) 
7.1.3 Appropriate responses to problems  
Timely identification of problems and appropriate response to them helps overcoming 
barriers to successful treatment completion. It is imperative that health workers do a 
proper assessment of problems, not only at the start of treatment but throughout, and 
understand the extent to which problems present barriers to successful treatment 
completion. A simple problem diagnostic tool can be used to identify the root cause of 
problems and engage PLTB and their family members or others as appropriate in 
developing a problem-solving plan during treatment. The cause of problems vary: 
however, my study findings suggest the following were common – DOT at a DOTS 
centre; PLTBs’ lack of knowledge; poor interpersonal communication between care 
provider and PLTB; physical inability due to severity of disease; conflict between 
work and DOTS Centre opening times; long waiting times at DOTS centres; 
transportation to DOTS centre; stigma and discrimination associated with TB in the 
community and workplaces; jobs requiring mobility; side-effects of TB drugs; health 
workers’ lack of understanding of PLTBs’ needs; lack of family and social support; 
unaffordable cost of care; socio-cultural beliefs; poor relationships with care 
providers; psychological fear of TB disease; PLTBs’ lack of motivation; loss of job 
and income; etc. The purpose of this prerequisite is to identify which problem or 
problems present barriers to the PLTB continuing TB treatment, and, jointly with the 
PLTB and his/her family, to find a way to address them. To do so, the health worker 
and the PLTB need to develop a partnership and mutual trust. Although it may be that 
not all problems are resolved by the health system, as they vary in their nature – 
social, financial, behavioural and structural – joint attempts to understand and 
overcome them greatly contribute to the PLTB developing a positive attitude towards 
treatment. 
7.1.4 Appropriate socio-cultural responses  
PLTB come from varying background, so it is imperative that health workers discuss 
their cultural, religious, and other personal beliefs with regard to TB. The beliefs held 
among the community and individuals including the PLTB and his/her family 
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members often present barriers in TB treatment, and in many instances huge 
disrespect to PLTB and their family in workplaces and the community, which can be 
deleterious to successful treatment completion without appropriate responses. I also 
found that health workers tried with good intentions to address some of these beliefs, 
but in doing so often failed to respect the long-held beliefs of the PLTB, and 
consequently no positive change occurred. I also found that an understanding of the 
PLTB’s socio-cultural background helps to predict social and family support provided 
to PLTB during TB treatment. Other studies have drawn similar conclusions 
(Sagbakken et al., 2007; Kirwan et al., 2009). 
7.1.5 Supervision and patient support  
In the light of my findings and the local context I see supervision and patient support 
as an approach to patient support that identifies and tries to address barriers that hinder 
successful TB treatment completion. This approach requires mutual respect between 
the PLTB and provider and should be implemented in ways that permit supervision 
and patient support to be tailored to the needs of PLTBs in the context where 
treatment is being provided. To develop and implement the approach, it is imperative 
to establish a mutually acceptable partnership between the health worker(s) and the 
PLTB which will then facilitate identification of barriers that could hinder successful 
TB treatment completion, and of appropriate solutions. During my study I identified 
various issues which could be addressed using this approach: for example, where 
context-specific treatment supervision is appropriate, the programme can use a reliable 
family member or community volunteer supervisor, or self-administered treatment, 
after ensuring that the PLTB understands the important of treatment continuation and 
that monitoring measures are in place. Where necessary, based on the needs of the 
PLTB, the programme should consider provision of other support: e.g. nutritional 
supplementation during TB treatment; support for travel costs; social support to the 
PLTB during and after completion of TB treatment; or child care during the treatment 
period. 
7.1.6 Appropriate interpersonal communication  
That is health information tailored to the PLTB’s needs and context. For this, a 
mutually acceptable relationship between health worker and PLTB is crucial. It is 
important to assess information needs at different times. For example, a majority of 
the PLTBs who participated in the study were in shock when they heard that they had 
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TB, and imparting detailed information on TB and treatment at this stage may not be 
useful. Understanding the different information needs at different stages of treatment 
is essential. There is ample evidence suggesting that PLTB generally comply with 
information provided if the health communication is tailored to the information needs, 
is provided in participatory manner and the PLTB helps make the decisions and 
chooses the solutions to problems rather than being told what to do.  To do this, health 
workers need to create a conducive environment where communication can take place 
with no interference. 
7.1.7 Care with respect and dignity  
I found that for successful treatment completion it is vital to provide quality TB care 
in a dignified manner irrespective of resources, gender, caste, ethnicity, age, language, 
religious beliefs, sexual orientation, culture, or having another illness including HIV. 
TB services need be delivered without stigma and discrimination in health care 
settings, communities and workplaces. It is equally important to extend this respect to 
family members, as they are very often the main providers of support to the PLTB.  
7.1.8 Individual privacy  
I found poor confidentiality of information about PLTB in DOTS centres and 
elsewhere. In the face of stigma and discrimination, health workers need to consider 
the privacy of each PLTB. Any information collected that may be disclosed for public 
health reasons must be with the PLTB’s consent: in obtaining consent, the purpose of 
gathering the information and its potential use needs to be properly explained to the 
PLTB. Many PLTB would not like personal information to be disclosed: this wish 
needs to be respected by health workers and should not affect PLTBs’ treatment. 
Health workers therefore need to keep all medical records confidential.  
7.1.9 Mutually beneficial relationship  
I found that successful treatment completion will not be achieved in the face of a poor 
relationship between the health care provider and the PLTB. In my study, it was often 
the case that PLTBs were passive recipients and health workers always controlled the 
overall treatment process. Health workers need to think innovatively about how a 
partnership can be established so that the PLTB and health workers can benefit from 
achieving successful treatment completion. In developing partnerships with PLTBs, 
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health workers should also consider engaging family members of PLTB so 
relationships are strengthened and continued. 
 
Figure 17: The revised conceptual framework 
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The revised framework brings the family member close to the PLTB – a big change 
from the original framework - as support from the family appeared to be crucial at 
every stage of TB treatment. Likewise, a vital role is played by context such as 
national and international policy and guidelines, and in particular, the NTP urban TB 
control policy, the ISTC, the Stop TB strategy and the Patient Charter for TB Care. 
Three key players, the NTP, the community and the PLTB and his/her family play 
vital roles in establishing the major prerequisites for successful treatment completion, 
so meaningful contributions are needed from all three players. To do so they need to 
interact and be engaged in designing the implementation plan. The major prerequisites 
presented in the framework are interdependent. I found that the absence of any of 
these prerequisites will affect successful treatment completion: so effective 
implementation of all prerequisites is needed to help reduce the burden on PLTB and 
their families, thus maximising the likelihood of successful treatment completion.  
In conclusion, there is a strong case for putting PLTBs at the centre of TB service 
delivery to achieve successful treatment completion and patient satisfaction. The 
identified prerequisites in the revised framework (Figure 17), when implemented 
effectively, should help develop more patient-centred care in the NTP. It will increase 
access to affordable care and motivation of PLTB, promote shared decision-making 
practices and ownership of the decisions made, foster a mutual partnership with 
service providers and enable development of more responsive TB service delivery in 
addressing PLTBs’ preferences during TB treatment. However, there are many 
challenges to successful implementation of patient-centred care in the current NTP 
setting: limited resources and capacity; increasing numbers of urban migrants from 
various parts of the country and lack of familiarity among TB service providers of 
different cultural beliefs relating to TB across different social statuses; language 
barriers in communication; and unclear roles of stakeholders engaged in urban TB 
control programmes. In addition, practicing a patient-centred approach in TB clinics 
also requires development of a locally feasible guideline, not only for health service 
providers, but also for PLTBs and their families, to empower them to ensure 
appropriate care. I do not therefore suggest a fundamental transformation of TB 
service delivery operations in the existing NTP. Instead, I suggest, a carefully planned 
phase-wise move towards patient-centred care through implementation of the 
identified prerequisites. It is however, important that perceived freedoms under a more 
patient-centred approach should not compromise the service quality and fundamental 
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essence of TB control such as the use of microscopy in diagnosis and follow-up; the 
use of standard drug regimens; regular intake of TB drugs; and other standards of care.  
In TB control globally there is a strong desire to promote standards of TB care, 
emphasised through publication of the ISTC which sets 21 standards of TB care, of 
which 7 are standards for treatment. This has initiated a debate within the NTP: 
whether the NTP should focus on the standards or the targets or both equally. The 
Nepal NTP has adopted the ISTC in principle thus committing to the standards; but 
existing service delivery is not well focused on the standards of care. On the other 
hand, the programme is guided by its targets and strives to achieve them, an approach 
which often undermines the standards of care. Both standards and targets are 
important, but it is however difficult for the NTP to immediately shift its intervention 
development from a focus on targets to a focus on standards of care. Making a shift 
will require considerable planning backed up by adequate resources. 
7.2 Implementation framework 
The implementation framework that follows aims to implement the revised conceptual 
framework within the contexts of urban TB control in Nepal and of the existing 
policies of the Nepal NTP. The implementation framework may also be relevant to 
other settings with similar contexts: however, the aim of my study was not to identify 
a generalised model.  
It is fundamental that public health programme policies and interventions aimed at 
improving people’s health and wellbeing need to be supported by effective 
implementation frameworks that take into account the local context; the broader social 
determinants of population relating to health; the target beneficiaries and their needs; 
the availability of resources; the socio-cultural context; health system structures and 
health service delivery strategies; existing policies and practices; and frameworks to 
monitor the effectiveness of intervention implementation. Only then can an 
implementation framework be implemented effectively. Note that by ‘implementation 
framework’ I mean an approach to help translating study findings into policy and 
practice. It is not, however, a fixed implementation design, but rather should be seen 
as an interactive and flexible framework that may change as implementation 
progresses and lessons are learned.  
The proposed implementation framework, Figure 18, has four key parts: their features 
are described below.  
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7.2.1 Policy  
It is imperative to revise the existing NTP policies and guidelines, and in particular 
those that relate to TB service delivery; TB treatment management; and the urban TB 
programme. Revision of the policies and guidelines need to be in line with 
contemporary national and international policies and guidelines and the findings of 
this study. Policy revision should also consider lessons learned during the ten year 
course of the urban TB control programme and the local context of urban areas: 
growing urbanisation, increasing inequalities in health service delivery and utilisation 
in urban areas, increasing urban poverty and various social determinants of urban 
health. It is also important that the policy revision reflects the essence of the Nepal 
Health Sector Programme Implementation Plan, which calls for effective EHCS 
delivery with a focus on poor and socially excluded groups, regardless of (urban/rural) 
location. To best improve TB services for currently unreached population groups, the 
policy revision should incorporate the ideas included in the recently developed Gender 
Equality and Social Inclusion Strategy in Health. The policy revision should also take 
into account the multiple stakeholders in urban areas, including the local PPP model 
(Newell et al., 2006), and health care providers who provide services to the poor and 
excluded (Malmborg et al., 2006), and define their roles and responsibilities in the 
light of their institutional and individual roles as health service providers. As I stated 
earlier, policy revision is not a one-off process, but should reflect lessons learned as 
implementation progresses; thus the arrows in figure 17 suggest the interactive and 
reflective features of the implementation framework. My study findings suggest that 
in the past PLTB and community members have not been involved in the policy 
development/revision process. However, it would be a mistake not to get their input 
into future policy revisions as they will bring insights into developing locally feasible 
approaches based on their first hand experience dealing with TB diagnosis and 
treatment. 
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7.2.2 Implementation plan:  
Another key step in the framework is to develop a detailed implementation plan in line 
with the policy revisions. The following steps should be included in the process of 
developing the implementation plan, to ensure the plan is feasible and effective.  
(a) map existing and potential health service providers in the area, including providers 
of services to the urban poor and excluded (Malmborg et al., 2006) to guide the 
development of a feasible plan.  
(b) map available resources, including existing and potential resources (including 
locally identified resources) to ensure the plan is fully funded. A cost sharing health 
financing approach with a focus on reaching the poor and excluded should be 
considered in this exercise if appropriate in the context.  
It may not be feasible to implement the plan across all urban areas simultaneously, so 
stepwise implementation should be considered, along with an explicit process of 
incorporating lessons learnt from each step. It is worth repeating that it is essential to 
fully engage PLTB and community members in each step.  
7.2.3 Service reform:  
At the outset, I should make it clear that I do not foresee a major health service reform 
as envisaged by the MoHP in Nepal and elsewhere: rather I suggest a simple 
modification of existing TB service delivery in urban areas which has been there for 
many years, largely unchanged despite the emergence locally of better information 
and elsewhere of innovative approaches. Before actually planning a reform, there must 
be a clear understanding of what people want from health service providers, health 
service mechanisms or the broader health system, as appropriate. My study suggests 
that what people want is the best possible standard of affordable care, accessible to all, 
regardless of individual characteristics or any conditionality. Although my study 
focused on TB and PLTB, this may also apply to other programmes. I therefore 
suggest TB service delivery reform needs to be aligned with the prerequisites 
identified and discussed in 6.3, the revised conceptual framework, and the revised 
policy as discussed earlier in this section. Simple changes to existing TB service 
delivery mechanisms would reduce the burden on PLTB and their families, and in 
many cases health care providers, thus contributing to successful treatment 
completion. For instance, the relationship between health care providers and PLTB 
could be redefined, and appropriate ways found to develop partnerships through 
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strengthened relationships. This would not create substantial additional costs for the 
programme. In this service reform area, I suggest the programme looks at the existing 
barriers that hinder PLTB in diagnosis and treatment and find possible ways to address 
them by changing services as appropriate taking the local context into account. The 
service reform should be seen as a series of ongoing, routine improvements in the 
programme, rather than one off reform or reform at fixed intervals. Small changes in 
service delivery mechanisms to improve TB service delivery need not wait a long 
time. As I mentioned previously, when planning even simple TB service reforms, 
involvement of PLTB and community members is vital. 
7.2.4 Monitoring and evaluation:  
It is important that any intervention is periodically and frequently assessed with 
effective monitoring and evaluation measures: this must be properly embedded in 
the programme so that lessons learned during monitoring can be used to improve 
the intervention. Since monitoring and evaluation not only describes outputs and 
outcomes, but also guides further improvements, it is vital to ensure the 
participation of PLTB, their families and community members in the process of 
evaluating the intervention, so that any resultant changes are acceptable and 
affordable to PLTB. I believe that findings from evaluation of the intervention 
would inform policy revision, so that the programme could further advance in 
developing patient-centred care in TB service delivery.   
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Figure 18: Proposed implementation framework for successful TB treatment 
completion 
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7.3 The study’s contribution to the body of knowledge 
My study area was not novel and unexplored, as there have been many studies relating 
to treatment completion for TB and other diseases. However, the context in which my 
study was performed was different: to my knowledge, there has been no such study of 
Nepal’s urban TB control programme previously. Thus my findings have contributed 
to the knowledge base on urban TB control.   
Several studies have identified the need for further research in this area, to deepen 
understanding on why and how poor treatment completion presents a continuous threat 
to modern TB control. This need has intensified in the light of the increasing 
emergence of drug resistant TB (Shah et al., 2007) and its association to poverty. My 
study may be seen as a response to this call.  
My study findings demonstrate that successful completion of TB treatment in the 
context of urban Nepal was not straightforward for many PLTB. Despite ongoing 
difficulties, PLTB continued their treatment and a majority of them completed the full 
course of treatment according to NTP policy. The issue of why and how PLTB were 
able to overcome the difficulties that arose during TB treatment was investigated in 
depth. It became completely clear that PLTBs’ families’ untiring efforts and support 
greatly facilitated the treatment process, regardless of the socio-cultural, financial and 
education status of the family. I also identified that this mutual support occurred not 
only during the illness but beyond the period of treatment, despite the devastating 
impact of TB on the entire family. I believe this finding highlights the need to redefine 
the role of family members in PLTBs’ treatment: this has been overlooked in many 
NTPs including the Nepal NTP, despite evidence of the effectiveness of properly 
involving family members in treatment (Newell et al., 2006).  
There have been many studies which identify non-completion as a pressing issue in 
controlling TB: however, very few addressed how this issue could be tackled through 
establishing locally feasible patient-centred care with no major modification in 
existing TB control procedures. My study presents a framework which aims to reduce 
(and ultimately eliminate) obstacles encountered by PLTB and their families during 
treatment through establishing basic prerequisites in NTP. In the setting where I 
conducted my study, the prerequisites could be implemented through simple 
modifications to the existing TB service delivery setup.  
My study also demonstrated that the problems encountered by PLTB include 
not only access to TB services, but also the absence of essential health care 
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services to address minor illnesses that occurred during TB treatment. Thus, the 
study gives evidence that it is essential to integrate TB care and comprehensive 
essential health services in urban areas, if TB control programme is to achieve its 
aim of reaching the unreached, and in particular the urban poor including migrants. 
7.4 Uptake of research findings during research 
During my doctoral research, I worked closely with the Nepal NTP. My involvement 
ranged from writing funding proposals for the entire programme to providing 
technical support in policy development and research. My ongoing involvement 
provided me with opportunities to disseminate some interim findings from my 
research, and encourage their adoption into policy. I note here some specific 
contributions I made to the Nepal NTP that arose from my doctoral research, which 
facilitated not only the urban TB control programme but also the entire NTP.  
• Development of urban TB control programme guidelines: In collaboration 
with the NTP I took an active role in conceptualising and developing the 
guideline which have been adopted by the NTP and used throughout the 
programme. The stakeholders welcomed the urban TB guidelines and have 
started using them as appropriate to their local contexts. Following insightful 
comments from stakeholders after initial implementation, I am engaged with 
the NTP in ongoing revisions of the guideline.   
• Revision of NTP manuals and training materials: I took the opportunities 
presented by period revisions to ensure my research findings were 
incorporated. Despite a degree of reluctance among the NTP authorities to 
move from a conventional TB control approach, my engagement in revision of 
the NTP policy and educational materials influenced incorporation of local 
learning. Although not all the local knowledge was included, this was a 
welcoming shift towards an approach to address PLTBs needs.  
• Scaling up of TB services in urban areas of Nepal: Although the focus of my 
study was in the urban setting of Kathmandu, my involvement with the NTP 
contributed to scale-up TB services in other cities of Nepal. 
• Securing patient support in NTP funding: During the study period, I actively 
contributed to developing funding proposals for the NTP to the Global Fund, 
which were successful. In the proposals, I influenced the NTP authorities to 
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consider financial support to people with MDR-TB for transportation and 
accommodation, which is now being implemented for all MDR TB cases. 
My experience over the years tells me that long-term, meaningful engagement is 
essential for researchers to be able to influence policy through research. Note that 
long-term engagement and support to the NTP would not have been possible if I had 
only been a doctoral research student. Research uptake to policy and practice would 
have stopped had I not received support for further research and development from 
other sources. During the time of my doctoral research I therefore set up a research 
and development NGO primarily focusing on TB research in Nepal, through which I 
was able to work with researchers from the Nuffield Centre for International Health 
and Development, University of Leeds, UK, who in particular facilitated guidance and 
funding for other related research. Thus, although it would be unfair to attribute all 
research uptake to my doctoral research project, there is no question that it provided a 
significant opportunity for me to influence policy through my research findings.    
7.5 Further research 
During the course of my research, a number of possible areas for further extensions to 
my research have emerged.  
One such research area is to assess the intervention suggested by the revised 
conceptual framework and the proposed implementation framework and deepen 
understanding of its effectiveness in reducing barriers to successful treatment 
completion. Evaluation, using mixed quantitative and qualitative methods, would 
further aid understanding of obstacles to successful treatment completion.  
The study findings demonstrated that the urban poor, and especially economic 
migrants, had major difficulties overcoming the many obstacles they encountered, due 
to their poverty and the complexity of their positions in society. Further research 
focusing on the poverty dimension of successful TB treatment completion would 
provide additional insight to help the urban TB control programme reach the poor and 
vulnerable.  
Finally, the study found that health service delivery in urban areas is complex due to 
multiple providers, and undefined roles and responsibilities. Further research is 
needed that looks at how the burden of all PLTBs’ illness (including but not restricted 
to TB) could better be tackled in the context of this complex but incomplete web of 
basic health care delivery in urban areas.  
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ANNEXES 
Annex 1: In-depth Interview Guide (PLTB) 
Preparation 
– Arrange interview location and seating as comfortable to the respondent 
– Check recorder if the respondent consented to record the interview 
– Read the context, if any external interferences seen try to avoid them  
– Welcome & greet respondent and say thank you for participating in the interview 
Introduction of interviewer: I am Sushil Chandra Baral, a PhD student at the Nuffield 
Centre for International Health and Development, Leeds Institute of Health Sciences, 
University of Leeds, UK. I live in Kathmandu.  
Background information: I am conducting my PhD research on “Tuberculosis treatment 
completion in urban areas of Nepal”, in urban areas of Kathmandu Valley: Kathmandu 
and Lalitpur. I am trying to understand views and experiences of people with TB about 
their illness and treatment and whether any problems or issues have affected their 
treatment and their lives. I hope that what I learn from you will help in the design of a 
patient-friendly TB service delivery to improve TB treatment with no or reduced problems 
to people with TB and their families.  
Confidentiality and recording: Your participation is completely voluntary and this 
interview is strictly confidential. Your name will be kept completely separate from the 
information you give, so please feel free to speak openly.  
If it’s ok with you, I would like to use a recorder, so I don’t miss anything important you 
might say to me, although I may make a couple of notes in my notebook as well. Nobody 
except myself and my supervisors will hear this recording and after the interview I will 
write down everything that was said on to paper and delete the recording.  
Is that ok?  YES/NO (ask respondent) 
If you do not wish your interview to be recorded, it is also fine. I will take notes but the 
interview time may be extended by 10 to 15 minutes.   
Terminate the interview if the respondent does not want to be interviewed or not 
feeling comfortable, or not answering the questions asked.  
If the participant agreed to take part: 
Procedure: Explain that - you have agreed to participate in the study by giving an 
interview. Now I am going to start with a few questions about your experiences, feelings 
and thoughts regarding your illness and treatment. The interview will take about 45 
minutes to an hour. Everything you say is strictly confidential so I want you to feel at ease 
and free to speak openly. However, if there are any questions I ask you that you don’t 
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want to answer or feel uncomfortable answering just say so and I shall move on to next. 
Also, if at anytime you want to stop the interview just say so. Whether you talk with me 
today or not, it will have no effect on any treatment you or anyone else gets. 
Do you fully understand? Do you have any questions? (ask respondent) 
KEY INTERVIEW QUESTIONS 
- First of all, tell me about yourself and your family. 
(Note down: age, ethnicity & caste, place of residence, occupation, marital status, level of 
education and household composition. If these don’t come up spontaneously, ask when 
appropriate) 
- Tell me about your illness. 
- Tell me what you experienced while seeking care and diagnosis of your illness. 
- Tell me about your treatment process. 
- Tell me how you experienced your treatment. 
- Tell me how you were treated, perceived by health workers, family members, 
community members, relatives, friends, colleagues, employer etc.  
- Tell me about any support that you received during your treatment and your views 
on why they supported you, if any. 
- Tell me how you find TB services in this DOTS centre. 
- Tell me what concerns or worries you have regarding your TB treatment. 
- Tell me about the major problems/difficulties that you are facing in your treatment. 
- Tell me how you have been managing problems or difficult situations in order to be 
able to stay in treatment. 
- Tell me if you have any suggestions to the programme to make your remaining 
treatment easier. 
Ask other questions on the issues raised by the respondent. 
Note: always remember to ask probing questions such as why things happened so; why 
she/he thought so; why he/she did so; what happened as consequence of what; why this 
why not that – in asking probing questions constantly think of the issues raised by the 
respondent and put questions appropriately as relevant to the topic of discussion.  
In the end of interview: It’s been really interesting hearing about your experiences and 
your thoughts and feelings. Thank you very much. Before we end the discussion, is there 
anything else anyone would like to say? Thank you very much for your time and for 
participating. 
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Annex 2: Focus Group Discussion Guideline (PLTB group)  
Research Title: Tuberculosis treatment completion in urban areas of Nepal 
Selection of team 
FGD team will include a maximum of 3 members: Facilitator, Rapporteur and a supporter. 
The facilitator will facilitate the discussion, rapporteur will help recording the discussions 
and observations, and a supporter will help with registration and arranging refreshments.  
Selection of participants 
FGD will be conducted with people with TB who are continuing treatment from urban 
DOTS centers of Kathmandu and Lalitpur districts. Efforts will be made to make the 
group homogenous i.e. male group, female group, migrants. 
Location, Time and Date 
Participants will be well consulted about the FGD location, time and date. Appropriate 
locations will be identified taking into consideration  the local context, distance for  
participants, feasibility and external interferences. Efforts will be made to identify a 
training hall nearby the DOTS centre. If a training hall with adequate space exists in 
respective DOTS centre, which can be considered for FGD venue. Seating arrangements 
will be informal. Each FGD will take about 1-2 hours.  
Conduction of FGD 
The following steps should be considered while conducting FGD: 
- Rapport building and introduction: set up group at ease, introduction between 
participants and FGD team, explain the purpose of FGD; 
- Phrase the questions carefully. Ask open ended question e.g. what problems did you 
face during your treatment? And why, when? 
- Use probing techniques such as: repeat the question, give some clues to understand 
the issues and ask in details, pause for the answer, repeat the reply- it helps to 
stimulate conversation, ask why-questions for more detail information, use neutral 
comments- anything else? Why do you feel in this way? 
- balance the discussion: in groups some participants can dominate the discussion. 
Therefore to balance out the participation and discussion the following measures 
could be applied: address questions to individuals who are not participating in the 
discussion; give non verbal clues; summarize the points and refocus the discussion; 
give thanks for giving ideas/sharing experiences and move to another topic with 
their consent. 
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- Consider the following activities at the time of discussion: Coding of each 
participants like 01, 02…and so on; note taking regarding what was said  by which 
code no. of participant etc  
- Rapporteur will be placed at visible place so that he/she can identify what is missing 
as per discussion guideline and will indicate to the facilitator. 
Major areas discussed 
The following topics will be discussed, but not limited to: experience of participants with 
illness; issues that hindered or helped PLTB during their treatment; stigma and 
discrimination related to TB in community, family and institution; self-motivation and 
feelings about their illness; support gained from – health workers, family, relatives, 
friends and colleagues, and community members; provision of existing TB treatment 
delivery modality especially on DOT and their experiences; information and 
communication with regard to their disease and other causes; behaviour of service 
providers, family members and community people; factors that hinder PLTB in continuing 
their treatment; what could be done by the programme to reduce the burden on PLTB 
during the TB treatment.  
Recording of discussion 
The following activities will be carried out to record the FGD: 
- Note taking will be done reflecting the discussion as well as non verbal behaviour 
like facial expression, hand movement etc. 
- After finishing each FGD, information and team’s expression will be summarized 
- Discussion will be reported in participants’ language including their phrases 
End: discussion will end by giving a big thank you to the participants for their 
participation and time. Refreshments will be served after the formal closure of the 
discussion. 
Annex 3: Information Sheet 
Research Title: Tuberculosis treatment completion in urban areas of Nepal 
Introduction 
I am Sushil Chandra Baral, a PhD student at the Nuffield Centre for International Health 
and Development, Leeds Institute of Health Sciences, University of Leeds, UK. I am 
conducting my PhD research on “Tuberculosis treatment completion in urban areas of 
Nepal”, in urban areas of Kathmandu Valley: Kathmandu and Lalitpur. This information 
sheet will tell you about my research. Please take your time reading it or if you prefer I 
can read out for you. This information sheet may contain words that you may have 
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difficulties to understand. Please ask questions and I can explain you. If you wish you can 
talk the information sheet over with others.  
What is the purpose of the study? 
The study is to understand experiences, problems and issues faced by People Living 
with TB during their treatment. It also looks at the  various coping strategies and 
responses to the problems in order  to be able to identify better ways of addressing the 
issues in the given programme. The study aims to contribute to the National TB 
Programme to design and implement a patient-friendly TB service where people with 
TB can continue and complete their treatment with fewer  problems.  
Why have I been chosen for the study? 
You have been taking TB treatment from this DOTS centre and you can more easily 
explain problems and issues that you are experiencing during your TB treatment.  
What happens if I agree to take part? 
If you agree to participate, you will be asked to give an interview, which will take 
about 45 minutes to an hour. I will conduct the interview. You can choose the 
interview location as you like. If you do not wish to answer any of the questions during 
the interview, you may say NO and I will move on to the next question. No one else but  
you and I will be in the interview unless you would like someone else to be there. 
What happens if I refuse to take part or withdraw? 
Your participation in this research is completely voluntary.  It is up to you whether you 
take part or not. You are still free to withdraw at any time and without giving a reason.  A 
decision to withdraw at any time, or a decision not to take part, will not in any way affect 
the services you receive from this and any other DOTS centres. 
What are the benefits of taking part? 
If you participate in the study, you will help us to understand effective ways of 
addressing problems and issues that may have been hindering or helping people with 
TB during their treatment. There are no direct benefits to you but this study hopes to 
improve the care of people with TB like you in the future. 
What are the possible disadvantages and risks of taking part? 
There are no added risks involved in participating in this study. However, there may be 
a risk that you may feel uncomfortable talking about some of the questions. You do not 
have to answer any question or take part in the interview if you feel talking about them 
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makes you uncomfortable. Whether you agree or not to answer the question it will 
make no difference to the services that you have been receiving.  
Will my participation in the study be kept confidential?  
Yes. Your participation in this study will be kept private and confidential and any 
information you share with us will also be kept private and confidential.  Any information 
about you will have a number instead of a name to maintain confidentiality.   
What will happen to the findings of the study? 
The study findings will be published in my PhD thesis. The findings will also be 
published in journals but you will not be identified or identifiable in any publications. I 
hope the findings will help to design and implement a people-friendly TB care in the 
National TB Programme.  
Who is paying for the research? 
I am paying the cost for this study. No additional funding has been received for this study.  
If you have any questions at any time please contact: Mr. Sushil Chandra Baral, PO 
Box: 24133, Kathmandu, Nepal. Tel: 977-01-4238045, Fax: 977-01-102016.  
Email: sushilbaral@hotmail.com 
.................................................................................................................... 
Annex 4: Consent Form 
Research Title: Tuberculosis treatment completion in urban areas of Nepal 
The following should be read by or read to the participant and the participant should 
indicate whether they agree with each part of the consent form. 
• I understand the purpose of this research 
• I have had the opportunity to ask questions or raise any concerns about the research 
• I am satisfied that my questions and concerns have been answered adequately 
• I understand that I will participate in an interview that will last for about an hour  
• I understand that my participation in this research is completely voluntary 
• I understand that I am free to withdraw from the research without repercussions 
• I understand that I can halt the interview at any point if I feel uncomfortable 
• I understand that all information I give will be kept confidential 
• I give consent for this interview to be tape-recorded 
• I agree to take part in this research 
 
Participant signature ………………… 
If verbal consent obtained 
Signature of witness………………… 
Witness name ………………………… 
Date and time consent given ……… 
